cid	atc	pert_iname	canonical_smiles	canonical_smiles_stereo	pert_id	inst_id	rna_plate	rna_well	pert_type	pert_dose	pert_dose_unit	pert_time	pert_time_unit	cell_id	cell_type	base_cell_id	precursor_cell_id	modification	sample_type	primary_site	subtype	original_growth_pattern	provider_catalog_id	original_source_vendor	donor_age	donor_sex	donor_ethnicity
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_A375_6H_X1_B3_DUO52HI53LO:E11	CPC004_A375_6H_X1	E11	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_A375_6H_X2_B3_DUO52HI53LO:E11	CPC004_A375_6H_X2	E11	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_A375_6H_X3_B3_DUO52HI53LO:E11	CPC004_A375_6H_X3	E11	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC017_A375_6H_X4_F1B5_DUO52HI53LO:M02	CPC017_A375_6H_X4	M02	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC020_A375_6H_X1_B4_DUO52HI53LO:F21	CPC020_A375_6H_X1	F21	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC020_A375_6H_X2_B4_DUO52HI53LO:F21	CPC020_A375_6H_X2	F21	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC020_A375_6H_X3_B4_DUO52HI53LO:F21	CPC020_A375_6H_X3	F21	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC020_A375_6H_X4_B5_DUO52HI53LO:F21	CPC020_A375_6H_X4	F21	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC020_A375_6H_X5_F1B5_DUO52HI53LO:F21	CPC020_A375_6H_X5	F21	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC017_A375_6H_X2_B4_DUO52HI53LO:M02	CPC017_A375_6H_X2	M02	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC017_A375_6H_X3_B4_DUO52HI53LO:M02	CPC017_A375_6H_X3	M02	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_A375_24H_X1_B3_DUO52HI53LO:C12	CPC005_A375_24H_X1	C12	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_A375_24H_X2_B3_DUO52HI53LO:C12	CPC005_A375_24H_X2	C12	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_A375_24H_X3_B3_DUO52HI53LO:C12	CPC005_A375_24H_X3	C12	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_A375_6H_X1_B3_DUO52HI53LO:C12	CPC005_A375_6H_X1	C12	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_A375_6H_X2_B3_DUO52HI53LO:C12	CPC005_A375_6H_X2	C12	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_A375_6H_X3_B3_DUO52HI53LO:C12	CPC005_A375_6H_X3	C12	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_A375_6H_X1_B4_DUO52HI53LO:H14	CPC020_A375_6H_X1	H14	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_A375_6H_X1_B4_DUO52HI53LO:L24	CPC020_A375_6H_X1	L24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_A375_6H_X2_B4_DUO52HI53LO:H14	CPC020_A375_6H_X2	H14	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_A375_6H_X2_B4_DUO52HI53LO:L24	CPC020_A375_6H_X2	L24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_A375_6H_X3_B4_DUO52HI53LO:H14	CPC020_A375_6H_X3	H14	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_A375_6H_X3_B4_DUO52HI53LO:L24	CPC020_A375_6H_X3	L24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_A375_6H_X4_B5_DUO52HI53LO:H14	CPC020_A375_6H_X4	H14	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_A375_6H_X4_B5_DUO52HI53LO:L24	CPC020_A375_6H_X4	L24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_A375_6H_X5_F1B5_DUO52HI53LO:H14	CPC020_A375_6H_X5	H14	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_A375_6H_X5_F1B5_DUO52HI53LO:L24	CPC020_A375_6H_X5	L24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_6H_X1_B10:O03	BRAF001_A375_6H_X1	O03	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_6H_X1_B10:O04	BRAF001_A375_6H_X1	O04	trt_cp	2.5	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_6H_X1_B10:O11	BRAF001_A375_6H_X1	O11	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_6H_X1_B10:O12	BRAF001_A375_6H_X1	O12	trt_cp	2.5	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_6H_X1_B10:O19	BRAF001_A375_6H_X1	O19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_6H_X1_B10:O20	BRAF001_A375_6H_X1	O20	trt_cp	2.5	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_6H_X1_B10:P03	BRAF001_A375_6H_X1	P03	trt_cp	0.625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_6H_X1_B10:P04	BRAF001_A375_6H_X1	P04	trt_cp	0.15625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_6H_X1_B10:P11	BRAF001_A375_6H_X1	P11	trt_cp	0.625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_6H_X1_B10:P12	BRAF001_A375_6H_X1	P12	trt_cp	0.15625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_6H_X1_B10:P19	BRAF001_A375_6H_X1	P19	trt_cp	0.625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_6H_X1_B10:P20	BRAF001_A375_6H_X1	P20	trt_cp	0.15625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_6H_X2_B10:O03	BRAF001_A375_6H_X2	O03	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_6H_X2_B10:O04	BRAF001_A375_6H_X2	O04	trt_cp	2.5	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_6H_X2_B10:O11	BRAF001_A375_6H_X2	O11	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_6H_X2_B10:O19	BRAF001_A375_6H_X2	O19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_6H_X2_B10:O20	BRAF001_A375_6H_X2	O20	trt_cp	2.5	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_6H_X2_B10:P03	BRAF001_A375_6H_X2	P03	trt_cp	0.625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_6H_X2_B10:P04	BRAF001_A375_6H_X2	P04	trt_cp	0.15625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_6H_X2_B10:P11	BRAF001_A375_6H_X2	P11	trt_cp	0.625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_6H_X2_B10:P12	BRAF001_A375_6H_X2	P12	trt_cp	0.15625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_6H_X2_B10:P19	BRAF001_A375_6H_X2	P19	trt_cp	0.625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_6H_X2_B10:P20	BRAF001_A375_6H_X2	P20	trt_cp	0.15625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_6H_X3_B10:O03	BRAF001_A375_6H_X3	O03	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_6H_X3_B10:O04	BRAF001_A375_6H_X3	O04	trt_cp	2.5	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_6H_X3_B10:O11	BRAF001_A375_6H_X3	O11	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_6H_X3_B10:O12	BRAF001_A375_6H_X3	O12	trt_cp	2.5	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_6H_X3_B10:O19	BRAF001_A375_6H_X3	O19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_6H_X3_B10:O20	BRAF001_A375_6H_X3	O20	trt_cp	2.5	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_6H_X3_B10:P03	BRAF001_A375_6H_X3	P03	trt_cp	0.625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_6H_X3_B10:P04	BRAF001_A375_6H_X3	P04	trt_cp	0.15625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_6H_X3_B10:P11	BRAF001_A375_6H_X3	P11	trt_cp	0.625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_6H_X3_B10:P12	BRAF001_A375_6H_X3	P12	trt_cp	0.15625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_6H_X3_B10:P19	BRAF001_A375_6H_X3	P19	trt_cp	0.625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_6H_X3_B10:P20	BRAF001_A375_6H_X3	P20	trt_cp	0.15625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_24H_X1_B10:O03	BRAF001_A375_24H_X1	O03	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_24H_X1_B10:O04	BRAF001_A375_24H_X1	O04	trt_cp	2.5	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_24H_X1_B10:O11	BRAF001_A375_24H_X1	O11	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_24H_X1_B10:O12	BRAF001_A375_24H_X1	O12	trt_cp	2.5	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_24H_X1_B10:O19	BRAF001_A375_24H_X1	O19	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_24H_X1_B10:O20	BRAF001_A375_24H_X1	O20	trt_cp	2.5	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_24H_X1_B10:P03	BRAF001_A375_24H_X1	P03	trt_cp	0.625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_24H_X1_B10:P04	BRAF001_A375_24H_X1	P04	trt_cp	0.15625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_24H_X1_B10:P11	BRAF001_A375_24H_X1	P11	trt_cp	0.625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_24H_X1_B10:P12	BRAF001_A375_24H_X1	P12	trt_cp	0.15625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_24H_X1_B10:P19	BRAF001_A375_24H_X1	P19	trt_cp	0.625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_24H_X1_B10:P20	BRAF001_A375_24H_X1	P20	trt_cp	0.15625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_24H_X2_B10:O03	BRAF001_A375_24H_X2	O03	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_24H_X2_B10:O04	BRAF001_A375_24H_X2	O04	trt_cp	2.5	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_24H_X2_B10:O11	BRAF001_A375_24H_X2	O11	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_24H_X2_B10:O12	BRAF001_A375_24H_X2	O12	trt_cp	2.5	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_24H_X2_B10:O19	BRAF001_A375_24H_X2	O19	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_24H_X2_B10:O20	BRAF001_A375_24H_X2	O20	trt_cp	2.5	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_24H_X2_B10:P03	BRAF001_A375_24H_X2	P03	trt_cp	0.625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_24H_X2_B10:P04	BRAF001_A375_24H_X2	P04	trt_cp	0.15625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_24H_X2_B10:P11	BRAF001_A375_24H_X2	P11	trt_cp	0.625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_24H_X2_B10:P12	BRAF001_A375_24H_X2	P12	trt_cp	0.15625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_24H_X2_B10:P19	BRAF001_A375_24H_X2	P19	trt_cp	0.625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_24H_X2_B10:P20	BRAF001_A375_24H_X2	P20	trt_cp	0.15625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_24H_X4_B11:O03	BRAF001_A375_24H_X4	O03	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_24H_X4_B11:O04	BRAF001_A375_24H_X4	O04	trt_cp	2.5	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_24H_X4_B11:O11	BRAF001_A375_24H_X4	O11	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_24H_X4_B11:O12	BRAF001_A375_24H_X4	O12	trt_cp	2.5	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_24H_X4_B11:O19	BRAF001_A375_24H_X4	O19	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_24H_X4_B11:O20	BRAF001_A375_24H_X4	O20	trt_cp	2.5	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_24H_X4_B11:P03	BRAF001_A375_24H_X4	P03	trt_cp	0.625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_24H_X4_B11:P04	BRAF001_A375_24H_X4	P04	trt_cp	0.15625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_24H_X4_B11:P11	BRAF001_A375_24H_X4	P11	trt_cp	0.625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_24H_X4_B11:P12	BRAF001_A375_24H_X4	P12	trt_cp	0.15625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_24H_X4_B11:P19	BRAF001_A375_24H_X4	P19	trt_cp	0.625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_A375_24H_X4_B11:P20	BRAF001_A375_24H_X4	P20	trt_cp	0.15625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC018_A375_6H_X4_F1B5_DUO52HI53LO:F20	CPC018_A375_6H_X4	F20	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC018_A375_6H_X5_F1B5_DUO52HI53LO:F20	CPC018_A375_6H_X5	F20	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC020_A375_6H_X1_B4_DUO52HI53LO:P19	CPC020_A375_6H_X1	P19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC020_A375_6H_X2_B4_DUO52HI53LO:P19	CPC020_A375_6H_X2	P19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC020_A375_6H_X3_B4_DUO52HI53LO:P19	CPC020_A375_6H_X3	P19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC020_A375_6H_X4_B5_DUO52HI53LO:P19	CPC020_A375_6H_X4	P19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC018_A375_6H_X1_B4_DUO52HI53LO:F20	CPC018_A375_6H_X1	F20	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC018_A375_6H_X2_B4_DUO52HI53LO:F20	CPC018_A375_6H_X2	F20	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC018_A375_6H_X3_B4_DUO52HI53LO:F20	CPC018_A375_6H_X3	F20	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_A375_6H_X1_B3_DUO52HI53LO:I02	CPC004_A375_6H_X1	I02	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_A375_6H_X2_B3_DUO52HI53LO:I02	CPC004_A375_6H_X2	I02	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_A375_6H_X3_B3_DUO52HI53LO:I02	CPC004_A375_6H_X3	I02	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_A375_6H_X1_B4_DUO52HI53LO:N08	CPC016_A375_6H_X1	N08	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_A375_6H_X2_B4_DUO52HI53LO:N08	CPC016_A375_6H_X2	N08	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_A375_6H_X3_B4_DUO52HI53LO:N08	CPC016_A375_6H_X3	N08	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_A375_6H_X4_B5_DUO52HI53LO:N08	CPC016_A375_6H_X4	N08	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_A375_6H_X5_B5_DUO52HI53LO:N08	CPC016_A375_6H_X5	N08	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_A375_6H_X1_B3_DUO52HI53LO:I02	CPC004_A375_6H_X1	I02	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_A375_6H_X2_B3_DUO52HI53LO:I02	CPC004_A375_6H_X2	I02	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_A375_6H_X3_B3_DUO52HI53LO:I02	CPC004_A375_6H_X3	I02	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_A375_6H_X1_B4_DUO52HI53LO:N08	CPC016_A375_6H_X1	N08	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_A375_6H_X2_B4_DUO52HI53LO:N08	CPC016_A375_6H_X2	N08	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_A375_6H_X3_B4_DUO52HI53LO:N08	CPC016_A375_6H_X3	N08	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_A375_6H_X4_B5_DUO52HI53LO:N08	CPC016_A375_6H_X4	N08	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_A375_6H_X5_B5_DUO52HI53LO:N08	CPC016_A375_6H_X5	N08	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3947	N06AA07	lofepramine	CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)CC(=O)C4=CC=C(C=C4)Cl	CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1	BRD-K82147103	CPC011_A375_6H_X1_B3_DUO52HI53LO:M10	CPC011_A375_6H_X1	M10	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3947	N06AA07	lofepramine	CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)CC(=O)C4=CC=C(C=C4)Cl	CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1	BRD-K82147103	CPC011_A375_6H_X2_B3_DUO52HI53LO:M10	CPC011_A375_6H_X2	M10	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3947	N06AA07	lofepramine	CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)CC(=O)C4=CC=C(C=C4)Cl	CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1	BRD-K82147103	CPC011_A375_6H_X3_B3_DUO52HI53LO:M10	CPC011_A375_6H_X3	M10	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC017_A375_6H_X4_F1B5_DUO52HI53LO:L04	CPC017_A375_6H_X4	L04	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC017_A375_6H_X2_B4_DUO52HI53LO:L04	CPC017_A375_6H_X2	L04	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC017_A375_6H_X3_B4_DUO52HI53LO:L04	CPC017_A375_6H_X3	L04	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC015_A375_6H_X1_B4_DUO52HI53LO:J10	CPC015_A375_6H_X1	J10	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC015_A375_6H_X2_B4_DUO52HI53LO:J10	CPC015_A375_6H_X2	J10	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC015_A375_6H_X3_B4_DUO52HI53LO:J10	CPC015_A375_6H_X3	J10	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_6H_X1_B10:O07	BRAF001_A375_6H_X1	O07	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_6H_X1_B10:O08	BRAF001_A375_6H_X1	O08	trt_cp	2.5	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_6H_X1_B10:O15	BRAF001_A375_6H_X1	O15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_6H_X1_B10:O16	BRAF001_A375_6H_X1	O16	trt_cp	2.5	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_6H_X1_B10:O23	BRAF001_A375_6H_X1	O23	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_6H_X1_B10:O24	BRAF001_A375_6H_X1	O24	trt_cp	2.5	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_6H_X1_B10:P07	BRAF001_A375_6H_X1	P07	trt_cp	0.625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_6H_X1_B10:P08	BRAF001_A375_6H_X1	P08	trt_cp	0.15625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_6H_X1_B10:P15	BRAF001_A375_6H_X1	P15	trt_cp	0.625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_6H_X1_B10:P16	BRAF001_A375_6H_X1	P16	trt_cp	0.15625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_6H_X1_B10:P23	BRAF001_A375_6H_X1	P23	trt_cp	0.625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_6H_X2_B10:O07	BRAF001_A375_6H_X2	O07	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_6H_X2_B10:O08	BRAF001_A375_6H_X2	O08	trt_cp	2.5	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_6H_X2_B10:O15	BRAF001_A375_6H_X2	O15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_6H_X2_B10:O16	BRAF001_A375_6H_X2	O16	trt_cp	2.5	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_6H_X2_B10:O23	BRAF001_A375_6H_X2	O23	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_6H_X2_B10:O24	BRAF001_A375_6H_X2	O24	trt_cp	2.5	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_6H_X2_B10:P07	BRAF001_A375_6H_X2	P07	trt_cp	0.625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_6H_X2_B10:P08	BRAF001_A375_6H_X2	P08	trt_cp	0.15625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_6H_X2_B10:P15	BRAF001_A375_6H_X2	P15	trt_cp	0.625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_6H_X2_B10:P16	BRAF001_A375_6H_X2	P16	trt_cp	0.15625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_6H_X2_B10:P23	BRAF001_A375_6H_X2	P23	trt_cp	0.625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_6H_X3_B10:O07	BRAF001_A375_6H_X3	O07	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_6H_X3_B10:O08	BRAF001_A375_6H_X3	O08	trt_cp	2.5	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_6H_X3_B10:O15	BRAF001_A375_6H_X3	O15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_6H_X3_B10:O16	BRAF001_A375_6H_X3	O16	trt_cp	2.5	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_6H_X3_B10:O23	BRAF001_A375_6H_X3	O23	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_6H_X3_B10:O24	BRAF001_A375_6H_X3	O24	trt_cp	2.5	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_6H_X3_B10:P07	BRAF001_A375_6H_X3	P07	trt_cp	0.625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_6H_X3_B10:P08	BRAF001_A375_6H_X3	P08	trt_cp	0.15625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_6H_X3_B10:P15	BRAF001_A375_6H_X3	P15	trt_cp	0.625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_6H_X3_B10:P16	BRAF001_A375_6H_X3	P16	trt_cp	0.15625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_6H_X3_B10:P23	BRAF001_A375_6H_X3	P23	trt_cp	0.625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_6H_X3_B10:P24	BRAF001_A375_6H_X3	P24	trt_cp	0.15625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_24H_X1_B10:O07	BRAF001_A375_24H_X1	O07	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_24H_X1_B10:O08	BRAF001_A375_24H_X1	O08	trt_cp	2.5	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_24H_X1_B10:O15	BRAF001_A375_24H_X1	O15	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_24H_X1_B10:O16	BRAF001_A375_24H_X1	O16	trt_cp	2.5	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_24H_X1_B10:O23	BRAF001_A375_24H_X1	O23	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_24H_X1_B10:O24	BRAF001_A375_24H_X1	O24	trt_cp	2.5	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_24H_X1_B10:P07	BRAF001_A375_24H_X1	P07	trt_cp	0.625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_24H_X1_B10:P08	BRAF001_A375_24H_X1	P08	trt_cp	0.15625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_24H_X1_B10:P15	BRAF001_A375_24H_X1	P15	trt_cp	0.625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_24H_X1_B10:P16	BRAF001_A375_24H_X1	P16	trt_cp	0.15625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_24H_X1_B10:P23	BRAF001_A375_24H_X1	P23	trt_cp	0.625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_24H_X1_B10:P24	BRAF001_A375_24H_X1	P24	trt_cp	0.15625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_24H_X2_B10:O07	BRAF001_A375_24H_X2	O07	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_24H_X2_B10:O08	BRAF001_A375_24H_X2	O08	trt_cp	2.5	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_24H_X2_B10:O15	BRAF001_A375_24H_X2	O15	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_24H_X2_B10:O16	BRAF001_A375_24H_X2	O16	trt_cp	2.5	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_24H_X2_B10:O23	BRAF001_A375_24H_X2	O23	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_24H_X2_B10:O24	BRAF001_A375_24H_X2	O24	trt_cp	2.5	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_24H_X2_B10:P08	BRAF001_A375_24H_X2	P08	trt_cp	0.15625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_24H_X2_B10:P15	BRAF001_A375_24H_X2	P15	trt_cp	0.625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_24H_X2_B10:P16	BRAF001_A375_24H_X2	P16	trt_cp	0.15625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_24H_X2_B10:P23	BRAF001_A375_24H_X2	P23	trt_cp	0.625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_24H_X4_B11:O07	BRAF001_A375_24H_X4	O07	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_24H_X4_B11:O08	BRAF001_A375_24H_X4	O08	trt_cp	2.5	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_24H_X4_B11:O15	BRAF001_A375_24H_X4	O15	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_24H_X4_B11:O16	BRAF001_A375_24H_X4	O16	trt_cp	2.5	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_24H_X4_B11:O23	BRAF001_A375_24H_X4	O23	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_24H_X4_B11:O24	BRAF001_A375_24H_X4	O24	trt_cp	2.5	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_24H_X4_B11:P07	BRAF001_A375_24H_X4	P07	trt_cp	0.625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_24H_X4_B11:P08	BRAF001_A375_24H_X4	P08	trt_cp	0.15625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_24H_X4_B11:P15	BRAF001_A375_24H_X4	P15	trt_cp	0.625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_24H_X4_B11:P16	BRAF001_A375_24H_X4	P16	trt_cp	0.15625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_24H_X4_B11:P23	BRAF001_A375_24H_X4	P23	trt_cp	0.625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_A375_24H_X4_B11:P24	BRAF001_A375_24H_X4	P24	trt_cp	0.15625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC018_A375_6H_X4_F1B5_DUO52HI53LO:J19	CPC018_A375_6H_X4	J19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC018_A375_6H_X5_F1B5_DUO52HI53LO:J19	CPC018_A375_6H_X5	J19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC018_A375_6H_X1_B4_DUO52HI53LO:J19	CPC018_A375_6H_X1	J19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC018_A375_6H_X2_B4_DUO52HI53LO:J19	CPC018_A375_6H_X2	J19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC018_A375_6H_X3_B4_DUO52HI53LO:J19	CPC018_A375_6H_X3	J19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_A375_6H_X1_B3_DUO52HI53LO:J02	CPC004_A375_6H_X1	J02	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_A375_6H_X2_B3_DUO52HI53LO:J02	CPC004_A375_6H_X2	J02	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_A375_6H_X3_B3_DUO52HI53LO:J02	CPC004_A375_6H_X3	J02	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC015_A375_6H_X1_B4_DUO52HI53LO:L03	CPC015_A375_6H_X1	L03	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC015_A375_6H_X2_B4_DUO52HI53LO:L03	CPC015_A375_6H_X2	L03	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC015_A375_6H_X3_B4_DUO52HI53LO:L03	CPC015_A375_6H_X3	L03	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC004_A375_6H_X1_B3_DUO52HI53LO:K17	CPC004_A375_6H_X1	K17	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC004_A375_6H_X2_B3_DUO52HI53LO:K17	CPC004_A375_6H_X2	K17	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC004_A375_6H_X3_B3_DUO52HI53LO:K17	CPC004_A375_6H_X3	K17	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC018_A375_6H_X4_F1B5_DUO52HI53LO:A20	CPC018_A375_6H_X4	A20	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC018_A375_6H_X5_F1B5_DUO52HI53LO:A20	CPC018_A375_6H_X5	A20	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC018_A375_6H_X1_B4_DUO52HI53LO:A20	CPC018_A375_6H_X1	A20	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC018_A375_6H_X2_B4_DUO52HI53LO:A20	CPC018_A375_6H_X2	A20	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC018_A375_6H_X3_B4_DUO52HI53LO:A20	CPC018_A375_6H_X3	A20	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_A375_6H_X1_B3_DUO52HI53LO:G23	CPC004_A375_6H_X1	G23	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_A375_6H_X2_B3_DUO52HI53LO:G23	CPC004_A375_6H_X2	G23	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_A375_6H_X3_B3_DUO52HI53LO:G23	CPC004_A375_6H_X3	G23	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC017_A375_6H_X4_F1B5_DUO52HI53LO:O16	CPC017_A375_6H_X4	O16	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC011_A375_6H_X1_B3_DUO52HI53LO:G15	CPC011_A375_6H_X1	G15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC011_A375_6H_X2_B3_DUO52HI53LO:G15	CPC011_A375_6H_X2	G15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC011_A375_6H_X3_B3_DUO52HI53LO:G15	CPC011_A375_6H_X3	G15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC017_A375_6H_X2_B4_DUO52HI53LO:O16	CPC017_A375_6H_X2	O16	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC017_A375_6H_X3_B4_DUO52HI53LO:O16	CPC017_A375_6H_X3	O16	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC017_A375_6H_X4_F1B5_DUO52HI53LO:I07	CPC017_A375_6H_X4	I07	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC020_A375_6H_X1_B4_DUO52HI53LO:O02	CPC020_A375_6H_X1	O02	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC020_A375_6H_X3_B4_DUO52HI53LO:O02	CPC020_A375_6H_X3	O02	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC020_A375_6H_X4_B5_DUO52HI53LO:O02	CPC020_A375_6H_X4	O02	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC020_A375_6H_X5_F1B5_DUO52HI53LO:O02	CPC020_A375_6H_X5	O02	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC017_A375_6H_X2_B4_DUO52HI53LO:I07	CPC017_A375_6H_X2	I07	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC017_A375_6H_X3_B4_DUO52HI53LO:I07	CPC017_A375_6H_X3	I07	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC017_A375_6H_X4_F1B5_DUO52HI53LO:I11	CPC017_A375_6H_X4	I11	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC017_A375_6H_X2_B4_DUO52HI53LO:I11	CPC017_A375_6H_X2	I11	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC017_A375_6H_X3_B4_DUO52HI53LO:I11	CPC017_A375_6H_X3	I11	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_A375_6H_X1_B3_DUO52HI53LO:E01	CPC004_A375_6H_X1	E01	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_A375_6H_X2_B3_DUO52HI53LO:E01	CPC004_A375_6H_X2	E01	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_A375_6H_X3_B3_DUO52HI53LO:E01	CPC004_A375_6H_X3	E01	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC017_A375_6H_X4_F1B5_DUO52HI53LO:K18	CPC017_A375_6H_X4	K18	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_A375_6H_X1_B4_DUO52HI53LO:F24	CPC020_A375_6H_X1	F24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_A375_6H_X1_B4_DUO52HI53LO:H08	CPC020_A375_6H_X1	H08	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_A375_6H_X2_B4_DUO52HI53LO:F24	CPC020_A375_6H_X2	F24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_A375_6H_X2_B4_DUO52HI53LO:H08	CPC020_A375_6H_X2	H08	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_A375_6H_X3_B4_DUO52HI53LO:F24	CPC020_A375_6H_X3	F24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_A375_6H_X3_B4_DUO52HI53LO:H08	CPC020_A375_6H_X3	H08	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_A375_6H_X4_B5_DUO52HI53LO:F24	CPC020_A375_6H_X4	F24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_A375_6H_X4_B5_DUO52HI53LO:H08	CPC020_A375_6H_X4	H08	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_A375_6H_X5_F1B5_DUO52HI53LO:F24	CPC020_A375_6H_X5	F24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_A375_6H_X5_F1B5_DUO52HI53LO:H08	CPC020_A375_6H_X5	H08	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC017_A375_6H_X2_B4_DUO52HI53LO:K18	CPC017_A375_6H_X2	K18	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC017_A375_6H_X3_B4_DUO52HI53LO:K18	CPC017_A375_6H_X3	K18	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_A375_24H_X1_B3_DUO52HI53LO:N07	CPC005_A375_24H_X1	N07	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_A375_24H_X2_B3_DUO52HI53LO:N07	CPC005_A375_24H_X2	N07	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_A375_24H_X3_B3_DUO52HI53LO:N07	CPC005_A375_24H_X3	N07	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_A375_6H_X1_B3_DUO52HI53LO:N07	CPC005_A375_6H_X1	N07	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_A375_6H_X2_B3_DUO52HI53LO:N07	CPC005_A375_6H_X2	N07	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_A375_6H_X3_B3_DUO52HI53LO:N07	CPC005_A375_6H_X3	N07	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC018_A375_6H_X4_F1B5_DUO52HI53LO:H09	CPC018_A375_6H_X4	H09	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC018_A375_6H_X5_F1B5_DUO52HI53LO:H09	CPC018_A375_6H_X5	H09	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC011_A375_6H_X1_B3_DUO52HI53LO:O15	CPC011_A375_6H_X1	O15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC011_A375_6H_X2_B3_DUO52HI53LO:O15	CPC011_A375_6H_X2	O15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC011_A375_6H_X3_B3_DUO52HI53LO:O15	CPC011_A375_6H_X3	O15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC018_A375_6H_X1_B4_DUO52HI53LO:H09	CPC018_A375_6H_X1	H09	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC018_A375_6H_X2_B4_DUO52HI53LO:H09	CPC018_A375_6H_X2	H09	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC018_A375_6H_X3_B4_DUO52HI53LO:H09	CPC018_A375_6H_X3	H09	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_A375_24H_X1_B3_DUO52HI53LO:P19	CPC005_A375_24H_X1	P19	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_A375_24H_X2_B3_DUO52HI53LO:P19	CPC005_A375_24H_X2	P19	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_A375_24H_X3_B3_DUO52HI53LO:P19	CPC005_A375_24H_X3	P19	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_A375_6H_X1_B3_DUO52HI53LO:P19	CPC005_A375_6H_X1	P19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_A375_6H_X2_B3_DUO52HI53LO:P19	CPC005_A375_6H_X2	P19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_A375_6H_X3_B3_DUO52HI53LO:P19	CPC005_A375_6H_X3	P19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_A375_6H_X2_F1B3_DUO52HI53LO:J24	CPC009_A375_6H_X2	J24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_A375_6H_X5_F1B5_DUO52HI53LO:J24	CPC009_A375_6H_X5	J24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_A375_6H_X1_B3_DUO52HI53LO:J24	CPC009_A375_6H_X1	J24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_A375_6H_X4_B5_DUO52HI53LO:J24	CPC009_A375_6H_X4	J24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_A375_24H_X1_B3_DUO52HI53LO:F24	CPC005_A375_24H_X1	F24	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_A375_24H_X2_B3_DUO52HI53LO:F24	CPC005_A375_24H_X2	F24	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_A375_24H_X3_B3_DUO52HI53LO:F24	CPC005_A375_24H_X3	F24	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_A375_6H_X1_B3_DUO52HI53LO:F24	CPC005_A375_6H_X1	F24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_A375_6H_X2_B3_DUO52HI53LO:F24	CPC005_A375_6H_X2	F24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_A375_6H_X3_B3_DUO52HI53LO:F24	CPC005_A375_6H_X3	F24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_A375_6H_X1_B3_DUO52HI53LO:B24	CPC009_A375_6H_X1	B24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_A375_6H_X2_F1B3_DUO52HI53LO:B24	CPC009_A375_6H_X2	B24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_A375_6H_X4_B5_DUO52HI53LO:B24	CPC009_A375_6H_X4	B24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_A375_6H_X5_F1B5_DUO52HI53LO:B24	CPC009_A375_6H_X5	B24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC011_A375_6H_X1_B3_DUO52HI53LO:P10	CPC011_A375_6H_X1	P10	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC011_A375_6H_X2_B3_DUO52HI53LO:P10	CPC011_A375_6H_X2	P10	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC011_A375_6H_X3_B3_DUO52HI53LO:P10	CPC011_A375_6H_X3	P10	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_A375_6H_X1_B4_DUO52HI53LO:B15	CPC020_A375_6H_X1	B15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_A375_6H_X2_B4_DUO52HI53LO:B15	CPC020_A375_6H_X2	B15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_A375_6H_X3_B4_DUO52HI53LO:B15	CPC020_A375_6H_X3	B15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_A375_6H_X4_B5_DUO52HI53LO:B15	CPC020_A375_6H_X4	B15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_A375_6H_X5_F1B5_DUO52HI53LO:B15	CPC020_A375_6H_X5	B15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K19277754	CPC011_A375_6H_X1_B3_DUO52HI53LO:I12	CPC011_A375_6H_X1	I12	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K19277754	CPC011_A375_6H_X2_B3_DUO52HI53LO:I12	CPC011_A375_6H_X2	I12	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K19277754	CPC011_A375_6H_X3_B3_DUO52HI53LO:I12	CPC011_A375_6H_X3	I12	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_A375_6H_X1_B3_DUO52HI53LO:H24	CPC004_A375_6H_X1	H24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_A375_6H_X2_B3_DUO52HI53LO:H24	CPC004_A375_6H_X2	H24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_A375_6H_X3_B3_DUO52HI53LO:H24	CPC004_A375_6H_X3	H24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC011_A375_6H_X1_B3_DUO52HI53LO:I21	CPC011_A375_6H_X1	I21	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC011_A375_6H_X2_B3_DUO52HI53LO:I21	CPC011_A375_6H_X2	I21	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC011_A375_6H_X3_B3_DUO52HI53LO:I21	CPC011_A375_6H_X3	I21	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC015_A375_6H_X1_B4_DUO52HI53LO:L01	CPC015_A375_6H_X1	L01	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC015_A375_6H_X2_B4_DUO52HI53LO:L01	CPC015_A375_6H_X2	L01	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC015_A375_6H_X3_B4_DUO52HI53LO:L01	CPC015_A375_6H_X3	L01	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_A375_6H_X1_B3_DUO52HI53LO:H13	CPC004_A375_6H_X1	H13	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_A375_6H_X2_B3_DUO52HI53LO:H13	CPC004_A375_6H_X2	H13	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_A375_6H_X3_B3_DUO52HI53LO:H13	CPC004_A375_6H_X3	H13	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC011_A375_6H_X1_B3_DUO52HI53LO:L11	CPC011_A375_6H_X1	L11	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC011_A375_6H_X2_B3_DUO52HI53LO:L11	CPC011_A375_6H_X2	L11	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC011_A375_6H_X3_B3_DUO52HI53LO:L11	CPC011_A375_6H_X3	L11	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC015_A375_6H_X1_B4_DUO52HI53LO:K04	CPC015_A375_6H_X1	K04	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC015_A375_6H_X2_B4_DUO52HI53LO:K04	CPC015_A375_6H_X2	K04	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC015_A375_6H_X3_B4_DUO52HI53LO:K04	CPC015_A375_6H_X3	K04	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_A375_6H_X1_B3_DUO52HI53LO:J04	CPC004_A375_6H_X1	J04	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_A375_6H_X2_B3_DUO52HI53LO:J04	CPC004_A375_6H_X2	J04	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_A375_6H_X3_B3_DUO52HI53LO:J04	CPC004_A375_6H_X3	J04	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC015_A375_6H_X1_B4_DUO52HI53LO:L05	CPC015_A375_6H_X1	L05	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC015_A375_6H_X2_B4_DUO52HI53LO:L05	CPC015_A375_6H_X2	L05	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC015_A375_6H_X3_B4_DUO52HI53LO:L05	CPC015_A375_6H_X3	L05	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K31534764	CPC011_A375_6H_X1_B3_DUO52HI53LO:E15	CPC011_A375_6H_X1	E15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K31534764	CPC011_A375_6H_X2_B3_DUO52HI53LO:E15	CPC011_A375_6H_X2	E15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K31534764	CPC011_A375_6H_X3_B3_DUO52HI53LO:E15	CPC011_A375_6H_X3	E15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC016_A375_6H_X1_B4_DUO52HI53LO:M15	CPC016_A375_6H_X1	M15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC016_A375_6H_X2_B4_DUO52HI53LO:M15	CPC016_A375_6H_X2	M15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC016_A375_6H_X3_B4_DUO52HI53LO:M15	CPC016_A375_6H_X3	M15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC016_A375_6H_X4_B5_DUO52HI53LO:M15	CPC016_A375_6H_X4	M15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC016_A375_6H_X5_B5_DUO52HI53LO:M15	CPC016_A375_6H_X5	M15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_A375_6H_X1_B3_DUO52HI53LO:H07	CPC004_A375_6H_X1	H07	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_A375_6H_X2_B3_DUO52HI53LO:H07	CPC004_A375_6H_X2	H07	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_A375_6H_X3_B3_DUO52HI53LO:H07	CPC004_A375_6H_X3	H07	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC011_A375_6H_X1_B3_DUO52HI53LO:D11	CPC011_A375_6H_X1	D11	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC011_A375_6H_X2_B3_DUO52HI53LO:D11	CPC011_A375_6H_X2	D11	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC011_A375_6H_X3_B3_DUO52HI53LO:D11	CPC011_A375_6H_X3	D11	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC015_A375_6H_X1_B4_DUO52HI53LO:I22	CPC015_A375_6H_X1	I22	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC015_A375_6H_X2_B4_DUO52HI53LO:I22	CPC015_A375_6H_X2	I22	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC015_A375_6H_X3_B4_DUO52HI53LO:I22	CPC015_A375_6H_X3	I22	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC016_A375_6H_X1_B4_DUO52HI53LO:M20	CPC016_A375_6H_X1	M20	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC016_A375_6H_X2_B4_DUO52HI53LO:M20	CPC016_A375_6H_X2	M20	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC016_A375_6H_X3_B4_DUO52HI53LO:M20	CPC016_A375_6H_X3	M20	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC016_A375_6H_X4_B5_DUO52HI53LO:M20	CPC016_A375_6H_X4	M20	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC016_A375_6H_X5_B5_DUO52HI53LO:M20	CPC016_A375_6H_X5	M20	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPC010_A375_6H_X4_B5_DUO52HI53LO:P24	CPC010_A375_6H_X4	P24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC009_A375_6H_X1_B3_DUO52HI53LO:K23	CPC009_A375_6H_X1	K23	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC009_A375_6H_X2_F1B3_DUO52HI53LO:K23	CPC009_A375_6H_X2	K23	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC009_A375_6H_X4_B5_DUO52HI53LO:K23	CPC009_A375_6H_X4	K23	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC009_A375_6H_X5_F1B5_DUO52HI53LO:K23	CPC009_A375_6H_X5	K23	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC011_A375_6H_X1_B3_DUO52HI53LO:I11	CPC011_A375_6H_X1	I11	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC011_A375_6H_X2_B3_DUO52HI53LO:I11	CPC011_A375_6H_X2	I11	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC011_A375_6H_X3_B3_DUO52HI53LO:I11	CPC011_A375_6H_X3	I11	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_A375_24H_X1_B3_DUO52HI53LO:E19	CPC005_A375_24H_X1	E19	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_A375_24H_X2_B3_DUO52HI53LO:E19	CPC005_A375_24H_X2	E19	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_A375_24H_X3_B3_DUO52HI53LO:E19	CPC005_A375_24H_X3	E19	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_A375_6H_X1_B3_DUO52HI53LO:E19	CPC005_A375_6H_X1	E19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_A375_6H_X2_B3_DUO52HI53LO:E19	CPC005_A375_6H_X2	E19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_A375_6H_X3_B3_DUO52HI53LO:E19	CPC005_A375_6H_X3	E19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPC011_A375_6H_X1_B3_DUO52HI53LO:A16	CPC011_A375_6H_X1	A16	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPC011_A375_6H_X2_B3_DUO52HI53LO:A16	CPC011_A375_6H_X2	A16	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPC011_A375_6H_X3_B3_DUO52HI53LO:A16	CPC011_A375_6H_X3	A16	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC016_A375_6H_X1_B4_DUO52HI53LO:O06	CPC016_A375_6H_X1	O06	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC016_A375_6H_X2_B4_DUO52HI53LO:O06	CPC016_A375_6H_X2	O06	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC016_A375_6H_X3_B4_DUO52HI53LO:O06	CPC016_A375_6H_X3	O06	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC016_A375_6H_X4_B5_DUO52HI53LO:O06	CPC016_A375_6H_X4	O06	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC016_A375_6H_X5_B5_DUO52HI53LO:O06	CPC016_A375_6H_X5	O06	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_A375_6H_X5_F1B5_DUO52HI53LO:K04	CPC020_A375_6H_X5	K04	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_A375_6H_X1_B4_DUO52HI53LO:K04	CPC020_A375_6H_X1	K04	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_A375_6H_X2_B4_DUO52HI53LO:K04	CPC020_A375_6H_X2	K04	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_A375_6H_X3_B4_DUO52HI53LO:K04	CPC020_A375_6H_X3	K04	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_A375_6H_X4_B5_DUO52HI53LO:K04	CPC020_A375_6H_X4	K04	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_A375_6H_X1_B3_DUO52HI53LO:I06	CPC004_A375_6H_X1	I06	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_A375_6H_X2_B3_DUO52HI53LO:I06	CPC004_A375_6H_X2	I06	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_A375_6H_X3_B3_DUO52HI53LO:I06	CPC004_A375_6H_X3	I06	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC011_A375_6H_X1_B3_DUO52HI53LO:K13	CPC011_A375_6H_X1	K13	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC011_A375_6H_X2_B3_DUO52HI53LO:K13	CPC011_A375_6H_X2	K13	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC011_A375_6H_X3_B3_DUO52HI53LO:K13	CPC011_A375_6H_X3	K13	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC016_A375_6H_X1_B4_DUO52HI53LO:N14	CPC016_A375_6H_X1	N14	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC016_A375_6H_X2_B4_DUO52HI53LO:N14	CPC016_A375_6H_X2	N14	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC016_A375_6H_X3_B4_DUO52HI53LO:N14	CPC016_A375_6H_X3	N14	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC016_A375_6H_X4_B5_DUO52HI53LO:N14	CPC016_A375_6H_X4	N14	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC016_A375_6H_X5_B5_DUO52HI53LO:N14	CPC016_A375_6H_X5	N14	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC011_A375_6H_X1_B3_DUO52HI53LO:J05	CPC011_A375_6H_X1	J05	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC011_A375_6H_X2_B3_DUO52HI53LO:J05	CPC011_A375_6H_X2	J05	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC011_A375_6H_X3_B3_DUO52HI53LO:J05	CPC011_A375_6H_X3	J05	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC016_A375_6H_X1_B4_DUO52HI53LO:K22	CPC016_A375_6H_X1	K22	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC016_A375_6H_X2_B4_DUO52HI53LO:K22	CPC016_A375_6H_X2	K22	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC016_A375_6H_X3_B4_DUO52HI53LO:K22	CPC016_A375_6H_X3	K22	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC016_A375_6H_X4_B5_DUO52HI53LO:K22	CPC016_A375_6H_X4	K22	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC016_A375_6H_X5_B5_DUO52HI53LO:K22	CPC016_A375_6H_X5	K22	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_A375_24H_X1_B3_DUO52HI53LO:E10	CPC005_A375_24H_X1	E10	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_A375_24H_X2_B3_DUO52HI53LO:E10	CPC005_A375_24H_X2	E10	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_A375_24H_X3_B3_DUO52HI53LO:E10	CPC005_A375_24H_X3	E10	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_A375_6H_X1_B3_DUO52HI53LO:E10	CPC005_A375_6H_X1	E10	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_A375_6H_X2_B3_DUO52HI53LO:E10	CPC005_A375_6H_X2	E10	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_A375_6H_X3_B3_DUO52HI53LO:E10	CPC005_A375_6H_X3	E10	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC011_A375_6H_X1_B3_DUO52HI53LO:A13	CPC011_A375_6H_X1	A13	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC011_A375_6H_X2_B3_DUO52HI53LO:A13	CPC011_A375_6H_X2	A13	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC011_A375_6H_X3_B3_DUO52HI53LO:A13	CPC011_A375_6H_X3	A13	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC016_A375_6H_X1_B4_DUO52HI53LO:C19	CPC016_A375_6H_X1	C19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC016_A375_6H_X2_B4_DUO52HI53LO:C19	CPC016_A375_6H_X2	C19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC016_A375_6H_X3_B4_DUO52HI53LO:C19	CPC016_A375_6H_X3	C19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC016_A375_6H_X4_B5_DUO52HI53LO:C19	CPC016_A375_6H_X4	C19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC016_A375_6H_X5_B5_DUO52HI53LO:C19	CPC016_A375_6H_X5	C19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_A375_6H_X1_B3_DUO52HI53LO:A16	CPC004_A375_6H_X1	A16	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_A375_6H_X2_B3_DUO52HI53LO:A16	CPC004_A375_6H_X2	A16	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_A375_6H_X3_B3_DUO52HI53LO:A16	CPC004_A375_6H_X3	A16	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC011_A375_6H_X2_B3_DUO52HI53LO:G23	CPC011_A375_6H_X2	G23	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC011_A375_6H_X3_B3_DUO52HI53LO:G23	CPC011_A375_6H_X3	G23	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC016_A375_6H_X1_B4_DUO52HI53LO:H06	CPC016_A375_6H_X1	H06	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC016_A375_6H_X2_B4_DUO52HI53LO:H06	CPC016_A375_6H_X2	H06	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC016_A375_6H_X3_B4_DUO52HI53LO:H06	CPC016_A375_6H_X3	H06	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC016_A375_6H_X4_B5_DUO52HI53LO:H06	CPC016_A375_6H_X4	H06	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC016_A375_6H_X5_B5_DUO52HI53LO:H06	CPC016_A375_6H_X5	H06	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-K83153774	CPC020_A375_6H_X1_B4_DUO52HI53LO:D15	CPC020_A375_6H_X1	D15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-K83153774	CPC020_A375_6H_X2_B4_DUO52HI53LO:D15	CPC020_A375_6H_X2	D15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-K83153774	CPC020_A375_6H_X4_B5_DUO52HI53LO:D15	CPC020_A375_6H_X4	D15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-K83153774	CPC020_A375_6H_X5_F1B5_DUO52HI53LO:D15	CPC020_A375_6H_X5	D15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_A375_6H_X1_B3_DUO52HI53LO:J08	CPC004_A375_6H_X1	J08	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_A375_6H_X2_B3_DUO52HI53LO:J08	CPC004_A375_6H_X2	J08	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_A375_6H_X3_B3_DUO52HI53LO:J08	CPC004_A375_6H_X3	J08	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC015_A375_6H_X1_B4_DUO52HI53LO:L09	CPC015_A375_6H_X1	L09	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC015_A375_6H_X2_B4_DUO52HI53LO:L09	CPC015_A375_6H_X2	L09	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC015_A375_6H_X3_B4_DUO52HI53LO:L09	CPC015_A375_6H_X3	L09	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_A375_6H_X1_B3_DUO52HI53LO:G10	CPC011_A375_6H_X1	G10	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_A375_6H_X2_B3_DUO52HI53LO:G10	CPC011_A375_6H_X2	G10	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_A375_6H_X3_B3_DUO52HI53LO:G10	CPC011_A375_6H_X3	G10	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_A375_6H_X1_B3_DUO52HI53LO:B03	CPC011_A375_6H_X1	B03	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_A375_6H_X2_B3_DUO52HI53LO:B03	CPC011_A375_6H_X2	B03	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_A375_6H_X3_B3_DUO52HI53LO:B03	CPC011_A375_6H_X3	B03	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_A375_24H_X1_B3_DUO52HI53LO:M14	CPC005_A375_24H_X1	M14	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_A375_24H_X2_B3_DUO52HI53LO:M14	CPC005_A375_24H_X2	M14	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_A375_24H_X3_B3_DUO52HI53LO:M14	CPC005_A375_24H_X3	M14	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_A375_6H_X1_B3_DUO52HI53LO:M14	CPC005_A375_6H_X1	M14	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_A375_6H_X2_B3_DUO52HI53LO:M14	CPC005_A375_6H_X2	M14	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_A375_6H_X3_B3_DUO52HI53LO:M14	CPC005_A375_6H_X3	M14	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_A375_6H_X1_B3_DUO52HI53LO:J06	CPC004_A375_6H_X1	J06	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_A375_6H_X2_B3_DUO52HI53LO:J06	CPC004_A375_6H_X2	J06	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_A375_6H_X3_B3_DUO52HI53LO:J06	CPC004_A375_6H_X3	J06	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC011_A375_6H_X1_B3_DUO52HI53LO:J19	CPC011_A375_6H_X1	J19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC011_A375_6H_X2_B3_DUO52HI53LO:J19	CPC011_A375_6H_X2	J19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC011_A375_6H_X3_B3_DUO52HI53LO:J19	CPC011_A375_6H_X3	J19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC015_A375_6H_X1_B4_DUO52HI53LO:L07	CPC015_A375_6H_X1	L07	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC015_A375_6H_X2_B4_DUO52HI53LO:L07	CPC015_A375_6H_X2	L07	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC015_A375_6H_X3_B4_DUO52HI53LO:L07	CPC015_A375_6H_X3	L07	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
65833	N06AX17	milnacipran	CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2	CCN(CC)C(=O)C1(c2ccccc2)CC1CN	BRD-K02227374	CPC011_A375_6H_X1_B3_DUO52HI53LO:H14	CPC011_A375_6H_X1	H14	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
65833	N06AX17	milnacipran	CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2	CCN(CC)C(=O)C1(c2ccccc2)CC1CN	BRD-K02227374	CPC011_A375_6H_X2_B3_DUO52HI53LO:H14	CPC011_A375_6H_X2	H14	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
65833	N06AX17	milnacipran	CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2	CCN(CC)C(=O)C1(c2ccccc2)CC1CN	BRD-K02227374	CPC011_A375_6H_X3_B3_DUO52HI53LO:H14	CPC011_A375_6H_X3	H14	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC017_A375_6H_X4_F1B5_DUO52HI53LO:F21	CPC017_A375_6H_X4	F21	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC017_A375_6H_X2_B4_DUO52HI53LO:F21	CPC017_A375_6H_X2	F21	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC017_A375_6H_X3_B4_DUO52HI53LO:F21	CPC017_A375_6H_X3	F21	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_A375_6H_X1_B3_DUO52HI53LO:J03	CPC004_A375_6H_X1	J03	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_A375_6H_X2_B3_DUO52HI53LO:J03	CPC004_A375_6H_X2	J03	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_A375_6H_X3_B3_DUO52HI53LO:J03	CPC004_A375_6H_X3	J03	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_A375_6H_X2_F1B3_DUO52HI53LO:G22	CPC010_A375_6H_X2	G22	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_A375_6H_X3_B3_DUO52HI53LO:G22	CPC010_A375_6H_X3	G22	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_A375_6H_X4_B5_DUO52HI53LO:G22	CPC010_A375_6H_X4	G22	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC011_A375_6H_X1_B3_DUO52HI53LO:I05	CPC011_A375_6H_X1	I05	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC011_A375_6H_X2_B3_DUO52HI53LO:I05	CPC011_A375_6H_X2	I05	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC011_A375_6H_X3_B3_DUO52HI53LO:I05	CPC011_A375_6H_X3	I05	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC015_A375_6H_X1_B4_DUO52HI53LO:K18	CPC015_A375_6H_X1	K18	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC015_A375_6H_X2_B4_DUO52HI53LO:K18	CPC015_A375_6H_X2	K18	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC015_A375_6H_X3_B4_DUO52HI53LO:K18	CPC015_A375_6H_X3	K18	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_HA1E_24H_X1_B3_DUO52HI53LO:E11	CPC004_HA1E_24H_X1	E11	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_HA1E_24H_X2_B3_DUO52HI53LO:E11	CPC004_HA1E_24H_X2	E11	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_HA1E_24H_X3_B3_DUO52HI53LO:E11	CPC004_HA1E_24H_X3	E11	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_HA1E_6H_X1_B3_DUO52HI53LO:E11	CPC004_HA1E_6H_X1	E11	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_HA1E_6H_X2_B3_DUO52HI53LO:E11	CPC004_HA1E_6H_X2	E11	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_HA1E_6H_X3_B3_DUO52HI53LO:E11	CPC004_HA1E_6H_X3	E11	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC020_HA1E_6H_X1_F1B3_DUO52HI53LO:F21	CPC020_HA1E_6H_X1	F21	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC020_HA1E_6H_X2_F1B3_DUO52HI53LO:F21	CPC020_HA1E_6H_X2	F21	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC020_HA1E_6H_X3_F1B3_DUO52HI53LO:F21	CPC020_HA1E_6H_X3	F21	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_HA1E_24H_X1_B3_DUO52HI53LO:C12	CPC005_HA1E_24H_X1	C12	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_HA1E_24H_X2_B3_DUO52HI53LO:C12	CPC005_HA1E_24H_X2	C12	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_HA1E_24H_X3_B3_DUO52HI53LO:C12	CPC005_HA1E_24H_X3	C12	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_HA1E_6H_X1_B3_DUO52HI53LO:C12	CPC005_HA1E_6H_X1	C12	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_HA1E_6H_X3_B3_DUO52HI53LO:C12	CPC005_HA1E_6H_X3	C12	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_HA1E_6H_X1_F1B3_DUO52HI53LO:H14	CPC020_HA1E_6H_X1	H14	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_HA1E_6H_X1_F1B3_DUO52HI53LO:L24	CPC020_HA1E_6H_X1	L24	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_HA1E_6H_X2_F1B3_DUO52HI53LO:H14	CPC020_HA1E_6H_X2	H14	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_HA1E_6H_X2_F1B3_DUO52HI53LO:L24	CPC020_HA1E_6H_X2	L24	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_HA1E_6H_X3_F1B3_DUO52HI53LO:H14	CPC020_HA1E_6H_X3	H14	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_HA1E_6H_X3_F1B3_DUO52HI53LO:L24	CPC020_HA1E_6H_X3	L24	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC002_HA1E_24H_X1_B3_DUO52HI53LO:G20	CPC002_HA1E_24H_X1	G20	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC002_HA1E_24H_X2_B3_DUO52HI53LO:G20	CPC002_HA1E_24H_X2	G20	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC002_HA1E_24H_X3_B3_DUO52HI53LO:G20	CPC002_HA1E_24H_X3	G20	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC002_HA1E_6H_X1_B3_DUO52HI53LO:G20	CPC002_HA1E_6H_X1	G20	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC002_HA1E_6H_X2_B3_DUO52HI53LO:G20	CPC002_HA1E_6H_X2	G20	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC002_HA1E_6H_X3_B3_DUO52HI53LO:G20	CPC002_HA1E_6H_X3	G20	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC020_HA1E_6H_X1_F1B3_DUO52HI53LO:P19	CPC020_HA1E_6H_X1	P19	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC020_HA1E_6H_X2_F1B3_DUO52HI53LO:P19	CPC020_HA1E_6H_X2	P19	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_HA1E_24H_X1_B3_DUO52HI53LO:I02	CPC004_HA1E_24H_X1	I02	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_HA1E_24H_X2_B3_DUO52HI53LO:I02	CPC004_HA1E_24H_X2	I02	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_HA1E_24H_X3_B3_DUO52HI53LO:I02	CPC004_HA1E_24H_X3	I02	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_HA1E_6H_X1_B3_DUO52HI53LO:I02	CPC004_HA1E_6H_X1	I02	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_HA1E_6H_X2_B3_DUO52HI53LO:I02	CPC004_HA1E_6H_X2	I02	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_HA1E_6H_X3_B3_DUO52HI53LO:I02	CPC004_HA1E_6H_X3	I02	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_HA1E_24H_X1_B3_DUO52HI53LO:I02	CPC004_HA1E_24H_X1	I02	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_HA1E_24H_X2_B3_DUO52HI53LO:I02	CPC004_HA1E_24H_X2	I02	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_HA1E_24H_X3_B3_DUO52HI53LO:I02	CPC004_HA1E_24H_X3	I02	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_HA1E_6H_X1_B3_DUO52HI53LO:I02	CPC004_HA1E_6H_X1	I02	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_HA1E_6H_X2_B3_DUO52HI53LO:I02	CPC004_HA1E_6H_X2	I02	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_HA1E_6H_X3_B3_DUO52HI53LO:I02	CPC004_HA1E_6H_X3	I02	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
3947	N06AA07	lofepramine	CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)CC(=O)C4=CC=C(C=C4)Cl	CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1	BRD-K82147103	CPC011_HA1E_6H_X1_F1B3_DUO52HI53LO:M10	CPC011_HA1E_6H_X1	M10	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
3947	N06AA07	lofepramine	CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)CC(=O)C4=CC=C(C=C4)Cl	CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1	BRD-K82147103	CPC011_HA1E_6H_X3_F1B3_DUO52HI53LO:M10	CPC011_HA1E_6H_X3	M10	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC001_HA1E_24H_X1_B3_DUO52HI53LO:O20	CPC001_HA1E_24H_X1	O20	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC001_HA1E_24H_X2_B3_DUO52HI53LO:O20	CPC001_HA1E_24H_X2	O20	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC001_HA1E_24H_X3_B3_DUO52HI53LO:O20	CPC001_HA1E_24H_X3	O20	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC001_HA1E_6H_X1_B3_DUO52HI53LO:O20	CPC001_HA1E_6H_X1	O20	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC001_HA1E_6H_X2_B3_DUO52HI53LO:O20	CPC001_HA1E_6H_X2	O20	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC001_HA1E_6H_X3_B3_DUO52HI53LO:O20	CPC001_HA1E_6H_X3	O20	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC003_HA1E_24H_X1_B3_DUO52HI53LO:I02	CPC003_HA1E_24H_X1	I02	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC003_HA1E_24H_X2_B3_DUO52HI53LO:I02	CPC003_HA1E_24H_X2	I02	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC003_HA1E_24H_X3_B3_DUO52HI53LO:I02	CPC003_HA1E_24H_X3	I02	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC003_HA1E_6H_X2_B3_DUO52HI53LO:I02	CPC003_HA1E_6H_X2	I02	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC003_HA1E_6H_X3_B3_DUO52HI53LO:I02	CPC003_HA1E_6H_X3	I02	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC002_HA1E_24H_X1_B3_DUO52HI53LO:O11	CPC002_HA1E_24H_X1	O11	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC002_HA1E_24H_X2_B3_DUO52HI53LO:O11	CPC002_HA1E_24H_X2	O11	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC002_HA1E_24H_X3_B3_DUO52HI53LO:O11	CPC002_HA1E_24H_X3	O11	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC002_HA1E_6H_X1_B3_DUO52HI53LO:O11	CPC002_HA1E_6H_X1	O11	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC002_HA1E_6H_X2_B3_DUO52HI53LO:O11	CPC002_HA1E_6H_X2	O11	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_HA1E_24H_X1_B3_DUO52HI53LO:J02	CPC004_HA1E_24H_X1	J02	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_HA1E_24H_X2_B3_DUO52HI53LO:J02	CPC004_HA1E_24H_X2	J02	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_HA1E_24H_X3_B3_DUO52HI53LO:J02	CPC004_HA1E_24H_X3	J02	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_HA1E_6H_X1_B3_DUO52HI53LO:J02	CPC004_HA1E_6H_X1	J02	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_HA1E_6H_X2_B3_DUO52HI53LO:J02	CPC004_HA1E_6H_X2	J02	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_HA1E_6H_X3_B3_DUO52HI53LO:J02	CPC004_HA1E_6H_X3	J02	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC004_HA1E_24H_X1_B3_DUO52HI53LO:K17	CPC004_HA1E_24H_X1	K17	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC004_HA1E_24H_X2_B3_DUO52HI53LO:K17	CPC004_HA1E_24H_X2	K17	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC004_HA1E_24H_X3_B3_DUO52HI53LO:K17	CPC004_HA1E_24H_X3	K17	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC004_HA1E_6H_X1_B3_DUO52HI53LO:K17	CPC004_HA1E_6H_X1	K17	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC004_HA1E_6H_X2_B3_DUO52HI53LO:K17	CPC004_HA1E_6H_X2	K17	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_HA1E_24H_X1_B3_DUO52HI53LO:G23	CPC004_HA1E_24H_X1	G23	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_HA1E_24H_X2_B3_DUO52HI53LO:G23	CPC004_HA1E_24H_X2	G23	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_HA1E_24H_X3_B3_DUO52HI53LO:G23	CPC004_HA1E_24H_X3	G23	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_HA1E_6H_X1_B3_DUO52HI53LO:G23	CPC004_HA1E_6H_X1	G23	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_HA1E_6H_X2_B3_DUO52HI53LO:G23	CPC004_HA1E_6H_X2	G23	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_HA1E_6H_X3_B3_DUO52HI53LO:G23	CPC004_HA1E_6H_X3	G23	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC011_HA1E_6H_X1_F1B3_DUO52HI53LO:G15	CPC011_HA1E_6H_X1	G15	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC011_HA1E_6H_X3_F1B3_DUO52HI53LO:G15	CPC011_HA1E_6H_X3	G15	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC002_HA1E_24H_X1_B3_DUO52HI53LO:F11	CPC002_HA1E_24H_X1	F11	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC002_HA1E_24H_X2_B3_DUO52HI53LO:F11	CPC002_HA1E_24H_X2	F11	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC002_HA1E_24H_X3_B3_DUO52HI53LO:F11	CPC002_HA1E_24H_X3	F11	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC002_HA1E_6H_X1_B3_DUO52HI53LO:F11	CPC002_HA1E_6H_X1	F11	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC002_HA1E_6H_X2_B3_DUO52HI53LO:F11	CPC002_HA1E_6H_X2	F11	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC002_HA1E_6H_X3_B3_DUO52HI53LO:F11	CPC002_HA1E_6H_X3	F11	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC020_HA1E_6H_X1_F1B3_DUO52HI53LO:O02	CPC020_HA1E_6H_X1	O02	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC020_HA1E_6H_X2_F1B3_DUO52HI53LO:O02	CPC020_HA1E_6H_X2	O02	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC020_HA1E_6H_X3_F1B3_DUO52HI53LO:O02	CPC020_HA1E_6H_X3	O02	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC002_HA1E_24H_X1_B3_DUO52HI53LO:F15	CPC002_HA1E_24H_X1	F15	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC002_HA1E_24H_X2_B3_DUO52HI53LO:F15	CPC002_HA1E_24H_X2	F15	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC002_HA1E_24H_X3_B3_DUO52HI53LO:F15	CPC002_HA1E_24H_X3	F15	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC002_HA1E_6H_X1_B3_DUO52HI53LO:F15	CPC002_HA1E_6H_X1	F15	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC002_HA1E_6H_X2_B3_DUO52HI53LO:F15	CPC002_HA1E_6H_X2	F15	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC002_HA1E_6H_X3_B3_DUO52HI53LO:F15	CPC002_HA1E_6H_X3	F15	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_HA1E_24H_X1_B3_DUO52HI53LO:E01	CPC004_HA1E_24H_X1	E01	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_HA1E_24H_X3_B3_DUO52HI53LO:E01	CPC004_HA1E_24H_X3	E01	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_HA1E_6H_X2_B3_DUO52HI53LO:E01	CPC004_HA1E_6H_X2	E01	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_HA1E_6H_X3_B3_DUO52HI53LO:E01	CPC004_HA1E_6H_X3	E01	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_HA1E_6H_X1_F1B3_DUO52HI53LO:F24	CPC020_HA1E_6H_X1	F24	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_HA1E_6H_X1_F1B3_DUO52HI53LO:H08	CPC020_HA1E_6H_X1	H08	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_HA1E_6H_X2_F1B3_DUO52HI53LO:F24	CPC020_HA1E_6H_X2	F24	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_HA1E_6H_X2_F1B3_DUO52HI53LO:H08	CPC020_HA1E_6H_X2	H08	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_HA1E_6H_X3_F1B3_DUO52HI53LO:F24	CPC020_HA1E_6H_X3	F24	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_HA1E_6H_X3_F1B3_DUO52HI53LO:H08	CPC020_HA1E_6H_X3	H08	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_HA1E_24H_X1_B3_DUO52HI53LO:N07	CPC005_HA1E_24H_X1	N07	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_HA1E_24H_X2_B3_DUO52HI53LO:N07	CPC005_HA1E_24H_X2	N07	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_HA1E_24H_X3_B3_DUO52HI53LO:N07	CPC005_HA1E_24H_X3	N07	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_HA1E_6H_X1_B3_DUO52HI53LO:N07	CPC005_HA1E_6H_X1	N07	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_HA1E_6H_X3_B3_DUO52HI53LO:N07	CPC005_HA1E_6H_X3	N07	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC002_HA1E_24H_X1_B3_DUO52HI53LO:K21	CPC002_HA1E_24H_X1	K21	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC002_HA1E_24H_X2_B3_DUO52HI53LO:K21	CPC002_HA1E_24H_X2	K21	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC002_HA1E_24H_X3_B3_DUO52HI53LO:K21	CPC002_HA1E_24H_X3	K21	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC002_HA1E_6H_X1_B3_DUO52HI53LO:K21	CPC002_HA1E_6H_X1	K21	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC002_HA1E_6H_X2_B3_DUO52HI53LO:K21	CPC002_HA1E_6H_X2	K21	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC002_HA1E_6H_X3_B3_DUO52HI53LO:K21	CPC002_HA1E_6H_X3	K21	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC011_HA1E_6H_X1_F1B3_DUO52HI53LO:O15	CPC011_HA1E_6H_X1	O15	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC011_HA1E_6H_X3_F1B3_DUO52HI53LO:O15	CPC011_HA1E_6H_X3	O15	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_HA1E_24H_X1_B3_DUO52HI53LO:P19	CPC005_HA1E_24H_X1	P19	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_HA1E_24H_X2_B3_DUO52HI53LO:P19	CPC005_HA1E_24H_X2	P19	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_HA1E_24H_X3_B3_DUO52HI53LO:P19	CPC005_HA1E_24H_X3	P19	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_HA1E_6H_X1_B3_DUO52HI53LO:P19	CPC005_HA1E_6H_X1	P19	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_HA1E_6H_X3_B3_DUO52HI53LO:P19	CPC005_HA1E_6H_X3	P19	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_HA1E_6H_X2_F1B3_DUO52HI53LO:J24	CPC009_HA1E_6H_X2	J24	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_HA1E_6H_X1_B4_DUO52HI53LO:J24	CPC009_HA1E_6H_X1	J24	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_HA1E_6H_X3_B4_DUO52HI53LO:J24	CPC009_HA1E_6H_X3	J24	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_HA1E_24H_X1_B3_DUO52HI53LO:F24	CPC005_HA1E_24H_X1	F24	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_HA1E_24H_X2_B3_DUO52HI53LO:F24	CPC005_HA1E_24H_X2	F24	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_HA1E_24H_X3_B3_DUO52HI53LO:F24	CPC005_HA1E_24H_X3	F24	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_HA1E_6H_X1_B3_DUO52HI53LO:F24	CPC005_HA1E_6H_X1	F24	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_HA1E_6H_X3_B3_DUO52HI53LO:F24	CPC005_HA1E_6H_X3	F24	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_HA1E_6H_X1_B4_DUO52HI53LO:B24	CPC009_HA1E_6H_X1	B24	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_HA1E_6H_X2_F1B3_DUO52HI53LO:B24	CPC009_HA1E_6H_X2	B24	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_HA1E_6H_X3_B4_DUO52HI53LO:B24	CPC009_HA1E_6H_X3	B24	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC011_HA1E_6H_X1_F1B3_DUO52HI53LO:P10	CPC011_HA1E_6H_X1	P10	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC011_HA1E_6H_X3_F1B3_DUO52HI53LO:P10	CPC011_HA1E_6H_X3	P10	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_HA1E_6H_X1_F1B3_DUO52HI53LO:B15	CPC020_HA1E_6H_X1	B15	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_HA1E_6H_X2_F1B3_DUO52HI53LO:B15	CPC020_HA1E_6H_X2	B15	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_HA1E_6H_X3_F1B3_DUO52HI53LO:B15	CPC020_HA1E_6H_X3	B15	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K19277754	CPC011_HA1E_6H_X1_F1B3_DUO52HI53LO:I12	CPC011_HA1E_6H_X1	I12	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K19277754	CPC011_HA1E_6H_X3_F1B3_DUO52HI53LO:I12	CPC011_HA1E_6H_X3	I12	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_HA1E_24H_X1_B3_DUO52HI53LO:H24	CPC004_HA1E_24H_X1	H24	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_HA1E_24H_X2_B3_DUO52HI53LO:H24	CPC004_HA1E_24H_X2	H24	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_HA1E_24H_X3_B3_DUO52HI53LO:H24	CPC004_HA1E_24H_X3	H24	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_HA1E_6H_X1_B3_DUO52HI53LO:H24	CPC004_HA1E_6H_X1	H24	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_HA1E_6H_X2_B3_DUO52HI53LO:H24	CPC004_HA1E_6H_X2	H24	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_HA1E_6H_X3_B3_DUO52HI53LO:H24	CPC004_HA1E_6H_X3	H24	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC011_HA1E_6H_X1_F1B3_DUO52HI53LO:I21	CPC011_HA1E_6H_X1	I21	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC011_HA1E_6H_X3_F1B3_DUO52HI53LO:I21	CPC011_HA1E_6H_X3	I21	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_HA1E_24H_X1_B3_DUO52HI53LO:H13	CPC004_HA1E_24H_X1	H13	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_HA1E_24H_X2_B3_DUO52HI53LO:H13	CPC004_HA1E_24H_X2	H13	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_HA1E_24H_X3_B3_DUO52HI53LO:H13	CPC004_HA1E_24H_X3	H13	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_HA1E_6H_X1_B3_DUO52HI53LO:H13	CPC004_HA1E_6H_X1	H13	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_HA1E_6H_X2_B3_DUO52HI53LO:H13	CPC004_HA1E_6H_X2	H13	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_HA1E_6H_X3_B3_DUO52HI53LO:H13	CPC004_HA1E_6H_X3	H13	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC011_HA1E_6H_X1_F1B3_DUO52HI53LO:L11	CPC011_HA1E_6H_X1	L11	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC011_HA1E_6H_X3_F1B3_DUO52HI53LO:L11	CPC011_HA1E_6H_X3	L11	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_HA1E_24H_X1_B3_DUO52HI53LO:J04	CPC004_HA1E_24H_X1	J04	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_HA1E_24H_X2_B3_DUO52HI53LO:J04	CPC004_HA1E_24H_X2	J04	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_HA1E_24H_X3_B3_DUO52HI53LO:J04	CPC004_HA1E_24H_X3	J04	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_HA1E_6H_X1_B3_DUO52HI53LO:J04	CPC004_HA1E_6H_X1	J04	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_HA1E_6H_X2_B3_DUO52HI53LO:J04	CPC004_HA1E_6H_X2	J04	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_HA1E_6H_X3_B3_DUO52HI53LO:J04	CPC004_HA1E_6H_X3	J04	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K31534764	CPC011_HA1E_6H_X1_F1B3_DUO52HI53LO:E15	CPC011_HA1E_6H_X1	E15	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K31534764	CPC011_HA1E_6H_X3_F1B3_DUO52HI53LO:E15	CPC011_HA1E_6H_X3	E15	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC003_HA1E_24H_X1_B3_DUO52HI53LO:P05	CPC003_HA1E_24H_X1	P05	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC003_HA1E_24H_X2_B3_DUO52HI53LO:P05	CPC003_HA1E_24H_X2	P05	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC003_HA1E_24H_X3_B3_DUO52HI53LO:P05	CPC003_HA1E_24H_X3	P05	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC003_HA1E_6H_X2_B3_DUO52HI53LO:P05	CPC003_HA1E_6H_X2	P05	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC003_HA1E_6H_X3_B3_DUO52HI53LO:P05	CPC003_HA1E_6H_X3	P05	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_HA1E_24H_X1_B3_DUO52HI53LO:H07	CPC004_HA1E_24H_X1	H07	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_HA1E_24H_X2_B3_DUO52HI53LO:H07	CPC004_HA1E_24H_X2	H07	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_HA1E_24H_X3_B3_DUO52HI53LO:H07	CPC004_HA1E_24H_X3	H07	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_HA1E_6H_X1_B3_DUO52HI53LO:H07	CPC004_HA1E_6H_X1	H07	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_HA1E_6H_X2_B3_DUO52HI53LO:H07	CPC004_HA1E_6H_X2	H07	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_HA1E_6H_X3_B3_DUO52HI53LO:H07	CPC004_HA1E_6H_X3	H07	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC011_HA1E_6H_X1_F1B3_DUO52HI53LO:D11	CPC011_HA1E_6H_X1	D11	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC011_HA1E_6H_X3_F1B3_DUO52HI53LO:D11	CPC011_HA1E_6H_X3	D11	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC002_HA1E_24H_X1_B3_DUO52HI53LO:H22	CPC002_HA1E_24H_X1	H22	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC002_HA1E_24H_X2_B3_DUO52HI53LO:H22	CPC002_HA1E_24H_X2	H22	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC002_HA1E_24H_X3_B3_DUO52HI53LO:H22	CPC002_HA1E_24H_X3	H22	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC002_HA1E_6H_X1_B3_DUO52HI53LO:H22	CPC002_HA1E_6H_X1	H22	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC002_HA1E_6H_X2_B3_DUO52HI53LO:H22	CPC002_HA1E_6H_X2	H22	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPC010_HA1E_6H_X1_B4_DUO52HI53LO:P24	CPC010_HA1E_6H_X1	P24	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPC010_HA1E_6H_X2_B4_DUO52HI53LO:P24	CPC010_HA1E_6H_X2	P24	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPC010_HA1E_6H_X3_F1B3_DUO52HI53LO:P24	CPC010_HA1E_6H_X3	P24	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC009_HA1E_6H_X1_B4_DUO52HI53LO:K23	CPC009_HA1E_6H_X1	K23	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC009_HA1E_6H_X2_F1B3_DUO52HI53LO:K23	CPC009_HA1E_6H_X2	K23	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC009_HA1E_6H_X3_B4_DUO52HI53LO:K23	CPC009_HA1E_6H_X3	K23	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC011_HA1E_6H_X1_F1B3_DUO52HI53LO:I11	CPC011_HA1E_6H_X1	I11	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC011_HA1E_6H_X3_F1B3_DUO52HI53LO:I11	CPC011_HA1E_6H_X3	I11	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_HA1E_24H_X2_B3_DUO52HI53LO:E19	CPC005_HA1E_24H_X2	E19	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_HA1E_24H_X3_B3_DUO52HI53LO:E19	CPC005_HA1E_24H_X3	E19	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_HA1E_6H_X1_B3_DUO52HI53LO:E19	CPC005_HA1E_6H_X1	E19	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_HA1E_6H_X3_B3_DUO52HI53LO:E19	CPC005_HA1E_6H_X3	E19	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPC011_HA1E_6H_X1_F1B3_DUO52HI53LO:A16	CPC011_HA1E_6H_X1	A16	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPC011_HA1E_6H_X3_F1B3_DUO52HI53LO:A16	CPC011_HA1E_6H_X3	A16	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
6305	N06AX02	tryptophan	C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)N	NC(Cc1c[nH]c2ccccc12)C(=O)O	BRD-A07106394	CRCGN004_HA1E_24H_X6_F1B7_DUO52HI53LO:F12	CRCGN004_HA1E_24H_X6	F12	trt_cp	20.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
6305	N06AX02	tryptophan	C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)N	NC(Cc1c[nH]c2ccccc12)C(=O)O	BRD-A07106394	CRCGN004_HA1E_24H_X6_F1B7_DUO52HI53LO:I18	CRCGN004_HA1E_24H_X6	I18	trt_cp	20.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
6305	N06AX02	tryptophan	C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)N	NC(Cc1c[nH]c2ccccc12)C(=O)O	BRD-A07106394	CRCGN004_HA1E_24H_X6_F1B7_DUO52HI53LO:M05	CRCGN004_HA1E_24H_X6	M05	trt_cp	20.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
6305	N06AX02	tryptophan	C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)N	NC(Cc1c[nH]c2ccccc12)C(=O)O	BRD-A07106394	CRCGN004_HA1E_24H_X7_F1B7_DUO52HI53LO:F12	CRCGN004_HA1E_24H_X7	F12	trt_cp	20.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
6305	N06AX02	tryptophan	C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)N	NC(Cc1c[nH]c2ccccc12)C(=O)O	BRD-A07106394	CRCGN004_HA1E_24H_X7_F1B7_DUO52HI53LO:I18	CRCGN004_HA1E_24H_X7	I18	trt_cp	20.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
6305	N06AX02	tryptophan	C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)N	NC(Cc1c[nH]c2ccccc12)C(=O)O	BRD-A07106394	CRCGN004_HA1E_24H_X7_F1B7_DUO52HI53LO:M05	CRCGN004_HA1E_24H_X7	M05	trt_cp	20.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
6305	N06AX02	tryptophan	C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)N	NC(Cc1c[nH]c2ccccc12)C(=O)O	BRD-A07106394	CRCGN004_HA1E_24H_X8_F1B7_DUO52HI53LO:F12	CRCGN004_HA1E_24H_X8	F12	trt_cp	20.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
6305	N06AX02	tryptophan	C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)N	NC(Cc1c[nH]c2ccccc12)C(=O)O	BRD-A07106394	CRCGN004_HA1E_24H_X8_F1B7_DUO52HI53LO:I18	CRCGN004_HA1E_24H_X8	I18	trt_cp	20.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
6305	N06AX02	tryptophan	C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)N	NC(Cc1c[nH]c2ccccc12)C(=O)O	BRD-A07106394	CRCGN004_HA1E_24H_X8_F1B7_DUO52HI53LO:M05	CRCGN004_HA1E_24H_X8	M05	trt_cp	20.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
6305	N06AX02	tryptophan	C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)N	NC(Cc1c[nH]c2ccccc12)C(=O)O	BRD-A07106394	CRCGN001_HA1E_24H_X1_F1B4_DUO52HI53LO:F12	CRCGN001_HA1E_24H_X1	F12	trt_cp	20.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
6305	N06AX02	tryptophan	C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)N	NC(Cc1c[nH]c2ccccc12)C(=O)O	BRD-A07106394	CRCGN001_HA1E_24H_X1_F1B4_DUO52HI53LO:I18	CRCGN001_HA1E_24H_X1	I18	trt_cp	20.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
6305	N06AX02	tryptophan	C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)N	NC(Cc1c[nH]c2ccccc12)C(=O)O	BRD-A07106394	CRCGN001_HA1E_24H_X1_F1B4_DUO52HI53LO:M05	CRCGN001_HA1E_24H_X1	M05	trt_cp	20.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
6305	N06AX02	tryptophan	C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)N	NC(Cc1c[nH]c2ccccc12)C(=O)O	BRD-A07106394	CRCGN001_HA1E_24H_X2_F1B4_DUO52HI53LO:F12	CRCGN001_HA1E_24H_X2	F12	trt_cp	20.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
6305	N06AX02	tryptophan	C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)N	NC(Cc1c[nH]c2ccccc12)C(=O)O	BRD-A07106394	CRCGN001_HA1E_24H_X2_F1B4_DUO52HI53LO:I18	CRCGN001_HA1E_24H_X2	I18	trt_cp	20.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
6305	N06AX02	tryptophan	C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)N	NC(Cc1c[nH]c2ccccc12)C(=O)O	BRD-A07106394	CRCGN001_HA1E_24H_X2_F1B4_DUO52HI53LO:M05	CRCGN001_HA1E_24H_X2	M05	trt_cp	20.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
6305	N06AX02	tryptophan	C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)N	NC(Cc1c[nH]c2ccccc12)C(=O)O	BRD-A07106394	CRCGN001_HA1E_24H_X3_F1B4_DUO52HI53LO:F12	CRCGN001_HA1E_24H_X3	F12	trt_cp	20.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
6305	N06AX02	tryptophan	C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)N	NC(Cc1c[nH]c2ccccc12)C(=O)O	BRD-A07106394	CRCGN001_HA1E_24H_X3_F1B4_DUO52HI53LO:I18	CRCGN001_HA1E_24H_X3	I18	trt_cp	20.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
6305	N06AX02	tryptophan	C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)N	NC(Cc1c[nH]c2ccccc12)C(=O)O	BRD-A07106394	CRCGN001_HA1E_24H_X3_F1B4_DUO52HI53LO:M05	CRCGN001_HA1E_24H_X3	M05	trt_cp	20.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
6305	N06AX02	tryptophan	C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)N	NC(Cc1c[nH]c2ccccc12)C(=O)O	BRD-A07106394	CRCGN001_HA1E_6H_X1_F1B4_DUO52HI53LO:F12	CRCGN001_HA1E_6H_X1	F12	trt_cp	20.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
6305	N06AX02	tryptophan	C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)N	NC(Cc1c[nH]c2ccccc12)C(=O)O	BRD-A07106394	CRCGN001_HA1E_6H_X1_F1B4_DUO52HI53LO:I18	CRCGN001_HA1E_6H_X1	I18	trt_cp	20.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
6305	N06AX02	tryptophan	C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)N	NC(Cc1c[nH]c2ccccc12)C(=O)O	BRD-A07106394	CRCGN001_HA1E_6H_X1_F1B4_DUO52HI53LO:M05	CRCGN001_HA1E_6H_X1	M05	trt_cp	20.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
6305	N06AX02	tryptophan	C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)N	NC(Cc1c[nH]c2ccccc12)C(=O)O	BRD-A07106394	CRCGN001_HA1E_6H_X2_F1B4_DUO52HI53LO:F12	CRCGN001_HA1E_6H_X2	F12	trt_cp	20.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
6305	N06AX02	tryptophan	C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)N	NC(Cc1c[nH]c2ccccc12)C(=O)O	BRD-A07106394	CRCGN001_HA1E_6H_X2_F1B4_DUO52HI53LO:I18	CRCGN001_HA1E_6H_X2	I18	trt_cp	20.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
6305	N06AX02	tryptophan	C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)N	NC(Cc1c[nH]c2ccccc12)C(=O)O	BRD-A07106394	CRCGN001_HA1E_6H_X2_F1B4_DUO52HI53LO:M05	CRCGN001_HA1E_6H_X2	M05	trt_cp	20.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
6305	N06AX02	tryptophan	C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)N	NC(Cc1c[nH]c2ccccc12)C(=O)O	BRD-A07106394	CRCGN001_HA1E_6H_X3_F1B4_DUO52HI53LO:F12	CRCGN001_HA1E_6H_X3	F12	trt_cp	20.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
6305	N06AX02	tryptophan	C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)N	NC(Cc1c[nH]c2ccccc12)C(=O)O	BRD-A07106394	CRCGN001_HA1E_6H_X3_F1B4_DUO52HI53LO:I18	CRCGN001_HA1E_6H_X3	I18	trt_cp	20.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
6305	N06AX02	tryptophan	C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)N	NC(Cc1c[nH]c2ccccc12)C(=O)O	BRD-A07106394	CRCGN001_HA1E_6H_X3_F1B4_DUO52HI53LO:M05	CRCGN001_HA1E_6H_X3	M05	trt_cp	20.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC002_HA1E_24H_X1_B3_DUO52HI53LO:J08	CPC002_HA1E_24H_X1	J08	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC002_HA1E_24H_X2_B3_DUO52HI53LO:J08	CPC002_HA1E_24H_X2	J08	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC002_HA1E_24H_X3_B3_DUO52HI53LO:J08	CPC002_HA1E_24H_X3	J08	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC002_HA1E_6H_X1_B3_DUO52HI53LO:J08	CPC002_HA1E_6H_X1	J08	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC002_HA1E_6H_X2_B3_DUO52HI53LO:J08	CPC002_HA1E_6H_X2	J08	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC002_HA1E_6H_X3_B3_DUO52HI53LO:J08	CPC002_HA1E_6H_X3	J08	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_HA1E_6H_X1_F1B3_DUO52HI53LO:K04	CPC020_HA1E_6H_X1	K04	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_HA1E_6H_X2_F1B3_DUO52HI53LO:K04	CPC020_HA1E_6H_X2	K04	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_HA1E_6H_X3_F1B3_DUO52HI53LO:K04	CPC020_HA1E_6H_X3	K04	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_HA1E_24H_X1_B3_DUO52HI53LO:I06	CPC004_HA1E_24H_X1	I06	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_HA1E_24H_X2_B3_DUO52HI53LO:I06	CPC004_HA1E_24H_X2	I06	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_HA1E_24H_X3_B3_DUO52HI53LO:I06	CPC004_HA1E_24H_X3	I06	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_HA1E_6H_X1_B3_DUO52HI53LO:I06	CPC004_HA1E_6H_X1	I06	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_HA1E_6H_X2_B3_DUO52HI53LO:I06	CPC004_HA1E_6H_X2	I06	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_HA1E_6H_X3_B3_DUO52HI53LO:I06	CPC004_HA1E_6H_X3	I06	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC011_HA1E_6H_X1_F1B3_DUO52HI53LO:K13	CPC011_HA1E_6H_X1	K13	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC011_HA1E_6H_X3_F1B3_DUO52HI53LO:K13	CPC011_HA1E_6H_X3	K13	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC002_HA1E_24H_X1_B3_DUO52HI53LO:H02	CPC002_HA1E_24H_X1	H02	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC002_HA1E_24H_X2_B3_DUO52HI53LO:H02	CPC002_HA1E_24H_X2	H02	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC002_HA1E_24H_X3_B3_DUO52HI53LO:H02	CPC002_HA1E_24H_X3	H02	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC002_HA1E_6H_X1_B3_DUO52HI53LO:H02	CPC002_HA1E_6H_X1	H02	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC002_HA1E_6H_X2_B3_DUO52HI53LO:H02	CPC002_HA1E_6H_X2	H02	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC002_HA1E_6H_X3_B3_DUO52HI53LO:H02	CPC002_HA1E_6H_X3	H02	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC011_HA1E_6H_X1_F1B3_DUO52HI53LO:J05	CPC011_HA1E_6H_X1	J05	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC011_HA1E_6H_X3_F1B3_DUO52HI53LO:J05	CPC011_HA1E_6H_X3	J05	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_HA1E_24H_X1_B3_DUO52HI53LO:E10	CPC005_HA1E_24H_X1	E10	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_HA1E_24H_X2_B3_DUO52HI53LO:E10	CPC005_HA1E_24H_X2	E10	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_HA1E_24H_X3_B3_DUO52HI53LO:E10	CPC005_HA1E_24H_X3	E10	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_HA1E_6H_X1_B3_DUO52HI53LO:E10	CPC005_HA1E_6H_X1	E10	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_HA1E_6H_X3_B3_DUO52HI53LO:E10	CPC005_HA1E_6H_X3	E10	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC003_HA1E_24H_X1_B3_DUO52HI53LO:F01	CPC003_HA1E_24H_X1	F01	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC003_HA1E_24H_X2_B3_DUO52HI53LO:F01	CPC003_HA1E_24H_X2	F01	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC003_HA1E_24H_X3_B3_DUO52HI53LO:F01	CPC003_HA1E_24H_X3	F01	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC003_HA1E_6H_X2_B3_DUO52HI53LO:F01	CPC003_HA1E_6H_X2	F01	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC003_HA1E_6H_X3_B3_DUO52HI53LO:F01	CPC003_HA1E_6H_X3	F01	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC011_HA1E_6H_X1_F1B3_DUO52HI53LO:A13	CPC011_HA1E_6H_X1	A13	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC011_HA1E_6H_X3_F1B3_DUO52HI53LO:A13	CPC011_HA1E_6H_X3	A13	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_HA1E_24H_X1_B3_DUO52HI53LO:A16	CPC004_HA1E_24H_X1	A16	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_HA1E_24H_X2_B3_DUO52HI53LO:A16	CPC004_HA1E_24H_X2	A16	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_HA1E_24H_X3_B3_DUO52HI53LO:A16	CPC004_HA1E_24H_X3	A16	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_HA1E_6H_X1_B3_DUO52HI53LO:A16	CPC004_HA1E_6H_X1	A16	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_HA1E_6H_X2_B3_DUO52HI53LO:A16	CPC004_HA1E_6H_X2	A16	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_HA1E_6H_X3_B3_DUO52HI53LO:A16	CPC004_HA1E_6H_X3	A16	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC011_HA1E_6H_X1_F1B3_DUO52HI53LO:G23	CPC011_HA1E_6H_X1	G23	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC011_HA1E_6H_X3_F1B3_DUO52HI53LO:G23	CPC011_HA1E_6H_X3	G23	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-K83153774	CPC020_HA1E_6H_X1_F1B3_DUO52HI53LO:D15	CPC020_HA1E_6H_X1	D15	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-K83153774	CPC020_HA1E_6H_X2_F1B3_DUO52HI53LO:D15	CPC020_HA1E_6H_X2	D15	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-K83153774	CPC020_HA1E_6H_X3_F1B3_DUO52HI53LO:D15	CPC020_HA1E_6H_X3	D15	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_HA1E_24H_X1_B3_DUO52HI53LO:J08	CPC004_HA1E_24H_X1	J08	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_HA1E_24H_X2_B3_DUO52HI53LO:J08	CPC004_HA1E_24H_X2	J08	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_HA1E_24H_X3_B3_DUO52HI53LO:J08	CPC004_HA1E_24H_X3	J08	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_HA1E_6H_X1_B3_DUO52HI53LO:J08	CPC004_HA1E_6H_X1	J08	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_HA1E_6H_X2_B3_DUO52HI53LO:J08	CPC004_HA1E_6H_X2	J08	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_HA1E_6H_X3_B3_DUO52HI53LO:J08	CPC004_HA1E_6H_X3	J08	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_HA1E_6H_X1_F1B3_DUO52HI53LO:G10	CPC011_HA1E_6H_X1	G10	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_HA1E_6H_X3_F1B3_DUO52HI53LO:G10	CPC011_HA1E_6H_X3	G10	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_HA1E_6H_X1_F1B3_DUO52HI53LO:B03	CPC011_HA1E_6H_X1	B03	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_HA1E_6H_X3_F1B3_DUO52HI53LO:B03	CPC011_HA1E_6H_X3	B03	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_HA1E_24H_X1_B3_DUO52HI53LO:M14	CPC005_HA1E_24H_X1	M14	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_HA1E_24H_X2_B3_DUO52HI53LO:M14	CPC005_HA1E_24H_X2	M14	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_HA1E_24H_X3_B3_DUO52HI53LO:M14	CPC005_HA1E_24H_X3	M14	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_HA1E_6H_X1_B3_DUO52HI53LO:M14	CPC005_HA1E_6H_X1	M14	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_HA1E_6H_X3_B3_DUO52HI53LO:M14	CPC005_HA1E_6H_X3	M14	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_HA1E_24H_X1_B3_DUO52HI53LO:J06	CPC004_HA1E_24H_X1	J06	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_HA1E_24H_X2_B3_DUO52HI53LO:J06	CPC004_HA1E_24H_X2	J06	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_HA1E_24H_X3_B3_DUO52HI53LO:J06	CPC004_HA1E_24H_X3	J06	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_HA1E_6H_X1_B3_DUO52HI53LO:J06	CPC004_HA1E_6H_X1	J06	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_HA1E_6H_X2_B3_DUO52HI53LO:J06	CPC004_HA1E_6H_X2	J06	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_HA1E_6H_X3_B3_DUO52HI53LO:J06	CPC004_HA1E_6H_X3	J06	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC011_HA1E_6H_X1_F1B3_DUO52HI53LO:J19	CPC011_HA1E_6H_X1	J19	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC011_HA1E_6H_X3_F1B3_DUO52HI53LO:J19	CPC011_HA1E_6H_X3	J19	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
65833	N06AX17	milnacipran	CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2	CCN(CC)C(=O)C1(c2ccccc2)CC1CN	BRD-K02227374	CPC011_HA1E_6H_X1_F1B3_DUO52HI53LO:H14	CPC011_HA1E_6H_X1	H14	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
65833	N06AX17	milnacipran	CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2	CCN(CC)C(=O)C1(c2ccccc2)CC1CN	BRD-K02227374	CPC011_HA1E_6H_X3_F1B3_DUO52HI53LO:H14	CPC011_HA1E_6H_X3	H14	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC001_HA1E_24H_X1_B3_DUO52HI53LO:L21	CPC001_HA1E_24H_X1	L21	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC001_HA1E_24H_X2_B3_DUO52HI53LO:L21	CPC001_HA1E_24H_X2	L21	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC001_HA1E_24H_X3_B3_DUO52HI53LO:L21	CPC001_HA1E_24H_X3	L21	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC001_HA1E_6H_X1_B3_DUO52HI53LO:L21	CPC001_HA1E_6H_X1	L21	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC001_HA1E_6H_X2_B3_DUO52HI53LO:L21	CPC001_HA1E_6H_X2	L21	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC001_HA1E_6H_X3_B3_DUO52HI53LO:L21	CPC001_HA1E_6H_X3	L21	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_HA1E_24H_X1_B3_DUO52HI53LO:J03	CPC004_HA1E_24H_X1	J03	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_HA1E_24H_X2_B3_DUO52HI53LO:J03	CPC004_HA1E_24H_X2	J03	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_HA1E_24H_X3_B3_DUO52HI53LO:J03	CPC004_HA1E_24H_X3	J03	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_HA1E_6H_X1_B3_DUO52HI53LO:J03	CPC004_HA1E_6H_X1	J03	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_HA1E_6H_X2_B3_DUO52HI53LO:J03	CPC004_HA1E_6H_X2	J03	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_HA1E_6H_X3_B3_DUO52HI53LO:J03	CPC004_HA1E_6H_X3	J03	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_HA1E_6H_X1_B4_DUO52HI53LO:G22	CPC010_HA1E_6H_X1	G22	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_HA1E_6H_X2_B4_DUO52HI53LO:G22	CPC010_HA1E_6H_X2	G22	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_HA1E_6H_X3_F1B3_DUO52HI53LO:G22	CPC010_HA1E_6H_X3	G22	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC011_HA1E_6H_X1_F1B3_DUO52HI53LO:I05	CPC011_HA1E_6H_X1	I05	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC011_HA1E_6H_X3_F1B3_DUO52HI53LO:I05	CPC011_HA1E_6H_X3	I05	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_HEPG2_6H_X1_B5_DUO52HI53LO:E11	CPC004_HEPG2_6H_X1	E11	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC017_HEPG2_6H_X1_F1B4_DUO52HI53LO:M02	CPC017_HEPG2_6H_X1	M02	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC017_HEPG2_6H_X3_F1B4_DUO52HI53LO:M02	CPC017_HEPG2_6H_X3	M02	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC017_HEPG2_6H_X4_F1B4_DUO52HI53LO:M02	CPC017_HEPG2_6H_X4	M02	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_HEPG2_6H_X2_F1B5_DUO52HI53LO:E11	CPC004_HEPG2_6H_X2	E11	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_HEPG2_6H_X3.L2_F2B5_DUO52HI53LO:E11	CPC004_HEPG2_6H_X3.L2	E11	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC018_HEPG2_6H_X1_F1B3_DUO52HI53LO:F20	CPC018_HEPG2_6H_X1	F20	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC018_HEPG2_6H_X2_F1B4_DUO52HI53LO:F20	CPC018_HEPG2_6H_X2	F20	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC018_HEPG2_6H_X3_F1B3_DUO52HI53LO:F20	CPC018_HEPG2_6H_X3	F20	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_HEPG2_6H_X1_B5_DUO52HI53LO:I02	CPC004_HEPG2_6H_X1	I02	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_HEPG2_6H_X2_F1B5_DUO52HI53LO:I02	CPC004_HEPG2_6H_X2	I02	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_HEPG2_6H_X1_F1B4_DUO52HI53LO:N08	CPC016_HEPG2_6H_X1	N08	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_HEPG2_6H_X3_F1B4_DUO52HI53LO:N08	CPC016_HEPG2_6H_X3	N08	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_HEPG2_6H_X4_F1B4_DUO52HI53LO:N08	CPC016_HEPG2_6H_X4	N08	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_HEPG2_6H_X3.L2_F2B5_DUO52HI53LO:I02	CPC004_HEPG2_6H_X3.L2	I02	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_HEPG2_6H_X1_B5_DUO52HI53LO:I02	CPC004_HEPG2_6H_X1	I02	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_HEPG2_6H_X2_F1B5_DUO52HI53LO:I02	CPC004_HEPG2_6H_X2	I02	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_HEPG2_6H_X1_F1B4_DUO52HI53LO:N08	CPC016_HEPG2_6H_X1	N08	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_HEPG2_6H_X3_F1B4_DUO52HI53LO:N08	CPC016_HEPG2_6H_X3	N08	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_HEPG2_6H_X4_F1B4_DUO52HI53LO:N08	CPC016_HEPG2_6H_X4	N08	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_HEPG2_6H_X3.L2_F2B5_DUO52HI53LO:I02	CPC004_HEPG2_6H_X3.L2	I02	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC017_HEPG2_6H_X1_F1B4_DUO52HI53LO:L04	CPC017_HEPG2_6H_X1	L04	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC017_HEPG2_6H_X3_F1B4_DUO52HI53LO:L04	CPC017_HEPG2_6H_X3	L04	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC017_HEPG2_6H_X4_F1B4_DUO52HI53LO:L04	CPC017_HEPG2_6H_X4	L04	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC015_HEPG2_6H_X2.L2_F2B5_DUO52HI53LO:J10	CPC015_HEPG2_6H_X2.L2	J10	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC015_HEPG2_6H_X3.L2_F1B5_DUO52HI53LO:J10	CPC015_HEPG2_6H_X3.L2	J10	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC018_HEPG2_6H_X1_F1B3_DUO52HI53LO:J19	CPC018_HEPG2_6H_X1	J19	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC018_HEPG2_6H_X2_F1B4_DUO52HI53LO:J19	CPC018_HEPG2_6H_X2	J19	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC018_HEPG2_6H_X3_F1B3_DUO52HI53LO:J19	CPC018_HEPG2_6H_X3	J19	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC015_HEPG2_6H_X2.L2_F2B5_DUO52HI53LO:L03	CPC015_HEPG2_6H_X2.L2	L03	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC015_HEPG2_6H_X3.L2_F1B5_DUO52HI53LO:L03	CPC015_HEPG2_6H_X3.L2	L03	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_HEPG2_6H_X1_B5_DUO52HI53LO:J02	CPC004_HEPG2_6H_X1	J02	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_HEPG2_6H_X2_F1B5_DUO52HI53LO:J02	CPC004_HEPG2_6H_X2	J02	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_HEPG2_6H_X3.L2_F2B5_DUO52HI53LO:J02	CPC004_HEPG2_6H_X3.L2	J02	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC004_HEPG2_6H_X1_B5_DUO52HI53LO:K17	CPC004_HEPG2_6H_X1	K17	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC018_HEPG2_6H_X1_F1B3_DUO52HI53LO:A20	CPC018_HEPG2_6H_X1	A20	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC018_HEPG2_6H_X2_F1B4_DUO52HI53LO:A20	CPC018_HEPG2_6H_X2	A20	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC018_HEPG2_6H_X3_F1B3_DUO52HI53LO:A20	CPC018_HEPG2_6H_X3	A20	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC004_HEPG2_6H_X2_F1B5_DUO52HI53LO:K17	CPC004_HEPG2_6H_X2	K17	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC004_HEPG2_6H_X3.L2_F2B5_DUO52HI53LO:K17	CPC004_HEPG2_6H_X3.L2	K17	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_HEPG2_6H_X1_B5_DUO52HI53LO:G23	CPC004_HEPG2_6H_X1	G23	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC017_HEPG2_6H_X1_F1B4_DUO52HI53LO:O16	CPC017_HEPG2_6H_X1	O16	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC017_HEPG2_6H_X3_F1B4_DUO52HI53LO:O16	CPC017_HEPG2_6H_X3	O16	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC017_HEPG2_6H_X4_F1B4_DUO52HI53LO:O16	CPC017_HEPG2_6H_X4	O16	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_HEPG2_6H_X2_F1B5_DUO52HI53LO:G23	CPC004_HEPG2_6H_X2	G23	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_HEPG2_6H_X3.L2_F2B5_DUO52HI53LO:G23	CPC004_HEPG2_6H_X3.L2	G23	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC017_HEPG2_6H_X1_F1B4_DUO52HI53LO:I07	CPC017_HEPG2_6H_X1	I07	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC017_HEPG2_6H_X3_F1B4_DUO52HI53LO:I07	CPC017_HEPG2_6H_X3	I07	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC017_HEPG2_6H_X4_F1B4_DUO52HI53LO:I07	CPC017_HEPG2_6H_X4	I07	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC017_HEPG2_6H_X1_F1B4_DUO52HI53LO:I11	CPC017_HEPG2_6H_X1	I11	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC017_HEPG2_6H_X3_F1B4_DUO52HI53LO:I11	CPC017_HEPG2_6H_X3	I11	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC017_HEPG2_6H_X4_F1B4_DUO52HI53LO:I11	CPC017_HEPG2_6H_X4	I11	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_HEPG2_6H_X1_B5_DUO52HI53LO:E01	CPC004_HEPG2_6H_X1	E01	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_HEPG2_6H_X2_F1B5_DUO52HI53LO:E01	CPC004_HEPG2_6H_X2	E01	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_HEPG2_6H_X3.L2_F2B5_DUO52HI53LO:E01	CPC004_HEPG2_6H_X3.L2	E01	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC017_HEPG2_6H_X1_F1B4_DUO52HI53LO:K18	CPC017_HEPG2_6H_X1	K18	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC017_HEPG2_6H_X3_F1B4_DUO52HI53LO:K18	CPC017_HEPG2_6H_X3	K18	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC017_HEPG2_6H_X4_F1B4_DUO52HI53LO:K18	CPC017_HEPG2_6H_X4	K18	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC018_HEPG2_6H_X1_F1B3_DUO52HI53LO:H09	CPC018_HEPG2_6H_X1	H09	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC018_HEPG2_6H_X2_F1B4_DUO52HI53LO:H09	CPC018_HEPG2_6H_X2	H09	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC018_HEPG2_6H_X3_F1B3_DUO52HI53LO:H09	CPC018_HEPG2_6H_X3	H09	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_HEPG2_6H_X1_B4_DUO52HI53LO:J24	CPC009_HEPG2_6H_X1	J24	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_HEPG2_6H_X2_F1B3_DUO52HI53LO:J24	CPC009_HEPG2_6H_X2	J24	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_HEPG2_6H_X3_F1B3_DUO52HI53LO:J24	CPC009_HEPG2_6H_X3	J24	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_HEPG2_6H_X1_B4_DUO52HI53LO:B24	CPC009_HEPG2_6H_X1	B24	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_HEPG2_6H_X2_F1B3_DUO52HI53LO:B24	CPC009_HEPG2_6H_X2	B24	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_HEPG2_6H_X3_F1B3_DUO52HI53LO:B24	CPC009_HEPG2_6H_X3	B24	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_HEPG2_6H_X1_B5_DUO52HI53LO:H24	CPC004_HEPG2_6H_X1	H24	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC015_HEPG2_6H_X2.L2_F2B5_DUO52HI53LO:L01	CPC015_HEPG2_6H_X2.L2	L01	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC015_HEPG2_6H_X3.L2_F1B5_DUO52HI53LO:L01	CPC015_HEPG2_6H_X3.L2	L01	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_HEPG2_6H_X2_F1B5_DUO52HI53LO:H24	CPC004_HEPG2_6H_X2	H24	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_HEPG2_6H_X3.L2_F2B5_DUO52HI53LO:H24	CPC004_HEPG2_6H_X3.L2	H24	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_HEPG2_6H_X1_B5_DUO52HI53LO:H13	CPC004_HEPG2_6H_X1	H13	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC015_HEPG2_6H_X2.L2_F2B5_DUO52HI53LO:K04	CPC015_HEPG2_6H_X2.L2	K04	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC015_HEPG2_6H_X3.L2_F1B5_DUO52HI53LO:K04	CPC015_HEPG2_6H_X3.L2	K04	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_HEPG2_6H_X2_F1B5_DUO52HI53LO:H13	CPC004_HEPG2_6H_X2	H13	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_HEPG2_6H_X3.L2_F2B5_DUO52HI53LO:H13	CPC004_HEPG2_6H_X3.L2	H13	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_HEPG2_6H_X1_B5_DUO52HI53LO:J04	CPC004_HEPG2_6H_X1	J04	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_HEPG2_6H_X2_F1B5_DUO52HI53LO:J04	CPC004_HEPG2_6H_X2	J04	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_HEPG2_6H_X3.L2_F2B5_DUO52HI53LO:J04	CPC004_HEPG2_6H_X3.L2	J04	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC015_HEPG2_6H_X2.L2_F2B5_DUO52HI53LO:L05	CPC015_HEPG2_6H_X2.L2	L05	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC015_HEPG2_6H_X3.L2_F1B5_DUO52HI53LO:L05	CPC015_HEPG2_6H_X3.L2	L05	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC016_HEPG2_6H_X1_F1B4_DUO52HI53LO:M15	CPC016_HEPG2_6H_X1	M15	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC016_HEPG2_6H_X3_F1B4_DUO52HI53LO:M15	CPC016_HEPG2_6H_X3	M15	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC016_HEPG2_6H_X4_F1B4_DUO52HI53LO:M15	CPC016_HEPG2_6H_X4	M15	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_HEPG2_6H_X1_B5_DUO52HI53LO:H07	CPC004_HEPG2_6H_X1	H07	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_HEPG2_6H_X2_F1B5_DUO52HI53LO:H07	CPC004_HEPG2_6H_X2	H07	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC015_HEPG2_6H_X2.L2_F2B5_DUO52HI53LO:I22	CPC015_HEPG2_6H_X2.L2	I22	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC015_HEPG2_6H_X3.L2_F1B5_DUO52HI53LO:I22	CPC015_HEPG2_6H_X3.L2	I22	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_HEPG2_6H_X3.L2_F2B5_DUO52HI53LO:H07	CPC004_HEPG2_6H_X3.L2	H07	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC016_HEPG2_6H_X1_F1B4_DUO52HI53LO:M20	CPC016_HEPG2_6H_X1	M20	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC016_HEPG2_6H_X3_F1B4_DUO52HI53LO:M20	CPC016_HEPG2_6H_X3	M20	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC016_HEPG2_6H_X4_F1B4_DUO52HI53LO:M20	CPC016_HEPG2_6H_X4	M20	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPC010_HEPG2_6H_X3_B4_DUO52HI53LO:P24	CPC010_HEPG2_6H_X3	P24	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC009_HEPG2_6H_X1_B4_DUO52HI53LO:K23	CPC009_HEPG2_6H_X1	K23	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC009_HEPG2_6H_X2_F1B3_DUO52HI53LO:K23	CPC009_HEPG2_6H_X2	K23	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC009_HEPG2_6H_X3_F1B3_DUO52HI53LO:K23	CPC009_HEPG2_6H_X3	K23	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC016_HEPG2_6H_X3_F1B4_DUO52HI53LO:O06	CPC016_HEPG2_6H_X3	O06	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_HEPG2_6H_X1_B5_DUO52HI53LO:I06	CPC004_HEPG2_6H_X1	I06	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC016_HEPG2_6H_X1_F1B4_DUO52HI53LO:N14	CPC016_HEPG2_6H_X1	N14	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC016_HEPG2_6H_X3_F1B4_DUO52HI53LO:N14	CPC016_HEPG2_6H_X3	N14	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC016_HEPG2_6H_X4_F1B4_DUO52HI53LO:N14	CPC016_HEPG2_6H_X4	N14	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_HEPG2_6H_X2_F1B5_DUO52HI53LO:I06	CPC004_HEPG2_6H_X2	I06	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_HEPG2_6H_X3.L2_F2B5_DUO52HI53LO:I06	CPC004_HEPG2_6H_X3.L2	I06	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC016_HEPG2_6H_X3_F1B4_DUO52HI53LO:K22	CPC016_HEPG2_6H_X3	K22	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC016_HEPG2_6H_X4_F1B4_DUO52HI53LO:K22	CPC016_HEPG2_6H_X4	K22	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC016_HEPG2_6H_X1_F1B4_DUO52HI53LO:C19	CPC016_HEPG2_6H_X1	C19	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC016_HEPG2_6H_X3_F1B4_DUO52HI53LO:C19	CPC016_HEPG2_6H_X3	C19	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC016_HEPG2_6H_X4_F1B4_DUO52HI53LO:C19	CPC016_HEPG2_6H_X4	C19	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_HEPG2_6H_X1_B5_DUO52HI53LO:A16	CPC004_HEPG2_6H_X1	A16	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_HEPG2_6H_X2_F1B5_DUO52HI53LO:A16	CPC004_HEPG2_6H_X2	A16	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_HEPG2_6H_X3.L2_F2B5_DUO52HI53LO:A16	CPC004_HEPG2_6H_X3.L2	A16	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC016_HEPG2_6H_X1_F1B4_DUO52HI53LO:H06	CPC016_HEPG2_6H_X1	H06	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC016_HEPG2_6H_X3_F1B4_DUO52HI53LO:H06	CPC016_HEPG2_6H_X3	H06	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC016_HEPG2_6H_X4_F1B4_DUO52HI53LO:H06	CPC016_HEPG2_6H_X4	H06	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_HEPG2_6H_X1_B5_DUO52HI53LO:J08	CPC004_HEPG2_6H_X1	J08	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_HEPG2_6H_X2_F1B5_DUO52HI53LO:J08	CPC004_HEPG2_6H_X2	J08	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_HEPG2_6H_X3.L2_F2B5_DUO52HI53LO:J08	CPC004_HEPG2_6H_X3.L2	J08	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC015_HEPG2_6H_X2.L2_F2B5_DUO52HI53LO:L09	CPC015_HEPG2_6H_X2.L2	L09	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC015_HEPG2_6H_X3.L2_F1B5_DUO52HI53LO:L09	CPC015_HEPG2_6H_X3.L2	L09	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_HEPG2_6H_X1_B5_DUO52HI53LO:J06	CPC004_HEPG2_6H_X1	J06	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_HEPG2_6H_X2_F1B5_DUO52HI53LO:J06	CPC004_HEPG2_6H_X2	J06	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_HEPG2_6H_X3.L2_F2B5_DUO52HI53LO:J06	CPC004_HEPG2_6H_X3.L2	J06	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC015_HEPG2_6H_X2.L2_F2B5_DUO52HI53LO:L07	CPC015_HEPG2_6H_X2.L2	L07	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC015_HEPG2_6H_X3.L2_F1B5_DUO52HI53LO:L07	CPC015_HEPG2_6H_X3.L2	L07	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC017_HEPG2_6H_X1_F1B4_DUO52HI53LO:F21	CPC017_HEPG2_6H_X1	F21	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC017_HEPG2_6H_X3_F1B4_DUO52HI53LO:F21	CPC017_HEPG2_6H_X3	F21	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC017_HEPG2_6H_X4_F1B4_DUO52HI53LO:F21	CPC017_HEPG2_6H_X4	F21	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_HEPG2_6H_X1_B5_DUO52HI53LO:J03	CPC004_HEPG2_6H_X1	J03	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_HEPG2_6H_X1_B4_DUO52HI53LO:G22	CPC010_HEPG2_6H_X1	G22	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_HEPG2_6H_X2_B4_DUO52HI53LO:G22	CPC010_HEPG2_6H_X2	G22	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_HEPG2_6H_X3_B4_DUO52HI53LO:G22	CPC010_HEPG2_6H_X3	G22	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC015_HEPG2_6H_X2.L2_F2B5_DUO52HI53LO:K18	CPC015_HEPG2_6H_X2.L2	K18	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC015_HEPG2_6H_X3.L2_F1B5_DUO52HI53LO:K18	CPC015_HEPG2_6H_X3.L2	K18	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_HEPG2_6H_X2_F1B5_DUO52HI53LO:J03	CPC004_HEPG2_6H_X2	J03	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_HEPG2_6H_X3.L2_F2B5_DUO52HI53LO:J03	CPC004_HEPG2_6H_X3.L2	J03	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_HT29_6H_X1_B3_DUO52HI53LO:E11	CPC004_HT29_6H_X1	E11	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_HT29_6H_X2_B3_DUO52HI53LO:E11	CPC004_HT29_6H_X2	E11	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_HT29_6H_X3_B3_DUO52HI53LO:E11	CPC004_HT29_6H_X3	E11	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_HT29_6H_X4_B5_DUO52HI53LO:E11	CPC004_HT29_6H_X4	E11	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_HT29_6H_X5_B5_DUO52HI53LO:E11	CPC004_HT29_6H_X5	E11	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC017_HT29_6H_X5_F1B5_DUO52HI53LO:M02	CPC017_HT29_6H_X5	M02	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC020_HT29_6H_X1.L2_F1B5_DUO52HI53LO:F21	CPC020_HT29_6H_X1.L2	F21	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC020_HT29_6H_X2.L2_B6_DUO52HI53LO:F21	CPC020_HT29_6H_X2.L2	F21	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC020_HT29_6H_X4_B5_DUO52HI53LO:F21	CPC020_HT29_6H_X4	F21	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC020_HT29_6H_X5_B5_DUO52HI53LO:F21	CPC020_HT29_6H_X5	F21	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC017_HT29_6H_X1_B4_DUO52HI53LO:M02	CPC017_HT29_6H_X1	M02	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC017_HT29_6H_X2_B4_DUO52HI53LO:M02	CPC017_HT29_6H_X2	M02	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC017_HT29_6H_X3_B4_DUO52HI53LO:M02	CPC017_HT29_6H_X3	M02	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC017_HT29_6H_X4_B5_DUO52HI53LO:M02	CPC017_HT29_6H_X4	M02	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_HT29_24H_X1_B3_DUO52HI53LO:C12	CPC005_HT29_24H_X1	C12	trt_cp	10.0	um	24	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_HT29_24H_X2_B3_DUO52HI53LO:C12	CPC005_HT29_24H_X2	C12	trt_cp	10.0	um	24	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_HT29_24H_X3_B3_DUO52HI53LO:C12	CPC005_HT29_24H_X3	C12	trt_cp	10.0	um	24	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_HT29_6H_X1_B3_DUO52HI53LO:C12	CPC005_HT29_6H_X1	C12	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_HT29_6H_X2_B3_DUO52HI53LO:C12	CPC005_HT29_6H_X2	C12	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_HT29_6H_X3_B3_DUO52HI53LO:C12	CPC005_HT29_6H_X3	C12	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_HT29_6H_X1.L2_F1B5_DUO52HI53LO:H14	CPC020_HT29_6H_X1.L2	H14	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_HT29_6H_X1.L2_F1B5_DUO52HI53LO:L24	CPC020_HT29_6H_X1.L2	L24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_HT29_6H_X2.L2_B6_DUO52HI53LO:H14	CPC020_HT29_6H_X2.L2	H14	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_HT29_6H_X2.L2_B6_DUO52HI53LO:L24	CPC020_HT29_6H_X2.L2	L24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_HT29_6H_X4_B5_DUO52HI53LO:H14	CPC020_HT29_6H_X4	H14	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_HT29_6H_X4_B5_DUO52HI53LO:L24	CPC020_HT29_6H_X4	L24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_HT29_6H_X5_B5_DUO52HI53LO:H14	CPC020_HT29_6H_X5	H14	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_HT29_6H_X5_B5_DUO52HI53LO:L24	CPC020_HT29_6H_X5	L24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC018_HT29_6H_X4_F1B5_DUO52HI53LO:F20	CPC018_HT29_6H_X4	F20	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC020_HT29_6H_X1.L2_F1B5_DUO52HI53LO:P19	CPC020_HT29_6H_X1.L2	P19	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC020_HT29_6H_X2.L2_B6_DUO52HI53LO:P19	CPC020_HT29_6H_X2.L2	P19	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC020_HT29_6H_X5_B5_DUO52HI53LO:P19	CPC020_HT29_6H_X5	P19	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC018_HT29_6H_X1_B4_DUO52HI53LO:F20	CPC018_HT29_6H_X1	F20	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC018_HT29_6H_X2_B4_DUO52HI53LO:F20	CPC018_HT29_6H_X2	F20	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC018_HT29_6H_X3_B4_DUO52HI53LO:F20	CPC018_HT29_6H_X3	F20	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC018_HT29_6H_X5_B5_DUO52HI53LO:F20	CPC018_HT29_6H_X5	F20	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_HT29_6H_X1_B3_DUO52HI53LO:I02	CPC004_HT29_6H_X1	I02	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_HT29_6H_X2_B3_DUO52HI53LO:I02	CPC004_HT29_6H_X2	I02	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_HT29_6H_X3_B3_DUO52HI53LO:I02	CPC004_HT29_6H_X3	I02	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_HT29_6H_X4_B5_DUO52HI53LO:I02	CPC004_HT29_6H_X4	I02	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_HT29_6H_X5_B5_DUO52HI53LO:I02	CPC004_HT29_6H_X5	I02	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_HT29_6H_X5_F1B5_DUO52HI53LO:N08	CPC016_HT29_6H_X5	N08	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_HT29_6H_X1_B4_DUO52HI53LO:N08	CPC016_HT29_6H_X1	N08	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_HT29_6H_X2_B4_DUO52HI53LO:N08	CPC016_HT29_6H_X2	N08	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_HT29_6H_X3_B4_DUO52HI53LO:N08	CPC016_HT29_6H_X3	N08	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_HT29_6H_X4_B5_DUO52HI53LO:N08	CPC016_HT29_6H_X4	N08	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_HT29_6H_X1_B3_DUO52HI53LO:I02	CPC004_HT29_6H_X1	I02	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_HT29_6H_X2_B3_DUO52HI53LO:I02	CPC004_HT29_6H_X2	I02	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_HT29_6H_X3_B3_DUO52HI53LO:I02	CPC004_HT29_6H_X3	I02	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_HT29_6H_X4_B5_DUO52HI53LO:I02	CPC004_HT29_6H_X4	I02	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_HT29_6H_X5_B5_DUO52HI53LO:I02	CPC004_HT29_6H_X5	I02	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_HT29_6H_X5_F1B5_DUO52HI53LO:N08	CPC016_HT29_6H_X5	N08	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_HT29_6H_X1_B4_DUO52HI53LO:N08	CPC016_HT29_6H_X1	N08	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_HT29_6H_X2_B4_DUO52HI53LO:N08	CPC016_HT29_6H_X2	N08	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_HT29_6H_X3_B4_DUO52HI53LO:N08	CPC016_HT29_6H_X3	N08	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_HT29_6H_X4_B5_DUO52HI53LO:N08	CPC016_HT29_6H_X4	N08	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
3947	N06AA07	lofepramine	CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)CC(=O)C4=CC=C(C=C4)Cl	CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1	BRD-K82147103	CPC011_HT29_6H_X1_B3_DUO52HI53LO:M10	CPC011_HT29_6H_X1	M10	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
3947	N06AA07	lofepramine	CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)CC(=O)C4=CC=C(C=C4)Cl	CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1	BRD-K82147103	CPC011_HT29_6H_X2_B3_DUO52HI53LO:M10	CPC011_HT29_6H_X2	M10	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
3947	N06AA07	lofepramine	CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)CC(=O)C4=CC=C(C=C4)Cl	CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1	BRD-K82147103	CPC011_HT29_6H_X4_B5_DUO52HI53LO:M10	CPC011_HT29_6H_X4	M10	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
3947	N06AA07	lofepramine	CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)CC(=O)C4=CC=C(C=C4)Cl	CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1	BRD-K82147103	CPC011_HT29_6H_X5_B5_DUO52HI53LO:M10	CPC011_HT29_6H_X5	M10	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC017_HT29_6H_X5_F1B5_DUO52HI53LO:L04	CPC017_HT29_6H_X5	L04	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC017_HT29_6H_X1_B4_DUO52HI53LO:L04	CPC017_HT29_6H_X1	L04	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC017_HT29_6H_X2_B4_DUO52HI53LO:L04	CPC017_HT29_6H_X2	L04	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC017_HT29_6H_X3_B4_DUO52HI53LO:L04	CPC017_HT29_6H_X3	L04	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC017_HT29_6H_X4_B5_DUO52HI53LO:L04	CPC017_HT29_6H_X4	L04	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC015_HT29_6H_X1_B4_DUO52HI53LO:J10	CPC015_HT29_6H_X1	J10	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC015_HT29_6H_X3_B4_DUO52HI53LO:J10	CPC015_HT29_6H_X3	J10	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC015_HT29_6H_X5_B5_DUO52HI53LO:J10	CPC015_HT29_6H_X5	J10	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC018_HT29_6H_X4_F1B5_DUO52HI53LO:J19	CPC018_HT29_6H_X4	J19	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC018_HT29_6H_X1_B4_DUO52HI53LO:J19	CPC018_HT29_6H_X1	J19	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC018_HT29_6H_X2_B4_DUO52HI53LO:J19	CPC018_HT29_6H_X2	J19	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC018_HT29_6H_X3_B4_DUO52HI53LO:J19	CPC018_HT29_6H_X3	J19	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC018_HT29_6H_X5_B5_DUO52HI53LO:J19	CPC018_HT29_6H_X5	J19	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_HT29_6H_X1_B3_DUO52HI53LO:J02	CPC004_HT29_6H_X1	J02	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_HT29_6H_X2_B3_DUO52HI53LO:J02	CPC004_HT29_6H_X2	J02	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_HT29_6H_X3_B3_DUO52HI53LO:J02	CPC004_HT29_6H_X3	J02	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_HT29_6H_X4_B5_DUO52HI53LO:J02	CPC004_HT29_6H_X4	J02	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_HT29_6H_X5_B5_DUO52HI53LO:J02	CPC004_HT29_6H_X5	J02	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC015_HT29_6H_X1_B4_DUO52HI53LO:L03	CPC015_HT29_6H_X1	L03	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC015_HT29_6H_X3_B4_DUO52HI53LO:L03	CPC015_HT29_6H_X3	L03	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC015_HT29_6H_X5_B5_DUO52HI53LO:L03	CPC015_HT29_6H_X5	L03	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC004_HT29_6H_X1_B3_DUO52HI53LO:K17	CPC004_HT29_6H_X1	K17	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC004_HT29_6H_X2_B3_DUO52HI53LO:K17	CPC004_HT29_6H_X2	K17	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC004_HT29_6H_X3_B3_DUO52HI53LO:K17	CPC004_HT29_6H_X3	K17	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC004_HT29_6H_X4_B5_DUO52HI53LO:K17	CPC004_HT29_6H_X4	K17	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC004_HT29_6H_X5_B5_DUO52HI53LO:K17	CPC004_HT29_6H_X5	K17	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC018_HT29_6H_X4_F1B5_DUO52HI53LO:A20	CPC018_HT29_6H_X4	A20	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC018_HT29_6H_X1_B4_DUO52HI53LO:A20	CPC018_HT29_6H_X1	A20	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC018_HT29_6H_X2_B4_DUO52HI53LO:A20	CPC018_HT29_6H_X2	A20	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC018_HT29_6H_X3_B4_DUO52HI53LO:A20	CPC018_HT29_6H_X3	A20	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC018_HT29_6H_X5_B5_DUO52HI53LO:A20	CPC018_HT29_6H_X5	A20	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_HT29_6H_X1_B3_DUO52HI53LO:G23	CPC004_HT29_6H_X1	G23	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_HT29_6H_X2_B3_DUO52HI53LO:G23	CPC004_HT29_6H_X2	G23	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_HT29_6H_X3_B3_DUO52HI53LO:G23	CPC004_HT29_6H_X3	G23	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_HT29_6H_X4_B5_DUO52HI53LO:G23	CPC004_HT29_6H_X4	G23	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_HT29_6H_X5_B5_DUO52HI53LO:G23	CPC004_HT29_6H_X5	G23	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC017_HT29_6H_X5_F1B5_DUO52HI53LO:O16	CPC017_HT29_6H_X5	O16	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC011_HT29_6H_X1_B3_DUO52HI53LO:G15	CPC011_HT29_6H_X1	G15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC011_HT29_6H_X2_B3_DUO52HI53LO:G15	CPC011_HT29_6H_X2	G15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC011_HT29_6H_X4_B5_DUO52HI53LO:G15	CPC011_HT29_6H_X4	G15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC011_HT29_6H_X5_B5_DUO52HI53LO:G15	CPC011_HT29_6H_X5	G15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC017_HT29_6H_X1_B4_DUO52HI53LO:O16	CPC017_HT29_6H_X1	O16	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC017_HT29_6H_X2_B4_DUO52HI53LO:O16	CPC017_HT29_6H_X2	O16	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC017_HT29_6H_X3_B4_DUO52HI53LO:O16	CPC017_HT29_6H_X3	O16	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC017_HT29_6H_X4_B5_DUO52HI53LO:O16	CPC017_HT29_6H_X4	O16	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC017_HT29_6H_X5_F1B5_DUO52HI53LO:I07	CPC017_HT29_6H_X5	I07	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC020_HT29_6H_X1.L2_F1B5_DUO52HI53LO:O02	CPC020_HT29_6H_X1.L2	O02	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC020_HT29_6H_X2.L2_B6_DUO52HI53LO:O02	CPC020_HT29_6H_X2.L2	O02	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC020_HT29_6H_X4_B5_DUO52HI53LO:O02	CPC020_HT29_6H_X4	O02	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC020_HT29_6H_X5_B5_DUO52HI53LO:O02	CPC020_HT29_6H_X5	O02	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC017_HT29_6H_X1_B4_DUO52HI53LO:I07	CPC017_HT29_6H_X1	I07	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC017_HT29_6H_X2_B4_DUO52HI53LO:I07	CPC017_HT29_6H_X2	I07	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC017_HT29_6H_X3_B4_DUO52HI53LO:I07	CPC017_HT29_6H_X3	I07	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC017_HT29_6H_X5_F1B5_DUO52HI53LO:I11	CPC017_HT29_6H_X5	I11	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC017_HT29_6H_X1_B4_DUO52HI53LO:I11	CPC017_HT29_6H_X1	I11	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC017_HT29_6H_X2_B4_DUO52HI53LO:I11	CPC017_HT29_6H_X2	I11	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC017_HT29_6H_X3_B4_DUO52HI53LO:I11	CPC017_HT29_6H_X3	I11	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC017_HT29_6H_X4_B5_DUO52HI53LO:I11	CPC017_HT29_6H_X4	I11	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_HT29_6H_X1_B3_DUO52HI53LO:E01	CPC004_HT29_6H_X1	E01	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_HT29_6H_X2_B3_DUO52HI53LO:E01	CPC004_HT29_6H_X2	E01	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_HT29_6H_X3_B3_DUO52HI53LO:E01	CPC004_HT29_6H_X3	E01	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_HT29_6H_X4_B5_DUO52HI53LO:E01	CPC004_HT29_6H_X4	E01	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_HT29_6H_X5_B5_DUO52HI53LO:E01	CPC004_HT29_6H_X5	E01	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC017_HT29_6H_X5_F1B5_DUO52HI53LO:K18	CPC017_HT29_6H_X5	K18	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_HT29_6H_X1.L2_F1B5_DUO52HI53LO:F24	CPC020_HT29_6H_X1.L2	F24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_HT29_6H_X1.L2_F1B5_DUO52HI53LO:H08	CPC020_HT29_6H_X1.L2	H08	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_HT29_6H_X2.L2_B6_DUO52HI53LO:F24	CPC020_HT29_6H_X2.L2	F24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_HT29_6H_X2.L2_B6_DUO52HI53LO:H08	CPC020_HT29_6H_X2.L2	H08	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_HT29_6H_X4_B5_DUO52HI53LO:F24	CPC020_HT29_6H_X4	F24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_HT29_6H_X4_B5_DUO52HI53LO:H08	CPC020_HT29_6H_X4	H08	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_HT29_6H_X5_B5_DUO52HI53LO:F24	CPC020_HT29_6H_X5	F24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_HT29_6H_X5_B5_DUO52HI53LO:H08	CPC020_HT29_6H_X5	H08	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC017_HT29_6H_X1_B4_DUO52HI53LO:K18	CPC017_HT29_6H_X1	K18	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC017_HT29_6H_X2_B4_DUO52HI53LO:K18	CPC017_HT29_6H_X2	K18	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC017_HT29_6H_X3_B4_DUO52HI53LO:K18	CPC017_HT29_6H_X3	K18	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC017_HT29_6H_X4_B5_DUO52HI53LO:K18	CPC017_HT29_6H_X4	K18	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_HT29_24H_X1_B3_DUO52HI53LO:N07	CPC005_HT29_24H_X1	N07	trt_cp	10.0	um	24	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_HT29_24H_X2_B3_DUO52HI53LO:N07	CPC005_HT29_24H_X2	N07	trt_cp	10.0	um	24	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_HT29_24H_X3_B3_DUO52HI53LO:N07	CPC005_HT29_24H_X3	N07	trt_cp	10.0	um	24	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_HT29_6H_X1_B3_DUO52HI53LO:N07	CPC005_HT29_6H_X1	N07	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_HT29_6H_X2_B3_DUO52HI53LO:N07	CPC005_HT29_6H_X2	N07	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_HT29_6H_X3_B3_DUO52HI53LO:N07	CPC005_HT29_6H_X3	N07	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC018_HT29_6H_X4_F1B5_DUO52HI53LO:H09	CPC018_HT29_6H_X4	H09	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC011_HT29_6H_X1_B3_DUO52HI53LO:O15	CPC011_HT29_6H_X1	O15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC011_HT29_6H_X2_B3_DUO52HI53LO:O15	CPC011_HT29_6H_X2	O15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC011_HT29_6H_X4_B5_DUO52HI53LO:O15	CPC011_HT29_6H_X4	O15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC011_HT29_6H_X5_B5_DUO52HI53LO:O15	CPC011_HT29_6H_X5	O15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC018_HT29_6H_X1_B4_DUO52HI53LO:H09	CPC018_HT29_6H_X1	H09	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC018_HT29_6H_X2_B4_DUO52HI53LO:H09	CPC018_HT29_6H_X2	H09	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC018_HT29_6H_X3_B4_DUO52HI53LO:H09	CPC018_HT29_6H_X3	H09	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC018_HT29_6H_X5_B5_DUO52HI53LO:H09	CPC018_HT29_6H_X5	H09	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_HT29_24H_X1_B3_DUO52HI53LO:P19	CPC005_HT29_24H_X1	P19	trt_cp	10.0	um	24	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_HT29_24H_X2_B3_DUO52HI53LO:P19	CPC005_HT29_24H_X2	P19	trt_cp	10.0	um	24	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_HT29_24H_X3_B3_DUO52HI53LO:P19	CPC005_HT29_24H_X3	P19	trt_cp	10.0	um	24	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_HT29_6H_X1_B3_DUO52HI53LO:P19	CPC005_HT29_6H_X1	P19	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_HT29_6H_X2_B3_DUO52HI53LO:P19	CPC005_HT29_6H_X2	P19	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_HT29_6H_X3_B3_DUO52HI53LO:P19	CPC005_HT29_6H_X3	P19	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_HT29_6H_X1_B3_DUO52HI53LO:J24	CPC009_HT29_6H_X1	J24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_HT29_6H_X3_B3_DUO52HI53LO:J24	CPC009_HT29_6H_X3	J24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_HT29_6H_X5_B5_DUO52HI53LO:J24	CPC009_HT29_6H_X5	J24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_HT29_24H_X1_B3_DUO52HI53LO:F24	CPC005_HT29_24H_X1	F24	trt_cp	10.0	um	24	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_HT29_24H_X2_B3_DUO52HI53LO:F24	CPC005_HT29_24H_X2	F24	trt_cp	10.0	um	24	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_HT29_24H_X3_B3_DUO52HI53LO:F24	CPC005_HT29_24H_X3	F24	trt_cp	10.0	um	24	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_HT29_6H_X1_B3_DUO52HI53LO:F24	CPC005_HT29_6H_X1	F24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_HT29_6H_X2_B3_DUO52HI53LO:F24	CPC005_HT29_6H_X2	F24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_HT29_6H_X3_B3_DUO52HI53LO:F24	CPC005_HT29_6H_X3	F24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_HT29_6H_X1_B3_DUO52HI53LO:B24	CPC009_HT29_6H_X1	B24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_HT29_6H_X3_B3_DUO52HI53LO:B24	CPC009_HT29_6H_X3	B24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_HT29_6H_X5_B5_DUO52HI53LO:B24	CPC009_HT29_6H_X5	B24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC011_HT29_6H_X1_B3_DUO52HI53LO:P10	CPC011_HT29_6H_X1	P10	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC011_HT29_6H_X2_B3_DUO52HI53LO:P10	CPC011_HT29_6H_X2	P10	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC011_HT29_6H_X4_B5_DUO52HI53LO:P10	CPC011_HT29_6H_X4	P10	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC011_HT29_6H_X5_B5_DUO52HI53LO:P10	CPC011_HT29_6H_X5	P10	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_HT29_6H_X1.L2_F1B5_DUO52HI53LO:B15	CPC020_HT29_6H_X1.L2	B15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_HT29_6H_X2.L2_B6_DUO52HI53LO:B15	CPC020_HT29_6H_X2.L2	B15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_HT29_6H_X4_B5_DUO52HI53LO:B15	CPC020_HT29_6H_X4	B15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_HT29_6H_X5_B5_DUO52HI53LO:B15	CPC020_HT29_6H_X5	B15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K19277754	CPC011_HT29_6H_X1_B3_DUO52HI53LO:I12	CPC011_HT29_6H_X1	I12	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K19277754	CPC011_HT29_6H_X2_B3_DUO52HI53LO:I12	CPC011_HT29_6H_X2	I12	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K19277754	CPC011_HT29_6H_X4_B5_DUO52HI53LO:I12	CPC011_HT29_6H_X4	I12	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K19277754	CPC011_HT29_6H_X5_B5_DUO52HI53LO:I12	CPC011_HT29_6H_X5	I12	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_HT29_6H_X1_B3_DUO52HI53LO:H24	CPC004_HT29_6H_X1	H24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_HT29_6H_X2_B3_DUO52HI53LO:H24	CPC004_HT29_6H_X2	H24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_HT29_6H_X3_B3_DUO52HI53LO:H24	CPC004_HT29_6H_X3	H24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_HT29_6H_X4_B5_DUO52HI53LO:H24	CPC004_HT29_6H_X4	H24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_HT29_6H_X5_B5_DUO52HI53LO:H24	CPC004_HT29_6H_X5	H24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC011_HT29_6H_X1_B3_DUO52HI53LO:I21	CPC011_HT29_6H_X1	I21	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC011_HT29_6H_X2_B3_DUO52HI53LO:I21	CPC011_HT29_6H_X2	I21	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC011_HT29_6H_X4_B5_DUO52HI53LO:I21	CPC011_HT29_6H_X4	I21	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC011_HT29_6H_X5_B5_DUO52HI53LO:I21	CPC011_HT29_6H_X5	I21	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC015_HT29_6H_X1_B4_DUO52HI53LO:L01	CPC015_HT29_6H_X1	L01	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC015_HT29_6H_X3_B4_DUO52HI53LO:L01	CPC015_HT29_6H_X3	L01	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC015_HT29_6H_X5_B5_DUO52HI53LO:L01	CPC015_HT29_6H_X5	L01	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_HT29_6H_X1_B3_DUO52HI53LO:H13	CPC004_HT29_6H_X1	H13	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_HT29_6H_X2_B3_DUO52HI53LO:H13	CPC004_HT29_6H_X2	H13	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_HT29_6H_X3_B3_DUO52HI53LO:H13	CPC004_HT29_6H_X3	H13	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_HT29_6H_X4_B5_DUO52HI53LO:H13	CPC004_HT29_6H_X4	H13	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_HT29_6H_X5_B5_DUO52HI53LO:H13	CPC004_HT29_6H_X5	H13	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC011_HT29_6H_X1_B3_DUO52HI53LO:L11	CPC011_HT29_6H_X1	L11	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC011_HT29_6H_X2_B3_DUO52HI53LO:L11	CPC011_HT29_6H_X2	L11	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC011_HT29_6H_X4_B5_DUO52HI53LO:L11	CPC011_HT29_6H_X4	L11	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC011_HT29_6H_X5_B5_DUO52HI53LO:L11	CPC011_HT29_6H_X5	L11	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC015_HT29_6H_X1_B4_DUO52HI53LO:K04	CPC015_HT29_6H_X1	K04	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC015_HT29_6H_X3_B4_DUO52HI53LO:K04	CPC015_HT29_6H_X3	K04	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC015_HT29_6H_X5_B5_DUO52HI53LO:K04	CPC015_HT29_6H_X5	K04	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_HT29_6H_X1_B3_DUO52HI53LO:J04	CPC004_HT29_6H_X1	J04	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_HT29_6H_X2_B3_DUO52HI53LO:J04	CPC004_HT29_6H_X2	J04	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_HT29_6H_X3_B3_DUO52HI53LO:J04	CPC004_HT29_6H_X3	J04	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_HT29_6H_X4_B5_DUO52HI53LO:J04	CPC004_HT29_6H_X4	J04	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_HT29_6H_X5_B5_DUO52HI53LO:J04	CPC004_HT29_6H_X5	J04	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC015_HT29_6H_X1_B4_DUO52HI53LO:L05	CPC015_HT29_6H_X1	L05	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC015_HT29_6H_X3_B4_DUO52HI53LO:L05	CPC015_HT29_6H_X3	L05	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC015_HT29_6H_X5_B5_DUO52HI53LO:L05	CPC015_HT29_6H_X5	L05	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K31534764	CPC011_HT29_6H_X1_B3_DUO52HI53LO:E15	CPC011_HT29_6H_X1	E15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K31534764	CPC011_HT29_6H_X2_B3_DUO52HI53LO:E15	CPC011_HT29_6H_X2	E15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K31534764	CPC011_HT29_6H_X4_B5_DUO52HI53LO:E15	CPC011_HT29_6H_X4	E15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K31534764	CPC011_HT29_6H_X5_B5_DUO52HI53LO:E15	CPC011_HT29_6H_X5	E15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC016_HT29_6H_X5_F1B5_DUO52HI53LO:M15	CPC016_HT29_6H_X5	M15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC016_HT29_6H_X1_B4_DUO52HI53LO:M15	CPC016_HT29_6H_X1	M15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC016_HT29_6H_X2_B4_DUO52HI53LO:M15	CPC016_HT29_6H_X2	M15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC016_HT29_6H_X3_B4_DUO52HI53LO:M15	CPC016_HT29_6H_X3	M15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC016_HT29_6H_X4_B5_DUO52HI53LO:M15	CPC016_HT29_6H_X4	M15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_HT29_6H_X1_B3_DUO52HI53LO:H07	CPC004_HT29_6H_X1	H07	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_HT29_6H_X2_B3_DUO52HI53LO:H07	CPC004_HT29_6H_X2	H07	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_HT29_6H_X3_B3_DUO52HI53LO:H07	CPC004_HT29_6H_X3	H07	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_HT29_6H_X4_B5_DUO52HI53LO:H07	CPC004_HT29_6H_X4	H07	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_HT29_6H_X5_B5_DUO52HI53LO:H07	CPC004_HT29_6H_X5	H07	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC011_HT29_6H_X1_B3_DUO52HI53LO:D11	CPC011_HT29_6H_X1	D11	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC011_HT29_6H_X2_B3_DUO52HI53LO:D11	CPC011_HT29_6H_X2	D11	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC011_HT29_6H_X4_B5_DUO52HI53LO:D11	CPC011_HT29_6H_X4	D11	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC011_HT29_6H_X5_B5_DUO52HI53LO:D11	CPC011_HT29_6H_X5	D11	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC015_HT29_6H_X1_B4_DUO52HI53LO:I22	CPC015_HT29_6H_X1	I22	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC015_HT29_6H_X3_B4_DUO52HI53LO:I22	CPC015_HT29_6H_X3	I22	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC015_HT29_6H_X5_B5_DUO52HI53LO:I22	CPC015_HT29_6H_X5	I22	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC016_HT29_6H_X5_F1B5_DUO52HI53LO:M20	CPC016_HT29_6H_X5	M20	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC016_HT29_6H_X1_B4_DUO52HI53LO:M20	CPC016_HT29_6H_X1	M20	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC016_HT29_6H_X2_B4_DUO52HI53LO:M20	CPC016_HT29_6H_X2	M20	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC016_HT29_6H_X3_B4_DUO52HI53LO:M20	CPC016_HT29_6H_X3	M20	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC016_HT29_6H_X4_B5_DUO52HI53LO:M20	CPC016_HT29_6H_X4	M20	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPC010_HT29_6H_X1_B3_DUO52HI53LO:P24	CPC010_HT29_6H_X1	P24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPC010_HT29_6H_X2_B3_DUO52HI53LO:P24	CPC010_HT29_6H_X2	P24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPC010_HT29_6H_X4_B5_DUO52HI53LO:P24	CPC010_HT29_6H_X4	P24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPC010_HT29_6H_X5_B5_DUO52HI53LO:P24	CPC010_HT29_6H_X5	P24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC009_HT29_6H_X1_B3_DUO52HI53LO:K23	CPC009_HT29_6H_X1	K23	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC009_HT29_6H_X3_B3_DUO52HI53LO:K23	CPC009_HT29_6H_X3	K23	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC009_HT29_6H_X5_B5_DUO52HI53LO:K23	CPC009_HT29_6H_X5	K23	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC011_HT29_6H_X1_B3_DUO52HI53LO:I11	CPC011_HT29_6H_X1	I11	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC011_HT29_6H_X2_B3_DUO52HI53LO:I11	CPC011_HT29_6H_X2	I11	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC011_HT29_6H_X4_B5_DUO52HI53LO:I11	CPC011_HT29_6H_X4	I11	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC011_HT29_6H_X5_B5_DUO52HI53LO:I11	CPC011_HT29_6H_X5	I11	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_HT29_24H_X1_B3_DUO52HI53LO:E19	CPC005_HT29_24H_X1	E19	trt_cp	10.0	um	24	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_HT29_24H_X2_B3_DUO52HI53LO:E19	CPC005_HT29_24H_X2	E19	trt_cp	10.0	um	24	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_HT29_24H_X3_B3_DUO52HI53LO:E19	CPC005_HT29_24H_X3	E19	trt_cp	10.0	um	24	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_HT29_6H_X1_B3_DUO52HI53LO:E19	CPC005_HT29_6H_X1	E19	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_HT29_6H_X2_B3_DUO52HI53LO:E19	CPC005_HT29_6H_X2	E19	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_HT29_6H_X3_B3_DUO52HI53LO:E19	CPC005_HT29_6H_X3	E19	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPC011_HT29_6H_X1_B3_DUO52HI53LO:A16	CPC011_HT29_6H_X1	A16	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPC011_HT29_6H_X2_B3_DUO52HI53LO:A16	CPC011_HT29_6H_X2	A16	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPC011_HT29_6H_X4_B5_DUO52HI53LO:A16	CPC011_HT29_6H_X4	A16	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPC011_HT29_6H_X5_B5_DUO52HI53LO:A16	CPC011_HT29_6H_X5	A16	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC016_HT29_6H_X5_F1B5_DUO52HI53LO:O06	CPC016_HT29_6H_X5	O06	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC016_HT29_6H_X1_B4_DUO52HI53LO:O06	CPC016_HT29_6H_X1	O06	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC016_HT29_6H_X2_B4_DUO52HI53LO:O06	CPC016_HT29_6H_X2	O06	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC016_HT29_6H_X3_B4_DUO52HI53LO:O06	CPC016_HT29_6H_X3	O06	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC016_HT29_6H_X4_B5_DUO52HI53LO:O06	CPC016_HT29_6H_X4	O06	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_HT29_6H_X1.L2_F1B5_DUO52HI53LO:K04	CPC020_HT29_6H_X1.L2	K04	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_HT29_6H_X2.L2_B6_DUO52HI53LO:K04	CPC020_HT29_6H_X2.L2	K04	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_HT29_6H_X4_B5_DUO52HI53LO:K04	CPC020_HT29_6H_X4	K04	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_HT29_6H_X5_B5_DUO52HI53LO:K04	CPC020_HT29_6H_X5	K04	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_HT29_6H_X1_B3_DUO52HI53LO:I06	CPC004_HT29_6H_X1	I06	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_HT29_6H_X2_B3_DUO52HI53LO:I06	CPC004_HT29_6H_X2	I06	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_HT29_6H_X3_B3_DUO52HI53LO:I06	CPC004_HT29_6H_X3	I06	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_HT29_6H_X4_B5_DUO52HI53LO:I06	CPC004_HT29_6H_X4	I06	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_HT29_6H_X5_B5_DUO52HI53LO:I06	CPC004_HT29_6H_X5	I06	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC016_HT29_6H_X5_F1B5_DUO52HI53LO:N14	CPC016_HT29_6H_X5	N14	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC011_HT29_6H_X1_B3_DUO52HI53LO:K13	CPC011_HT29_6H_X1	K13	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC011_HT29_6H_X2_B3_DUO52HI53LO:K13	CPC011_HT29_6H_X2	K13	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC011_HT29_6H_X4_B5_DUO52HI53LO:K13	CPC011_HT29_6H_X4	K13	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC011_HT29_6H_X5_B5_DUO52HI53LO:K13	CPC011_HT29_6H_X5	K13	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC016_HT29_6H_X1_B4_DUO52HI53LO:N14	CPC016_HT29_6H_X1	N14	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC016_HT29_6H_X2_B4_DUO52HI53LO:N14	CPC016_HT29_6H_X2	N14	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC016_HT29_6H_X3_B4_DUO52HI53LO:N14	CPC016_HT29_6H_X3	N14	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC016_HT29_6H_X4_B5_DUO52HI53LO:N14	CPC016_HT29_6H_X4	N14	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC016_HT29_6H_X5_F1B5_DUO52HI53LO:K22	CPC016_HT29_6H_X5	K22	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC011_HT29_6H_X1_B3_DUO52HI53LO:J05	CPC011_HT29_6H_X1	J05	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC011_HT29_6H_X2_B3_DUO52HI53LO:J05	CPC011_HT29_6H_X2	J05	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC011_HT29_6H_X4_B5_DUO52HI53LO:J05	CPC011_HT29_6H_X4	J05	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC011_HT29_6H_X5_B5_DUO52HI53LO:J05	CPC011_HT29_6H_X5	J05	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC016_HT29_6H_X1_B4_DUO52HI53LO:K22	CPC016_HT29_6H_X1	K22	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC016_HT29_6H_X2_B4_DUO52HI53LO:K22	CPC016_HT29_6H_X2	K22	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC016_HT29_6H_X3_B4_DUO52HI53LO:K22	CPC016_HT29_6H_X3	K22	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC016_HT29_6H_X4_B5_DUO52HI53LO:K22	CPC016_HT29_6H_X4	K22	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_HT29_24H_X1_B3_DUO52HI53LO:E10	CPC005_HT29_24H_X1	E10	trt_cp	10.0	um	24	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_HT29_24H_X2_B3_DUO52HI53LO:E10	CPC005_HT29_24H_X2	E10	trt_cp	10.0	um	24	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_HT29_24H_X3_B3_DUO52HI53LO:E10	CPC005_HT29_24H_X3	E10	trt_cp	10.0	um	24	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_HT29_6H_X1_B3_DUO52HI53LO:E10	CPC005_HT29_6H_X1	E10	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_HT29_6H_X2_B3_DUO52HI53LO:E10	CPC005_HT29_6H_X2	E10	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_HT29_6H_X3_B3_DUO52HI53LO:E10	CPC005_HT29_6H_X3	E10	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC016_HT29_6H_X5_F1B5_DUO52HI53LO:C19	CPC016_HT29_6H_X5	C19	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC011_HT29_6H_X1_B3_DUO52HI53LO:A13	CPC011_HT29_6H_X1	A13	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC011_HT29_6H_X2_B3_DUO52HI53LO:A13	CPC011_HT29_6H_X2	A13	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC011_HT29_6H_X4_B5_DUO52HI53LO:A13	CPC011_HT29_6H_X4	A13	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC011_HT29_6H_X5_B5_DUO52HI53LO:A13	CPC011_HT29_6H_X5	A13	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC016_HT29_6H_X1_B4_DUO52HI53LO:C19	CPC016_HT29_6H_X1	C19	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC016_HT29_6H_X2_B4_DUO52HI53LO:C19	CPC016_HT29_6H_X2	C19	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC016_HT29_6H_X3_B4_DUO52HI53LO:C19	CPC016_HT29_6H_X3	C19	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC016_HT29_6H_X4_B5_DUO52HI53LO:C19	CPC016_HT29_6H_X4	C19	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_HT29_6H_X1_B3_DUO52HI53LO:A16	CPC004_HT29_6H_X1	A16	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_HT29_6H_X2_B3_DUO52HI53LO:A16	CPC004_HT29_6H_X2	A16	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_HT29_6H_X3_B3_DUO52HI53LO:A16	CPC004_HT29_6H_X3	A16	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_HT29_6H_X4_B5_DUO52HI53LO:A16	CPC004_HT29_6H_X4	A16	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_HT29_6H_X5_B5_DUO52HI53LO:A16	CPC004_HT29_6H_X5	A16	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC016_HT29_6H_X5_F1B5_DUO52HI53LO:H06	CPC016_HT29_6H_X5	H06	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC011_HT29_6H_X1_B3_DUO52HI53LO:G23	CPC011_HT29_6H_X1	G23	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC011_HT29_6H_X2_B3_DUO52HI53LO:G23	CPC011_HT29_6H_X2	G23	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC011_HT29_6H_X4_B5_DUO52HI53LO:G23	CPC011_HT29_6H_X4	G23	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC011_HT29_6H_X5_B5_DUO52HI53LO:G23	CPC011_HT29_6H_X5	G23	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC016_HT29_6H_X1_B4_DUO52HI53LO:H06	CPC016_HT29_6H_X1	H06	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC016_HT29_6H_X2_B4_DUO52HI53LO:H06	CPC016_HT29_6H_X2	H06	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC016_HT29_6H_X3_B4_DUO52HI53LO:H06	CPC016_HT29_6H_X3	H06	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC016_HT29_6H_X4_B5_DUO52HI53LO:H06	CPC016_HT29_6H_X4	H06	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-K83153774	CPC020_HT29_6H_X1.L2_F1B5_DUO52HI53LO:D15	CPC020_HT29_6H_X1.L2	D15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-K83153774	CPC020_HT29_6H_X2.L2_B6_DUO52HI53LO:D15	CPC020_HT29_6H_X2.L2	D15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-K83153774	CPC020_HT29_6H_X4_B5_DUO52HI53LO:D15	CPC020_HT29_6H_X4	D15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-K83153774	CPC020_HT29_6H_X5_B5_DUO52HI53LO:D15	CPC020_HT29_6H_X5	D15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_HT29_6H_X1_B3_DUO52HI53LO:J08	CPC004_HT29_6H_X1	J08	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_HT29_6H_X2_B3_DUO52HI53LO:J08	CPC004_HT29_6H_X2	J08	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_HT29_6H_X3_B3_DUO52HI53LO:J08	CPC004_HT29_6H_X3	J08	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_HT29_6H_X4_B5_DUO52HI53LO:J08	CPC004_HT29_6H_X4	J08	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_HT29_6H_X5_B5_DUO52HI53LO:J08	CPC004_HT29_6H_X5	J08	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC015_HT29_6H_X1_B4_DUO52HI53LO:L09	CPC015_HT29_6H_X1	L09	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC015_HT29_6H_X3_B4_DUO52HI53LO:L09	CPC015_HT29_6H_X3	L09	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC015_HT29_6H_X5_B5_DUO52HI53LO:L09	CPC015_HT29_6H_X5	L09	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_HT29_6H_X1_B3_DUO52HI53LO:G10	CPC011_HT29_6H_X1	G10	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_HT29_6H_X2_B3_DUO52HI53LO:G10	CPC011_HT29_6H_X2	G10	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_HT29_6H_X4_B5_DUO52HI53LO:G10	CPC011_HT29_6H_X4	G10	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_HT29_6H_X5_B5_DUO52HI53LO:G10	CPC011_HT29_6H_X5	G10	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_HT29_6H_X1_B3_DUO52HI53LO:B03	CPC011_HT29_6H_X1	B03	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_HT29_6H_X2_B3_DUO52HI53LO:B03	CPC011_HT29_6H_X2	B03	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_HT29_6H_X4_B5_DUO52HI53LO:B03	CPC011_HT29_6H_X4	B03	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_HT29_6H_X5_B5_DUO52HI53LO:B03	CPC011_HT29_6H_X5	B03	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_HT29_24H_X1_B3_DUO52HI53LO:M14	CPC005_HT29_24H_X1	M14	trt_cp	10.0	um	24	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_HT29_24H_X2_B3_DUO52HI53LO:M14	CPC005_HT29_24H_X2	M14	trt_cp	10.0	um	24	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_HT29_24H_X3_B3_DUO52HI53LO:M14	CPC005_HT29_24H_X3	M14	trt_cp	10.0	um	24	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_HT29_6H_X1_B3_DUO52HI53LO:M14	CPC005_HT29_6H_X1	M14	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_HT29_6H_X2_B3_DUO52HI53LO:M14	CPC005_HT29_6H_X2	M14	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_HT29_6H_X3_B3_DUO52HI53LO:M14	CPC005_HT29_6H_X3	M14	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_HT29_6H_X1_B3_DUO52HI53LO:J06	CPC004_HT29_6H_X1	J06	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_HT29_6H_X2_B3_DUO52HI53LO:J06	CPC004_HT29_6H_X2	J06	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_HT29_6H_X3_B3_DUO52HI53LO:J06	CPC004_HT29_6H_X3	J06	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_HT29_6H_X4_B5_DUO52HI53LO:J06	CPC004_HT29_6H_X4	J06	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_HT29_6H_X5_B5_DUO52HI53LO:J06	CPC004_HT29_6H_X5	J06	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC011_HT29_6H_X1_B3_DUO52HI53LO:J19	CPC011_HT29_6H_X1	J19	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC011_HT29_6H_X2_B3_DUO52HI53LO:J19	CPC011_HT29_6H_X2	J19	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC011_HT29_6H_X4_B5_DUO52HI53LO:J19	CPC011_HT29_6H_X4	J19	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC011_HT29_6H_X5_B5_DUO52HI53LO:J19	CPC011_HT29_6H_X5	J19	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC015_HT29_6H_X1_B4_DUO52HI53LO:L07	CPC015_HT29_6H_X1	L07	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC015_HT29_6H_X3_B4_DUO52HI53LO:L07	CPC015_HT29_6H_X3	L07	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC015_HT29_6H_X5_B5_DUO52HI53LO:L07	CPC015_HT29_6H_X5	L07	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
65833	N06AX17	milnacipran	CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2	CCN(CC)C(=O)C1(c2ccccc2)CC1CN	BRD-K02227374	CPC011_HT29_6H_X1_B3_DUO52HI53LO:H14	CPC011_HT29_6H_X1	H14	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
65833	N06AX17	milnacipran	CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2	CCN(CC)C(=O)C1(c2ccccc2)CC1CN	BRD-K02227374	CPC011_HT29_6H_X2_B3_DUO52HI53LO:H14	CPC011_HT29_6H_X2	H14	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
65833	N06AX17	milnacipran	CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2	CCN(CC)C(=O)C1(c2ccccc2)CC1CN	BRD-K02227374	CPC011_HT29_6H_X4_B5_DUO52HI53LO:H14	CPC011_HT29_6H_X4	H14	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
65833	N06AX17	milnacipran	CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2	CCN(CC)C(=O)C1(c2ccccc2)CC1CN	BRD-K02227374	CPC011_HT29_6H_X5_B5_DUO52HI53LO:H14	CPC011_HT29_6H_X5	H14	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC017_HT29_6H_X5_F1B5_DUO52HI53LO:F21	CPC017_HT29_6H_X5	F21	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC017_HT29_6H_X1_B4_DUO52HI53LO:F21	CPC017_HT29_6H_X1	F21	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC017_HT29_6H_X2_B4_DUO52HI53LO:F21	CPC017_HT29_6H_X2	F21	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC017_HT29_6H_X3_B4_DUO52HI53LO:F21	CPC017_HT29_6H_X3	F21	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC017_HT29_6H_X4_B5_DUO52HI53LO:F21	CPC017_HT29_6H_X4	F21	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_HT29_6H_X1_B3_DUO52HI53LO:J03	CPC004_HT29_6H_X1	J03	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_HT29_6H_X2_B3_DUO52HI53LO:J03	CPC004_HT29_6H_X2	J03	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_HT29_6H_X3_B3_DUO52HI53LO:J03	CPC004_HT29_6H_X3	J03	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_HT29_6H_X4_B5_DUO52HI53LO:J03	CPC004_HT29_6H_X4	J03	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_HT29_6H_X5_B5_DUO52HI53LO:J03	CPC004_HT29_6H_X5	J03	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_HT29_6H_X1_B3_DUO52HI53LO:G22	CPC010_HT29_6H_X1	G22	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_HT29_6H_X2_B3_DUO52HI53LO:G22	CPC010_HT29_6H_X2	G22	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_HT29_6H_X3_B3_DUO52HI53LO:G22	CPC010_HT29_6H_X3	G22	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_HT29_6H_X4_B5_DUO52HI53LO:G22	CPC010_HT29_6H_X4	G22	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_HT29_6H_X5_B5_DUO52HI53LO:G22	CPC010_HT29_6H_X5	G22	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC011_HT29_6H_X1_B3_DUO52HI53LO:I05	CPC011_HT29_6H_X1	I05	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC011_HT29_6H_X2_B3_DUO52HI53LO:I05	CPC011_HT29_6H_X2	I05	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC011_HT29_6H_X4_B5_DUO52HI53LO:I05	CPC011_HT29_6H_X4	I05	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC011_HT29_6H_X5_B5_DUO52HI53LO:I05	CPC011_HT29_6H_X5	I05	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC015_HT29_6H_X1_B4_DUO52HI53LO:K18	CPC015_HT29_6H_X1	K18	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC015_HT29_6H_X3_B4_DUO52HI53LO:K18	CPC015_HT29_6H_X3	K18	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC015_HT29_6H_X5_B5_DUO52HI53LO:K18	CPC015_HT29_6H_X5	K18	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_MCF7_6H_X1_B3_DUO52HI53LO:E11	CPC004_MCF7_6H_X1	E11	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_MCF7_6H_X2_B3_DUO52HI53LO:E11	CPC004_MCF7_6H_X2	E11	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC017_MCF7_24H_X1_B4_DUO52HI53LO:M02	CPC017_MCF7_24H_X1	M02	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC017_MCF7_24H_X2_B4_DUO52HI53LO:M02	CPC017_MCF7_24H_X2	M02	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC017_MCF7_24H_X3_B4_DUO52HI53LO:M02	CPC017_MCF7_24H_X3	M02	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC017_MCF7_24H_X4_B5_DUO52HI53LO:M02	CPC017_MCF7_24H_X4	M02	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC017_MCF7_24H_X5_B5_DUO52HI53LO:M02	CPC017_MCF7_24H_X5	M02	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC017_MCF7_6H_X5_F2B4_DUO52HI53LO:M02	CPC017_MCF7_6H_X5	M02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC020_MCF7_24H_X1_F1B4_DUO52HI53LO:F21	CPC020_MCF7_24H_X1	F21	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC020_MCF7_24H_X2_F1B4_DUO52HI53LO:F21	CPC020_MCF7_24H_X2	F21	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC020_MCF7_24H_X3_F1B4_DUO52HI53LO:F21	CPC020_MCF7_24H_X3	F21	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC020_MCF7_24H_X5_B5_DUO52HI53LO:F21	CPC020_MCF7_24H_X5	F21	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC020_MCF7_6H_X1_B4_DUO52HI53LO:F21	CPC020_MCF7_6H_X1	F21	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC020_MCF7_6H_X2_B4_DUO52HI53LO:F21	CPC020_MCF7_6H_X2	F21	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC020_MCF7_6H_X3_B4_DUO52HI53LO:F21	CPC020_MCF7_6H_X3	F21	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC020_MCF7_6H_X5_F1B5_DUO52HI53LO:F21	CPC020_MCF7_6H_X5	F21	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPD001_MCF7_24H_X1_B6_DUO52HI53LO:E02	CPD001_MCF7_24H_X1	E02	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPD001_MCF7_24H_X2_B6_DUO52HI53LO:E02	CPD001_MCF7_24H_X2	E02	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPD001_MCF7_24H_X3_B6_DUO52HI53LO:E02	CPD001_MCF7_24H_X3	E02	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPD001_MCF7_6H_X1.A2_B6_DUO52HI53LO:E02	CPD001_MCF7_6H_X1.A2	E02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPD001_MCF7_6H_X1_B6_DUO52HI53LO:E02	CPD001_MCF7_6H_X1	E02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPD001_MCF7_6H_X2_B6_DUO52HI53LO:E02	CPD001_MCF7_6H_X2	E02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPD001_MCF7_6H_X3_B6_DUO52HI53LO:E02	CPD001_MCF7_6H_X3	E02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_MCF7_6H_X4_F1B5_DUO52HI53LO:E11	CPC004_MCF7_6H_X4	E11	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_MCF7_6H_X5_F1B5_DUO52HI53LO:E11	CPC004_MCF7_6H_X5	E11	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC017_MCF7_6H_X1_B4_DUO52HI53LO:M02	CPC017_MCF7_6H_X1	M02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC017_MCF7_6H_X2_B4_DUO52HI53LO:M02	CPC017_MCF7_6H_X2	M02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC017_MCF7_6H_X3_B4_DUO52HI53LO:M02	CPC017_MCF7_6H_X3	M02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_MCF7_24H_X1_B4_DUO52HI53LO:C12	CPC005_MCF7_24H_X1	C12	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_MCF7_24H_X2_B4_DUO52HI53LO:C12	CPC005_MCF7_24H_X2	C12	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_MCF7_24H_X3_B4_DUO52HI53LO:C12	CPC005_MCF7_24H_X3	C12	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_MCF7_24H_X4_B5_DUO52HI53LO:C12	CPC005_MCF7_24H_X4	C12	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_MCF7_6H_X1_B3_DUO52HI53LO:C12	CPC005_MCF7_6H_X1	C12	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_MCF7_6H_X2_B3_DUO52HI53LO:C12	CPC005_MCF7_6H_X2	C12	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_MCF7_6H_X2_F1B3_DUO52HI53LO:C12	CPC005_MCF7_6H_X2	C12	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_MCF7_6H_X3_B3_DUO52HI53LO:C12	CPC005_MCF7_6H_X3	C12	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_MCF7_6H_X5_F1B5_DUO52HI53LO:C12	CPC005_MCF7_6H_X5	C12	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_MCF7_24H_X1_F1B4_DUO52HI53LO:H14	CPC020_MCF7_24H_X1	H14	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_MCF7_24H_X1_F1B4_DUO52HI53LO:L24	CPC020_MCF7_24H_X1	L24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_MCF7_24H_X2_F1B4_DUO52HI53LO:H14	CPC020_MCF7_24H_X2	H14	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_MCF7_24H_X2_F1B4_DUO52HI53LO:L24	CPC020_MCF7_24H_X2	L24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_MCF7_24H_X3_F1B4_DUO52HI53LO:H14	CPC020_MCF7_24H_X3	H14	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_MCF7_24H_X3_F1B4_DUO52HI53LO:L24	CPC020_MCF7_24H_X3	L24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_MCF7_24H_X4_F2B4_DUO52HI53LO:H14	CPC020_MCF7_24H_X4	H14	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_MCF7_24H_X4_F2B4_DUO52HI53LO:L24	CPC020_MCF7_24H_X4	L24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_MCF7_24H_X5_B5_DUO52HI53LO:H14	CPC020_MCF7_24H_X5	H14	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_MCF7_24H_X5_B5_DUO52HI53LO:L24	CPC020_MCF7_24H_X5	L24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_MCF7_6H_X1_B4_DUO52HI53LO:H14	CPC020_MCF7_6H_X1	H14	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_MCF7_6H_X1_B4_DUO52HI53LO:L24	CPC020_MCF7_6H_X1	L24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_MCF7_6H_X2_B4_DUO52HI53LO:H14	CPC020_MCF7_6H_X2	H14	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_MCF7_6H_X2_B4_DUO52HI53LO:L24	CPC020_MCF7_6H_X2	L24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_MCF7_6H_X3_B4_DUO52HI53LO:H14	CPC020_MCF7_6H_X3	H14	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_MCF7_6H_X3_B4_DUO52HI53LO:L24	CPC020_MCF7_6H_X3	L24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_MCF7_6H_X5_F1B5_DUO52HI53LO:H14	CPC020_MCF7_6H_X5	H14	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_MCF7_6H_X5_F1B5_DUO52HI53LO:L24	CPC020_MCF7_6H_X5	L24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPD001_MCF7_24H_X1_B6_DUO52HI53LO:O05	CPD001_MCF7_24H_X1	O05	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPD001_MCF7_24H_X2_B6_DUO52HI53LO:O05	CPD001_MCF7_24H_X2	O05	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPD001_MCF7_24H_X3_B6_DUO52HI53LO:O05	CPD001_MCF7_24H_X3	O05	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPD001_MCF7_6H_X1.A2_B6_DUO52HI53LO:O05	CPD001_MCF7_6H_X1.A2	O05	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPD001_MCF7_6H_X1_B6_DUO52HI53LO:O05	CPD001_MCF7_6H_X1	O05	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPD001_MCF7_6H_X2_B6_DUO52HI53LO:O05	CPD001_MCF7_6H_X2	O05	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPD001_MCF7_6H_X3_B6_DUO52HI53LO:O05	CPD001_MCF7_6H_X3	O05	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_MCF7_24H_X5_F2B4_DUO52HI53LO:C12	CPC005_MCF7_24H_X5	C12	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC018_MCF7_24H_X1_B4_DUO52HI53LO:F20	CPC018_MCF7_24H_X1	F20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC018_MCF7_24H_X2_B4_DUO52HI53LO:F20	CPC018_MCF7_24H_X2	F20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC018_MCF7_24H_X3_B4_DUO52HI53LO:F20	CPC018_MCF7_24H_X3	F20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC018_MCF7_24H_X4_B5_DUO52HI53LO:F20	CPC018_MCF7_24H_X4	F20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC020_MCF7_24H_X1_F1B4_DUO52HI53LO:P19	CPC020_MCF7_24H_X1	P19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC020_MCF7_24H_X2_F1B4_DUO52HI53LO:P19	CPC020_MCF7_24H_X2	P19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC020_MCF7_24H_X3_F1B4_DUO52HI53LO:P19	CPC020_MCF7_24H_X3	P19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC020_MCF7_24H_X4_F2B4_DUO52HI53LO:P19	CPC020_MCF7_24H_X4	P19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC020_MCF7_24H_X5_B5_DUO52HI53LO:P19	CPC020_MCF7_24H_X5	P19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC020_MCF7_6H_X1_B4_DUO52HI53LO:P19	CPC020_MCF7_6H_X1	P19	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC020_MCF7_6H_X2_B4_DUO52HI53LO:P19	CPC020_MCF7_6H_X2	P19	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC020_MCF7_6H_X3_B4_DUO52HI53LO:P19	CPC020_MCF7_6H_X3	P19	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC020_MCF7_6H_X5_F1B5_DUO52HI53LO:P19	CPC020_MCF7_6H_X5	P19	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPD001_MCF7_24H_X1_B6_DUO52HI53LO:F20	CPD001_MCF7_24H_X1	F20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPD001_MCF7_24H_X2_B6_DUO52HI53LO:F20	CPD001_MCF7_24H_X2	F20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPD001_MCF7_24H_X3_B6_DUO52HI53LO:F20	CPD001_MCF7_24H_X3	F20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPD001_MCF7_6H_X1.A2_B6_DUO52HI53LO:F20	CPD001_MCF7_6H_X1.A2	F20	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPD001_MCF7_6H_X1_B6_DUO52HI53LO:F20	CPD001_MCF7_6H_X1	F20	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPD001_MCF7_6H_X2_B6_DUO52HI53LO:F20	CPD001_MCF7_6H_X2	F20	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPD001_MCF7_6H_X3_B6_DUO52HI53LO:F20	CPD001_MCF7_6H_X3	F20	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC018_MCF7_6H_X1_B4_DUO52HI53LO:F20	CPC018_MCF7_6H_X1	F20	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC018_MCF7_6H_X2_B4_DUO52HI53LO:F20	CPC018_MCF7_6H_X2	F20	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC018_MCF7_6H_X3_B4_DUO52HI53LO:F20	CPC018_MCF7_6H_X3	F20	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
9417	N06AA05	opipramol	C1CN(CCN1CCCN2C3=CC=CC=C3C=CC4=CC=CC=C42)CCO	OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1	BRD-K43786866	CPD002_MCF7_24H_X1_B6_DUO52HI53LO:H08	CPD002_MCF7_24H_X1	H08	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
9417	N06AA05	opipramol	C1CN(CCN1CCCN2C3=CC=CC=C3C=CC4=CC=CC=C42)CCO	OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1	BRD-K43786866	CPD002_MCF7_24H_X2_B6_DUO52HI53LO:H08	CPD002_MCF7_24H_X2	H08	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
9417	N06AA05	opipramol	C1CN(CCN1CCCN2C3=CC=CC=C3C=CC4=CC=CC=C42)CCO	OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1	BRD-K43786866	CPD002_MCF7_24H_X3_B6_DUO52HI53LO:H08	CPD002_MCF7_24H_X3	H08	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
9417	N06AA05	opipramol	C1CN(CCN1CCCN2C3=CC=CC=C3C=CC4=CC=CC=C42)CCO	OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1	BRD-K43786866	CPD002_MCF7_6H_X1_B6_DUO52HI53LO:H08	CPD002_MCF7_6H_X1	H08	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
9417	N06AA05	opipramol	C1CN(CCN1CCCN2C3=CC=CC=C3C=CC4=CC=CC=C42)CCO	OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1	BRD-K43786866	CPD002_MCF7_6H_X2_B6_DUO52HI53LO:H08	CPD002_MCF7_6H_X2	H08	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
9417	N06AA05	opipramol	C1CN(CCN1CCCN2C3=CC=CC=C3C=CC4=CC=CC=C42)CCO	OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1	BRD-K43786866	CPD002_MCF7_6H_X3_B6_DUO52HI53LO:H08	CPD002_MCF7_6H_X3	H08	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_MCF7_6H_X1_B3_DUO52HI53LO:I02	CPC004_MCF7_6H_X1	I02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_MCF7_6H_X2_B3_DUO52HI53LO:I02	CPC004_MCF7_6H_X2	I02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_MCF7_6H_X4_F1B5_DUO52HI53LO:I02	CPC004_MCF7_6H_X4	I02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_MCF7_6H_X5_F1B5_DUO52HI53LO:I02	CPC004_MCF7_6H_X5	I02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_MCF7_24H_X2_B4_DUO52HI53LO:N08	CPC016_MCF7_24H_X2	N08	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_MCF7_24H_X3_B4_DUO52HI53LO:N08	CPC016_MCF7_24H_X3	N08	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_MCF7_24H_X4_B5_DUO52HI53LO:N08	CPC016_MCF7_24H_X4	N08	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_MCF7_24H_X5_B5_DUO52HI53LO:N08	CPC016_MCF7_24H_X5	N08	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_MCF7_6H_X5_F2B5_DUO52HI53LO:N08	CPC016_MCF7_6H_X5	N08	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPD003_MCF7_24H_X1_B6_DUO52HI53LO:A13	CPD003_MCF7_24H_X1	A13	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPD003_MCF7_24H_X2.L2_B6_DUO52HI53LO:A13	CPD003_MCF7_24H_X2.L2	A13	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPD003_MCF7_24H_X3.L2_B6_DUO52HI53LO:A13	CPD003_MCF7_24H_X3.L2	A13	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPD003_MCF7_24H_X3_B6_DUO52HI53LO:A13	CPD003_MCF7_24H_X3	A13	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPD003_MCF7_6H_X1_B6_DUO52HI53LO:A13	CPD003_MCF7_6H_X1	A13	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPD003_MCF7_6H_X2_B6_DUO52HI53LO:A13	CPD003_MCF7_6H_X2	A13	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_MCF7_6H_X1_B4_DUO52HI53LO:N08	CPC016_MCF7_6H_X1	N08	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_MCF7_6H_X2_B4_DUO52HI53LO:N08	CPC016_MCF7_6H_X2	N08	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_MCF7_6H_X1_B3_DUO52HI53LO:I02	CPC004_MCF7_6H_X1	I02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_MCF7_6H_X2_B3_DUO52HI53LO:I02	CPC004_MCF7_6H_X2	I02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_MCF7_6H_X4_F1B5_DUO52HI53LO:I02	CPC004_MCF7_6H_X4	I02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_MCF7_6H_X5_F1B5_DUO52HI53LO:I02	CPC004_MCF7_6H_X5	I02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_MCF7_24H_X2_B4_DUO52HI53LO:N08	CPC016_MCF7_24H_X2	N08	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_MCF7_24H_X3_B4_DUO52HI53LO:N08	CPC016_MCF7_24H_X3	N08	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_MCF7_24H_X4_B5_DUO52HI53LO:N08	CPC016_MCF7_24H_X4	N08	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_MCF7_24H_X5_B5_DUO52HI53LO:N08	CPC016_MCF7_24H_X5	N08	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_MCF7_6H_X5_F2B5_DUO52HI53LO:N08	CPC016_MCF7_6H_X5	N08	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPD003_MCF7_24H_X1_B6_DUO52HI53LO:A13	CPD003_MCF7_24H_X1	A13	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPD003_MCF7_24H_X2.L2_B6_DUO52HI53LO:A13	CPD003_MCF7_24H_X2.L2	A13	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPD003_MCF7_24H_X3.L2_B6_DUO52HI53LO:A13	CPD003_MCF7_24H_X3.L2	A13	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPD003_MCF7_24H_X3_B6_DUO52HI53LO:A13	CPD003_MCF7_24H_X3	A13	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPD003_MCF7_6H_X1_B6_DUO52HI53LO:A13	CPD003_MCF7_6H_X1	A13	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPD003_MCF7_6H_X2_B6_DUO52HI53LO:A13	CPD003_MCF7_6H_X2	A13	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_MCF7_6H_X1_B4_DUO52HI53LO:N08	CPC016_MCF7_6H_X1	N08	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_MCF7_6H_X2_B4_DUO52HI53LO:N08	CPC016_MCF7_6H_X2	N08	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3947	N06AA07	lofepramine	CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)CC(=O)C4=CC=C(C=C4)Cl	CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1	BRD-K82147103	CPC011_MCF7_24H_X4_B5_DUO52HI53LO:M10	CPC011_MCF7_24H_X4	M10	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3947	N06AA07	lofepramine	CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)CC(=O)C4=CC=C(C=C4)Cl	CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1	BRD-K82147103	CPC011_MCF7_24H_X5_B5_DUO52HI53LO:M10	CPC011_MCF7_24H_X5	M10	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3947	N06AA07	lofepramine	CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)CC(=O)C4=CC=C(C=C4)Cl	CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1	BRD-K82147103	CPC011_MCF7_6H_X1_B3_DUO52HI53LO:M10	CPC011_MCF7_6H_X1	M10	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3947	N06AA07	lofepramine	CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)CC(=O)C4=CC=C(C=C4)Cl	CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1	BRD-K82147103	CPC011_MCF7_6H_X3_B3_DUO52HI53LO:M10	CPC011_MCF7_6H_X3	M10	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC017_MCF7_24H_X1_B4_DUO52HI53LO:L04	CPC017_MCF7_24H_X1	L04	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC017_MCF7_24H_X2_B4_DUO52HI53LO:L04	CPC017_MCF7_24H_X2	L04	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC017_MCF7_24H_X3_B4_DUO52HI53LO:L04	CPC017_MCF7_24H_X3	L04	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC017_MCF7_24H_X4_B5_DUO52HI53LO:L04	CPC017_MCF7_24H_X4	L04	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC017_MCF7_24H_X5_B5_DUO52HI53LO:L04	CPC017_MCF7_24H_X5	L04	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC017_MCF7_6H_X5_F2B4_DUO52HI53LO:L04	CPC017_MCF7_6H_X5	L04	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPD002_MCF7_24H_X1_B6_DUO52HI53LO:E15	CPD002_MCF7_24H_X1	E15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPD002_MCF7_24H_X2_B6_DUO52HI53LO:E15	CPD002_MCF7_24H_X2	E15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPD002_MCF7_24H_X3_B6_DUO52HI53LO:E15	CPD002_MCF7_24H_X3	E15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPD002_MCF7_6H_X1_B6_DUO52HI53LO:E15	CPD002_MCF7_6H_X1	E15	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPD002_MCF7_6H_X2_B6_DUO52HI53LO:E15	CPD002_MCF7_6H_X2	E15	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPD002_MCF7_6H_X3_B6_DUO52HI53LO:E15	CPD002_MCF7_6H_X3	E15	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC017_MCF7_6H_X1_B4_DUO52HI53LO:L04	CPC017_MCF7_6H_X1	L04	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC017_MCF7_6H_X2_B4_DUO52HI53LO:L04	CPC017_MCF7_6H_X2	L04	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC017_MCF7_6H_X3_B4_DUO52HI53LO:L04	CPC017_MCF7_6H_X3	L04	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC015_MCF7_24H_X1_B4_DUO52HI53LO:J10	CPC015_MCF7_24H_X1	J10	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC015_MCF7_24H_X2_B4_DUO52HI53LO:J10	CPC015_MCF7_24H_X2	J10	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC015_MCF7_24H_X3_B4_DUO52HI53LO:J10	CPC015_MCF7_24H_X3	J10	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC015_MCF7_24H_X4_B5_DUO52HI53LO:J10	CPC015_MCF7_24H_X4	J10	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC015_MCF7_24H_X5_F1B5_DUO52HI53LO:J10	CPC015_MCF7_24H_X5	J10	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC015_MCF7_6H_X4_F2B4_DUO52HI53LO:J10	CPC015_MCF7_6H_X4	J10	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC015_MCF7_6H_X5_F1B5_DUO52HI53LO:J10	CPC015_MCF7_6H_X5	J10	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPD001_MCF7_24H_X1_B6_DUO52HI53LO:O09	CPD001_MCF7_24H_X1	O09	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPD001_MCF7_24H_X2_B6_DUO52HI53LO:O09	CPD001_MCF7_24H_X2	O09	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPD001_MCF7_24H_X3_B6_DUO52HI53LO:O09	CPD001_MCF7_24H_X3	O09	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPD001_MCF7_6H_X1.A2_B6_DUO52HI53LO:O09	CPD001_MCF7_6H_X1.A2	O09	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPD001_MCF7_6H_X1_B6_DUO52HI53LO:O09	CPD001_MCF7_6H_X1	O09	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPD001_MCF7_6H_X2_B6_DUO52HI53LO:O09	CPD001_MCF7_6H_X2	O09	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPD001_MCF7_6H_X3_B6_DUO52HI53LO:O09	CPD001_MCF7_6H_X3	O09	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC015_MCF7_6H_X1_B4_DUO52HI53LO:J10	CPC015_MCF7_6H_X1	J10	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC015_MCF7_6H_X2_B4_DUO52HI53LO:J10	CPC015_MCF7_6H_X2	J10	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC015_MCF7_6H_X3_B3_DUO52HI53LO:J10	CPC015_MCF7_6H_X3	J10	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC015_MCF7_6H_X3_B4_DUO52HI53LO:J10	CPC015_MCF7_6H_X3	J10	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC018_MCF7_24H_X1_B4_DUO52HI53LO:J19	CPC018_MCF7_24H_X1	J19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC018_MCF7_24H_X2_B4_DUO52HI53LO:J19	CPC018_MCF7_24H_X2	J19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC018_MCF7_24H_X3_B4_DUO52HI53LO:J19	CPC018_MCF7_24H_X3	J19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC018_MCF7_24H_X4_B5_DUO52HI53LO:J19	CPC018_MCF7_24H_X4	J19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPD001_MCF7_24H_X1_B6_DUO52HI53LO:D10	CPD001_MCF7_24H_X1	D10	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPD001_MCF7_24H_X2_B6_DUO52HI53LO:D10	CPD001_MCF7_24H_X2	D10	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPD001_MCF7_24H_X3_B6_DUO52HI53LO:D10	CPD001_MCF7_24H_X3	D10	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPD001_MCF7_6H_X1.A2_B6_DUO52HI53LO:D10	CPD001_MCF7_6H_X1.A2	D10	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPD001_MCF7_6H_X1_B6_DUO52HI53LO:D10	CPD001_MCF7_6H_X1	D10	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPD001_MCF7_6H_X2_B6_DUO52HI53LO:D10	CPD001_MCF7_6H_X2	D10	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPD001_MCF7_6H_X3_B6_DUO52HI53LO:D10	CPD001_MCF7_6H_X3	D10	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC018_MCF7_6H_X1_B4_DUO52HI53LO:J19	CPC018_MCF7_6H_X1	J19	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC018_MCF7_6H_X2_B4_DUO52HI53LO:J19	CPC018_MCF7_6H_X2	J19	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC018_MCF7_6H_X3_B4_DUO52HI53LO:J19	CPC018_MCF7_6H_X3	J19	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_MCF7_6H_X1_B3_DUO52HI53LO:J02	CPC004_MCF7_6H_X1	J02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_MCF7_6H_X2_B3_DUO52HI53LO:J02	CPC004_MCF7_6H_X2	J02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC015_MCF7_24H_X1_B4_DUO52HI53LO:L03	CPC015_MCF7_24H_X1	L03	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC015_MCF7_24H_X2_B4_DUO52HI53LO:L03	CPC015_MCF7_24H_X2	L03	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC015_MCF7_24H_X3_B4_DUO52HI53LO:L03	CPC015_MCF7_24H_X3	L03	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC015_MCF7_24H_X4_B5_DUO52HI53LO:L03	CPC015_MCF7_24H_X4	L03	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC015_MCF7_24H_X5_F1B5_DUO52HI53LO:L03	CPC015_MCF7_24H_X5	L03	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC015_MCF7_6H_X4_F2B4_DUO52HI53LO:L03	CPC015_MCF7_6H_X4	L03	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC015_MCF7_6H_X5_F1B5_DUO52HI53LO:L03	CPC015_MCF7_6H_X5	L03	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPD003_MCF7_24H_X1_B6_DUO52HI53LO:I22	CPD003_MCF7_24H_X1	I22	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPD003_MCF7_24H_X3_B6_DUO52HI53LO:I22	CPD003_MCF7_24H_X3	I22	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPD003_MCF7_6H_X1_B6_DUO52HI53LO:I22	CPD003_MCF7_6H_X1	I22	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPD003_MCF7_6H_X2_B6_DUO52HI53LO:I22	CPD003_MCF7_6H_X2	I22	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_MCF7_6H_X4_F1B5_DUO52HI53LO:J02	CPC004_MCF7_6H_X4	J02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_MCF7_6H_X5_F1B5_DUO52HI53LO:J02	CPC004_MCF7_6H_X5	J02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC015_MCF7_6H_X1_B4_DUO52HI53LO:L03	CPC015_MCF7_6H_X1	L03	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC015_MCF7_6H_X2_B4_DUO52HI53LO:L03	CPC015_MCF7_6H_X2	L03	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC015_MCF7_6H_X3_B3_DUO52HI53LO:L03	CPC015_MCF7_6H_X3	L03	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC015_MCF7_6H_X3_B4_DUO52HI53LO:L03	CPC015_MCF7_6H_X3	L03	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPD003_MCF7_24H_X2.L2_B6_DUO52HI53LO:I22	CPD003_MCF7_24H_X2.L2	I22	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPD003_MCF7_24H_X3.L2_B6_DUO52HI53LO:I22	CPD003_MCF7_24H_X3.L2	I22	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC004_MCF7_6H_X1_B3_DUO52HI53LO:K17	CPC004_MCF7_6H_X1	K17	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC004_MCF7_6H_X2_B3_DUO52HI53LO:K17	CPC004_MCF7_6H_X2	K17	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC004_MCF7_6H_X4_F1B5_DUO52HI53LO:K17	CPC004_MCF7_6H_X4	K17	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC004_MCF7_6H_X5_F1B5_DUO52HI53LO:K17	CPC004_MCF7_6H_X5	K17	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC018_MCF7_24H_X1_B4_DUO52HI53LO:A20	CPC018_MCF7_24H_X1	A20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC018_MCF7_24H_X2_B4_DUO52HI53LO:A20	CPC018_MCF7_24H_X2	A20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC018_MCF7_24H_X3_B4_DUO52HI53LO:A20	CPC018_MCF7_24H_X3	A20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC018_MCF7_24H_X4_B5_DUO52HI53LO:A20	CPC018_MCF7_24H_X4	A20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPD001_MCF7_24H_X1_B6_DUO52HI53LO:F08	CPD001_MCF7_24H_X1	F08	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPD001_MCF7_24H_X2_B6_DUO52HI53LO:F08	CPD001_MCF7_24H_X2	F08	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPD001_MCF7_24H_X3_B6_DUO52HI53LO:F08	CPD001_MCF7_24H_X3	F08	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPD001_MCF7_6H_X1.A2_B6_DUO52HI53LO:F08	CPD001_MCF7_6H_X1.A2	F08	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPD001_MCF7_6H_X1_B6_DUO52HI53LO:F08	CPD001_MCF7_6H_X1	F08	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPD001_MCF7_6H_X2_B6_DUO52HI53LO:F08	CPD001_MCF7_6H_X2	F08	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPD001_MCF7_6H_X3_B6_DUO52HI53LO:F08	CPD001_MCF7_6H_X3	F08	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC018_MCF7_6H_X1_B4_DUO52HI53LO:A20	CPC018_MCF7_6H_X1	A20	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC018_MCF7_6H_X2_B4_DUO52HI53LO:A20	CPC018_MCF7_6H_X2	A20	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC018_MCF7_6H_X3_B4_DUO52HI53LO:A20	CPC018_MCF7_6H_X3	A20	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_MCF7_6H_X1_B3_DUO52HI53LO:G23	CPC004_MCF7_6H_X1	G23	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_MCF7_6H_X2_B3_DUO52HI53LO:G23	CPC004_MCF7_6H_X2	G23	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_MCF7_6H_X4_F1B5_DUO52HI53LO:G23	CPC004_MCF7_6H_X4	G23	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_MCF7_6H_X5_F1B5_DUO52HI53LO:G23	CPC004_MCF7_6H_X5	G23	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC017_MCF7_24H_X1_B4_DUO52HI53LO:O16	CPC017_MCF7_24H_X1	O16	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC017_MCF7_24H_X2_B4_DUO52HI53LO:O16	CPC017_MCF7_24H_X2	O16	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC017_MCF7_24H_X3_B4_DUO52HI53LO:O16	CPC017_MCF7_24H_X3	O16	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC017_MCF7_24H_X4_B5_DUO52HI53LO:O16	CPC017_MCF7_24H_X4	O16	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC017_MCF7_24H_X5_B5_DUO52HI53LO:O16	CPC017_MCF7_24H_X5	O16	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC017_MCF7_6H_X5_F2B4_DUO52HI53LO:O16	CPC017_MCF7_6H_X5	O16	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC011_MCF7_24H_X4_B5_DUO52HI53LO:G15	CPC011_MCF7_24H_X4	G15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC011_MCF7_24H_X5_B5_DUO52HI53LO:G15	CPC011_MCF7_24H_X5	G15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC011_MCF7_6H_X1_B3_DUO52HI53LO:G15	CPC011_MCF7_6H_X1	G15	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC011_MCF7_6H_X3_B3_DUO52HI53LO:G15	CPC011_MCF7_6H_X3	G15	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC017_MCF7_6H_X1_B4_DUO52HI53LO:O16	CPC017_MCF7_6H_X1	O16	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC017_MCF7_6H_X2_B4_DUO52HI53LO:O16	CPC017_MCF7_6H_X2	O16	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC017_MCF7_6H_X3_B4_DUO52HI53LO:O16	CPC017_MCF7_6H_X3	O16	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC017_MCF7_24H_X1_B4_DUO52HI53LO:I07	CPC017_MCF7_24H_X1	I07	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC017_MCF7_24H_X2_B4_DUO52HI53LO:I07	CPC017_MCF7_24H_X2	I07	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC017_MCF7_24H_X3_B4_DUO52HI53LO:I07	CPC017_MCF7_24H_X3	I07	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC017_MCF7_24H_X4_B5_DUO52HI53LO:I07	CPC017_MCF7_24H_X4	I07	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC017_MCF7_24H_X5_B5_DUO52HI53LO:I07	CPC017_MCF7_24H_X5	I07	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC017_MCF7_6H_X5_F2B4_DUO52HI53LO:I07	CPC017_MCF7_6H_X5	I07	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC020_MCF7_24H_X1_F1B4_DUO52HI53LO:O02	CPC020_MCF7_24H_X1	O02	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC020_MCF7_24H_X2_F1B4_DUO52HI53LO:O02	CPC020_MCF7_24H_X2	O02	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC020_MCF7_24H_X3_F1B4_DUO52HI53LO:O02	CPC020_MCF7_24H_X3	O02	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC020_MCF7_24H_X4_F2B4_DUO52HI53LO:O02	CPC020_MCF7_24H_X4	O02	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC020_MCF7_24H_X5_B5_DUO52HI53LO:O02	CPC020_MCF7_24H_X5	O02	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC020_MCF7_6H_X1_B4_DUO52HI53LO:O02	CPC020_MCF7_6H_X1	O02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC020_MCF7_6H_X2_B4_DUO52HI53LO:O02	CPC020_MCF7_6H_X2	O02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC020_MCF7_6H_X3_B4_DUO52HI53LO:O02	CPC020_MCF7_6H_X3	O02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC020_MCF7_6H_X5_F1B5_DUO52HI53LO:O02	CPC020_MCF7_6H_X5	O02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC017_MCF7_6H_X1_B4_DUO52HI53LO:I07	CPC017_MCF7_6H_X1	I07	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC017_MCF7_6H_X2_B4_DUO52HI53LO:I07	CPC017_MCF7_6H_X2	I07	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC017_MCF7_6H_X3_B4_DUO52HI53LO:I07	CPC017_MCF7_6H_X3	I07	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC017_MCF7_24H_X1_B4_DUO52HI53LO:I11	CPC017_MCF7_24H_X1	I11	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC017_MCF7_24H_X2_B4_DUO52HI53LO:I11	CPC017_MCF7_24H_X2	I11	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC017_MCF7_24H_X3_B4_DUO52HI53LO:I11	CPC017_MCF7_24H_X3	I11	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC017_MCF7_24H_X4_B5_DUO52HI53LO:I11	CPC017_MCF7_24H_X4	I11	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC017_MCF7_24H_X5_B5_DUO52HI53LO:I11	CPC017_MCF7_24H_X5	I11	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC017_MCF7_6H_X5_F2B4_DUO52HI53LO:I11	CPC017_MCF7_6H_X5	I11	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC017_MCF7_6H_X1_B4_DUO52HI53LO:I11	CPC017_MCF7_6H_X1	I11	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC017_MCF7_6H_X2_B4_DUO52HI53LO:I11	CPC017_MCF7_6H_X2	I11	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC017_MCF7_6H_X3_B4_DUO52HI53LO:I11	CPC017_MCF7_6H_X3	I11	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_MCF7_6H_X1_B3_DUO52HI53LO:E01	CPC004_MCF7_6H_X1	E01	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_MCF7_6H_X2_B3_DUO52HI53LO:E01	CPC004_MCF7_6H_X2	E01	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_MCF7_6H_X4_F1B5_DUO52HI53LO:E01	CPC004_MCF7_6H_X4	E01	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_MCF7_6H_X5_F1B5_DUO52HI53LO:E01	CPC004_MCF7_6H_X5	E01	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC017_MCF7_24H_X1_B4_DUO52HI53LO:K18	CPC017_MCF7_24H_X1	K18	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC017_MCF7_24H_X2_B4_DUO52HI53LO:K18	CPC017_MCF7_24H_X2	K18	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC017_MCF7_24H_X3_B4_DUO52HI53LO:K18	CPC017_MCF7_24H_X3	K18	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC017_MCF7_24H_X4_B5_DUO52HI53LO:K18	CPC017_MCF7_24H_X4	K18	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC017_MCF7_24H_X5_B5_DUO52HI53LO:K18	CPC017_MCF7_24H_X5	K18	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC017_MCF7_6H_X5_F2B4_DUO52HI53LO:K18	CPC017_MCF7_6H_X5	K18	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_MCF7_24H_X1_F1B4_DUO52HI53LO:F24	CPC020_MCF7_24H_X1	F24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_MCF7_24H_X1_F1B4_DUO52HI53LO:H08	CPC020_MCF7_24H_X1	H08	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_MCF7_24H_X2_F1B4_DUO52HI53LO:F24	CPC020_MCF7_24H_X2	F24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_MCF7_24H_X2_F1B4_DUO52HI53LO:H08	CPC020_MCF7_24H_X2	H08	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_MCF7_24H_X3_F1B4_DUO52HI53LO:F24	CPC020_MCF7_24H_X3	F24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_MCF7_24H_X3_F1B4_DUO52HI53LO:H08	CPC020_MCF7_24H_X3	H08	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_MCF7_24H_X4_F2B4_DUO52HI53LO:F24	CPC020_MCF7_24H_X4	F24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_MCF7_24H_X4_F2B4_DUO52HI53LO:H08	CPC020_MCF7_24H_X4	H08	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_MCF7_24H_X5_B5_DUO52HI53LO:F24	CPC020_MCF7_24H_X5	F24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_MCF7_24H_X5_B5_DUO52HI53LO:H08	CPC020_MCF7_24H_X5	H08	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_MCF7_6H_X1_B4_DUO52HI53LO:F24	CPC020_MCF7_6H_X1	F24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_MCF7_6H_X1_B4_DUO52HI53LO:H08	CPC020_MCF7_6H_X1	H08	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_MCF7_6H_X2_B4_DUO52HI53LO:F24	CPC020_MCF7_6H_X2	F24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_MCF7_6H_X2_B4_DUO52HI53LO:H08	CPC020_MCF7_6H_X2	H08	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_MCF7_6H_X3_B4_DUO52HI53LO:F24	CPC020_MCF7_6H_X3	F24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_MCF7_6H_X3_B4_DUO52HI53LO:H08	CPC020_MCF7_6H_X3	H08	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_MCF7_6H_X5_F1B5_DUO52HI53LO:F24	CPC020_MCF7_6H_X5	F24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_MCF7_6H_X5_F1B5_DUO52HI53LO:H08	CPC020_MCF7_6H_X5	H08	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC017_MCF7_6H_X1_B4_DUO52HI53LO:K18	CPC017_MCF7_6H_X1	K18	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC017_MCF7_6H_X2_B4_DUO52HI53LO:K18	CPC017_MCF7_6H_X2	K18	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC017_MCF7_6H_X3_B4_DUO52HI53LO:K18	CPC017_MCF7_6H_X3	K18	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_MCF7_24H_X1_B4_DUO52HI53LO:N07	CPC005_MCF7_24H_X1	N07	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_MCF7_24H_X2_B4_DUO52HI53LO:N07	CPC005_MCF7_24H_X2	N07	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_MCF7_24H_X3_B4_DUO52HI53LO:N07	CPC005_MCF7_24H_X3	N07	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_MCF7_24H_X4_B5_DUO52HI53LO:N07	CPC005_MCF7_24H_X4	N07	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_MCF7_6H_X1_B3_DUO52HI53LO:N07	CPC005_MCF7_6H_X1	N07	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_MCF7_6H_X2_B3_DUO52HI53LO:N07	CPC005_MCF7_6H_X2	N07	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_MCF7_6H_X3_B3_DUO52HI53LO:N07	CPC005_MCF7_6H_X3	N07	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPD001_MCF7_24H_X1_B6_DUO52HI53LO:F23	CPD001_MCF7_24H_X1	F23	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPD001_MCF7_24H_X2_B6_DUO52HI53LO:F23	CPD001_MCF7_24H_X2	F23	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPD001_MCF7_24H_X3_B6_DUO52HI53LO:F23	CPD001_MCF7_24H_X3	F23	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPD001_MCF7_6H_X1.A2_B6_DUO52HI53LO:F23	CPD001_MCF7_6H_X1.A2	F23	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPD001_MCF7_6H_X1_B6_DUO52HI53LO:F23	CPD001_MCF7_6H_X1	F23	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPD001_MCF7_6H_X2_B6_DUO52HI53LO:F23	CPD001_MCF7_6H_X2	F23	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPD001_MCF7_6H_X3_B6_DUO52HI53LO:F23	CPD001_MCF7_6H_X3	F23	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_MCF7_24H_X5_F2B4_DUO52HI53LO:N07	CPC005_MCF7_24H_X5	N07	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_MCF7_6H_X2_F1B3_DUO52HI53LO:N07	CPC005_MCF7_6H_X2	N07	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_MCF7_6H_X5_F1B5_DUO52HI53LO:N07	CPC005_MCF7_6H_X5	N07	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC011_MCF7_24H_X4_B5_DUO52HI53LO:O15	CPC011_MCF7_24H_X4	O15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC011_MCF7_24H_X5_B5_DUO52HI53LO:O15	CPC011_MCF7_24H_X5	O15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC018_MCF7_24H_X1_B4_DUO52HI53LO:H09	CPC018_MCF7_24H_X1	H09	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC018_MCF7_24H_X2_B4_DUO52HI53LO:H09	CPC018_MCF7_24H_X2	H09	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC018_MCF7_24H_X3_B4_DUO52HI53LO:H09	CPC018_MCF7_24H_X3	H09	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC018_MCF7_24H_X4_B5_DUO52HI53LO:H09	CPC018_MCF7_24H_X4	H09	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC011_MCF7_6H_X1_B3_DUO52HI53LO:O15	CPC011_MCF7_6H_X1	O15	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC011_MCF7_6H_X3_B3_DUO52HI53LO:O15	CPC011_MCF7_6H_X3	O15	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC018_MCF7_6H_X1_B4_DUO52HI53LO:H09	CPC018_MCF7_6H_X1	H09	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC018_MCF7_6H_X2_B4_DUO52HI53LO:H09	CPC018_MCF7_6H_X2	H09	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC018_MCF7_6H_X3_B4_DUO52HI53LO:H09	CPC018_MCF7_6H_X3	H09	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_MCF7_24H_X1_B4_DUO52HI53LO:P19	CPC005_MCF7_24H_X1	P19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_MCF7_24H_X2_B4_DUO52HI53LO:P19	CPC005_MCF7_24H_X2	P19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_MCF7_24H_X3_B4_DUO52HI53LO:P19	CPC005_MCF7_24H_X3	P19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_MCF7_24H_X4_B5_DUO52HI53LO:P19	CPC005_MCF7_24H_X4	P19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_MCF7_6H_X1_B3_DUO52HI53LO:P19	CPC005_MCF7_6H_X1	P19	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_MCF7_6H_X2_B3_DUO52HI53LO:P19	CPC005_MCF7_6H_X2	P19	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_MCF7_6H_X2_F1B3_DUO52HI53LO:P19	CPC005_MCF7_6H_X2	P19	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_MCF7_6H_X3_B3_DUO52HI53LO:P19	CPC005_MCF7_6H_X3	P19	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_MCF7_24H_X4_B5_DUO52HI53LO:J24	CPC009_MCF7_24H_X4	J24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_MCF7_24H_X5_B5_DUO52HI53LO:J24	CPC009_MCF7_24H_X5	J24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_MCF7_6H_X3.A2_F1B3_DUO52HI53LO:J24	CPC009_MCF7_6H_X3.A2	J24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPD002_MCF7_24H_X1_B6_DUO52HI53LO:G04	CPD002_MCF7_24H_X1	G04	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPD002_MCF7_24H_X2_B6_DUO52HI53LO:G04	CPD002_MCF7_24H_X2	G04	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPD002_MCF7_24H_X3_B6_DUO52HI53LO:G04	CPD002_MCF7_24H_X3	G04	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPD002_MCF7_6H_X1_B6_DUO52HI53LO:G04	CPD002_MCF7_6H_X1	G04	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPD002_MCF7_6H_X2_B6_DUO52HI53LO:G04	CPD002_MCF7_6H_X2	G04	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPD002_MCF7_6H_X3_B6_DUO52HI53LO:G04	CPD002_MCF7_6H_X3	G04	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_MCF7_24H_X5_F2B4_DUO52HI53LO:P19	CPC005_MCF7_24H_X5	P19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_MCF7_6H_X1_B3_DUO52HI53LO:J24	CPC009_MCF7_6H_X1	J24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_MCF7_6H_X2_B3_DUO52HI53LO:J24	CPC009_MCF7_6H_X2	J24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_MCF7_24H_X1_B4_DUO52HI53LO:F24	CPC005_MCF7_24H_X1	F24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_MCF7_24H_X2_B4_DUO52HI53LO:F24	CPC005_MCF7_24H_X2	F24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_MCF7_24H_X3_B4_DUO52HI53LO:F24	CPC005_MCF7_24H_X3	F24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_MCF7_24H_X4_B5_DUO52HI53LO:F24	CPC005_MCF7_24H_X4	F24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_MCF7_6H_X1_B3_DUO52HI53LO:F24	CPC005_MCF7_6H_X1	F24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_MCF7_6H_X2_B3_DUO52HI53LO:F24	CPC005_MCF7_6H_X2	F24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_MCF7_6H_X2_F1B3_DUO52HI53LO:F24	CPC005_MCF7_6H_X2	F24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_MCF7_6H_X3_B3_DUO52HI53LO:F24	CPC005_MCF7_6H_X3	F24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_MCF7_6H_X5_F1B5_DUO52HI53LO:F24	CPC005_MCF7_6H_X5	F24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_MCF7_24H_X4_B5_DUO52HI53LO:B24	CPC009_MCF7_24H_X4	B24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_MCF7_24H_X5_B5_DUO52HI53LO:B24	CPC009_MCF7_24H_X5	B24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_MCF7_6H_X1_B3_DUO52HI53LO:B24	CPC009_MCF7_6H_X1	B24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_MCF7_6H_X2_B3_DUO52HI53LO:B24	CPC009_MCF7_6H_X2	B24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_MCF7_6H_X3.A2_F1B3_DUO52HI53LO:B24	CPC009_MCF7_6H_X3.A2	B24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPD002_MCF7_24H_X1_B6_DUO52HI53LO:L06	CPD002_MCF7_24H_X1	L06	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPD002_MCF7_24H_X2_B6_DUO52HI53LO:L06	CPD002_MCF7_24H_X2	L06	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPD002_MCF7_24H_X3_B6_DUO52HI53LO:L06	CPD002_MCF7_24H_X3	L06	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPD002_MCF7_6H_X1_B6_DUO52HI53LO:L06	CPD002_MCF7_6H_X1	L06	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPD002_MCF7_6H_X2_B6_DUO52HI53LO:L06	CPD002_MCF7_6H_X2	L06	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPD002_MCF7_6H_X3_B6_DUO52HI53LO:L06	CPD002_MCF7_6H_X3	L06	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_MCF7_24H_X5_F2B4_DUO52HI53LO:F24	CPC005_MCF7_24H_X5	F24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC011_MCF7_24H_X4_B5_DUO52HI53LO:P10	CPC011_MCF7_24H_X4	P10	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC011_MCF7_24H_X5_B5_DUO52HI53LO:P10	CPC011_MCF7_24H_X5	P10	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC011_MCF7_6H_X1_B3_DUO52HI53LO:P10	CPC011_MCF7_6H_X1	P10	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC011_MCF7_6H_X3_B3_DUO52HI53LO:P10	CPC011_MCF7_6H_X3	P10	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_MCF7_24H_X1_F1B4_DUO52HI53LO:B15	CPC020_MCF7_24H_X1	B15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_MCF7_24H_X2_F1B4_DUO52HI53LO:B15	CPC020_MCF7_24H_X2	B15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_MCF7_24H_X3_F1B4_DUO52HI53LO:B15	CPC020_MCF7_24H_X3	B15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_MCF7_24H_X4_F2B4_DUO52HI53LO:B15	CPC020_MCF7_24H_X4	B15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_MCF7_24H_X5_B5_DUO52HI53LO:B15	CPC020_MCF7_24H_X5	B15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_MCF7_6H_X1_B4_DUO52HI53LO:B15	CPC020_MCF7_6H_X1	B15	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_MCF7_6H_X2_B4_DUO52HI53LO:B15	CPC020_MCF7_6H_X2	B15	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_MCF7_6H_X3_B4_DUO52HI53LO:B15	CPC020_MCF7_6H_X3	B15	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_MCF7_6H_X5_F1B5_DUO52HI53LO:B15	CPC020_MCF7_6H_X5	B15	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K19277754	CPC011_MCF7_24H_X4_B5_DUO52HI53LO:I12	CPC011_MCF7_24H_X4	I12	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K19277754	CPC011_MCF7_24H_X5_B5_DUO52HI53LO:I12	CPC011_MCF7_24H_X5	I12	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K19277754	CPC011_MCF7_6H_X1_B3_DUO52HI53LO:I12	CPC011_MCF7_6H_X1	I12	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K19277754	CPC011_MCF7_6H_X3_B3_DUO52HI53LO:I12	CPC011_MCF7_6H_X3	I12	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_MCF7_6H_X1_B3_DUO52HI53LO:H24	CPC004_MCF7_6H_X1	H24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_MCF7_6H_X2_B3_DUO52HI53LO:H24	CPC004_MCF7_6H_X2	H24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_MCF7_6H_X4_F1B5_DUO52HI53LO:H24	CPC004_MCF7_6H_X4	H24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_MCF7_6H_X5_F1B5_DUO52HI53LO:H24	CPC004_MCF7_6H_X5	H24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC015_MCF7_24H_X1_B4_DUO52HI53LO:L01	CPC015_MCF7_24H_X1	L01	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC015_MCF7_24H_X2_B4_DUO52HI53LO:L01	CPC015_MCF7_24H_X2	L01	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC015_MCF7_24H_X3_B4_DUO52HI53LO:L01	CPC015_MCF7_24H_X3	L01	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC015_MCF7_24H_X4_B5_DUO52HI53LO:L01	CPC015_MCF7_24H_X4	L01	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC015_MCF7_24H_X5_F1B5_DUO52HI53LO:L01	CPC015_MCF7_24H_X5	L01	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC015_MCF7_6H_X4_F2B4_DUO52HI53LO:L01	CPC015_MCF7_6H_X4	L01	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC015_MCF7_6H_X5_F1B5_DUO52HI53LO:L01	CPC015_MCF7_6H_X5	L01	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPD003_MCF7_24H_X1_B6_DUO52HI53LO:K03	CPD003_MCF7_24H_X1	K03	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPD003_MCF7_24H_X2.L2_B6_DUO52HI53LO:K03	CPD003_MCF7_24H_X2.L2	K03	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPD003_MCF7_24H_X3.L2_B6_DUO52HI53LO:K03	CPD003_MCF7_24H_X3.L2	K03	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPD003_MCF7_24H_X3_B6_DUO52HI53LO:K03	CPD003_MCF7_24H_X3	K03	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPD003_MCF7_6H_X1_B6_DUO52HI53LO:K03	CPD003_MCF7_6H_X1	K03	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPD003_MCF7_6H_X2_B6_DUO52HI53LO:K03	CPD003_MCF7_6H_X2	K03	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC011_MCF7_24H_X4_B5_DUO52HI53LO:I21	CPC011_MCF7_24H_X4	I21	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC011_MCF7_24H_X5_B5_DUO52HI53LO:I21	CPC011_MCF7_24H_X5	I21	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC011_MCF7_6H_X1_B3_DUO52HI53LO:I21	CPC011_MCF7_6H_X1	I21	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC011_MCF7_6H_X3_B3_DUO52HI53LO:I21	CPC011_MCF7_6H_X3	I21	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC015_MCF7_6H_X1_B4_DUO52HI53LO:L01	CPC015_MCF7_6H_X1	L01	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC015_MCF7_6H_X2_B4_DUO52HI53LO:L01	CPC015_MCF7_6H_X2	L01	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC015_MCF7_6H_X3_B3_DUO52HI53LO:L01	CPC015_MCF7_6H_X3	L01	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC015_MCF7_6H_X3_B4_DUO52HI53LO:L01	CPC015_MCF7_6H_X3	L01	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K57174586	CPD003_MCF7_24H_X2.L2_B6_DUO52HI53LO:L09	CPD003_MCF7_24H_X2.L2	L09	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K57174586	CPD003_MCF7_24H_X3.L2_B6_DUO52HI53LO:L09	CPD003_MCF7_24H_X3.L2	L09	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K57174586	CPD003_MCF7_24H_X1_B6_DUO52HI53LO:L09	CPD003_MCF7_24H_X1	L09	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K57174586	CPD003_MCF7_24H_X3_B6_DUO52HI53LO:L09	CPD003_MCF7_24H_X3	L09	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K57174586	CPD003_MCF7_6H_X1_B6_DUO52HI53LO:L09	CPD003_MCF7_6H_X1	L09	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K57174586	CPD003_MCF7_6H_X2_B6_DUO52HI53LO:L09	CPD003_MCF7_6H_X2	L09	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_MCF7_6H_X1_B3_DUO52HI53LO:H13	CPC004_MCF7_6H_X1	H13	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_MCF7_6H_X2_B3_DUO52HI53LO:H13	CPC004_MCF7_6H_X2	H13	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_MCF7_6H_X4_F1B5_DUO52HI53LO:H13	CPC004_MCF7_6H_X4	H13	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_MCF7_6H_X5_F1B5_DUO52HI53LO:H13	CPC004_MCF7_6H_X5	H13	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC015_MCF7_24H_X1_B4_DUO52HI53LO:K04	CPC015_MCF7_24H_X1	K04	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC015_MCF7_24H_X2_B4_DUO52HI53LO:K04	CPC015_MCF7_24H_X2	K04	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC015_MCF7_24H_X3_B4_DUO52HI53LO:K04	CPC015_MCF7_24H_X3	K04	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC015_MCF7_24H_X4_B5_DUO52HI53LO:K04	CPC015_MCF7_24H_X4	K04	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC015_MCF7_24H_X5_F1B5_DUO52HI53LO:K04	CPC015_MCF7_24H_X5	K04	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC015_MCF7_6H_X4_F2B4_DUO52HI53LO:K04	CPC015_MCF7_6H_X4	K04	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC015_MCF7_6H_X5_F1B5_DUO52HI53LO:K04	CPC015_MCF7_6H_X5	K04	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC011_MCF7_24H_X4_B5_DUO52HI53LO:L11	CPC011_MCF7_24H_X4	L11	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC011_MCF7_24H_X5_B5_DUO52HI53LO:L11	CPC011_MCF7_24H_X5	L11	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC011_MCF7_6H_X1_B3_DUO52HI53LO:L11	CPC011_MCF7_6H_X1	L11	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC011_MCF7_6H_X3_B3_DUO52HI53LO:L11	CPC011_MCF7_6H_X3	L11	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC015_MCF7_6H_X1_B4_DUO52HI53LO:K04	CPC015_MCF7_6H_X1	K04	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC015_MCF7_6H_X2_B4_DUO52HI53LO:K04	CPC015_MCF7_6H_X2	K04	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC015_MCF7_6H_X3_B3_DUO52HI53LO:K04	CPC015_MCF7_6H_X3	K04	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC015_MCF7_6H_X3_B4_DUO52HI53LO:K04	CPC015_MCF7_6H_X3	K04	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_MCF7_6H_X1_B3_DUO52HI53LO:J04	CPC004_MCF7_6H_X1	J04	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_MCF7_6H_X2_B3_DUO52HI53LO:J04	CPC004_MCF7_6H_X2	J04	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_MCF7_6H_X4_F1B5_DUO52HI53LO:J04	CPC004_MCF7_6H_X4	J04	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_MCF7_6H_X5_F1B5_DUO52HI53LO:J04	CPC004_MCF7_6H_X5	J04	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC015_MCF7_24H_X1_B4_DUO52HI53LO:L05	CPC015_MCF7_24H_X1	L05	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC015_MCF7_24H_X2_B4_DUO52HI53LO:L05	CPC015_MCF7_24H_X2	L05	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC015_MCF7_24H_X3_B4_DUO52HI53LO:L05	CPC015_MCF7_24H_X3	L05	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC015_MCF7_24H_X4_B5_DUO52HI53LO:L05	CPC015_MCF7_24H_X4	L05	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC015_MCF7_24H_X5_F1B5_DUO52HI53LO:L05	CPC015_MCF7_24H_X5	L05	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC015_MCF7_6H_X4_F2B4_DUO52HI53LO:L05	CPC015_MCF7_6H_X4	L05	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC015_MCF7_6H_X5_F1B5_DUO52HI53LO:L05	CPC015_MCF7_6H_X5	L05	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC015_MCF7_6H_X1_B4_DUO52HI53LO:L05	CPC015_MCF7_6H_X1	L05	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC015_MCF7_6H_X2_B4_DUO52HI53LO:L05	CPC015_MCF7_6H_X2	L05	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC015_MCF7_6H_X3_B3_DUO52HI53LO:L05	CPC015_MCF7_6H_X3	L05	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC015_MCF7_6H_X3_B4_DUO52HI53LO:L05	CPC015_MCF7_6H_X3	L05	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K31534764	CPC011_MCF7_24H_X4_B5_DUO52HI53LO:E15	CPC011_MCF7_24H_X4	E15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K31534764	CPC011_MCF7_24H_X5_B5_DUO52HI53LO:E15	CPC011_MCF7_24H_X5	E15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K31534764	CPC011_MCF7_6H_X1_B3_DUO52HI53LO:E15	CPC011_MCF7_6H_X1	E15	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K31534764	CPC011_MCF7_6H_X3_B3_DUO52HI53LO:E15	CPC011_MCF7_6H_X3	E15	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC016_MCF7_24H_X2_B4_DUO52HI53LO:M15	CPC016_MCF7_24H_X2	M15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC016_MCF7_24H_X3_B4_DUO52HI53LO:M15	CPC016_MCF7_24H_X3	M15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC016_MCF7_24H_X4_B5_DUO52HI53LO:M15	CPC016_MCF7_24H_X4	M15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC016_MCF7_24H_X5_B5_DUO52HI53LO:M15	CPC016_MCF7_24H_X5	M15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC016_MCF7_6H_X5_F2B5_DUO52HI53LO:M15	CPC016_MCF7_6H_X5	M15	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPD003_MCF7_24H_X1_B6_DUO52HI53LO:H11	CPD003_MCF7_24H_X1	H11	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPD003_MCF7_24H_X2.L2_B6_DUO52HI53LO:H11	CPD003_MCF7_24H_X2.L2	H11	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPD003_MCF7_24H_X3.L2_B6_DUO52HI53LO:H11	CPD003_MCF7_24H_X3.L2	H11	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPD003_MCF7_24H_X3_B6_DUO52HI53LO:H11	CPD003_MCF7_24H_X3	H11	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPD003_MCF7_6H_X1_B6_DUO52HI53LO:H11	CPD003_MCF7_6H_X1	H11	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPD003_MCF7_6H_X2_B6_DUO52HI53LO:H11	CPD003_MCF7_6H_X2	H11	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC016_MCF7_6H_X1_B4_DUO52HI53LO:M15	CPC016_MCF7_6H_X1	M15	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC016_MCF7_6H_X2_B4_DUO52HI53LO:M15	CPC016_MCF7_6H_X2	M15	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_MCF7_6H_X1_B3_DUO52HI53LO:H07	CPC004_MCF7_6H_X1	H07	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_MCF7_6H_X2_B3_DUO52HI53LO:H07	CPC004_MCF7_6H_X2	H07	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_MCF7_6H_X4_F1B5_DUO52HI53LO:H07	CPC004_MCF7_6H_X4	H07	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_MCF7_6H_X5_F1B5_DUO52HI53LO:H07	CPC004_MCF7_6H_X5	H07	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC015_MCF7_24H_X1_B4_DUO52HI53LO:I22	CPC015_MCF7_24H_X1	I22	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC015_MCF7_24H_X2_B4_DUO52HI53LO:I22	CPC015_MCF7_24H_X2	I22	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC015_MCF7_24H_X3_B4_DUO52HI53LO:I22	CPC015_MCF7_24H_X3	I22	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC015_MCF7_24H_X4_B5_DUO52HI53LO:I22	CPC015_MCF7_24H_X4	I22	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC015_MCF7_24H_X5_F1B5_DUO52HI53LO:I22	CPC015_MCF7_24H_X5	I22	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC015_MCF7_6H_X4_F2B4_DUO52HI53LO:I22	CPC015_MCF7_6H_X4	I22	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC015_MCF7_6H_X5_F1B5_DUO52HI53LO:I22	CPC015_MCF7_6H_X5	I22	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPD002_MCF7_24H_X1_B6_DUO52HI53LO:D15	CPD002_MCF7_24H_X1	D15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPD002_MCF7_24H_X2_B6_DUO52HI53LO:D15	CPD002_MCF7_24H_X2	D15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPD002_MCF7_24H_X3_B6_DUO52HI53LO:D15	CPD002_MCF7_24H_X3	D15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC011_MCF7_24H_X4_B5_DUO52HI53LO:D11	CPC011_MCF7_24H_X4	D11	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC011_MCF7_24H_X5_B5_DUO52HI53LO:D11	CPC011_MCF7_24H_X5	D11	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC011_MCF7_6H_X1_B3_DUO52HI53LO:D11	CPC011_MCF7_6H_X1	D11	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC011_MCF7_6H_X3_B3_DUO52HI53LO:D11	CPC011_MCF7_6H_X3	D11	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC015_MCF7_6H_X1_B4_DUO52HI53LO:I22	CPC015_MCF7_6H_X1	I22	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC015_MCF7_6H_X2_B4_DUO52HI53LO:I22	CPC015_MCF7_6H_X2	I22	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC015_MCF7_6H_X3_B3_DUO52HI53LO:I22	CPC015_MCF7_6H_X3	I22	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC015_MCF7_6H_X3_B4_DUO52HI53LO:I22	CPC015_MCF7_6H_X3	I22	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPD002_MCF7_6H_X1_B6_DUO52HI53LO:D15	CPD002_MCF7_6H_X1	D15	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPD002_MCF7_6H_X2_B6_DUO52HI53LO:D15	CPD002_MCF7_6H_X2	D15	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPD002_MCF7_6H_X3_B6_DUO52HI53LO:D15	CPD002_MCF7_6H_X3	D15	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC016_MCF7_24H_X2_B4_DUO52HI53LO:M20	CPC016_MCF7_24H_X2	M20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC016_MCF7_24H_X3_B4_DUO52HI53LO:M20	CPC016_MCF7_24H_X3	M20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC016_MCF7_24H_X4_B5_DUO52HI53LO:M20	CPC016_MCF7_24H_X4	M20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC016_MCF7_24H_X5_B5_DUO52HI53LO:M20	CPC016_MCF7_24H_X5	M20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC016_MCF7_6H_X5_F2B5_DUO52HI53LO:M20	CPC016_MCF7_6H_X5	M20	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPD002_MCF7_24H_X1_B6_DUO52HI53LO:P01	CPD002_MCF7_24H_X1	P01	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPD002_MCF7_24H_X2_B6_DUO52HI53LO:P01	CPD002_MCF7_24H_X2	P01	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPD002_MCF7_24H_X3_B6_DUO52HI53LO:P01	CPD002_MCF7_24H_X3	P01	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC016_MCF7_6H_X1_B4_DUO52HI53LO:M20	CPC016_MCF7_6H_X1	M20	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC016_MCF7_6H_X2_B4_DUO52HI53LO:M20	CPC016_MCF7_6H_X2	M20	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPD002_MCF7_6H_X1_B6_DUO52HI53LO:P01	CPD002_MCF7_6H_X1	P01	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPD002_MCF7_6H_X2_B6_DUO52HI53LO:P01	CPD002_MCF7_6H_X2	P01	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPD002_MCF7_6H_X3_B6_DUO52HI53LO:P01	CPD002_MCF7_6H_X3	P01	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPC010_MCF7_24H_X1_B5_DUO52HI53LO:P24	CPC010_MCF7_24H_X1	P24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPC010_MCF7_24H_X2_B5_DUO52HI53LO:P24	CPC010_MCF7_24H_X2	P24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPC010_MCF7_24H_X5_B5_DUO52HI53LO:P24	CPC010_MCF7_24H_X5	P24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPC010_MCF7_6H_X2_B3_DUO52HI53LO:P24	CPC010_MCF7_6H_X2	P24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPC010_MCF7_6H_X3_B3_DUO52HI53LO:P24	CPC010_MCF7_6H_X3	P24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPC010_MCF7_6H_X4_F1B5_DUO52HI53LO:P24	CPC010_MCF7_6H_X4	P24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPD003_MCF7_24H_X2.L2_B6_DUO52HI53LO:L20	CPD003_MCF7_24H_X2.L2	L20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPD003_MCF7_24H_X3.L2_B6_DUO52HI53LO:L20	CPD003_MCF7_24H_X3.L2	L20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPD003_MCF7_24H_X1_B6_DUO52HI53LO:L20	CPD003_MCF7_24H_X1	L20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPD003_MCF7_24H_X3_B6_DUO52HI53LO:L20	CPD003_MCF7_24H_X3	L20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPD003_MCF7_6H_X1_B6_DUO52HI53LO:L20	CPD003_MCF7_6H_X1	L20	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPD003_MCF7_6H_X2_B6_DUO52HI53LO:L20	CPD003_MCF7_6H_X2	L20	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC009_MCF7_24H_X4_B5_DUO52HI53LO:K23	CPC009_MCF7_24H_X4	K23	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC009_MCF7_24H_X5_B5_DUO52HI53LO:K23	CPC009_MCF7_24H_X5	K23	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC009_MCF7_6H_X1_B3_DUO52HI53LO:K23	CPC009_MCF7_6H_X1	K23	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC009_MCF7_6H_X2_B3_DUO52HI53LO:K23	CPC009_MCF7_6H_X2	K23	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC009_MCF7_6H_X3.A2_F1B3_DUO52HI53LO:K23	CPC009_MCF7_6H_X3.A2	K23	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPD001_MCF7_24H_X1_B6_DUO52HI53LO:B21	CPD001_MCF7_24H_X1	B21	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPD001_MCF7_24H_X2_B6_DUO52HI53LO:B21	CPD001_MCF7_24H_X2	B21	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPD001_MCF7_24H_X3_B6_DUO52HI53LO:B21	CPD001_MCF7_24H_X3	B21	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPD001_MCF7_6H_X1.A2_B6_DUO52HI53LO:B21	CPD001_MCF7_6H_X1.A2	B21	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPD001_MCF7_6H_X1_B6_DUO52HI53LO:B21	CPD001_MCF7_6H_X1	B21	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPD001_MCF7_6H_X2_B6_DUO52HI53LO:B21	CPD001_MCF7_6H_X2	B21	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPD001_MCF7_6H_X3_B6_DUO52HI53LO:B21	CPD001_MCF7_6H_X3	B21	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC011_MCF7_24H_X4_B5_DUO52HI53LO:I11	CPC011_MCF7_24H_X4	I11	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC011_MCF7_24H_X5_B5_DUO52HI53LO:I11	CPC011_MCF7_24H_X5	I11	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC011_MCF7_6H_X1_B3_DUO52HI53LO:I11	CPC011_MCF7_6H_X1	I11	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC011_MCF7_6H_X3_B3_DUO52HI53LO:I11	CPC011_MCF7_6H_X3	I11	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_MCF7_24H_X1_B4_DUO52HI53LO:E19	CPC005_MCF7_24H_X1	E19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_MCF7_24H_X2_B4_DUO52HI53LO:E19	CPC005_MCF7_24H_X2	E19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_MCF7_24H_X3_B4_DUO52HI53LO:E19	CPC005_MCF7_24H_X3	E19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_MCF7_24H_X4_B5_DUO52HI53LO:E19	CPC005_MCF7_24H_X4	E19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_MCF7_6H_X1_B3_DUO52HI53LO:E19	CPC005_MCF7_6H_X1	E19	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_MCF7_6H_X2_B3_DUO52HI53LO:E19	CPC005_MCF7_6H_X2	E19	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_MCF7_6H_X2_F1B3_DUO52HI53LO:E19	CPC005_MCF7_6H_X2	E19	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_MCF7_6H_X3_B3_DUO52HI53LO:E19	CPC005_MCF7_6H_X3	E19	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_MCF7_6H_X5_F1B5_DUO52HI53LO:E19	CPC005_MCF7_6H_X5	E19	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_MCF7_24H_X5_F2B4_DUO52HI53LO:E19	CPC005_MCF7_24H_X5	E19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K88809146	CPD001_MCF7_24H_X1_B6_DUO52HI53LO:D07	CPD001_MCF7_24H_X1	D07	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K88809146	CPD001_MCF7_24H_X2_B6_DUO52HI53LO:D07	CPD001_MCF7_24H_X2	D07	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K88809146	CPD001_MCF7_24H_X3_B6_DUO52HI53LO:D07	CPD001_MCF7_24H_X3	D07	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K88809146	CPD001_MCF7_6H_X1.A2_B6_DUO52HI53LO:D07	CPD001_MCF7_6H_X1.A2	D07	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K88809146	CPD001_MCF7_6H_X1_B6_DUO52HI53LO:D07	CPD001_MCF7_6H_X1	D07	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K88809146	CPD001_MCF7_6H_X2_B6_DUO52HI53LO:D07	CPD001_MCF7_6H_X2	D07	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K88809146	CPD001_MCF7_6H_X3_B6_DUO52HI53LO:D07	CPD001_MCF7_6H_X3	D07	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPD001_MCF7_6H_X1.A2_B6_DUO52HI53LO:G02	CPD001_MCF7_6H_X1.A2	G02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPC011_MCF7_24H_X4_B5_DUO52HI53LO:A16	CPC011_MCF7_24H_X4	A16	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPC011_MCF7_24H_X5_B5_DUO52HI53LO:A16	CPC011_MCF7_24H_X5	A16	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPC011_MCF7_6H_X1_B3_DUO52HI53LO:A16	CPC011_MCF7_6H_X1	A16	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPC011_MCF7_6H_X3_B3_DUO52HI53LO:A16	CPC011_MCF7_6H_X3	A16	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPD001_MCF7_24H_X1_B6_DUO52HI53LO:G02	CPD001_MCF7_24H_X1	G02	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPD001_MCF7_24H_X2_B6_DUO52HI53LO:G02	CPD001_MCF7_24H_X2	G02	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPD001_MCF7_24H_X3_B6_DUO52HI53LO:G02	CPD001_MCF7_24H_X3	G02	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPD001_MCF7_6H_X1_B6_DUO52HI53LO:G02	CPD001_MCF7_6H_X1	G02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPD001_MCF7_6H_X2_B6_DUO52HI53LO:G02	CPD001_MCF7_6H_X2	G02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPD001_MCF7_6H_X3_B6_DUO52HI53LO:G02	CPD001_MCF7_6H_X3	G02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC016_MCF7_24H_X2_B4_DUO52HI53LO:O06	CPC016_MCF7_24H_X2	O06	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC016_MCF7_24H_X3_B4_DUO52HI53LO:O06	CPC016_MCF7_24H_X3	O06	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC016_MCF7_24H_X4_B5_DUO52HI53LO:O06	CPC016_MCF7_24H_X4	O06	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC016_MCF7_24H_X5_B5_DUO52HI53LO:O06	CPC016_MCF7_24H_X5	O06	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC016_MCF7_6H_X5_F2B5_DUO52HI53LO:O06	CPC016_MCF7_6H_X5	O06	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPD001_MCF7_24H_X1_B6_DUO52HI53LO:C20	CPD001_MCF7_24H_X1	C20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPD001_MCF7_24H_X2_B6_DUO52HI53LO:C20	CPD001_MCF7_24H_X2	C20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPD001_MCF7_24H_X3_B6_DUO52HI53LO:C20	CPD001_MCF7_24H_X3	C20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPD001_MCF7_6H_X1.A2_B6_DUO52HI53LO:C20	CPD001_MCF7_6H_X1.A2	C20	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPD001_MCF7_6H_X1_B6_DUO52HI53LO:C20	CPD001_MCF7_6H_X1	C20	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPD001_MCF7_6H_X2_B6_DUO52HI53LO:C20	CPD001_MCF7_6H_X2	C20	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPD001_MCF7_6H_X3_B6_DUO52HI53LO:C20	CPD001_MCF7_6H_X3	C20	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC016_MCF7_6H_X2_B4_DUO52HI53LO:O06	CPC016_MCF7_6H_X2	O06	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_MCF7_24H_X1_F1B4_DUO52HI53LO:K04	CPC020_MCF7_24H_X1	K04	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_MCF7_24H_X2_F1B4_DUO52HI53LO:K04	CPC020_MCF7_24H_X2	K04	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_MCF7_24H_X3_F1B4_DUO52HI53LO:K04	CPC020_MCF7_24H_X3	K04	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_MCF7_24H_X4_F2B4_DUO52HI53LO:K04	CPC020_MCF7_24H_X4	K04	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_MCF7_24H_X5_B5_DUO52HI53LO:K04	CPC020_MCF7_24H_X5	K04	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_MCF7_6H_X5_F1B5_DUO52HI53LO:K04	CPC020_MCF7_6H_X5	K04	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPD001_MCF7_24H_X1_B6_DUO52HI53LO:E18	CPD001_MCF7_24H_X1	E18	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPD001_MCF7_24H_X2_B6_DUO52HI53LO:E18	CPD001_MCF7_24H_X2	E18	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPD001_MCF7_24H_X3_B6_DUO52HI53LO:E18	CPD001_MCF7_24H_X3	E18	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPD001_MCF7_6H_X1.A2_B6_DUO52HI53LO:E18	CPD001_MCF7_6H_X1.A2	E18	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPD001_MCF7_6H_X1_B6_DUO52HI53LO:E18	CPD001_MCF7_6H_X1	E18	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPD001_MCF7_6H_X2_B6_DUO52HI53LO:E18	CPD001_MCF7_6H_X2	E18	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPD001_MCF7_6H_X3_B6_DUO52HI53LO:E18	CPD001_MCF7_6H_X3	E18	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_MCF7_6H_X1_B4_DUO52HI53LO:K04	CPC020_MCF7_6H_X1	K04	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_MCF7_6H_X2_B4_DUO52HI53LO:K04	CPC020_MCF7_6H_X2	K04	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_MCF7_6H_X3_B4_DUO52HI53LO:K04	CPC020_MCF7_6H_X3	K04	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_MCF7_6H_X1_B3_DUO52HI53LO:I06	CPC004_MCF7_6H_X1	I06	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_MCF7_6H_X2_B3_DUO52HI53LO:I06	CPC004_MCF7_6H_X2	I06	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_MCF7_6H_X4_F1B5_DUO52HI53LO:I06	CPC004_MCF7_6H_X4	I06	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_MCF7_6H_X5_F1B5_DUO52HI53LO:I06	CPC004_MCF7_6H_X5	I06	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC016_MCF7_24H_X2_B4_DUO52HI53LO:N14	CPC016_MCF7_24H_X2	N14	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC016_MCF7_24H_X3_B4_DUO52HI53LO:N14	CPC016_MCF7_24H_X3	N14	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC016_MCF7_24H_X4_B5_DUO52HI53LO:N14	CPC016_MCF7_24H_X4	N14	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC016_MCF7_24H_X5_B5_DUO52HI53LO:N14	CPC016_MCF7_24H_X5	N14	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC016_MCF7_6H_X5_F2B5_DUO52HI53LO:N14	CPC016_MCF7_6H_X5	N14	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPD001_MCF7_24H_X1_B6_DUO52HI53LO:L06	CPD001_MCF7_24H_X1	L06	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPD001_MCF7_24H_X2_B6_DUO52HI53LO:L06	CPD001_MCF7_24H_X2	L06	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPD001_MCF7_24H_X3_B6_DUO52HI53LO:L06	CPD001_MCF7_24H_X3	L06	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPD001_MCF7_6H_X1.A2_B6_DUO52HI53LO:L06	CPD001_MCF7_6H_X1.A2	L06	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPD001_MCF7_6H_X1_B6_DUO52HI53LO:L06	CPD001_MCF7_6H_X1	L06	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPD001_MCF7_6H_X2_B6_DUO52HI53LO:L06	CPD001_MCF7_6H_X2	L06	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPD001_MCF7_6H_X3_B6_DUO52HI53LO:L06	CPD001_MCF7_6H_X3	L06	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC011_MCF7_24H_X4_B5_DUO52HI53LO:K13	CPC011_MCF7_24H_X4	K13	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC011_MCF7_24H_X5_B5_DUO52HI53LO:K13	CPC011_MCF7_24H_X5	K13	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC011_MCF7_6H_X1_B3_DUO52HI53LO:K13	CPC011_MCF7_6H_X1	K13	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC011_MCF7_6H_X3_B3_DUO52HI53LO:K13	CPC011_MCF7_6H_X3	K13	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC016_MCF7_6H_X2_B4_DUO52HI53LO:N14	CPC016_MCF7_6H_X2	N14	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC016_MCF7_24H_X2_B4_DUO52HI53LO:K22	CPC016_MCF7_24H_X2	K22	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC016_MCF7_24H_X3_B4_DUO52HI53LO:K22	CPC016_MCF7_24H_X3	K22	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC016_MCF7_24H_X4_B5_DUO52HI53LO:K22	CPC016_MCF7_24H_X4	K22	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC016_MCF7_24H_X5_B5_DUO52HI53LO:K22	CPC016_MCF7_24H_X5	K22	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC016_MCF7_6H_X5_F2B5_DUO52HI53LO:K22	CPC016_MCF7_6H_X5	K22	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC011_MCF7_24H_X4_B5_DUO52HI53LO:J05	CPC011_MCF7_24H_X4	J05	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC011_MCF7_24H_X5_B5_DUO52HI53LO:J05	CPC011_MCF7_24H_X5	J05	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC011_MCF7_6H_X1_B3_DUO52HI53LO:J05	CPC011_MCF7_6H_X1	J05	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC011_MCF7_6H_X3_B3_DUO52HI53LO:J05	CPC011_MCF7_6H_X3	J05	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC016_MCF7_6H_X1_B4_DUO52HI53LO:K22	CPC016_MCF7_6H_X1	K22	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC016_MCF7_6H_X2_B4_DUO52HI53LO:K22	CPC016_MCF7_6H_X2	K22	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_MCF7_24H_X1_B4_DUO52HI53LO:E10	CPC005_MCF7_24H_X1	E10	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_MCF7_24H_X2_B4_DUO52HI53LO:E10	CPC005_MCF7_24H_X2	E10	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_MCF7_24H_X3_B4_DUO52HI53LO:E10	CPC005_MCF7_24H_X3	E10	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_MCF7_24H_X4_B5_DUO52HI53LO:E10	CPC005_MCF7_24H_X4	E10	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_MCF7_6H_X1_B3_DUO52HI53LO:E10	CPC005_MCF7_6H_X1	E10	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_MCF7_6H_X2_B3_DUO52HI53LO:E10	CPC005_MCF7_6H_X2	E10	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_MCF7_6H_X2_F1B3_DUO52HI53LO:E10	CPC005_MCF7_6H_X2	E10	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_MCF7_6H_X3_B3_DUO52HI53LO:E10	CPC005_MCF7_6H_X3	E10	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_MCF7_6H_X5_F1B5_DUO52HI53LO:E10	CPC005_MCF7_6H_X5	E10	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPD001_MCF7_24H_X1_B6_DUO52HI53LO:M13	CPD001_MCF7_24H_X1	M13	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPD001_MCF7_24H_X2_B6_DUO52HI53LO:M13	CPD001_MCF7_24H_X2	M13	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPD001_MCF7_24H_X3_B6_DUO52HI53LO:M13	CPD001_MCF7_24H_X3	M13	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPD001_MCF7_6H_X1.A2_B6_DUO52HI53LO:M13	CPD001_MCF7_6H_X1.A2	M13	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPD001_MCF7_6H_X1_B6_DUO52HI53LO:M13	CPD001_MCF7_6H_X1	M13	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPD001_MCF7_6H_X2_B6_DUO52HI53LO:M13	CPD001_MCF7_6H_X2	M13	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPD001_MCF7_6H_X3_B6_DUO52HI53LO:M13	CPD001_MCF7_6H_X3	M13	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_MCF7_24H_X5_F2B4_DUO52HI53LO:E10	CPC005_MCF7_24H_X5	E10	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC016_MCF7_24H_X2_B4_DUO52HI53LO:C19	CPC016_MCF7_24H_X2	C19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC016_MCF7_24H_X3_B4_DUO52HI53LO:C19	CPC016_MCF7_24H_X3	C19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC016_MCF7_24H_X4_B5_DUO52HI53LO:C19	CPC016_MCF7_24H_X4	C19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC016_MCF7_6H_X5_F2B5_DUO52HI53LO:C19	CPC016_MCF7_6H_X5	C19	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC011_MCF7_24H_X4_B5_DUO52HI53LO:A13	CPC011_MCF7_24H_X4	A13	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC011_MCF7_24H_X5_B5_DUO52HI53LO:A13	CPC011_MCF7_24H_X5	A13	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC011_MCF7_6H_X1_B3_DUO52HI53LO:A13	CPC011_MCF7_6H_X1	A13	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC011_MCF7_6H_X3_B3_DUO52HI53LO:A13	CPC011_MCF7_6H_X3	A13	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC016_MCF7_6H_X1_B4_DUO52HI53LO:C19	CPC016_MCF7_6H_X1	C19	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC016_MCF7_6H_X2_B4_DUO52HI53LO:C19	CPC016_MCF7_6H_X2	C19	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5666	N06AX09	viloxazine	CCOC1=CC=CC=C1OCC2CNCCO2	CCOc1ccccc1OCC1CNCCO1	BRD-A59198242	CPD003_MCF7_24H_X1_B6_DUO52HI53LO:E17	CPD003_MCF7_24H_X1	E17	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5666	N06AX09	viloxazine	CCOC1=CC=CC=C1OCC2CNCCO2	CCOc1ccccc1OCC1CNCCO1	BRD-A59198242	CPD003_MCF7_24H_X2.L2_B6_DUO52HI53LO:E17	CPD003_MCF7_24H_X2.L2	E17	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5666	N06AX09	viloxazine	CCOC1=CC=CC=C1OCC2CNCCO2	CCOc1ccccc1OCC1CNCCO1	BRD-A59198242	CPD003_MCF7_24H_X3.L2_B6_DUO52HI53LO:E17	CPD003_MCF7_24H_X3.L2	E17	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5666	N06AX09	viloxazine	CCOC1=CC=CC=C1OCC2CNCCO2	CCOc1ccccc1OCC1CNCCO1	BRD-A59198242	CPD003_MCF7_24H_X3_B6_DUO52HI53LO:E17	CPD003_MCF7_24H_X3	E17	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5666	N06AX09	viloxazine	CCOC1=CC=CC=C1OCC2CNCCO2	CCOc1ccccc1OCC1CNCCO1	BRD-A59198242	CPD003_MCF7_6H_X1_B6_DUO52HI53LO:E17	CPD003_MCF7_6H_X1	E17	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5666	N06AX09	viloxazine	CCOC1=CC=CC=C1OCC2CNCCO2	CCOc1ccccc1OCC1CNCCO1	BRD-A59198242	CPD003_MCF7_6H_X2_B6_DUO52HI53LO:E17	CPD003_MCF7_6H_X2	E17	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_MCF7_6H_X1_B3_DUO52HI53LO:A16	CPC004_MCF7_6H_X1	A16	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_MCF7_6H_X2_B3_DUO52HI53LO:A16	CPC004_MCF7_6H_X2	A16	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_MCF7_6H_X4_F1B5_DUO52HI53LO:A16	CPC004_MCF7_6H_X4	A16	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_MCF7_6H_X5_F1B5_DUO52HI53LO:A16	CPC004_MCF7_6H_X5	A16	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC016_MCF7_24H_X2_B4_DUO52HI53LO:H06	CPC016_MCF7_24H_X2	H06	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC016_MCF7_24H_X3_B4_DUO52HI53LO:H06	CPC016_MCF7_24H_X3	H06	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC016_MCF7_24H_X4_B5_DUO52HI53LO:H06	CPC016_MCF7_24H_X4	H06	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC016_MCF7_24H_X5_B5_DUO52HI53LO:H06	CPC016_MCF7_24H_X5	H06	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC016_MCF7_6H_X5_F2B5_DUO52HI53LO:H06	CPC016_MCF7_6H_X5	H06	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC011_MCF7_24H_X4_B5_DUO52HI53LO:G23	CPC011_MCF7_24H_X4	G23	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC011_MCF7_24H_X5_B5_DUO52HI53LO:G23	CPC011_MCF7_24H_X5	G23	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC011_MCF7_6H_X1_B3_DUO52HI53LO:G23	CPC011_MCF7_6H_X1	G23	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC011_MCF7_6H_X3_B3_DUO52HI53LO:G23	CPC011_MCF7_6H_X3	G23	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC016_MCF7_6H_X1_B4_DUO52HI53LO:H06	CPC016_MCF7_6H_X1	H06	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC016_MCF7_6H_X2_B4_DUO52HI53LO:H06	CPC016_MCF7_6H_X2	H06	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPD002_MCF7_24H_X1_B6_DUO52HI53LO:O14	CPD002_MCF7_24H_X1	O14	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPD002_MCF7_24H_X2_B6_DUO52HI53LO:O14	CPD002_MCF7_24H_X2	O14	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPD002_MCF7_24H_X3_B6_DUO52HI53LO:O14	CPD002_MCF7_24H_X3	O14	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPD002_MCF7_6H_X1_B6_DUO52HI53LO:O14	CPD002_MCF7_6H_X1	O14	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPD002_MCF7_6H_X2_B6_DUO52HI53LO:O14	CPD002_MCF7_6H_X2	O14	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPD002_MCF7_6H_X3_B6_DUO52HI53LO:O14	CPD002_MCF7_6H_X3	O14	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-K83153774	CPC020_MCF7_24H_X1_F1B4_DUO52HI53LO:D15	CPC020_MCF7_24H_X1	D15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-K83153774	CPC020_MCF7_24H_X2_F1B4_DUO52HI53LO:D15	CPC020_MCF7_24H_X2	D15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-K83153774	CPC020_MCF7_24H_X3_F1B4_DUO52HI53LO:D15	CPC020_MCF7_24H_X3	D15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-K83153774	CPC020_MCF7_24H_X4_F2B4_DUO52HI53LO:D15	CPC020_MCF7_24H_X4	D15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-K83153774	CPC020_MCF7_24H_X5_B5_DUO52HI53LO:D15	CPC020_MCF7_24H_X5	D15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-K83153774	CPC020_MCF7_6H_X1_B4_DUO52HI53LO:D15	CPC020_MCF7_6H_X1	D15	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-K83153774	CPC020_MCF7_6H_X2_B4_DUO52HI53LO:D15	CPC020_MCF7_6H_X2	D15	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-K83153774	CPC020_MCF7_6H_X3_B4_DUO52HI53LO:D15	CPC020_MCF7_6H_X3	D15	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-K83153774	CPC020_MCF7_6H_X5_F1B5_DUO52HI53LO:D15	CPC020_MCF7_6H_X5	D15	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_MCF7_6H_X1_B3_DUO52HI53LO:J08	CPC004_MCF7_6H_X1	J08	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_MCF7_6H_X2_B3_DUO52HI53LO:J08	CPC004_MCF7_6H_X2	J08	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_MCF7_6H_X4_F1B5_DUO52HI53LO:J08	CPC004_MCF7_6H_X4	J08	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_MCF7_6H_X5_F1B5_DUO52HI53LO:J08	CPC004_MCF7_6H_X5	J08	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_MCF7_24H_X4_B5_DUO52HI53LO:G10	CPC011_MCF7_24H_X4	G10	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_MCF7_24H_X5_B5_DUO52HI53LO:G10	CPC011_MCF7_24H_X5	G10	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC015_MCF7_24H_X1_B4_DUO52HI53LO:L09	CPC015_MCF7_24H_X1	L09	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC015_MCF7_24H_X2_B4_DUO52HI53LO:L09	CPC015_MCF7_24H_X2	L09	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC015_MCF7_24H_X3_B4_DUO52HI53LO:L09	CPC015_MCF7_24H_X3	L09	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC015_MCF7_24H_X4_B5_DUO52HI53LO:L09	CPC015_MCF7_24H_X4	L09	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC015_MCF7_24H_X5_F1B5_DUO52HI53LO:L09	CPC015_MCF7_24H_X5	L09	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC015_MCF7_6H_X1_B4_DUO52HI53LO:L09	CPC015_MCF7_6H_X1	L09	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC015_MCF7_6H_X2_B4_DUO52HI53LO:L09	CPC015_MCF7_6H_X2	L09	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC015_MCF7_6H_X3_B3_DUO52HI53LO:L09	CPC015_MCF7_6H_X3	L09	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC015_MCF7_6H_X3_B4_DUO52HI53LO:L09	CPC015_MCF7_6H_X3	L09	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC015_MCF7_6H_X4_F2B4_DUO52HI53LO:L09	CPC015_MCF7_6H_X4	L09	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC015_MCF7_6H_X5_F1B5_DUO52HI53LO:L09	CPC015_MCF7_6H_X5	L09	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPD001_MCF7_24H_X1_B6_DUO52HI53LO:B20	CPD001_MCF7_24H_X1	B20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPD001_MCF7_24H_X2_B6_DUO52HI53LO:B20	CPD001_MCF7_24H_X2	B20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPD001_MCF7_24H_X3_B6_DUO52HI53LO:B20	CPD001_MCF7_24H_X3	B20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPD001_MCF7_6H_X1.A2_B6_DUO52HI53LO:B20	CPD001_MCF7_6H_X1.A2	B20	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPD001_MCF7_6H_X1_B6_DUO52HI53LO:B20	CPD001_MCF7_6H_X1	B20	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPD001_MCF7_6H_X2_B6_DUO52HI53LO:B20	CPD001_MCF7_6H_X2	B20	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPD001_MCF7_6H_X3_B6_DUO52HI53LO:B20	CPD001_MCF7_6H_X3	B20	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_MCF7_24H_X4_B5_DUO52HI53LO:B03	CPC011_MCF7_24H_X4	B03	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_MCF7_24H_X5_B5_DUO52HI53LO:B03	CPC011_MCF7_24H_X5	B03	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_MCF7_6H_X1_B3_DUO52HI53LO:G10	CPC011_MCF7_6H_X1	G10	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_MCF7_6H_X3_B3_DUO52HI53LO:G10	CPC011_MCF7_6H_X3	G10	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_MCF7_6H_X1_B3_DUO52HI53LO:B03	CPC011_MCF7_6H_X1	B03	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_MCF7_6H_X3_B3_DUO52HI53LO:B03	CPC011_MCF7_6H_X3	B03	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_MCF7_24H_X1_B4_DUO52HI53LO:M14	CPC005_MCF7_24H_X1	M14	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_MCF7_24H_X2_B4_DUO52HI53LO:M14	CPC005_MCF7_24H_X2	M14	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_MCF7_24H_X3_B4_DUO52HI53LO:M14	CPC005_MCF7_24H_X3	M14	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_MCF7_24H_X4_B5_DUO52HI53LO:M14	CPC005_MCF7_24H_X4	M14	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_MCF7_24H_X5_F2B4_DUO52HI53LO:M14	CPC005_MCF7_24H_X5	M14	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_MCF7_6H_X1_B3_DUO52HI53LO:M14	CPC005_MCF7_6H_X1	M14	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_MCF7_6H_X2_B3_DUO52HI53LO:M14	CPC005_MCF7_6H_X2	M14	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_MCF7_6H_X2_F1B3_DUO52HI53LO:M14	CPC005_MCF7_6H_X2	M14	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_MCF7_6H_X3_B3_DUO52HI53LO:M14	CPC005_MCF7_6H_X3	M14	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_MCF7_6H_X5_F1B5_DUO52HI53LO:M14	CPC005_MCF7_6H_X5	M14	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_MCF7_6H_X1_B3_DUO52HI53LO:J06	CPC004_MCF7_6H_X1	J06	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_MCF7_6H_X2_B3_DUO52HI53LO:J06	CPC004_MCF7_6H_X2	J06	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_MCF7_6H_X4_F1B5_DUO52HI53LO:J06	CPC004_MCF7_6H_X4	J06	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_MCF7_6H_X5_F1B5_DUO52HI53LO:J06	CPC004_MCF7_6H_X5	J06	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC011_MCF7_24H_X4_B5_DUO52HI53LO:J19	CPC011_MCF7_24H_X4	J19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC011_MCF7_24H_X5_B5_DUO52HI53LO:J19	CPC011_MCF7_24H_X5	J19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC015_MCF7_24H_X1_B4_DUO52HI53LO:L07	CPC015_MCF7_24H_X1	L07	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC015_MCF7_24H_X2_B4_DUO52HI53LO:L07	CPC015_MCF7_24H_X2	L07	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC015_MCF7_24H_X3_B4_DUO52HI53LO:L07	CPC015_MCF7_24H_X3	L07	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC015_MCF7_24H_X4_B5_DUO52HI53LO:L07	CPC015_MCF7_24H_X4	L07	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC015_MCF7_24H_X5_F1B5_DUO52HI53LO:L07	CPC015_MCF7_24H_X5	L07	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC015_MCF7_6H_X4_F2B4_DUO52HI53LO:L07	CPC015_MCF7_6H_X4	L07	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC015_MCF7_6H_X5_F1B5_DUO52HI53LO:L07	CPC015_MCF7_6H_X5	L07	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC011_MCF7_6H_X1_B3_DUO52HI53LO:J19	CPC011_MCF7_6H_X1	J19	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC011_MCF7_6H_X3_B3_DUO52HI53LO:J19	CPC011_MCF7_6H_X3	J19	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC015_MCF7_6H_X1_B4_DUO52HI53LO:L07	CPC015_MCF7_6H_X1	L07	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC015_MCF7_6H_X2_B4_DUO52HI53LO:L07	CPC015_MCF7_6H_X2	L07	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC015_MCF7_6H_X3_B3_DUO52HI53LO:L07	CPC015_MCF7_6H_X3	L07	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC015_MCF7_6H_X3_B4_DUO52HI53LO:L07	CPC015_MCF7_6H_X3	L07	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPD002_MCF7_24H_X1_B6_DUO52HI53LO:L12	CPD002_MCF7_24H_X1	L12	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPD002_MCF7_24H_X2_B6_DUO52HI53LO:L12	CPD002_MCF7_24H_X2	L12	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPD002_MCF7_24H_X3_B6_DUO52HI53LO:L12	CPD002_MCF7_24H_X3	L12	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPD002_MCF7_6H_X1_B6_DUO52HI53LO:L12	CPD002_MCF7_6H_X1	L12	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPD002_MCF7_6H_X2_B6_DUO52HI53LO:L12	CPD002_MCF7_6H_X2	L12	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPD002_MCF7_6H_X3_B6_DUO52HI53LO:L12	CPD002_MCF7_6H_X3	L12	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
65833	N06AX17	milnacipran	CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2	CCN(CC)C(=O)C1(c2ccccc2)CC1CN	BRD-K02227374	CPC011_MCF7_24H_X4_B5_DUO52HI53LO:H14	CPC011_MCF7_24H_X4	H14	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
65833	N06AX17	milnacipran	CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2	CCN(CC)C(=O)C1(c2ccccc2)CC1CN	BRD-K02227374	CPC011_MCF7_24H_X5_B5_DUO52HI53LO:H14	CPC011_MCF7_24H_X5	H14	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
65833	N06AX17	milnacipran	CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2	CCN(CC)C(=O)C1(c2ccccc2)CC1CN	BRD-K02227374	CPC011_MCF7_6H_X1_B3_DUO52HI53LO:H14	CPC011_MCF7_6H_X1	H14	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
65833	N06AX17	milnacipran	CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2	CCN(CC)C(=O)C1(c2ccccc2)CC1CN	BRD-K02227374	CPC011_MCF7_6H_X3_B3_DUO52HI53LO:H14	CPC011_MCF7_6H_X3	H14	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC017_MCF7_24H_X1_B4_DUO52HI53LO:F21	CPC017_MCF7_24H_X1	F21	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC017_MCF7_24H_X2_B4_DUO52HI53LO:F21	CPC017_MCF7_24H_X2	F21	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC017_MCF7_24H_X3_B4_DUO52HI53LO:F21	CPC017_MCF7_24H_X3	F21	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC017_MCF7_24H_X4_B5_DUO52HI53LO:F21	CPC017_MCF7_24H_X4	F21	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC017_MCF7_6H_X5_F2B4_DUO52HI53LO:F21	CPC017_MCF7_6H_X5	F21	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC017_MCF7_6H_X1_B4_DUO52HI53LO:F21	CPC017_MCF7_6H_X1	F21	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC017_MCF7_6H_X2_B4_DUO52HI53LO:F21	CPC017_MCF7_6H_X2	F21	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC017_MCF7_6H_X3_B4_DUO52HI53LO:F21	CPC017_MCF7_6H_X3	F21	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-K32480324	CPD002_MCF7_24H_X1_B6_DUO52HI53LO:F03	CPD002_MCF7_24H_X1	F03	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-K32480324	CPD002_MCF7_24H_X2_B6_DUO52HI53LO:F03	CPD002_MCF7_24H_X2	F03	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-K32480324	CPD002_MCF7_24H_X3_B6_DUO52HI53LO:F03	CPD002_MCF7_24H_X3	F03	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-K32480324	CPD002_MCF7_6H_X1_B6_DUO52HI53LO:F03	CPD002_MCF7_6H_X1	F03	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-K32480324	CPD002_MCF7_6H_X2_B6_DUO52HI53LO:F03	CPD002_MCF7_6H_X2	F03	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-K32480324	CPD002_MCF7_6H_X3_B6_DUO52HI53LO:F03	CPD002_MCF7_6H_X3	F03	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_MCF7_6H_X1_B3_DUO52HI53LO:J03	CPC004_MCF7_6H_X1	J03	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_MCF7_6H_X2_B3_DUO52HI53LO:J03	CPC004_MCF7_6H_X2	J03	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_MCF7_6H_X4_F1B5_DUO52HI53LO:J03	CPC004_MCF7_6H_X4	J03	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_MCF7_6H_X5_F1B5_DUO52HI53LO:J03	CPC004_MCF7_6H_X5	J03	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_MCF7_24H_X1_B5_DUO52HI53LO:G22	CPC010_MCF7_24H_X1	G22	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_MCF7_24H_X2_B5_DUO52HI53LO:G22	CPC010_MCF7_24H_X2	G22	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_MCF7_24H_X3_B5_DUO52HI53LO:G22	CPC010_MCF7_24H_X3	G22	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_MCF7_24H_X5_B5_DUO52HI53LO:G22	CPC010_MCF7_24H_X5	G22	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_MCF7_6H_X2_B3_DUO52HI53LO:G22	CPC010_MCF7_6H_X2	G22	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_MCF7_6H_X3_B3_DUO52HI53LO:G22	CPC010_MCF7_6H_X3	G22	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_MCF7_6H_X4_F1B5_DUO52HI53LO:G22	CPC010_MCF7_6H_X4	G22	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC015_MCF7_24H_X1_B4_DUO52HI53LO:K18	CPC015_MCF7_24H_X1	K18	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC015_MCF7_24H_X2_B4_DUO52HI53LO:K18	CPC015_MCF7_24H_X2	K18	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC015_MCF7_24H_X3_B4_DUO52HI53LO:K18	CPC015_MCF7_24H_X3	K18	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC015_MCF7_24H_X4_B5_DUO52HI53LO:K18	CPC015_MCF7_24H_X4	K18	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC015_MCF7_24H_X5_F1B5_DUO52HI53LO:K18	CPC015_MCF7_24H_X5	K18	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC015_MCF7_6H_X4_F2B4_DUO52HI53LO:K18	CPC015_MCF7_6H_X4	K18	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC015_MCF7_6H_X5_F1B5_DUO52HI53LO:K18	CPC015_MCF7_6H_X5	K18	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC011_MCF7_24H_X4_B5_DUO52HI53LO:I05	CPC011_MCF7_24H_X4	I05	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC011_MCF7_24H_X5_B5_DUO52HI53LO:I05	CPC011_MCF7_24H_X5	I05	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC011_MCF7_6H_X1_B3_DUO52HI53LO:I05	CPC011_MCF7_6H_X1	I05	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC011_MCF7_6H_X3_B3_DUO52HI53LO:I05	CPC011_MCF7_6H_X3	I05	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC015_MCF7_6H_X1_B4_DUO52HI53LO:K18	CPC015_MCF7_6H_X1	K18	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC015_MCF7_6H_X2_B4_DUO52HI53LO:K18	CPC015_MCF7_6H_X2	K18	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC015_MCF7_6H_X3_B3_DUO52HI53LO:K18	CPC015_MCF7_6H_X3	K18	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC015_MCF7_6H_X3_B4_DUO52HI53LO:K18	CPC015_MCF7_6H_X3	K18	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_PC3_24H_X1_B3_DUO52HI53LO:E11	CPC004_PC3_24H_X1	E11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_PC3_24H_X2_B3_DUO52HI53LO:E11	CPC004_PC3_24H_X2	E11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_PC3_24H_X3_B3_DUO52HI53LO:E11	CPC004_PC3_24H_X3	E11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_PC3_24H_X4_B4_DUO52HI53LO:E11	CPC004_PC3_24H_X4	E11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_PC3_24H_X5_B5_DUO52HI53LO:E11	CPC004_PC3_24H_X5	E11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_PC3_6H_X1_B3_DUO52HI53LO:E11	CPC004_PC3_6H_X1	E11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_PC3_6H_X2_B3_DUO52HI53LO:E11	CPC004_PC3_6H_X2	E11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_PC3_6H_X3_B3_DUO52HI53LO:E11	CPC004_PC3_6H_X3	E11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_PC3_6H_X4_B4_DUO52HI53LO:E11	CPC004_PC3_6H_X4	E11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_PC3_6H_X5_F1B5_DUO52HI53LO:E11	CPC004_PC3_6H_X5	E11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC020_PC3_24H_X1_B5_DUO52HI53LO:F21	CPC020_PC3_24H_X1	F21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC020_PC3_24H_X2_B5_DUO52HI53LO:F21	CPC020_PC3_24H_X2	F21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC020_PC3_24H_X3_B5_DUO52HI53LO:F21	CPC020_PC3_24H_X3	F21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC020_PC3_24H_X4_B5_DUO52HI53LO:F21	CPC020_PC3_24H_X4	F21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC020_PC3_24H_X5_B5_DUO52HI53LO:F21	CPC020_PC3_24H_X5	F21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC020_PC3_6H_X4_F1B4_DUO52HI53LO:F21	CPC020_PC3_6H_X4	F21	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPD001_PC3_24H_X1_B6_DUO52HI53LO:E02	CPD001_PC3_24H_X1	E02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPD001_PC3_24H_X2_B6_DUO52HI53LO:E02	CPD001_PC3_24H_X2	E02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPD001_PC3_24H_X3_B6_DUO52HI53LO:E02	CPD001_PC3_24H_X3	E02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC020_PC3_6H_X1_B4_DUO52HI53LO:F21	CPC020_PC3_6H_X1	F21	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC020_PC3_6H_X2_B4_DUO52HI53LO:F21	CPC020_PC3_6H_X2	F21	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC020_PC3_6H_X3_B4_DUO52HI53LO:F21	CPC020_PC3_6H_X3	F21	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_PC3_24H_X1_B4_DUO52HI53LO:C12	CPC005_PC3_24H_X1	C12	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_PC3_24H_X2_B4_DUO52HI53LO:C12	CPC005_PC3_24H_X2	C12	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_PC3_24H_X3_B4_DUO52HI53LO:C12	CPC005_PC3_24H_X3	C12	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_PC3_24H_X4_B5_DUO52HI53LO:C12	CPC005_PC3_24H_X4	C12	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_PC3_24H_X5_B5_DUO52HI53LO:C12	CPC005_PC3_24H_X5	C12	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_PC3_6H_X1_B3_DUO52HI53LO:C12	CPC005_PC3_6H_X1	C12	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_PC3_6H_X2_B3_DUO52HI53LO:C12	CPC005_PC3_6H_X2	C12	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_PC3_6H_X3_B3_DUO52HI53LO:C12	CPC005_PC3_6H_X3	C12	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_PC3_6H_X5_F1B5_DUO52HI53LO:C12	CPC005_PC3_6H_X5	C12	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_PC3_24H_X1_B5_DUO52HI53LO:H14	CPC020_PC3_24H_X1	H14	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_PC3_24H_X1_B5_DUO52HI53LO:L24	CPC020_PC3_24H_X1	L24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_PC3_24H_X2_B5_DUO52HI53LO:H14	CPC020_PC3_24H_X2	H14	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_PC3_24H_X3_B5_DUO52HI53LO:H14	CPC020_PC3_24H_X3	H14	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_PC3_24H_X3_B5_DUO52HI53LO:L24	CPC020_PC3_24H_X3	L24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_PC3_24H_X4_B5_DUO52HI53LO:H14	CPC020_PC3_24H_X4	H14	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_PC3_24H_X5_B5_DUO52HI53LO:H14	CPC020_PC3_24H_X5	H14	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_PC3_24H_X5_B5_DUO52HI53LO:L24	CPC020_PC3_24H_X5	L24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_PC3_6H_X4_F1B4_DUO52HI53LO:H14	CPC020_PC3_6H_X4	H14	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_PC3_6H_X4_F1B4_DUO52HI53LO:L24	CPC020_PC3_6H_X4	L24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPD001_PC3_24H_X1_B6_DUO52HI53LO:O05	CPD001_PC3_24H_X1	O05	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPD001_PC3_24H_X2_B6_DUO52HI53LO:O05	CPD001_PC3_24H_X2	O05	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPD001_PC3_24H_X3_B6_DUO52HI53LO:O05	CPD001_PC3_24H_X3	O05	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_PC3_6H_X1_B4_DUO52HI53LO:H14	CPC020_PC3_6H_X1	H14	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_PC3_6H_X1_B4_DUO52HI53LO:L24	CPC020_PC3_6H_X1	L24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_PC3_6H_X2_B4_DUO52HI53LO:H14	CPC020_PC3_6H_X2	H14	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_PC3_6H_X2_B4_DUO52HI53LO:L24	CPC020_PC3_6H_X2	L24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_PC3_6H_X3_B4_DUO52HI53LO:H14	CPC020_PC3_6H_X3	H14	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_PC3_6H_X3_B4_DUO52HI53LO:L24	CPC020_PC3_6H_X3	L24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_PC3_6H_X5_B5_DUO52HI53LO:H14	CPC020_PC3_6H_X5	H14	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC002_PC3_24H_X1_B3_DUO52HI53LO:G20	CPC002_PC3_24H_X1	G20	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC002_PC3_24H_X2_B3_DUO52HI53LO:G20	CPC002_PC3_24H_X2	G20	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC002_PC3_24H_X3_B3_DUO52HI53LO:G20	CPC002_PC3_24H_X3	G20	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC002_PC3_24H_X4_B4_DUO52HI53LO:G20	CPC002_PC3_24H_X4	G20	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC002_PC3_6H_X1_B3_DUO52HI53LO:G20	CPC002_PC3_6H_X1	G20	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC002_PC3_6H_X2_B3_DUO52HI53LO:G20	CPC002_PC3_6H_X2	G20	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC002_PC3_6H_X3_B3_DUO52HI53LO:G20	CPC002_PC3_6H_X3	G20	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC002_PC3_6H_X4_B4_DUO52HI53LO:G20	CPC002_PC3_6H_X4	G20	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC002_PC3_6H_X5_F1B5_DUO52HI53LO:G20	CPC002_PC3_6H_X5	G20	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC020_PC3_24H_X1_B5_DUO52HI53LO:P19	CPC020_PC3_24H_X1	P19	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC020_PC3_24H_X2_B5_DUO52HI53LO:P19	CPC020_PC3_24H_X2	P19	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC020_PC3_24H_X3_B5_DUO52HI53LO:P19	CPC020_PC3_24H_X3	P19	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC020_PC3_24H_X4_B5_DUO52HI53LO:P19	CPC020_PC3_24H_X4	P19	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC020_PC3_24H_X5_B5_DUO52HI53LO:P19	CPC020_PC3_24H_X5	P19	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC020_PC3_6H_X4_F1B4_DUO52HI53LO:P19	CPC020_PC3_6H_X4	P19	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPD001_PC3_24H_X1_B6_DUO52HI53LO:F20	CPD001_PC3_24H_X1	F20	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPD001_PC3_24H_X2_B6_DUO52HI53LO:F20	CPD001_PC3_24H_X2	F20	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPD001_PC3_24H_X3_B6_DUO52HI53LO:F20	CPD001_PC3_24H_X3	F20	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC002_PC3_24H_X5_F1B5_DUO52HI53LO:G20	CPC002_PC3_24H_X5	G20	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC020_PC3_6H_X1_B4_DUO52HI53LO:P19	CPC020_PC3_6H_X1	P19	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC020_PC3_6H_X2_B4_DUO52HI53LO:P19	CPC020_PC3_6H_X2	P19	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC020_PC3_6H_X3_B4_DUO52HI53LO:P19	CPC020_PC3_6H_X3	P19	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC020_PC3_6H_X5_B5_DUO52HI53LO:P19	CPC020_PC3_6H_X5	P19	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
9417	N06AA05	opipramol	C1CN(CCN1CCCN2C3=CC=CC=C3C=CC4=CC=CC=C42)CCO	OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1	BRD-K43786866	CPD002_PC3_24H_X1_B6_DUO52HI53LO:H08	CPD002_PC3_24H_X1	H08	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
9417	N06AA05	opipramol	C1CN(CCN1CCCN2C3=CC=CC=C3C=CC4=CC=CC=C42)CCO	OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1	BRD-K43786866	CPD002_PC3_24H_X2_B6_DUO52HI53LO:H08	CPD002_PC3_24H_X2	H08	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
9417	N06AA05	opipramol	C1CN(CCN1CCCN2C3=CC=CC=C3C=CC4=CC=CC=C42)CCO	OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1	BRD-K43786866	CPD002_PC3_24H_X3_B6_DUO52HI53LO:H08	CPD002_PC3_24H_X3	H08	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
9417	N06AA05	opipramol	C1CN(CCN1CCCN2C3=CC=CC=C3C=CC4=CC=CC=C42)CCO	OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1	BRD-K43786866	CPD002_PC3_6H_X1_B6_DUO52HI53LO:H08	CPD002_PC3_6H_X1	H08	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
9417	N06AA05	opipramol	C1CN(CCN1CCCN2C3=CC=CC=C3C=CC4=CC=CC=C42)CCO	OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1	BRD-K43786866	CPD002_PC3_6H_X2_B6_DUO52HI53LO:H08	CPD002_PC3_6H_X2	H08	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
9417	N06AA05	opipramol	C1CN(CCN1CCCN2C3=CC=CC=C3C=CC4=CC=CC=C42)CCO	OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1	BRD-K43786866	CPD002_PC3_6H_X3_B6_DUO52HI53LO:H08	CPD002_PC3_6H_X3	H08	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_PC3_24H_X1_B3_DUO52HI53LO:I02	CPC004_PC3_24H_X1	I02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_PC3_24H_X2_B3_DUO52HI53LO:I02	CPC004_PC3_24H_X2	I02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_PC3_24H_X3_B3_DUO52HI53LO:I02	CPC004_PC3_24H_X3	I02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_PC3_24H_X4_B4_DUO52HI53LO:I02	CPC004_PC3_24H_X4	I02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_PC3_24H_X5_B5_DUO52HI53LO:I02	CPC004_PC3_24H_X5	I02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_PC3_6H_X1_B3_DUO52HI53LO:I02	CPC004_PC3_6H_X1	I02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_PC3_6H_X2_B3_DUO52HI53LO:I02	CPC004_PC3_6H_X2	I02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_PC3_6H_X3_B3_DUO52HI53LO:I02	CPC004_PC3_6H_X3	I02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_PC3_6H_X4_B4_DUO52HI53LO:I02	CPC004_PC3_6H_X4	I02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_PC3_6H_X5_F1B5_DUO52HI53LO:I02	CPC004_PC3_6H_X5	I02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPD003_PC3_24H_X1.L2_B6_DUO52HI53LO:A13	CPD003_PC3_24H_X1.L2	A13	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPD003_PC3_24H_X2.L2_B6_DUO52HI53LO:A13	CPD003_PC3_24H_X2.L2	A13	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPD003_PC3_6H_X1_B6_DUO52HI53LO:A13	CPD003_PC3_6H_X1	A13	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPD003_PC3_6H_X3.A2_B6_DUO52HI53LO:A13	CPD003_PC3_6H_X3.A2	A13	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPD003_PC3_6H_X3_B6_DUO52HI53LO:A13	CPD003_PC3_6H_X3	A13	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_PC3_24H_X1_B3_DUO52HI53LO:I02	CPC004_PC3_24H_X1	I02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_PC3_24H_X2_B3_DUO52HI53LO:I02	CPC004_PC3_24H_X2	I02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_PC3_24H_X3_B3_DUO52HI53LO:I02	CPC004_PC3_24H_X3	I02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_PC3_24H_X4_B4_DUO52HI53LO:I02	CPC004_PC3_24H_X4	I02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_PC3_24H_X5_B5_DUO52HI53LO:I02	CPC004_PC3_24H_X5	I02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_PC3_6H_X1_B3_DUO52HI53LO:I02	CPC004_PC3_6H_X1	I02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_PC3_6H_X2_B3_DUO52HI53LO:I02	CPC004_PC3_6H_X2	I02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_PC3_6H_X3_B3_DUO52HI53LO:I02	CPC004_PC3_6H_X3	I02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_PC3_6H_X4_B4_DUO52HI53LO:I02	CPC004_PC3_6H_X4	I02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_PC3_6H_X5_F1B5_DUO52HI53LO:I02	CPC004_PC3_6H_X5	I02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPD003_PC3_24H_X1.L2_B6_DUO52HI53LO:A13	CPD003_PC3_24H_X1.L2	A13	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPD003_PC3_24H_X2.L2_B6_DUO52HI53LO:A13	CPD003_PC3_24H_X2.L2	A13	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPD003_PC3_6H_X1_B6_DUO52HI53LO:A13	CPD003_PC3_6H_X1	A13	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPD003_PC3_6H_X3.A2_B6_DUO52HI53LO:A13	CPD003_PC3_6H_X3.A2	A13	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPD003_PC3_6H_X3_B6_DUO52HI53LO:A13	CPD003_PC3_6H_X3	A13	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3947	N06AA07	lofepramine	CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)CC(=O)C4=CC=C(C=C4)Cl	CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1	BRD-K82147103	CPC011_PC3_24H_X1_B3_DUO52HI53LO:M10	CPC011_PC3_24H_X1	M10	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3947	N06AA07	lofepramine	CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)CC(=O)C4=CC=C(C=C4)Cl	CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1	BRD-K82147103	CPC011_PC3_24H_X2_B3_DUO52HI53LO:M10	CPC011_PC3_24H_X2	M10	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3947	N06AA07	lofepramine	CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)CC(=O)C4=CC=C(C=C4)Cl	CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1	BRD-K82147103	CPC011_PC3_24H_X4_B5_DUO52HI53LO:M10	CPC011_PC3_24H_X4	M10	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3947	N06AA07	lofepramine	CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)CC(=O)C4=CC=C(C=C4)Cl	CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1	BRD-K82147103	CPC011_PC3_24H_X5_B5_DUO52HI53LO:M10	CPC011_PC3_24H_X5	M10	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3947	N06AA07	lofepramine	CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)CC(=O)C4=CC=C(C=C4)Cl	CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1	BRD-K82147103	CPC011_PC3_6H_X1_B3_DUO52HI53LO:M10	CPC011_PC3_6H_X1	M10	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3947	N06AA07	lofepramine	CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)CC(=O)C4=CC=C(C=C4)Cl	CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1	BRD-K82147103	CPC011_PC3_6H_X3_B3_DUO52HI53LO:M10	CPC011_PC3_6H_X3	M10	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3947	N06AA07	lofepramine	CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)CC(=O)C4=CC=C(C=C4)Cl	CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1	BRD-K82147103	CPC011_PC3_6H_X4_B5_DUO52HI53LO:M10	CPC011_PC3_6H_X4	M10	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3947	N06AA07	lofepramine	CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)CC(=O)C4=CC=C(C=C4)Cl	CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1	BRD-K82147103	CPC011_PC3_6H_X5_B5_DUO52HI53LO:M10	CPC011_PC3_6H_X5	M10	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC001_PC3_24H_X1_B3_DUO52HI53LO:O20	CPC001_PC3_24H_X1	O20	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC001_PC3_24H_X2_B3_DUO52HI53LO:O20	CPC001_PC3_24H_X2	O20	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC001_PC3_24H_X3_B3_DUO52HI53LO:O20	CPC001_PC3_24H_X3	O20	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC001_PC3_24H_X3_F1B3_DUO52HI53LO:O20	CPC001_PC3_24H_X3	O20	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC001_PC3_24H_X4_F2B4_DUO52HI53LO:O20	CPC001_PC3_24H_X4	O20	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC001_PC3_24H_X5_B5_DUO52HI53LO:O20	CPC001_PC3_24H_X5	O20	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC001_PC3_6H_X1_B3_DUO52HI53LO:O20	CPC001_PC3_6H_X1	O20	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC001_PC3_6H_X2_B3_DUO52HI53LO:O20	CPC001_PC3_6H_X2	O20	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC001_PC3_6H_X3_B3_DUO52HI53LO:O20	CPC001_PC3_6H_X3	O20	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC001_PC3_6H_X5.L2_F2B5_DUO52HI53LO:O20	CPC001_PC3_6H_X5.L2	O20	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPD002_PC3_24H_X1_B6_DUO52HI53LO:E15	CPD002_PC3_24H_X1	E15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPD002_PC3_24H_X2_B6_DUO52HI53LO:E15	CPD002_PC3_24H_X2	E15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPD002_PC3_24H_X3_B6_DUO52HI53LO:E15	CPD002_PC3_24H_X3	E15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPD002_PC3_6H_X1_B6_DUO52HI53LO:E15	CPD002_PC3_6H_X1	E15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPD002_PC3_6H_X2_B6_DUO52HI53LO:E15	CPD002_PC3_6H_X2	E15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPD002_PC3_6H_X3_B6_DUO52HI53LO:E15	CPD002_PC3_6H_X3	E15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC003_PC3_24H_X1_B3_DUO52HI53LO:I02	CPC003_PC3_24H_X1	I02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC003_PC3_24H_X2_B3_DUO52HI53LO:I02	CPC003_PC3_24H_X2	I02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC003_PC3_24H_X3_B3_DUO52HI53LO:I02	CPC003_PC3_24H_X3	I02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC003_PC3_24H_X5_B5_DUO52HI53LO:I02	CPC003_PC3_24H_X5	I02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC003_PC3_6H_X1_B3_DUO52HI53LO:I02	CPC003_PC3_6H_X1	I02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC003_PC3_6H_X3_B3_DUO52HI53LO:I02	CPC003_PC3_6H_X3	I02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC003_PC3_6H_X4_F2B4_DUO52HI53LO:I02	CPC003_PC3_6H_X4	I02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC003_PC3_6H_X5_F1B5_DUO52HI53LO:I02	CPC003_PC3_6H_X5	I02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPD001_PC3_24H_X1_B6_DUO52HI53LO:O09	CPD001_PC3_24H_X1	O09	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPD001_PC3_24H_X2_B6_DUO52HI53LO:O09	CPD001_PC3_24H_X2	O09	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPD001_PC3_24H_X3_B6_DUO52HI53LO:O09	CPD001_PC3_24H_X3	O09	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC003_PC3_24H_X4_F1B5_DUO52HI53LO:I02	CPC003_PC3_24H_X4	I02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC002_PC3_24H_X1_B3_DUO52HI53LO:O11	CPC002_PC3_24H_X1	O11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC002_PC3_24H_X3_B3_DUO52HI53LO:O11	CPC002_PC3_24H_X3	O11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC002_PC3_24H_X4_B4_DUO52HI53LO:O11	CPC002_PC3_24H_X4	O11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC002_PC3_24H_X5_F1B5_DUO52HI53LO:O11	CPC002_PC3_24H_X5	O11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC002_PC3_6H_X1_B3_DUO52HI53LO:O11	CPC002_PC3_6H_X1	O11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC002_PC3_6H_X2_B3_DUO52HI53LO:O11	CPC002_PC3_6H_X2	O11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC002_PC3_6H_X3_B3_DUO52HI53LO:O11	CPC002_PC3_6H_X3	O11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC002_PC3_6H_X4_B4_DUO52HI53LO:O11	CPC002_PC3_6H_X4	O11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC002_PC3_6H_X5_F1B5_DUO52HI53LO:O11	CPC002_PC3_6H_X5	O11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPD001_PC3_24H_X1_B6_DUO52HI53LO:D10	CPD001_PC3_24H_X1	D10	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPD001_PC3_24H_X2_B6_DUO52HI53LO:D10	CPD001_PC3_24H_X2	D10	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPD001_PC3_24H_X3_B6_DUO52HI53LO:D10	CPD001_PC3_24H_X3	D10	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_PC3_24H_X1_B3_DUO52HI53LO:J02	CPC004_PC3_24H_X1	J02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_PC3_24H_X2_B3_DUO52HI53LO:J02	CPC004_PC3_24H_X2	J02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_PC3_24H_X3_B3_DUO52HI53LO:J02	CPC004_PC3_24H_X3	J02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_PC3_24H_X4_B4_DUO52HI53LO:J02	CPC004_PC3_24H_X4	J02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_PC3_24H_X5_B5_DUO52HI53LO:J02	CPC004_PC3_24H_X5	J02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_PC3_6H_X1_B3_DUO52HI53LO:J02	CPC004_PC3_6H_X1	J02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_PC3_6H_X2_B3_DUO52HI53LO:J02	CPC004_PC3_6H_X2	J02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_PC3_6H_X3_B3_DUO52HI53LO:J02	CPC004_PC3_6H_X3	J02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_PC3_6H_X4_B4_DUO52HI53LO:J02	CPC004_PC3_6H_X4	J02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_PC3_6H_X5_F1B5_DUO52HI53LO:J02	CPC004_PC3_6H_X5	J02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPD003_PC3_24H_X1.L2_B6_DUO52HI53LO:I22	CPD003_PC3_24H_X1.L2	I22	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPD003_PC3_24H_X2.L2_B6_DUO52HI53LO:I22	CPD003_PC3_24H_X2.L2	I22	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPD003_PC3_6H_X1_B6_DUO52HI53LO:I22	CPD003_PC3_6H_X1	I22	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPD003_PC3_6H_X3.A2_B6_DUO52HI53LO:I22	CPD003_PC3_6H_X3.A2	I22	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPD003_PC3_6H_X3_B6_DUO52HI53LO:I22	CPD003_PC3_6H_X3	I22	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC004_PC3_24H_X1_B3_DUO52HI53LO:K17	CPC004_PC3_24H_X1	K17	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC004_PC3_24H_X2_B3_DUO52HI53LO:K17	CPC004_PC3_24H_X2	K17	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC004_PC3_24H_X3_B3_DUO52HI53LO:K17	CPC004_PC3_24H_X3	K17	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC004_PC3_24H_X4_B4_DUO52HI53LO:K17	CPC004_PC3_24H_X4	K17	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC004_PC3_24H_X5_B5_DUO52HI53LO:K17	CPC004_PC3_24H_X5	K17	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC004_PC3_6H_X1_B3_DUO52HI53LO:K17	CPC004_PC3_6H_X1	K17	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC004_PC3_6H_X2_B3_DUO52HI53LO:K17	CPC004_PC3_6H_X2	K17	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC004_PC3_6H_X4_B4_DUO52HI53LO:K17	CPC004_PC3_6H_X4	K17	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC004_PC3_6H_X5_F1B5_DUO52HI53LO:K17	CPC004_PC3_6H_X5	K17	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPD001_PC3_24H_X1_B6_DUO52HI53LO:F08	CPD001_PC3_24H_X1	F08	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPD001_PC3_24H_X2_B6_DUO52HI53LO:F08	CPD001_PC3_24H_X2	F08	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPD001_PC3_24H_X3_B6_DUO52HI53LO:F08	CPD001_PC3_24H_X3	F08	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_PC3_24H_X1_B3_DUO52HI53LO:G23	CPC004_PC3_24H_X1	G23	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_PC3_24H_X2_B3_DUO52HI53LO:G23	CPC004_PC3_24H_X2	G23	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_PC3_24H_X3_B3_DUO52HI53LO:G23	CPC004_PC3_24H_X3	G23	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_PC3_24H_X4_B4_DUO52HI53LO:G23	CPC004_PC3_24H_X4	G23	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_PC3_24H_X5_B5_DUO52HI53LO:G23	CPC004_PC3_24H_X5	G23	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_PC3_6H_X1_B3_DUO52HI53LO:G23	CPC004_PC3_6H_X1	G23	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_PC3_6H_X2_B3_DUO52HI53LO:G23	CPC004_PC3_6H_X2	G23	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_PC3_6H_X3_B3_DUO52HI53LO:G23	CPC004_PC3_6H_X3	G23	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_PC3_6H_X4_B4_DUO52HI53LO:G23	CPC004_PC3_6H_X4	G23	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_PC3_6H_X5_F1B5_DUO52HI53LO:G23	CPC004_PC3_6H_X5	G23	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC011_PC3_24H_X1_B3_DUO52HI53LO:G15	CPC011_PC3_24H_X1	G15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC011_PC3_24H_X2_B3_DUO52HI53LO:G15	CPC011_PC3_24H_X2	G15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC011_PC3_24H_X4_B5_DUO52HI53LO:G15	CPC011_PC3_24H_X4	G15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC011_PC3_24H_X5_B5_DUO52HI53LO:G15	CPC011_PC3_24H_X5	G15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC011_PC3_6H_X1_B3_DUO52HI53LO:G15	CPC011_PC3_6H_X1	G15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC011_PC3_6H_X3_B3_DUO52HI53LO:G15	CPC011_PC3_6H_X3	G15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC011_PC3_6H_X4_B5_DUO52HI53LO:G15	CPC011_PC3_6H_X4	G15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC011_PC3_6H_X5_B5_DUO52HI53LO:G15	CPC011_PC3_6H_X5	G15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC002_PC3_24H_X1_B3_DUO52HI53LO:F11	CPC002_PC3_24H_X1	F11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC002_PC3_24H_X2_B3_DUO52HI53LO:F11	CPC002_PC3_24H_X2	F11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC002_PC3_24H_X3_B3_DUO52HI53LO:F11	CPC002_PC3_24H_X3	F11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC002_PC3_24H_X4_B4_DUO52HI53LO:F11	CPC002_PC3_24H_X4	F11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC002_PC3_24H_X5_F1B5_DUO52HI53LO:F11	CPC002_PC3_24H_X5	F11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC002_PC3_6H_X1_B3_DUO52HI53LO:F11	CPC002_PC3_6H_X1	F11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC002_PC3_6H_X2_B3_DUO52HI53LO:F11	CPC002_PC3_6H_X2	F11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC002_PC3_6H_X3_B3_DUO52HI53LO:F11	CPC002_PC3_6H_X3	F11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC002_PC3_6H_X4_B4_DUO52HI53LO:F11	CPC002_PC3_6H_X4	F11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC002_PC3_6H_X5_F1B5_DUO52HI53LO:F11	CPC002_PC3_6H_X5	F11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC020_PC3_6H_X4_F1B4_DUO52HI53LO:O02	CPC020_PC3_6H_X4	O02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC020_PC3_24H_X1_B5_DUO52HI53LO:O02	CPC020_PC3_24H_X1	O02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC020_PC3_24H_X2_B5_DUO52HI53LO:O02	CPC020_PC3_24H_X2	O02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC020_PC3_24H_X3_B5_DUO52HI53LO:O02	CPC020_PC3_24H_X3	O02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC020_PC3_24H_X4_B5_DUO52HI53LO:O02	CPC020_PC3_24H_X4	O02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC020_PC3_24H_X5_B5_DUO52HI53LO:O02	CPC020_PC3_24H_X5	O02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC020_PC3_6H_X1_B4_DUO52HI53LO:O02	CPC020_PC3_6H_X1	O02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC020_PC3_6H_X2_B4_DUO52HI53LO:O02	CPC020_PC3_6H_X2	O02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC020_PC3_6H_X3_B4_DUO52HI53LO:O02	CPC020_PC3_6H_X3	O02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC020_PC3_6H_X5_B5_DUO52HI53LO:O02	CPC020_PC3_6H_X5	O02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC002_PC3_24H_X1_B3_DUO52HI53LO:F15	CPC002_PC3_24H_X1	F15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC002_PC3_24H_X2_B3_DUO52HI53LO:F15	CPC002_PC3_24H_X2	F15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC002_PC3_24H_X3_B3_DUO52HI53LO:F15	CPC002_PC3_24H_X3	F15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC002_PC3_24H_X4_B4_DUO52HI53LO:F15	CPC002_PC3_24H_X4	F15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC002_PC3_24H_X5_F1B5_DUO52HI53LO:F15	CPC002_PC3_24H_X5	F15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC002_PC3_6H_X1_B3_DUO52HI53LO:F15	CPC002_PC3_6H_X1	F15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC002_PC3_6H_X2_B3_DUO52HI53LO:F15	CPC002_PC3_6H_X2	F15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC002_PC3_6H_X3_B3_DUO52HI53LO:F15	CPC002_PC3_6H_X3	F15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC002_PC3_6H_X4_B4_DUO52HI53LO:F15	CPC002_PC3_6H_X4	F15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC002_PC3_6H_X5_F1B5_DUO52HI53LO:F15	CPC002_PC3_6H_X5	F15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_PC3_24H_X1_B3_DUO52HI53LO:E01	CPC004_PC3_24H_X1	E01	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_PC3_24H_X2_B3_DUO52HI53LO:E01	CPC004_PC3_24H_X2	E01	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_PC3_24H_X3_B3_DUO52HI53LO:E01	CPC004_PC3_24H_X3	E01	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_PC3_24H_X4_B4_DUO52HI53LO:E01	CPC004_PC3_24H_X4	E01	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_PC3_24H_X5_B5_DUO52HI53LO:E01	CPC004_PC3_24H_X5	E01	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_PC3_6H_X5_F1B5_DUO52HI53LO:E01	CPC004_PC3_6H_X5	E01	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_PC3_24H_X1_B5_DUO52HI53LO:F24	CPC020_PC3_24H_X1	F24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_PC3_24H_X1_B5_DUO52HI53LO:H08	CPC020_PC3_24H_X1	H08	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_PC3_24H_X2_B5_DUO52HI53LO:F24	CPC020_PC3_24H_X2	F24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_PC3_24H_X2_B5_DUO52HI53LO:H08	CPC020_PC3_24H_X2	H08	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_PC3_24H_X3_B5_DUO52HI53LO:F24	CPC020_PC3_24H_X3	F24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_PC3_24H_X3_B5_DUO52HI53LO:H08	CPC020_PC3_24H_X3	H08	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_PC3_24H_X4_B5_DUO52HI53LO:F24	CPC020_PC3_24H_X4	F24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_PC3_24H_X4_B5_DUO52HI53LO:H08	CPC020_PC3_24H_X4	H08	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_PC3_24H_X5_B5_DUO52HI53LO:F24	CPC020_PC3_24H_X5	F24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_PC3_24H_X5_B5_DUO52HI53LO:H08	CPC020_PC3_24H_X5	H08	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_PC3_6H_X4_F1B4_DUO52HI53LO:F24	CPC020_PC3_6H_X4	F24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_PC3_6H_X4_F1B4_DUO52HI53LO:H08	CPC020_PC3_6H_X4	H08	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_PC3_6H_X1_B3_DUO52HI53LO:E01	CPC004_PC3_6H_X1	E01	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_PC3_6H_X2_B3_DUO52HI53LO:E01	CPC004_PC3_6H_X2	E01	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_PC3_6H_X3_B3_DUO52HI53LO:E01	CPC004_PC3_6H_X3	E01	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_PC3_6H_X4_B4_DUO52HI53LO:E01	CPC004_PC3_6H_X4	E01	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_PC3_6H_X1_B4_DUO52HI53LO:F24	CPC020_PC3_6H_X1	F24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_PC3_6H_X1_B4_DUO52HI53LO:H08	CPC020_PC3_6H_X1	H08	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_PC3_6H_X2_B4_DUO52HI53LO:F24	CPC020_PC3_6H_X2	F24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_PC3_6H_X2_B4_DUO52HI53LO:H08	CPC020_PC3_6H_X2	H08	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_PC3_6H_X3_B4_DUO52HI53LO:F24	CPC020_PC3_6H_X3	F24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_PC3_6H_X3_B4_DUO52HI53LO:H08	CPC020_PC3_6H_X3	H08	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_PC3_6H_X5_B5_DUO52HI53LO:H08	CPC020_PC3_6H_X5	H08	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_PC3_24H_X1_B4_DUO52HI53LO:N07	CPC005_PC3_24H_X1	N07	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_PC3_24H_X2_B4_DUO52HI53LO:N07	CPC005_PC3_24H_X2	N07	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_PC3_24H_X3_B4_DUO52HI53LO:N07	CPC005_PC3_24H_X3	N07	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_PC3_24H_X4_B5_DUO52HI53LO:N07	CPC005_PC3_24H_X4	N07	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_PC3_24H_X5_B5_DUO52HI53LO:N07	CPC005_PC3_24H_X5	N07	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_PC3_6H_X1_B3_DUO52HI53LO:N07	CPC005_PC3_6H_X1	N07	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_PC3_6H_X2_B3_DUO52HI53LO:N07	CPC005_PC3_6H_X2	N07	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_PC3_6H_X3_B3_DUO52HI53LO:N07	CPC005_PC3_6H_X3	N07	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_PC3_6H_X5_F1B5_DUO52HI53LO:N07	CPC005_PC3_6H_X5	N07	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPD001_PC3_24H_X1_B6_DUO52HI53LO:F23	CPD001_PC3_24H_X1	F23	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPD001_PC3_24H_X2_B6_DUO52HI53LO:F23	CPD001_PC3_24H_X2	F23	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPD001_PC3_24H_X3_B6_DUO52HI53LO:F23	CPD001_PC3_24H_X3	F23	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC002_PC3_24H_X1_B3_DUO52HI53LO:K21	CPC002_PC3_24H_X1	K21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC002_PC3_24H_X2_B3_DUO52HI53LO:K21	CPC002_PC3_24H_X2	K21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC002_PC3_24H_X3_B3_DUO52HI53LO:K21	CPC002_PC3_24H_X3	K21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC002_PC3_24H_X4_B4_DUO52HI53LO:K21	CPC002_PC3_24H_X4	K21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC002_PC3_24H_X5_F1B5_DUO52HI53LO:K21	CPC002_PC3_24H_X5	K21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC002_PC3_6H_X1_B3_DUO52HI53LO:K21	CPC002_PC3_6H_X1	K21	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC002_PC3_6H_X2_B3_DUO52HI53LO:K21	CPC002_PC3_6H_X2	K21	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC002_PC3_6H_X3_B3_DUO52HI53LO:K21	CPC002_PC3_6H_X3	K21	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC002_PC3_6H_X4_B4_DUO52HI53LO:K21	CPC002_PC3_6H_X4	K21	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC002_PC3_6H_X5_F1B5_DUO52HI53LO:K21	CPC002_PC3_6H_X5	K21	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC011_PC3_24H_X1_B3_DUO52HI53LO:O15	CPC011_PC3_24H_X1	O15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC011_PC3_24H_X2_B3_DUO52HI53LO:O15	CPC011_PC3_24H_X2	O15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC011_PC3_24H_X4_B5_DUO52HI53LO:O15	CPC011_PC3_24H_X4	O15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC011_PC3_24H_X5_B5_DUO52HI53LO:O15	CPC011_PC3_24H_X5	O15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC011_PC3_6H_X1_B3_DUO52HI53LO:O15	CPC011_PC3_6H_X1	O15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC011_PC3_6H_X3_B3_DUO52HI53LO:O15	CPC011_PC3_6H_X3	O15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC011_PC3_6H_X4_B5_DUO52HI53LO:O15	CPC011_PC3_6H_X4	O15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC011_PC3_6H_X5_B5_DUO52HI53LO:O15	CPC011_PC3_6H_X5	O15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_PC3_24H_X1_B4_DUO52HI53LO:P19	CPC005_PC3_24H_X1	P19	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_PC3_24H_X2_B4_DUO52HI53LO:P19	CPC005_PC3_24H_X2	P19	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_PC3_24H_X3_B4_DUO52HI53LO:P19	CPC005_PC3_24H_X3	P19	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_PC3_24H_X4_B5_DUO52HI53LO:P19	CPC005_PC3_24H_X4	P19	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_PC3_24H_X5_B5_DUO52HI53LO:P19	CPC005_PC3_24H_X5	P19	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_PC3_6H_X1_B3_DUO52HI53LO:P19	CPC005_PC3_6H_X1	P19	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_PC3_6H_X2_B3_DUO52HI53LO:P19	CPC005_PC3_6H_X2	P19	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_PC3_6H_X3_B3_DUO52HI53LO:P19	CPC005_PC3_6H_X3	P19	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_PC3_6H_X5_F1B5_DUO52HI53LO:P19	CPC005_PC3_6H_X5	P19	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_PC3_24H_X1_F1B4_DUO52HI53LO:J24	CPC009_PC3_24H_X1	J24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_PC3_24H_X2_F1B4_DUO52HI53LO:J24	CPC009_PC3_24H_X2	J24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_PC3_24H_X3_F1B4_DUO52HI53LO:J24	CPC009_PC3_24H_X3	J24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_PC3_24H_X5_F1B5_DUO52HI53LO:J24	CPC009_PC3_24H_X5	J24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_PC3_6H_X3.A2_B4_DUO52HI53LO:J24	CPC009_PC3_6H_X3.A2	J24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_PC3_6H_X3_F1B3_DUO52HI53LO:J24	CPC009_PC3_6H_X3	J24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_PC3_6H_X5_F1B5_DUO52HI53LO:J24	CPC009_PC3_6H_X5	J24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPD002_PC3_24H_X1_B6_DUO52HI53LO:G04	CPD002_PC3_24H_X1	G04	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPD002_PC3_24H_X2_B6_DUO52HI53LO:G04	CPD002_PC3_24H_X2	G04	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPD002_PC3_24H_X3_B6_DUO52HI53LO:G04	CPD002_PC3_24H_X3	G04	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPD002_PC3_6H_X1_B6_DUO52HI53LO:G04	CPD002_PC3_6H_X1	G04	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPD002_PC3_6H_X2_B6_DUO52HI53LO:G04	CPD002_PC3_6H_X2	G04	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPD002_PC3_6H_X3_B6_DUO52HI53LO:G04	CPD002_PC3_6H_X3	G04	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_PC3_24H_X4_B5_DUO52HI53LO:J24	CPC009_PC3_24H_X4	J24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_PC3_6H_X1_B3_DUO52HI53LO:J24	CPC009_PC3_6H_X1	J24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_PC3_6H_X2_B3_DUO52HI53LO:J24	CPC009_PC3_6H_X2	J24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_PC3_6H_X3_B3_DUO52HI53LO:J24	CPC009_PC3_6H_X3	J24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_PC3_24H_X1_B4_DUO52HI53LO:F24	CPC005_PC3_24H_X1	F24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_PC3_24H_X2_B4_DUO52HI53LO:F24	CPC005_PC3_24H_X2	F24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_PC3_24H_X3_B4_DUO52HI53LO:F24	CPC005_PC3_24H_X3	F24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_PC3_24H_X4_B5_DUO52HI53LO:F24	CPC005_PC3_24H_X4	F24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_PC3_24H_X5_B5_DUO52HI53LO:F24	CPC005_PC3_24H_X5	F24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_PC3_6H_X1_B3_DUO52HI53LO:F24	CPC005_PC3_6H_X1	F24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_PC3_6H_X2_B3_DUO52HI53LO:F24	CPC005_PC3_6H_X2	F24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_PC3_6H_X3_B3_DUO52HI53LO:F24	CPC005_PC3_6H_X3	F24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_PC3_6H_X5_F1B5_DUO52HI53LO:F24	CPC005_PC3_6H_X5	F24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_PC3_24H_X1_F1B4_DUO52HI53LO:B24	CPC009_PC3_24H_X1	B24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_PC3_24H_X2_F1B4_DUO52HI53LO:B24	CPC009_PC3_24H_X2	B24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_PC3_24H_X3_F1B4_DUO52HI53LO:B24	CPC009_PC3_24H_X3	B24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_PC3_24H_X4_B5_DUO52HI53LO:B24	CPC009_PC3_24H_X4	B24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_PC3_24H_X5_F1B5_DUO52HI53LO:B24	CPC009_PC3_24H_X5	B24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_PC3_6H_X3.A2_B4_DUO52HI53LO:B24	CPC009_PC3_6H_X3.A2	B24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_PC3_6H_X3_F1B3_DUO52HI53LO:B24	CPC009_PC3_6H_X3	B24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_PC3_6H_X4_F1B5_DUO52HI53LO:B24	CPC009_PC3_6H_X4	B24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_PC3_6H_X5_F1B5_DUO52HI53LO:B24	CPC009_PC3_6H_X5	B24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPD002_PC3_24H_X1_B6_DUO52HI53LO:L06	CPD002_PC3_24H_X1	L06	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPD002_PC3_24H_X2_B6_DUO52HI53LO:L06	CPD002_PC3_24H_X2	L06	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPD002_PC3_24H_X3_B6_DUO52HI53LO:L06	CPD002_PC3_24H_X3	L06	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPD002_PC3_6H_X1_B6_DUO52HI53LO:L06	CPD002_PC3_6H_X1	L06	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPD002_PC3_6H_X2_B6_DUO52HI53LO:L06	CPD002_PC3_6H_X2	L06	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPD002_PC3_6H_X3_B6_DUO52HI53LO:L06	CPD002_PC3_6H_X3	L06	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_PC3_6H_X1_B3_DUO52HI53LO:B24	CPC009_PC3_6H_X1	B24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_PC3_6H_X2_B3_DUO52HI53LO:B24	CPC009_PC3_6H_X2	B24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_PC3_6H_X3_B3_DUO52HI53LO:B24	CPC009_PC3_6H_X3	B24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC011_PC3_24H_X1_B3_DUO52HI53LO:P10	CPC011_PC3_24H_X1	P10	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC011_PC3_24H_X2_B3_DUO52HI53LO:P10	CPC011_PC3_24H_X2	P10	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC011_PC3_24H_X4_B5_DUO52HI53LO:P10	CPC011_PC3_24H_X4	P10	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC011_PC3_24H_X5_B5_DUO52HI53LO:P10	CPC011_PC3_24H_X5	P10	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC011_PC3_6H_X1_B3_DUO52HI53LO:P10	CPC011_PC3_6H_X1	P10	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC011_PC3_6H_X3_B3_DUO52HI53LO:P10	CPC011_PC3_6H_X3	P10	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC011_PC3_6H_X4_B5_DUO52HI53LO:P10	CPC011_PC3_6H_X4	P10	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC011_PC3_6H_X5_B5_DUO52HI53LO:P10	CPC011_PC3_6H_X5	P10	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_PC3_24H_X1_B5_DUO52HI53LO:B15	CPC020_PC3_24H_X1	B15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_PC3_24H_X2_B5_DUO52HI53LO:B15	CPC020_PC3_24H_X2	B15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_PC3_24H_X3_B5_DUO52HI53LO:B15	CPC020_PC3_24H_X3	B15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_PC3_24H_X4_B5_DUO52HI53LO:B15	CPC020_PC3_24H_X4	B15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_PC3_24H_X5_B5_DUO52HI53LO:B15	CPC020_PC3_24H_X5	B15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_PC3_6H_X4_F1B4_DUO52HI53LO:B15	CPC020_PC3_6H_X4	B15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_PC3_6H_X1_B4_DUO52HI53LO:B15	CPC020_PC3_6H_X1	B15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_PC3_6H_X2_B4_DUO52HI53LO:B15	CPC020_PC3_6H_X2	B15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_PC3_6H_X3_B4_DUO52HI53LO:B15	CPC020_PC3_6H_X3	B15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_PC3_6H_X5_B5_DUO52HI53LO:B15	CPC020_PC3_6H_X5	B15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K19277754	CPC011_PC3_24H_X1_B3_DUO52HI53LO:I12	CPC011_PC3_24H_X1	I12	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K19277754	CPC011_PC3_24H_X2_B3_DUO52HI53LO:I12	CPC011_PC3_24H_X2	I12	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K19277754	CPC011_PC3_24H_X4_B5_DUO52HI53LO:I12	CPC011_PC3_24H_X4	I12	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K19277754	CPC011_PC3_24H_X5_B5_DUO52HI53LO:I12	CPC011_PC3_24H_X5	I12	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K19277754	CPC011_PC3_6H_X1_B3_DUO52HI53LO:I12	CPC011_PC3_6H_X1	I12	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K19277754	CPC011_PC3_6H_X3_B3_DUO52HI53LO:I12	CPC011_PC3_6H_X3	I12	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K19277754	CPC011_PC3_6H_X4_B5_DUO52HI53LO:I12	CPC011_PC3_6H_X4	I12	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K19277754	CPC011_PC3_6H_X5_B5_DUO52HI53LO:I12	CPC011_PC3_6H_X5	I12	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_PC3_24H_X1_B3_DUO52HI53LO:H24	CPC004_PC3_24H_X1	H24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_PC3_24H_X2_B3_DUO52HI53LO:H24	CPC004_PC3_24H_X2	H24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_PC3_24H_X3_B3_DUO52HI53LO:H24	CPC004_PC3_24H_X3	H24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_PC3_24H_X4_B4_DUO52HI53LO:H24	CPC004_PC3_24H_X4	H24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_PC3_24H_X5_B5_DUO52HI53LO:H24	CPC004_PC3_24H_X5	H24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_PC3_6H_X1_B3_DUO52HI53LO:H24	CPC004_PC3_6H_X1	H24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_PC3_6H_X2_B3_DUO52HI53LO:H24	CPC004_PC3_6H_X2	H24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_PC3_6H_X3_B3_DUO52HI53LO:H24	CPC004_PC3_6H_X3	H24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_PC3_6H_X4_B4_DUO52HI53LO:H24	CPC004_PC3_6H_X4	H24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_PC3_6H_X5_F1B5_DUO52HI53LO:H24	CPC004_PC3_6H_X5	H24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPD003_PC3_24H_X1.L2_B6_DUO52HI53LO:K03	CPD003_PC3_24H_X1.L2	K03	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPD003_PC3_24H_X2.L2_B6_DUO52HI53LO:K03	CPD003_PC3_24H_X2.L2	K03	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPD003_PC3_6H_X1_B6_DUO52HI53LO:K03	CPD003_PC3_6H_X1	K03	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPD003_PC3_6H_X3.A2_B6_DUO52HI53LO:K03	CPD003_PC3_6H_X3.A2	K03	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPD003_PC3_6H_X3_B6_DUO52HI53LO:K03	CPD003_PC3_6H_X3	K03	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC011_PC3_24H_X1_B3_DUO52HI53LO:I21	CPC011_PC3_24H_X1	I21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC011_PC3_24H_X2_B3_DUO52HI53LO:I21	CPC011_PC3_24H_X2	I21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC011_PC3_24H_X4_B5_DUO52HI53LO:I21	CPC011_PC3_24H_X4	I21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC011_PC3_24H_X5_B5_DUO52HI53LO:I21	CPC011_PC3_24H_X5	I21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC011_PC3_6H_X1_B3_DUO52HI53LO:I21	CPC011_PC3_6H_X1	I21	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC011_PC3_6H_X3_B3_DUO52HI53LO:I21	CPC011_PC3_6H_X3	I21	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC011_PC3_6H_X4_B5_DUO52HI53LO:I21	CPC011_PC3_6H_X4	I21	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC011_PC3_6H_X5_B5_DUO52HI53LO:I21	CPC011_PC3_6H_X5	I21	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K57174586	CPD003_PC3_24H_X1.L2_B6_DUO52HI53LO:L09	CPD003_PC3_24H_X1.L2	L09	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K57174586	CPD003_PC3_24H_X2.L2_B6_DUO52HI53LO:L09	CPD003_PC3_24H_X2.L2	L09	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K57174586	CPD003_PC3_6H_X3.A2_B6_DUO52HI53LO:L09	CPD003_PC3_6H_X3.A2	L09	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K57174586	CPD003_PC3_6H_X1_B6_DUO52HI53LO:L09	CPD003_PC3_6H_X1	L09	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K57174586	CPD003_PC3_6H_X3_B6_DUO52HI53LO:L09	CPD003_PC3_6H_X3	L09	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_PC3_24H_X2_B3_DUO52HI53LO:H13	CPC004_PC3_24H_X2	H13	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_PC3_24H_X3_B3_DUO52HI53LO:H13	CPC004_PC3_24H_X3	H13	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_PC3_24H_X4_B4_DUO52HI53LO:H13	CPC004_PC3_24H_X4	H13	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_PC3_24H_X5_B5_DUO52HI53LO:H13	CPC004_PC3_24H_X5	H13	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_PC3_6H_X1_B3_DUO52HI53LO:H13	CPC004_PC3_6H_X1	H13	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_PC3_6H_X2_B3_DUO52HI53LO:H13	CPC004_PC3_6H_X2	H13	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_PC3_6H_X3_B3_DUO52HI53LO:H13	CPC004_PC3_6H_X3	H13	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_PC3_6H_X4_B4_DUO52HI53LO:H13	CPC004_PC3_6H_X4	H13	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_PC3_6H_X5_F1B5_DUO52HI53LO:H13	CPC004_PC3_6H_X5	H13	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC011_PC3_24H_X1_B3_DUO52HI53LO:L11	CPC011_PC3_24H_X1	L11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC011_PC3_24H_X2_B3_DUO52HI53LO:L11	CPC011_PC3_24H_X2	L11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC011_PC3_24H_X4_B5_DUO52HI53LO:L11	CPC011_PC3_24H_X4	L11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC011_PC3_24H_X5_B5_DUO52HI53LO:L11	CPC011_PC3_24H_X5	L11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC011_PC3_6H_X1_B3_DUO52HI53LO:L11	CPC011_PC3_6H_X1	L11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC011_PC3_6H_X3_B3_DUO52HI53LO:L11	CPC011_PC3_6H_X3	L11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC011_PC3_6H_X4_B5_DUO52HI53LO:L11	CPC011_PC3_6H_X4	L11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC011_PC3_6H_X5_B5_DUO52HI53LO:L11	CPC011_PC3_6H_X5	L11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_PC3_24H_X1_B3_DUO52HI53LO:J04	CPC004_PC3_24H_X1	J04	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_PC3_24H_X2_B3_DUO52HI53LO:J04	CPC004_PC3_24H_X2	J04	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_PC3_24H_X3_B3_DUO52HI53LO:J04	CPC004_PC3_24H_X3	J04	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_PC3_24H_X4_B4_DUO52HI53LO:J04	CPC004_PC3_24H_X4	J04	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_PC3_24H_X5_B5_DUO52HI53LO:J04	CPC004_PC3_24H_X5	J04	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_PC3_6H_X1_B3_DUO52HI53LO:J04	CPC004_PC3_6H_X1	J04	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_PC3_6H_X2_B3_DUO52HI53LO:J04	CPC004_PC3_6H_X2	J04	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_PC3_6H_X3_B3_DUO52HI53LO:J04	CPC004_PC3_6H_X3	J04	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_PC3_6H_X4_B4_DUO52HI53LO:J04	CPC004_PC3_6H_X4	J04	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_PC3_6H_X5_F1B5_DUO52HI53LO:J04	CPC004_PC3_6H_X5	J04	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K31534764	CPC011_PC3_24H_X1_B3_DUO52HI53LO:E15	CPC011_PC3_24H_X1	E15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K31534764	CPC011_PC3_24H_X2_B3_DUO52HI53LO:E15	CPC011_PC3_24H_X2	E15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K31534764	CPC011_PC3_24H_X4_B5_DUO52HI53LO:E15	CPC011_PC3_24H_X4	E15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K31534764	CPC011_PC3_24H_X5_B5_DUO52HI53LO:E15	CPC011_PC3_24H_X5	E15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K31534764	CPC011_PC3_6H_X1_B3_DUO52HI53LO:E15	CPC011_PC3_6H_X1	E15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K31534764	CPC011_PC3_6H_X3_B3_DUO52HI53LO:E15	CPC011_PC3_6H_X3	E15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K31534764	CPC011_PC3_6H_X4_B5_DUO52HI53LO:E15	CPC011_PC3_6H_X4	E15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K31534764	CPC011_PC3_6H_X5_B5_DUO52HI53LO:E15	CPC011_PC3_6H_X5	E15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC003_PC3_24H_X1_B3_DUO52HI53LO:P05	CPC003_PC3_24H_X1	P05	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC003_PC3_24H_X2_B3_DUO52HI53LO:P05	CPC003_PC3_24H_X2	P05	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC003_PC3_24H_X3_B3_DUO52HI53LO:P05	CPC003_PC3_24H_X3	P05	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC003_PC3_24H_X4_F1B5_DUO52HI53LO:P05	CPC003_PC3_24H_X4	P05	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC003_PC3_24H_X5_B5_DUO52HI53LO:P05	CPC003_PC3_24H_X5	P05	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC003_PC3_6H_X1_B3_DUO52HI53LO:P05	CPC003_PC3_6H_X1	P05	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC003_PC3_6H_X3_B3_DUO52HI53LO:P05	CPC003_PC3_6H_X3	P05	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC003_PC3_6H_X4_F2B4_DUO52HI53LO:P05	CPC003_PC3_6H_X4	P05	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC003_PC3_6H_X5_F1B5_DUO52HI53LO:P05	CPC003_PC3_6H_X5	P05	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPD003_PC3_24H_X1.L2_B6_DUO52HI53LO:H11	CPD003_PC3_24H_X1.L2	H11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPD003_PC3_24H_X2.L2_B6_DUO52HI53LO:H11	CPD003_PC3_24H_X2.L2	H11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPD003_PC3_6H_X1_B6_DUO52HI53LO:H11	CPD003_PC3_6H_X1	H11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPD003_PC3_6H_X3.A2_B6_DUO52HI53LO:H11	CPD003_PC3_6H_X3.A2	H11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPD003_PC3_6H_X3_B6_DUO52HI53LO:H11	CPD003_PC3_6H_X3	H11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_PC3_24H_X1_B3_DUO52HI53LO:H07	CPC004_PC3_24H_X1	H07	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_PC3_24H_X2_B3_DUO52HI53LO:H07	CPC004_PC3_24H_X2	H07	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_PC3_24H_X3_B3_DUO52HI53LO:H07	CPC004_PC3_24H_X3	H07	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_PC3_24H_X4_B4_DUO52HI53LO:H07	CPC004_PC3_24H_X4	H07	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_PC3_24H_X5_B5_DUO52HI53LO:H07	CPC004_PC3_24H_X5	H07	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_PC3_6H_X1_B3_DUO52HI53LO:H07	CPC004_PC3_6H_X1	H07	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_PC3_6H_X2_B3_DUO52HI53LO:H07	CPC004_PC3_6H_X2	H07	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_PC3_6H_X3_B3_DUO52HI53LO:H07	CPC004_PC3_6H_X3	H07	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_PC3_6H_X4_B4_DUO52HI53LO:H07	CPC004_PC3_6H_X4	H07	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_PC3_6H_X5_F1B5_DUO52HI53LO:H07	CPC004_PC3_6H_X5	H07	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC011_PC3_24H_X1_B3_DUO52HI53LO:D11	CPC011_PC3_24H_X1	D11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC011_PC3_24H_X2_B3_DUO52HI53LO:D11	CPC011_PC3_24H_X2	D11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC011_PC3_24H_X4_B5_DUO52HI53LO:D11	CPC011_PC3_24H_X4	D11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC011_PC3_24H_X5_B5_DUO52HI53LO:D11	CPC011_PC3_24H_X5	D11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC011_PC3_6H_X1_B3_DUO52HI53LO:D11	CPC011_PC3_6H_X1	D11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC011_PC3_6H_X3_B3_DUO52HI53LO:D11	CPC011_PC3_6H_X3	D11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC011_PC3_6H_X4_B5_DUO52HI53LO:D11	CPC011_PC3_6H_X4	D11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC011_PC3_6H_X5_B5_DUO52HI53LO:D11	CPC011_PC3_6H_X5	D11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPD002_PC3_24H_X1_B6_DUO52HI53LO:D15	CPD002_PC3_24H_X1	D15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPD002_PC3_24H_X2_B6_DUO52HI53LO:D15	CPD002_PC3_24H_X2	D15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPD002_PC3_24H_X3_B6_DUO52HI53LO:D15	CPD002_PC3_24H_X3	D15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPD002_PC3_6H_X1_B6_DUO52HI53LO:D15	CPD002_PC3_6H_X1	D15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPD002_PC3_6H_X2_B6_DUO52HI53LO:D15	CPD002_PC3_6H_X2	D15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPD002_PC3_6H_X3_B6_DUO52HI53LO:D15	CPD002_PC3_6H_X3	D15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC002_PC3_24H_X1_B3_DUO52HI53LO:H22	CPC002_PC3_24H_X1	H22	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC002_PC3_24H_X2_B3_DUO52HI53LO:H22	CPC002_PC3_24H_X2	H22	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC002_PC3_24H_X3_B3_DUO52HI53LO:H22	CPC002_PC3_24H_X3	H22	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC002_PC3_24H_X4_B4_DUO52HI53LO:H22	CPC002_PC3_24H_X4	H22	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC002_PC3_24H_X5_F1B5_DUO52HI53LO:H22	CPC002_PC3_24H_X5	H22	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC002_PC3_6H_X1_B3_DUO52HI53LO:H22	CPC002_PC3_6H_X1	H22	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC002_PC3_6H_X2_B3_DUO52HI53LO:H22	CPC002_PC3_6H_X2	H22	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC002_PC3_6H_X3_B3_DUO52HI53LO:H22	CPC002_PC3_6H_X3	H22	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC002_PC3_6H_X4_B4_DUO52HI53LO:H22	CPC002_PC3_6H_X4	H22	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC002_PC3_6H_X5_F1B5_DUO52HI53LO:H22	CPC002_PC3_6H_X5	H22	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPD002_PC3_24H_X1_B6_DUO52HI53LO:P01	CPD002_PC3_24H_X1	P01	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPD002_PC3_24H_X3_B6_DUO52HI53LO:P01	CPD002_PC3_24H_X3	P01	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPD002_PC3_6H_X1_B6_DUO52HI53LO:P01	CPD002_PC3_6H_X1	P01	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPD002_PC3_6H_X2_B6_DUO52HI53LO:P01	CPD002_PC3_6H_X2	P01	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPD002_PC3_6H_X3_B6_DUO52HI53LO:P01	CPD002_PC3_6H_X3	P01	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPC010_PC3_24H_X1_F2B4_DUO52HI53LO:P24	CPC010_PC3_24H_X1	P24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPC010_PC3_24H_X2_B5_DUO52HI53LO:P24	CPC010_PC3_24H_X2	P24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPC010_PC3_24H_X3_B5_DUO52HI53LO:P24	CPC010_PC3_24H_X3	P24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPC010_PC3_24H_X4_F2B4_DUO52HI53LO:P24	CPC010_PC3_24H_X4	P24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPC010_PC3_24H_X5_B5_DUO52HI53LO:P24	CPC010_PC3_24H_X5	P24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPC010_PC3_6H_X4_F1B5_DUO52HI53LO:P24	CPC010_PC3_6H_X4	P24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPC010_PC3_6H_X5_F1B5_DUO52HI53LO:P24	CPC010_PC3_6H_X5	P24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPD003_PC3_24H_X1.L2_B6_DUO52HI53LO:L20	CPD003_PC3_24H_X1.L2	L20	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPD003_PC3_24H_X2.L2_B6_DUO52HI53LO:L20	CPD003_PC3_24H_X2.L2	L20	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPD003_PC3_6H_X3.A2_B6_DUO52HI53LO:L20	CPD003_PC3_6H_X3.A2	L20	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPD003_PC3_6H_X1_B6_DUO52HI53LO:L20	CPD003_PC3_6H_X1	L20	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPD003_PC3_6H_X3_B6_DUO52HI53LO:L20	CPD003_PC3_6H_X3	L20	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC009_PC3_24H_X1_F1B4_DUO52HI53LO:K23	CPC009_PC3_24H_X1	K23	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC009_PC3_24H_X2_F1B4_DUO52HI53LO:K23	CPC009_PC3_24H_X2	K23	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC009_PC3_24H_X3_F1B4_DUO52HI53LO:K23	CPC009_PC3_24H_X3	K23	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC009_PC3_24H_X4_B5_DUO52HI53LO:K23	CPC009_PC3_24H_X4	K23	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC009_PC3_24H_X5_F1B5_DUO52HI53LO:K23	CPC009_PC3_24H_X5	K23	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC009_PC3_6H_X3.A2_B4_DUO52HI53LO:K23	CPC009_PC3_6H_X3.A2	K23	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC009_PC3_6H_X3_F1B3_DUO52HI53LO:K23	CPC009_PC3_6H_X3	K23	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC009_PC3_6H_X5_F1B5_DUO52HI53LO:K23	CPC009_PC3_6H_X5	K23	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPD001_PC3_24H_X1_B6_DUO52HI53LO:B21	CPD001_PC3_24H_X1	B21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPD001_PC3_24H_X2_B6_DUO52HI53LO:B21	CPD001_PC3_24H_X2	B21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPD001_PC3_24H_X3_B6_DUO52HI53LO:B21	CPD001_PC3_24H_X3	B21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC009_PC3_6H_X1_B3_DUO52HI53LO:K23	CPC009_PC3_6H_X1	K23	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC009_PC3_6H_X2_B3_DUO52HI53LO:K23	CPC009_PC3_6H_X2	K23	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC009_PC3_6H_X3_B3_DUO52HI53LO:K23	CPC009_PC3_6H_X3	K23	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC011_PC3_24H_X1_B3_DUO52HI53LO:I11	CPC011_PC3_24H_X1	I11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC011_PC3_24H_X2_B3_DUO52HI53LO:I11	CPC011_PC3_24H_X2	I11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC011_PC3_24H_X4_B5_DUO52HI53LO:I11	CPC011_PC3_24H_X4	I11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC011_PC3_24H_X5_B5_DUO52HI53LO:I11	CPC011_PC3_24H_X5	I11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC011_PC3_6H_X1_B3_DUO52HI53LO:I11	CPC011_PC3_6H_X1	I11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC011_PC3_6H_X3_B3_DUO52HI53LO:I11	CPC011_PC3_6H_X3	I11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC011_PC3_6H_X4_B5_DUO52HI53LO:I11	CPC011_PC3_6H_X4	I11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC011_PC3_6H_X5_B5_DUO52HI53LO:I11	CPC011_PC3_6H_X5	I11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_PC3_24H_X1_B4_DUO52HI53LO:E19	CPC005_PC3_24H_X1	E19	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_PC3_24H_X2_B4_DUO52HI53LO:E19	CPC005_PC3_24H_X2	E19	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_PC3_24H_X3_B4_DUO52HI53LO:E19	CPC005_PC3_24H_X3	E19	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_PC3_24H_X4_B5_DUO52HI53LO:E19	CPC005_PC3_24H_X4	E19	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_PC3_24H_X5_B5_DUO52HI53LO:E19	CPC005_PC3_24H_X5	E19	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_PC3_6H_X1_B3_DUO52HI53LO:E19	CPC005_PC3_6H_X1	E19	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_PC3_6H_X2_B3_DUO52HI53LO:E19	CPC005_PC3_6H_X2	E19	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_PC3_6H_X3_B3_DUO52HI53LO:E19	CPC005_PC3_6H_X3	E19	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_PC3_6H_X5_F1B5_DUO52HI53LO:E19	CPC005_PC3_6H_X5	E19	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K88809146	CPD001_PC3_24H_X1_B6_DUO52HI53LO:D07	CPD001_PC3_24H_X1	D07	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K88809146	CPD001_PC3_24H_X2_B6_DUO52HI53LO:D07	CPD001_PC3_24H_X2	D07	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K88809146	CPD001_PC3_24H_X3_B6_DUO52HI53LO:D07	CPD001_PC3_24H_X3	D07	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPC011_PC3_24H_X1_B3_DUO52HI53LO:A16	CPC011_PC3_24H_X1	A16	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPC011_PC3_24H_X2_B3_DUO52HI53LO:A16	CPC011_PC3_24H_X2	A16	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPC011_PC3_24H_X4_B5_DUO52HI53LO:A16	CPC011_PC3_24H_X4	A16	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPC011_PC3_24H_X5_B5_DUO52HI53LO:A16	CPC011_PC3_24H_X5	A16	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPC011_PC3_6H_X1_B3_DUO52HI53LO:A16	CPC011_PC3_6H_X1	A16	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPC011_PC3_6H_X3_B3_DUO52HI53LO:A16	CPC011_PC3_6H_X3	A16	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPC011_PC3_6H_X4_B5_DUO52HI53LO:A16	CPC011_PC3_6H_X4	A16	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPC011_PC3_6H_X5_B5_DUO52HI53LO:A16	CPC011_PC3_6H_X5	A16	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPD001_PC3_24H_X1_B6_DUO52HI53LO:G02	CPD001_PC3_24H_X1	G02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPD001_PC3_24H_X2_B6_DUO52HI53LO:G02	CPD001_PC3_24H_X2	G02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPD001_PC3_24H_X3_B6_DUO52HI53LO:G02	CPD001_PC3_24H_X3	G02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC002_PC3_24H_X1_B3_DUO52HI53LO:J08	CPC002_PC3_24H_X1	J08	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC002_PC3_24H_X2_B3_DUO52HI53LO:J08	CPC002_PC3_24H_X2	J08	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC002_PC3_24H_X3_B3_DUO52HI53LO:J08	CPC002_PC3_24H_X3	J08	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC002_PC3_24H_X4_B4_DUO52HI53LO:J08	CPC002_PC3_24H_X4	J08	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC002_PC3_24H_X5_F1B5_DUO52HI53LO:J08	CPC002_PC3_24H_X5	J08	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC002_PC3_6H_X1_B3_DUO52HI53LO:J08	CPC002_PC3_6H_X1	J08	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC002_PC3_6H_X2_B3_DUO52HI53LO:J08	CPC002_PC3_6H_X2	J08	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC002_PC3_6H_X3_B3_DUO52HI53LO:J08	CPC002_PC3_6H_X3	J08	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC002_PC3_6H_X4_B4_DUO52HI53LO:J08	CPC002_PC3_6H_X4	J08	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC002_PC3_6H_X5_F1B5_DUO52HI53LO:J08	CPC002_PC3_6H_X5	J08	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPD001_PC3_24H_X1_B6_DUO52HI53LO:C20	CPD001_PC3_24H_X1	C20	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPD001_PC3_24H_X2_B6_DUO52HI53LO:C20	CPD001_PC3_24H_X2	C20	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPD001_PC3_24H_X3_B6_DUO52HI53LO:C20	CPD001_PC3_24H_X3	C20	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPD001_PC3_24H_X1_B6_DUO52HI53LO:E18	CPD001_PC3_24H_X1	E18	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPD001_PC3_24H_X2_B6_DUO52HI53LO:E18	CPD001_PC3_24H_X2	E18	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPD001_PC3_24H_X3_B6_DUO52HI53LO:E18	CPD001_PC3_24H_X3	E18	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_PC3_24H_X1_B5_DUO52HI53LO:K04	CPC020_PC3_24H_X1	K04	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_PC3_24H_X2_B5_DUO52HI53LO:K04	CPC020_PC3_24H_X2	K04	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_PC3_24H_X3_B5_DUO52HI53LO:K04	CPC020_PC3_24H_X3	K04	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_PC3_24H_X4_B5_DUO52HI53LO:K04	CPC020_PC3_24H_X4	K04	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_PC3_24H_X5_B5_DUO52HI53LO:K04	CPC020_PC3_24H_X5	K04	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_PC3_6H_X1_B4_DUO52HI53LO:K04	CPC020_PC3_6H_X1	K04	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_PC3_6H_X2_B4_DUO52HI53LO:K04	CPC020_PC3_6H_X2	K04	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_PC3_6H_X3_B4_DUO52HI53LO:K04	CPC020_PC3_6H_X3	K04	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_PC3_6H_X4_F1B4_DUO52HI53LO:K04	CPC020_PC3_6H_X4	K04	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_PC3_6H_X5_B5_DUO52HI53LO:K04	CPC020_PC3_6H_X5	K04	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_PC3_24H_X1_B3_DUO52HI53LO:I06	CPC004_PC3_24H_X1	I06	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_PC3_24H_X2_B3_DUO52HI53LO:I06	CPC004_PC3_24H_X2	I06	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_PC3_24H_X3_B3_DUO52HI53LO:I06	CPC004_PC3_24H_X3	I06	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_PC3_24H_X4_B4_DUO52HI53LO:I06	CPC004_PC3_24H_X4	I06	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_PC3_24H_X5_B5_DUO52HI53LO:I06	CPC004_PC3_24H_X5	I06	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_PC3_6H_X1_B3_DUO52HI53LO:I06	CPC004_PC3_6H_X1	I06	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_PC3_6H_X2_B3_DUO52HI53LO:I06	CPC004_PC3_6H_X2	I06	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_PC3_6H_X3_B3_DUO52HI53LO:I06	CPC004_PC3_6H_X3	I06	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_PC3_6H_X4_B4_DUO52HI53LO:I06	CPC004_PC3_6H_X4	I06	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_PC3_6H_X5_F1B5_DUO52HI53LO:I06	CPC004_PC3_6H_X5	I06	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPD001_PC3_24H_X1_B6_DUO52HI53LO:L06	CPD001_PC3_24H_X1	L06	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPD001_PC3_24H_X2_B6_DUO52HI53LO:L06	CPD001_PC3_24H_X2	L06	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPD001_PC3_24H_X3_B6_DUO52HI53LO:L06	CPD001_PC3_24H_X3	L06	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC011_PC3_24H_X1_B3_DUO52HI53LO:K13	CPC011_PC3_24H_X1	K13	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC011_PC3_24H_X2_B3_DUO52HI53LO:K13	CPC011_PC3_24H_X2	K13	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC011_PC3_24H_X4_B5_DUO52HI53LO:K13	CPC011_PC3_24H_X4	K13	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC011_PC3_24H_X5_B5_DUO52HI53LO:K13	CPC011_PC3_24H_X5	K13	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC011_PC3_6H_X1_B3_DUO52HI53LO:K13	CPC011_PC3_6H_X1	K13	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC011_PC3_6H_X3_B3_DUO52HI53LO:K13	CPC011_PC3_6H_X3	K13	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC011_PC3_6H_X4_B5_DUO52HI53LO:K13	CPC011_PC3_6H_X4	K13	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC011_PC3_6H_X5_B5_DUO52HI53LO:K13	CPC011_PC3_6H_X5	K13	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC002_PC3_24H_X1_B3_DUO52HI53LO:H02	CPC002_PC3_24H_X1	H02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC002_PC3_24H_X2_B3_DUO52HI53LO:H02	CPC002_PC3_24H_X2	H02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC002_PC3_24H_X3_B3_DUO52HI53LO:H02	CPC002_PC3_24H_X3	H02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC002_PC3_24H_X4_B4_DUO52HI53LO:H02	CPC002_PC3_24H_X4	H02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC002_PC3_24H_X5_F1B5_DUO52HI53LO:H02	CPC002_PC3_24H_X5	H02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC002_PC3_6H_X1_B3_DUO52HI53LO:H02	CPC002_PC3_6H_X1	H02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC002_PC3_6H_X2_B3_DUO52HI53LO:H02	CPC002_PC3_6H_X2	H02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC002_PC3_6H_X3_B3_DUO52HI53LO:H02	CPC002_PC3_6H_X3	H02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC002_PC3_6H_X4_B4_DUO52HI53LO:H02	CPC002_PC3_6H_X4	H02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC002_PC3_6H_X5_F1B5_DUO52HI53LO:H02	CPC002_PC3_6H_X5	H02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC011_PC3_24H_X1_B3_DUO52HI53LO:J05	CPC011_PC3_24H_X1	J05	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC011_PC3_24H_X2_B3_DUO52HI53LO:J05	CPC011_PC3_24H_X2	J05	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC011_PC3_24H_X4_B5_DUO52HI53LO:J05	CPC011_PC3_24H_X4	J05	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC011_PC3_24H_X5_B5_DUO52HI53LO:J05	CPC011_PC3_24H_X5	J05	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC011_PC3_6H_X1_B3_DUO52HI53LO:J05	CPC011_PC3_6H_X1	J05	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC011_PC3_6H_X3_B3_DUO52HI53LO:J05	CPC011_PC3_6H_X3	J05	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC011_PC3_6H_X4_B5_DUO52HI53LO:J05	CPC011_PC3_6H_X4	J05	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC011_PC3_6H_X5_B5_DUO52HI53LO:J05	CPC011_PC3_6H_X5	J05	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_PC3_24H_X1_B4_DUO52HI53LO:E10	CPC005_PC3_24H_X1	E10	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_PC3_24H_X2_B4_DUO52HI53LO:E10	CPC005_PC3_24H_X2	E10	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_PC3_24H_X3_B4_DUO52HI53LO:E10	CPC005_PC3_24H_X3	E10	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_PC3_24H_X4_B5_DUO52HI53LO:E10	CPC005_PC3_24H_X4	E10	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_PC3_24H_X5_B5_DUO52HI53LO:E10	CPC005_PC3_24H_X5	E10	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_PC3_6H_X1_B3_DUO52HI53LO:E10	CPC005_PC3_6H_X1	E10	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_PC3_6H_X2_B3_DUO52HI53LO:E10	CPC005_PC3_6H_X2	E10	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_PC3_6H_X3_B3_DUO52HI53LO:E10	CPC005_PC3_6H_X3	E10	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_PC3_6H_X5_F1B5_DUO52HI53LO:E10	CPC005_PC3_6H_X5	E10	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPD001_PC3_24H_X1_B6_DUO52HI53LO:M13	CPD001_PC3_24H_X1	M13	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPD001_PC3_24H_X2_B6_DUO52HI53LO:M13	CPD001_PC3_24H_X2	M13	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPD001_PC3_24H_X3_B6_DUO52HI53LO:M13	CPD001_PC3_24H_X3	M13	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC003_PC3_24H_X1_B3_DUO52HI53LO:F01	CPC003_PC3_24H_X1	F01	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC003_PC3_24H_X2_B3_DUO52HI53LO:F01	CPC003_PC3_24H_X2	F01	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC003_PC3_24H_X3_B3_DUO52HI53LO:F01	CPC003_PC3_24H_X3	F01	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC003_PC3_24H_X4_F1B5_DUO52HI53LO:F01	CPC003_PC3_24H_X4	F01	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC003_PC3_24H_X5_B5_DUO52HI53LO:F01	CPC003_PC3_24H_X5	F01	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC003_PC3_6H_X1_B3_DUO52HI53LO:F01	CPC003_PC3_6H_X1	F01	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC003_PC3_6H_X3_B3_DUO52HI53LO:F01	CPC003_PC3_6H_X3	F01	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC003_PC3_6H_X4_F2B4_DUO52HI53LO:F01	CPC003_PC3_6H_X4	F01	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC003_PC3_6H_X5_F1B5_DUO52HI53LO:F01	CPC003_PC3_6H_X5	F01	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC011_PC3_24H_X1_B3_DUO52HI53LO:A13	CPC011_PC3_24H_X1	A13	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC011_PC3_24H_X2_B3_DUO52HI53LO:A13	CPC011_PC3_24H_X2	A13	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC011_PC3_24H_X4_B5_DUO52HI53LO:A13	CPC011_PC3_24H_X4	A13	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC011_PC3_24H_X5_B5_DUO52HI53LO:A13	CPC011_PC3_24H_X5	A13	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC011_PC3_6H_X1_B3_DUO52HI53LO:A13	CPC011_PC3_6H_X1	A13	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC011_PC3_6H_X3_B3_DUO52HI53LO:A13	CPC011_PC3_6H_X3	A13	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC011_PC3_6H_X4_B5_DUO52HI53LO:A13	CPC011_PC3_6H_X4	A13	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC011_PC3_6H_X5_B5_DUO52HI53LO:A13	CPC011_PC3_6H_X5	A13	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5666	N06AX09	viloxazine	CCOC1=CC=CC=C1OCC2CNCCO2	CCOc1ccccc1OCC1CNCCO1	BRD-A59198242	CPD003_PC3_24H_X1.L2_B6_DUO52HI53LO:E17	CPD003_PC3_24H_X1.L2	E17	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5666	N06AX09	viloxazine	CCOC1=CC=CC=C1OCC2CNCCO2	CCOc1ccccc1OCC1CNCCO1	BRD-A59198242	CPD003_PC3_24H_X2.L2_B6_DUO52HI53LO:E17	CPD003_PC3_24H_X2.L2	E17	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5666	N06AX09	viloxazine	CCOC1=CC=CC=C1OCC2CNCCO2	CCOc1ccccc1OCC1CNCCO1	BRD-A59198242	CPD003_PC3_6H_X1_B6_DUO52HI53LO:E17	CPD003_PC3_6H_X1	E17	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5666	N06AX09	viloxazine	CCOC1=CC=CC=C1OCC2CNCCO2	CCOc1ccccc1OCC1CNCCO1	BRD-A59198242	CPD003_PC3_6H_X3.A2_B6_DUO52HI53LO:E17	CPD003_PC3_6H_X3.A2	E17	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5666	N06AX09	viloxazine	CCOC1=CC=CC=C1OCC2CNCCO2	CCOc1ccccc1OCC1CNCCO1	BRD-A59198242	CPD003_PC3_6H_X3_B6_DUO52HI53LO:E17	CPD003_PC3_6H_X3	E17	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_PC3_24H_X1_B3_DUO52HI53LO:A16	CPC004_PC3_24H_X1	A16	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_PC3_24H_X2_B3_DUO52HI53LO:A16	CPC004_PC3_24H_X2	A16	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_PC3_24H_X3_B3_DUO52HI53LO:A16	CPC004_PC3_24H_X3	A16	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_PC3_24H_X4_B4_DUO52HI53LO:A16	CPC004_PC3_24H_X4	A16	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_PC3_24H_X5_B5_DUO52HI53LO:A16	CPC004_PC3_24H_X5	A16	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_PC3_6H_X1_B3_DUO52HI53LO:A16	CPC004_PC3_6H_X1	A16	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_PC3_6H_X2_B3_DUO52HI53LO:A16	CPC004_PC3_6H_X2	A16	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_PC3_6H_X4_B4_DUO52HI53LO:A16	CPC004_PC3_6H_X4	A16	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_PC3_6H_X5_F1B5_DUO52HI53LO:A16	CPC004_PC3_6H_X5	A16	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC011_PC3_24H_X1_B3_DUO52HI53LO:G23	CPC011_PC3_24H_X1	G23	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC011_PC3_24H_X2_B3_DUO52HI53LO:G23	CPC011_PC3_24H_X2	G23	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC011_PC3_24H_X4_B5_DUO52HI53LO:G23	CPC011_PC3_24H_X4	G23	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC011_PC3_24H_X5_B5_DUO52HI53LO:G23	CPC011_PC3_24H_X5	G23	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC011_PC3_6H_X1_B3_DUO52HI53LO:G23	CPC011_PC3_6H_X1	G23	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC011_PC3_6H_X3_B3_DUO52HI53LO:G23	CPC011_PC3_6H_X3	G23	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC011_PC3_6H_X4_B5_DUO52HI53LO:G23	CPC011_PC3_6H_X4	G23	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC011_PC3_6H_X5_B5_DUO52HI53LO:G23	CPC011_PC3_6H_X5	G23	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPD002_PC3_24H_X1_B6_DUO52HI53LO:O14	CPD002_PC3_24H_X1	O14	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPD002_PC3_24H_X2_B6_DUO52HI53LO:O14	CPD002_PC3_24H_X2	O14	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPD002_PC3_24H_X3_B6_DUO52HI53LO:O14	CPD002_PC3_24H_X3	O14	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPD002_PC3_6H_X1_B6_DUO52HI53LO:O14	CPD002_PC3_6H_X1	O14	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPD002_PC3_6H_X2_B6_DUO52HI53LO:O14	CPD002_PC3_6H_X2	O14	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPD002_PC3_6H_X3_B6_DUO52HI53LO:O14	CPD002_PC3_6H_X3	O14	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-K83153774	CPC020_PC3_24H_X1_B5_DUO52HI53LO:D15	CPC020_PC3_24H_X1	D15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-K83153774	CPC020_PC3_24H_X2_B5_DUO52HI53LO:D15	CPC020_PC3_24H_X2	D15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-K83153774	CPC020_PC3_24H_X3_B5_DUO52HI53LO:D15	CPC020_PC3_24H_X3	D15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-K83153774	CPC020_PC3_24H_X4_B5_DUO52HI53LO:D15	CPC020_PC3_24H_X4	D15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-K83153774	CPC020_PC3_24H_X5_B5_DUO52HI53LO:D15	CPC020_PC3_24H_X5	D15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-K83153774	CPC020_PC3_6H_X1_B4_DUO52HI53LO:D15	CPC020_PC3_6H_X1	D15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-K83153774	CPC020_PC3_6H_X2_B4_DUO52HI53LO:D15	CPC020_PC3_6H_X2	D15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-K83153774	CPC020_PC3_6H_X3_B4_DUO52HI53LO:D15	CPC020_PC3_6H_X3	D15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-K83153774	CPC020_PC3_6H_X4_F1B4_DUO52HI53LO:D15	CPC020_PC3_6H_X4	D15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-K83153774	CPC020_PC3_6H_X5_B5_DUO52HI53LO:D15	CPC020_PC3_6H_X5	D15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_PC3_24H_X1_B3_DUO52HI53LO:J08	CPC004_PC3_24H_X1	J08	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_PC3_24H_X2_B3_DUO52HI53LO:J08	CPC004_PC3_24H_X2	J08	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_PC3_24H_X3_B3_DUO52HI53LO:J08	CPC004_PC3_24H_X3	J08	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_PC3_24H_X4_B4_DUO52HI53LO:J08	CPC004_PC3_24H_X4	J08	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_PC3_24H_X5_B5_DUO52HI53LO:J08	CPC004_PC3_24H_X5	J08	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_PC3_6H_X5_F1B5_DUO52HI53LO:J08	CPC004_PC3_6H_X5	J08	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPD001_PC3_24H_X1_B6_DUO52HI53LO:B20	CPD001_PC3_24H_X1	B20	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPD001_PC3_24H_X2_B6_DUO52HI53LO:B20	CPD001_PC3_24H_X2	B20	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPD001_PC3_24H_X3_B6_DUO52HI53LO:B20	CPD001_PC3_24H_X3	B20	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_PC3_6H_X1_B3_DUO52HI53LO:J08	CPC004_PC3_6H_X1	J08	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_PC3_6H_X2_B3_DUO52HI53LO:J08	CPC004_PC3_6H_X2	J08	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_PC3_6H_X3_B3_DUO52HI53LO:J08	CPC004_PC3_6H_X3	J08	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_PC3_6H_X4_B4_DUO52HI53LO:J08	CPC004_PC3_6H_X4	J08	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_PC3_24H_X1_B3_DUO52HI53LO:G10	CPC011_PC3_24H_X1	G10	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_PC3_24H_X2_B3_DUO52HI53LO:G10	CPC011_PC3_24H_X2	G10	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_PC3_24H_X4_B5_DUO52HI53LO:G10	CPC011_PC3_24H_X4	G10	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_PC3_24H_X5_B5_DUO52HI53LO:G10	CPC011_PC3_24H_X5	G10	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_PC3_24H_X1_B3_DUO52HI53LO:B03	CPC011_PC3_24H_X1	B03	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_PC3_24H_X2_B3_DUO52HI53LO:B03	CPC011_PC3_24H_X2	B03	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_PC3_24H_X4_B5_DUO52HI53LO:B03	CPC011_PC3_24H_X4	B03	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_PC3_24H_X5_B5_DUO52HI53LO:B03	CPC011_PC3_24H_X5	B03	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_PC3_6H_X1_B3_DUO52HI53LO:G10	CPC011_PC3_6H_X1	G10	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_PC3_6H_X3_B3_DUO52HI53LO:G10	CPC011_PC3_6H_X3	G10	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_PC3_6H_X4_B5_DUO52HI53LO:G10	CPC011_PC3_6H_X4	G10	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_PC3_6H_X5_B5_DUO52HI53LO:G10	CPC011_PC3_6H_X5	G10	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_PC3_6H_X1_B3_DUO52HI53LO:B03	CPC011_PC3_6H_X1	B03	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_PC3_6H_X3_B3_DUO52HI53LO:B03	CPC011_PC3_6H_X3	B03	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_PC3_6H_X4_B5_DUO52HI53LO:B03	CPC011_PC3_6H_X4	B03	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_PC3_6H_X5_B5_DUO52HI53LO:B03	CPC011_PC3_6H_X5	B03	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_PC3_24H_X1_B4_DUO52HI53LO:M14	CPC005_PC3_24H_X1	M14	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_PC3_24H_X2_B4_DUO52HI53LO:M14	CPC005_PC3_24H_X2	M14	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_PC3_24H_X3_B4_DUO52HI53LO:M14	CPC005_PC3_24H_X3	M14	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_PC3_24H_X4_B5_DUO52HI53LO:M14	CPC005_PC3_24H_X4	M14	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_PC3_24H_X5_B5_DUO52HI53LO:M14	CPC005_PC3_24H_X5	M14	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_PC3_6H_X5_F1B5_DUO52HI53LO:M14	CPC005_PC3_6H_X5	M14	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_PC3_6H_X1_B3_DUO52HI53LO:M14	CPC005_PC3_6H_X1	M14	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_PC3_6H_X2_B3_DUO52HI53LO:M14	CPC005_PC3_6H_X2	M14	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_PC3_6H_X3_B3_DUO52HI53LO:M14	CPC005_PC3_6H_X3	M14	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_PC3_24H_X1_B3_DUO52HI53LO:J06	CPC004_PC3_24H_X1	J06	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_PC3_24H_X2_B3_DUO52HI53LO:J06	CPC004_PC3_24H_X2	J06	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_PC3_24H_X3_B3_DUO52HI53LO:J06	CPC004_PC3_24H_X3	J06	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_PC3_24H_X4_B4_DUO52HI53LO:J06	CPC004_PC3_24H_X4	J06	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_PC3_24H_X5_B5_DUO52HI53LO:J06	CPC004_PC3_24H_X5	J06	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_PC3_6H_X1_B3_DUO52HI53LO:J06	CPC004_PC3_6H_X1	J06	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_PC3_6H_X2_B3_DUO52HI53LO:J06	CPC004_PC3_6H_X2	J06	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_PC3_6H_X3_B3_DUO52HI53LO:J06	CPC004_PC3_6H_X3	J06	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_PC3_6H_X4_B4_DUO52HI53LO:J06	CPC004_PC3_6H_X4	J06	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_PC3_6H_X5_F1B5_DUO52HI53LO:J06	CPC004_PC3_6H_X5	J06	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC011_PC3_24H_X1_B3_DUO52HI53LO:J19	CPC011_PC3_24H_X1	J19	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC011_PC3_24H_X2_B3_DUO52HI53LO:J19	CPC011_PC3_24H_X2	J19	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC011_PC3_24H_X4_B5_DUO52HI53LO:J19	CPC011_PC3_24H_X4	J19	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC011_PC3_24H_X5_B5_DUO52HI53LO:J19	CPC011_PC3_24H_X5	J19	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC011_PC3_6H_X1_B3_DUO52HI53LO:J19	CPC011_PC3_6H_X1	J19	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC011_PC3_6H_X3_B3_DUO52HI53LO:J19	CPC011_PC3_6H_X3	J19	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC011_PC3_6H_X4_B5_DUO52HI53LO:J19	CPC011_PC3_6H_X4	J19	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC011_PC3_6H_X5_B5_DUO52HI53LO:J19	CPC011_PC3_6H_X5	J19	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPD002_PC3_24H_X1_B6_DUO52HI53LO:L12	CPD002_PC3_24H_X1	L12	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPD002_PC3_24H_X2_B6_DUO52HI53LO:L12	CPD002_PC3_24H_X2	L12	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPD002_PC3_24H_X3_B6_DUO52HI53LO:L12	CPD002_PC3_24H_X3	L12	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPD002_PC3_6H_X1_B6_DUO52HI53LO:L12	CPD002_PC3_6H_X1	L12	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPD002_PC3_6H_X2_B6_DUO52HI53LO:L12	CPD002_PC3_6H_X2	L12	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPD002_PC3_6H_X3_B6_DUO52HI53LO:L12	CPD002_PC3_6H_X3	L12	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
65833	N06AX17	milnacipran	CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2	CCN(CC)C(=O)C1(c2ccccc2)CC1CN	BRD-K02227374	CPC011_PC3_24H_X1_B3_DUO52HI53LO:H14	CPC011_PC3_24H_X1	H14	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
65833	N06AX17	milnacipran	CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2	CCN(CC)C(=O)C1(c2ccccc2)CC1CN	BRD-K02227374	CPC011_PC3_24H_X2_B3_DUO52HI53LO:H14	CPC011_PC3_24H_X2	H14	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
65833	N06AX17	milnacipran	CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2	CCN(CC)C(=O)C1(c2ccccc2)CC1CN	BRD-K02227374	CPC011_PC3_24H_X4_B5_DUO52HI53LO:H14	CPC011_PC3_24H_X4	H14	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
65833	N06AX17	milnacipran	CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2	CCN(CC)C(=O)C1(c2ccccc2)CC1CN	BRD-K02227374	CPC011_PC3_24H_X5_B5_DUO52HI53LO:H14	CPC011_PC3_24H_X5	H14	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
65833	N06AX17	milnacipran	CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2	CCN(CC)C(=O)C1(c2ccccc2)CC1CN	BRD-K02227374	CPC011_PC3_6H_X1_B3_DUO52HI53LO:H14	CPC011_PC3_6H_X1	H14	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
65833	N06AX17	milnacipran	CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2	CCN(CC)C(=O)C1(c2ccccc2)CC1CN	BRD-K02227374	CPC011_PC3_6H_X3_B3_DUO52HI53LO:H14	CPC011_PC3_6H_X3	H14	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
65833	N06AX17	milnacipran	CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2	CCN(CC)C(=O)C1(c2ccccc2)CC1CN	BRD-K02227374	CPC011_PC3_6H_X4_B5_DUO52HI53LO:H14	CPC011_PC3_6H_X4	H14	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
65833	N06AX17	milnacipran	CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2	CCN(CC)C(=O)C1(c2ccccc2)CC1CN	BRD-K02227374	CPC011_PC3_6H_X5_B5_DUO52HI53LO:H14	CPC011_PC3_6H_X5	H14	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC001_PC3_24H_X1_B3_DUO52HI53LO:L21	CPC001_PC3_24H_X1	L21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC001_PC3_24H_X2_B3_DUO52HI53LO:L21	CPC001_PC3_24H_X2	L21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC001_PC3_24H_X3_B3_DUO52HI53LO:L21	CPC001_PC3_24H_X3	L21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC001_PC3_24H_X3_F1B3_DUO52HI53LO:L21	CPC001_PC3_24H_X3	L21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC001_PC3_24H_X4_F2B4_DUO52HI53LO:L21	CPC001_PC3_24H_X4	L21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC001_PC3_24H_X5_B5_DUO52HI53LO:L21	CPC001_PC3_24H_X5	L21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC001_PC3_6H_X1_B3_DUO52HI53LO:L21	CPC001_PC3_6H_X1	L21	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC001_PC3_6H_X2_B3_DUO52HI53LO:L21	CPC001_PC3_6H_X2	L21	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC001_PC3_6H_X3_B3_DUO52HI53LO:L21	CPC001_PC3_6H_X3	L21	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC001_PC3_6H_X5.L2_F2B5_DUO52HI53LO:L21	CPC001_PC3_6H_X5.L2	L21	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-K32480324	CPD002_PC3_24H_X1_B6_DUO52HI53LO:F03	CPD002_PC3_24H_X1	F03	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-K32480324	CPD002_PC3_24H_X2_B6_DUO52HI53LO:F03	CPD002_PC3_24H_X2	F03	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-K32480324	CPD002_PC3_24H_X3_B6_DUO52HI53LO:F03	CPD002_PC3_24H_X3	F03	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-K32480324	CPD002_PC3_6H_X1_B6_DUO52HI53LO:F03	CPD002_PC3_6H_X1	F03	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-K32480324	CPD002_PC3_6H_X2_B6_DUO52HI53LO:F03	CPD002_PC3_6H_X2	F03	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-K32480324	CPD002_PC3_6H_X3_B6_DUO52HI53LO:F03	CPD002_PC3_6H_X3	F03	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_PC3_24H_X2_B3_DUO52HI53LO:J03	CPC004_PC3_24H_X2	J03	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_PC3_24H_X3_B3_DUO52HI53LO:J03	CPC004_PC3_24H_X3	J03	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_PC3_24H_X4_B4_DUO52HI53LO:J03	CPC004_PC3_24H_X4	J03	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_PC3_24H_X5_B5_DUO52HI53LO:J03	CPC004_PC3_24H_X5	J03	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_PC3_6H_X1_B3_DUO52HI53LO:J03	CPC004_PC3_6H_X1	J03	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_PC3_6H_X2_B3_DUO52HI53LO:J03	CPC004_PC3_6H_X2	J03	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_PC3_6H_X3_B3_DUO52HI53LO:J03	CPC004_PC3_6H_X3	J03	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_PC3_6H_X4_B4_DUO52HI53LO:J03	CPC004_PC3_6H_X4	J03	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_PC3_6H_X5_F1B5_DUO52HI53LO:J03	CPC004_PC3_6H_X5	J03	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_PC3_24H_X1_F2B4_DUO52HI53LO:G22	CPC010_PC3_24H_X1	G22	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_PC3_24H_X2_B5_DUO52HI53LO:G22	CPC010_PC3_24H_X2	G22	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_PC3_24H_X3_B5_DUO52HI53LO:G22	CPC010_PC3_24H_X3	G22	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_PC3_24H_X4_F2B4_DUO52HI53LO:G22	CPC010_PC3_24H_X4	G22	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_PC3_24H_X5_B5_DUO52HI53LO:G22	CPC010_PC3_24H_X5	G22	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_PC3_6H_X1_B3_DUO52HI53LO:G22	CPC010_PC3_6H_X1	G22	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_PC3_6H_X2_B3_DUO52HI53LO:G22	CPC010_PC3_6H_X2	G22	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_PC3_6H_X3_B3_DUO52HI53LO:G22	CPC010_PC3_6H_X3	G22	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_PC3_6H_X4_F1B5_DUO52HI53LO:G22	CPC010_PC3_6H_X4	G22	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_PC3_6H_X5_F1B5_DUO52HI53LO:G22	CPC010_PC3_6H_X5	G22	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC011_PC3_24H_X1_B3_DUO52HI53LO:I05	CPC011_PC3_24H_X1	I05	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC011_PC3_24H_X2_B3_DUO52HI53LO:I05	CPC011_PC3_24H_X2	I05	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC011_PC3_24H_X4_B5_DUO52HI53LO:I05	CPC011_PC3_24H_X4	I05	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC011_PC3_24H_X5_B5_DUO52HI53LO:I05	CPC011_PC3_24H_X5	I05	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC011_PC3_6H_X1_B3_DUO52HI53LO:I05	CPC011_PC3_6H_X1	I05	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC011_PC3_6H_X3_B3_DUO52HI53LO:I05	CPC011_PC3_6H_X3	I05	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC011_PC3_6H_X4_B5_DUO52HI53LO:I05	CPC011_PC3_6H_X4	I05	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC011_PC3_6H_X5_B5_DUO52HI53LO:I05	CPC011_PC3_6H_X5	I05	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_VCAP_24H_X2_B5_DUO52HI53LO:E11	CPC004_VCAP_24H_X2	E11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_VCAP_24H_X5_B5_DUO52HI53LO:E11	CPC004_VCAP_24H_X5	E11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_VCAP_6H_X1_B5_DUO52HI53LO:E11	CPC004_VCAP_6H_X1	E11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_VCAP_6H_X5_B5_DUO52HI53LO:E11	CPC004_VCAP_6H_X5	E11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC020_VCAP_24H_X1_F1B5_DUO52HI53LO:F21	CPC020_VCAP_24H_X1	F21	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC020_VCAP_24H_X2_F1B5_DUO52HI53LO:F21	CPC020_VCAP_24H_X2	F21	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC020_VCAP_24H_X3_F1B5_DUO52HI53LO:F21	CPC020_VCAP_24H_X3	F21	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC020_VCAP_24H_X4_B5_DUO52HI53LO:F21	CPC020_VCAP_24H_X4	F21	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC020_VCAP_24H_X5_B5_DUO52HI53LO:F21	CPC020_VCAP_24H_X5	F21	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC020_VCAP_6H_X1_F1B3_DUO52HI53LO:F21	CPC020_VCAP_6H_X1	F21	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC020_VCAP_6H_X2_B4_DUO52HI53LO:F21	CPC020_VCAP_6H_X2	F21	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC020_VCAP_6H_X3_B4_DUO52HI53LO:F21	CPC020_VCAP_6H_X3	F21	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC020_VCAP_6H_X4_B5_DUO52HI53LO:F21	CPC020_VCAP_6H_X4	F21	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC020_VCAP_6H_X5_B5_DUO52HI53LO:F21	CPC020_VCAP_6H_X5	F21	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_VCAP_24H_X1_F1B5_DUO52HI53LO:E11	CPC004_VCAP_24H_X1	E11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_VCAP_24H_X3_F1B5_DUO52HI53LO:E11	CPC004_VCAP_24H_X3	E11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_VCAP_24H_X4.A2_F1B5_DUO52HI53LO:E11	CPC004_VCAP_24H_X4.A2	E11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_VCAP_24H_X4_F1B5_DUO52HI53LO:E11	CPC004_VCAP_24H_X4	E11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_VCAP_6H_X2_F1B5_DUO52HI53LO:E11	CPC004_VCAP_6H_X2	E11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_VCAP_6H_X3_F1B5_DUO52HI53LO:E11	CPC004_VCAP_6H_X3	E11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_VCAP_24H_X1_B3_DUO52HI53LO:C12	CPC005_VCAP_24H_X1	C12	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_VCAP_24H_X2_B3_DUO52HI53LO:C12	CPC005_VCAP_24H_X2	C12	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_VCAP_24H_X3_B3_DUO52HI53LO:C12	CPC005_VCAP_24H_X3	C12	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_VCAP_6H_X1_F1B3_DUO52HI53LO:C12	CPC005_VCAP_6H_X1	C12	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_VCAP_6H_X2_F1B3_DUO52HI53LO:C12	CPC005_VCAP_6H_X2	C12	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_VCAP_6H_X4_B5_DUO52HI53LO:C12	CPC005_VCAP_6H_X4	C12	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_VCAP_6H_X5_B5_DUO52HI53LO:C12	CPC005_VCAP_6H_X5	C12	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_VCAP_24H_X1_F1B5_DUO52HI53LO:H14	CPC020_VCAP_24H_X1	H14	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_VCAP_24H_X1_F1B5_DUO52HI53LO:L24	CPC020_VCAP_24H_X1	L24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_VCAP_24H_X2_F1B5_DUO52HI53LO:H14	CPC020_VCAP_24H_X2	H14	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_VCAP_24H_X2_F1B5_DUO52HI53LO:L24	CPC020_VCAP_24H_X2	L24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_VCAP_24H_X3_F1B5_DUO52HI53LO:H14	CPC020_VCAP_24H_X3	H14	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_VCAP_24H_X3_F1B5_DUO52HI53LO:L24	CPC020_VCAP_24H_X3	L24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_VCAP_24H_X4_B5_DUO52HI53LO:H14	CPC020_VCAP_24H_X4	H14	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_VCAP_24H_X4_B5_DUO52HI53LO:L24	CPC020_VCAP_24H_X4	L24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_VCAP_24H_X5_B5_DUO52HI53LO:H14	CPC020_VCAP_24H_X5	H14	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_VCAP_24H_X5_B5_DUO52HI53LO:L24	CPC020_VCAP_24H_X5	L24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_VCAP_6H_X1_F1B3_DUO52HI53LO:H14	CPC020_VCAP_6H_X1	H14	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_VCAP_6H_X1_F1B3_DUO52HI53LO:L24	CPC020_VCAP_6H_X1	L24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_VCAP_6H_X2_B4_DUO52HI53LO:H14	CPC020_VCAP_6H_X2	H14	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_VCAP_6H_X2_B4_DUO52HI53LO:L24	CPC020_VCAP_6H_X2	L24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_VCAP_6H_X3_B4_DUO52HI53LO:H14	CPC020_VCAP_6H_X3	H14	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_VCAP_6H_X3_B4_DUO52HI53LO:L24	CPC020_VCAP_6H_X3	L24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_VCAP_6H_X4_B5_DUO52HI53LO:H14	CPC020_VCAP_6H_X4	H14	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_VCAP_6H_X4_B5_DUO52HI53LO:L24	CPC020_VCAP_6H_X4	L24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_VCAP_6H_X5_B5_DUO52HI53LO:H14	CPC020_VCAP_6H_X5	H14	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_VCAP_6H_X5_B5_DUO52HI53LO:L24	CPC020_VCAP_6H_X5	L24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_VCAP_24H_X4_F1B5_DUO52HI53LO:C12	CPC005_VCAP_24H_X4	C12	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_VCAP_24H_X5_F2B4_DUO52HI53LO:C12	CPC005_VCAP_24H_X5	C12	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC002_VCAP_24H_X1_B3_DUO52HI53LO:G20	CPC002_VCAP_24H_X1	G20	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC002_VCAP_24H_X2_B3_DUO52HI53LO:G20	CPC002_VCAP_24H_X2	G20	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC002_VCAP_24H_X3_B3_DUO52HI53LO:G20	CPC002_VCAP_24H_X3	G20	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC002_VCAP_6H_X5_B5_DUO52HI53LO:G20	CPC002_VCAP_6H_X5	G20	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC020_VCAP_24H_X1_F1B5_DUO52HI53LO:P19	CPC020_VCAP_24H_X1	P19	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC020_VCAP_24H_X2_F1B5_DUO52HI53LO:P19	CPC020_VCAP_24H_X2	P19	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC020_VCAP_24H_X3_F1B5_DUO52HI53LO:P19	CPC020_VCAP_24H_X3	P19	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC020_VCAP_24H_X4_B5_DUO52HI53LO:P19	CPC020_VCAP_24H_X4	P19	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC020_VCAP_24H_X5_B5_DUO52HI53LO:P19	CPC020_VCAP_24H_X5	P19	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC020_VCAP_6H_X1_F1B3_DUO52HI53LO:P19	CPC020_VCAP_6H_X1	P19	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC020_VCAP_6H_X2_B4_DUO52HI53LO:P19	CPC020_VCAP_6H_X2	P19	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC020_VCAP_6H_X3_B4_DUO52HI53LO:P19	CPC020_VCAP_6H_X3	P19	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC020_VCAP_6H_X4_B5_DUO52HI53LO:P19	CPC020_VCAP_6H_X4	P19	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC020_VCAP_6H_X5_B5_DUO52HI53LO:P19	CPC020_VCAP_6H_X5	P19	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC002_VCAP_6H_X1_F1B5_DUO52HI53LO:G20	CPC002_VCAP_6H_X1	G20	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC002_VCAP_6H_X2_F1B5_DUO52HI53LO:G20	CPC002_VCAP_6H_X2	G20	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_VCAP_24H_X1_F1B5_DUO52HI53LO:I02	CPC004_VCAP_24H_X1	I02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_VCAP_24H_X2_B5_DUO52HI53LO:I02	CPC004_VCAP_24H_X2	I02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_VCAP_24H_X3_F1B5_DUO52HI53LO:I02	CPC004_VCAP_24H_X3	I02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_VCAP_24H_X4_F1B5_DUO52HI53LO:I02	CPC004_VCAP_24H_X4	I02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_VCAP_24H_X5_B5_DUO52HI53LO:I02	CPC004_VCAP_24H_X5	I02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_VCAP_6H_X1_B5_DUO52HI53LO:I02	CPC004_VCAP_6H_X1	I02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_VCAP_6H_X2_F1B5_DUO52HI53LO:I02	CPC004_VCAP_6H_X2	I02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_VCAP_6H_X3_F1B5_DUO52HI53LO:I02	CPC004_VCAP_6H_X3	I02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_VCAP_6H_X5_B5_DUO52HI53LO:I02	CPC004_VCAP_6H_X5	I02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_VCAP_24H_X4.A2_F1B5_DUO52HI53LO:I02	CPC004_VCAP_24H_X4.A2	I02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_VCAP_24H_X1_F1B5_DUO52HI53LO:I02	CPC004_VCAP_24H_X1	I02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_VCAP_24H_X2_B5_DUO52HI53LO:I02	CPC004_VCAP_24H_X2	I02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_VCAP_24H_X3_F1B5_DUO52HI53LO:I02	CPC004_VCAP_24H_X3	I02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_VCAP_24H_X4_F1B5_DUO52HI53LO:I02	CPC004_VCAP_24H_X4	I02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_VCAP_24H_X5_B5_DUO52HI53LO:I02	CPC004_VCAP_24H_X5	I02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_VCAP_6H_X1_B5_DUO52HI53LO:I02	CPC004_VCAP_6H_X1	I02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_VCAP_6H_X2_F1B5_DUO52HI53LO:I02	CPC004_VCAP_6H_X2	I02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_VCAP_6H_X3_F1B5_DUO52HI53LO:I02	CPC004_VCAP_6H_X3	I02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_VCAP_6H_X5_B5_DUO52HI53LO:I02	CPC004_VCAP_6H_X5	I02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_VCAP_24H_X4.A2_F1B5_DUO52HI53LO:I02	CPC004_VCAP_24H_X4.A2	I02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3947	N06AA07	lofepramine	CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)CC(=O)C4=CC=C(C=C4)Cl	CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1	BRD-K82147103	CPC011_VCAP_24H_X2_F1B5_DUO52HI53LO:M10	CPC011_VCAP_24H_X2	M10	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3947	N06AA07	lofepramine	CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)CC(=O)C4=CC=C(C=C4)Cl	CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1	BRD-K82147103	CPC011_VCAP_6H_X2_F2B4_DUO52HI53LO:M10	CPC011_VCAP_6H_X2	M10	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3947	N06AA07	lofepramine	CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)CC(=O)C4=CC=C(C=C4)Cl	CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1	BRD-K82147103	CPC011_VCAP_6H_X4_F1B5_DUO52HI53LO:M10	CPC011_VCAP_6H_X4	M10	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3947	N06AA07	lofepramine	CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)CC(=O)C4=CC=C(C=C4)Cl	CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1	BRD-K82147103	CPC011_VCAP_6H_X5_F1B5_DUO52HI53LO:M10	CPC011_VCAP_6H_X5	M10	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3947	N06AA07	lofepramine	CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)CC(=O)C4=CC=C(C=C4)Cl	CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1	BRD-K82147103	CPC011_VCAP_24H_X1_B5_DUO52HI53LO:M10	CPC011_VCAP_24H_X1	M10	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3947	N06AA07	lofepramine	CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)CC(=O)C4=CC=C(C=C4)Cl	CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1	BRD-K82147103	CPC011_VCAP_24H_X3_B5_DUO52HI53LO:M10	CPC011_VCAP_24H_X3	M10	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3947	N06AA07	lofepramine	CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)CC(=O)C4=CC=C(C=C4)Cl	CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1	BRD-K82147103	CPC011_VCAP_24H_X4_B5_DUO52HI53LO:M10	CPC011_VCAP_24H_X4	M10	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3947	N06AA07	lofepramine	CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)CC(=O)C4=CC=C(C=C4)Cl	CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1	BRD-K82147103	CPC011_VCAP_24H_X5_B5_DUO52HI53LO:M10	CPC011_VCAP_24H_X5	M10	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3947	N06AA07	lofepramine	CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)CC(=O)C4=CC=C(C=C4)Cl	CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1	BRD-K82147103	CPC011_VCAP_6H_X1_B5_DUO52HI53LO:M10	CPC011_VCAP_6H_X1	M10	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3947	N06AA07	lofepramine	CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)CC(=O)C4=CC=C(C=C4)Cl	CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1	BRD-K82147103	CPC011_VCAP_6H_X3_B5_DUO52HI53LO:M10	CPC011_VCAP_6H_X3	M10	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC001_VCAP_24H_X1_B3_DUO52HI53LO:O20	CPC001_VCAP_24H_X1	O20	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC001_VCAP_24H_X2_B3_DUO52HI53LO:O20	CPC001_VCAP_24H_X2	O20	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC001_VCAP_24H_X3_B3_DUO52HI53LO:O20	CPC001_VCAP_24H_X3	O20	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC001_VCAP_24H_X4.A2_F1B5_DUO52HI53LO:O20	CPC001_VCAP_24H_X4.A2	O20	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC001_VCAP_24H_X4_F1B5_DUO52HI53LO:O20	CPC001_VCAP_24H_X4	O20	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC001_VCAP_24H_X5_F2B4_DUO52HI53LO:O20	CPC001_VCAP_24H_X5	O20	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC001_VCAP_6H_X1.A2_F1B5_DUO52HI53LO:O20	CPC001_VCAP_6H_X1.A2	O20	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC001_VCAP_6H_X1_F1B5_DUO52HI53LO:O20	CPC001_VCAP_6H_X1	O20	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC001_VCAP_6H_X2_B5_DUO52HI53LO:O20	CPC001_VCAP_6H_X2	O20	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC001_VCAP_6H_X3_F1B5_DUO52HI53LO:O20	CPC001_VCAP_6H_X3	O20	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC001_VCAP_6H_X4_B5_DUO52HI53LO:O20	CPC001_VCAP_6H_X4	O20	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC001_VCAP_6H_X5_B5_DUO52HI53LO:O20	CPC001_VCAP_6H_X5	O20	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC003_VCAP_24H_X1_B3_DUO52HI53LO:I02	CPC003_VCAP_24H_X1	I02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC003_VCAP_24H_X3_B3_DUO52HI53LO:I02	CPC003_VCAP_24H_X3	I02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC003_VCAP_6H_X2_B5_DUO52HI53LO:I02	CPC003_VCAP_6H_X2	I02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC003_VCAP_6H_X3_B5_DUO52HI53LO:I02	CPC003_VCAP_6H_X3	I02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC003_VCAP_6H_X4_B5_DUO52HI53LO:I02	CPC003_VCAP_6H_X4	I02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC003_VCAP_6H_X1_F2B4_DUO52HI53LO:I02	CPC003_VCAP_6H_X1	I02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC003_VCAP_6H_X5_F1B5_DUO52HI53LO:I02	CPC003_VCAP_6H_X5	I02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC002_VCAP_24H_X1_B3_DUO52HI53LO:O11	CPC002_VCAP_24H_X1	O11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC002_VCAP_24H_X2_B3_DUO52HI53LO:O11	CPC002_VCAP_24H_X2	O11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC002_VCAP_24H_X3_B3_DUO52HI53LO:O11	CPC002_VCAP_24H_X3	O11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC002_VCAP_6H_X1_F1B5_DUO52HI53LO:O11	CPC002_VCAP_6H_X1	O11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC002_VCAP_6H_X2_F1B5_DUO52HI53LO:O11	CPC002_VCAP_6H_X2	O11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC002_VCAP_6H_X4_B5_DUO52HI53LO:O11	CPC002_VCAP_6H_X4	O11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC002_VCAP_6H_X5_B5_DUO52HI53LO:O11	CPC002_VCAP_6H_X5	O11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_VCAP_24H_X2_B5_DUO52HI53LO:J02	CPC004_VCAP_24H_X2	J02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_VCAP_24H_X5_B5_DUO52HI53LO:J02	CPC004_VCAP_24H_X5	J02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_VCAP_6H_X1_B5_DUO52HI53LO:J02	CPC004_VCAP_6H_X1	J02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_VCAP_6H_X5_B5_DUO52HI53LO:J02	CPC004_VCAP_6H_X5	J02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_VCAP_24H_X1_F1B5_DUO52HI53LO:J02	CPC004_VCAP_24H_X1	J02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_VCAP_24H_X3_F1B5_DUO52HI53LO:J02	CPC004_VCAP_24H_X3	J02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_VCAP_24H_X4.A2_F1B5_DUO52HI53LO:J02	CPC004_VCAP_24H_X4.A2	J02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_VCAP_24H_X4_F1B5_DUO52HI53LO:J02	CPC004_VCAP_24H_X4	J02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_VCAP_6H_X2_F1B5_DUO52HI53LO:J02	CPC004_VCAP_6H_X2	J02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_VCAP_6H_X3_F1B5_DUO52HI53LO:J02	CPC004_VCAP_6H_X3	J02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC004_VCAP_24H_X1_F1B5_DUO52HI53LO:K17	CPC004_VCAP_24H_X1	K17	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC004_VCAP_24H_X2_B5_DUO52HI53LO:K17	CPC004_VCAP_24H_X2	K17	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC004_VCAP_24H_X3_F1B5_DUO52HI53LO:K17	CPC004_VCAP_24H_X3	K17	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC004_VCAP_24H_X4_F1B5_DUO52HI53LO:K17	CPC004_VCAP_24H_X4	K17	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC004_VCAP_24H_X5_B5_DUO52HI53LO:K17	CPC004_VCAP_24H_X5	K17	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC004_VCAP_6H_X2_F1B5_DUO52HI53LO:K17	CPC004_VCAP_6H_X2	K17	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC004_VCAP_6H_X3_F1B5_DUO52HI53LO:K17	CPC004_VCAP_6H_X3	K17	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC004_VCAP_6H_X5_B5_DUO52HI53LO:K17	CPC004_VCAP_6H_X5	K17	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_VCAP_24H_X1_F1B5_DUO52HI53LO:G23	CPC004_VCAP_24H_X1	G23	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_VCAP_24H_X2_B5_DUO52HI53LO:G23	CPC004_VCAP_24H_X2	G23	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_VCAP_24H_X3_F1B5_DUO52HI53LO:G23	CPC004_VCAP_24H_X3	G23	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_VCAP_24H_X4_F1B5_DUO52HI53LO:G23	CPC004_VCAP_24H_X4	G23	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_VCAP_24H_X5_B5_DUO52HI53LO:G23	CPC004_VCAP_24H_X5	G23	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_VCAP_6H_X1_B5_DUO52HI53LO:G23	CPC004_VCAP_6H_X1	G23	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_VCAP_6H_X2_F1B5_DUO52HI53LO:G23	CPC004_VCAP_6H_X2	G23	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_VCAP_6H_X3_F1B5_DUO52HI53LO:G23	CPC004_VCAP_6H_X3	G23	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_VCAP_6H_X5_B5_DUO52HI53LO:G23	CPC004_VCAP_6H_X5	G23	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_VCAP_24H_X4.A2_F1B5_DUO52HI53LO:G23	CPC004_VCAP_24H_X4.A2	G23	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC011_VCAP_24H_X1_B5_DUO52HI53LO:G15	CPC011_VCAP_24H_X1	G15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC011_VCAP_24H_X2_F1B5_DUO52HI53LO:G15	CPC011_VCAP_24H_X2	G15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC011_VCAP_24H_X3_B5_DUO52HI53LO:G15	CPC011_VCAP_24H_X3	G15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC011_VCAP_24H_X4_B5_DUO52HI53LO:G15	CPC011_VCAP_24H_X4	G15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC011_VCAP_24H_X5_B5_DUO52HI53LO:G15	CPC011_VCAP_24H_X5	G15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC011_VCAP_6H_X1_B5_DUO52HI53LO:G15	CPC011_VCAP_6H_X1	G15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC011_VCAP_6H_X2_F2B4_DUO52HI53LO:G15	CPC011_VCAP_6H_X2	G15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC011_VCAP_6H_X3_B5_DUO52HI53LO:G15	CPC011_VCAP_6H_X3	G15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC011_VCAP_6H_X4_F1B5_DUO52HI53LO:G15	CPC011_VCAP_6H_X4	G15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC011_VCAP_6H_X5_F1B5_DUO52HI53LO:G15	CPC011_VCAP_6H_X5	G15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC002_VCAP_24H_X1_B3_DUO52HI53LO:F11	CPC002_VCAP_24H_X1	F11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC002_VCAP_24H_X2_B3_DUO52HI53LO:F11	CPC002_VCAP_24H_X2	F11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC002_VCAP_24H_X3_B3_DUO52HI53LO:F11	CPC002_VCAP_24H_X3	F11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC002_VCAP_6H_X1_F1B5_DUO52HI53LO:F11	CPC002_VCAP_6H_X1	F11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC002_VCAP_6H_X2_F1B5_DUO52HI53LO:F11	CPC002_VCAP_6H_X2	F11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC002_VCAP_6H_X4_B5_DUO52HI53LO:F11	CPC002_VCAP_6H_X4	F11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC002_VCAP_6H_X5_B5_DUO52HI53LO:F11	CPC002_VCAP_6H_X5	F11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC020_VCAP_24H_X1_F1B5_DUO52HI53LO:O02	CPC020_VCAP_24H_X1	O02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC020_VCAP_24H_X2_F1B5_DUO52HI53LO:O02	CPC020_VCAP_24H_X2	O02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC020_VCAP_24H_X3_F1B5_DUO52HI53LO:O02	CPC020_VCAP_24H_X3	O02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC020_VCAP_24H_X4_B5_DUO52HI53LO:O02	CPC020_VCAP_24H_X4	O02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC020_VCAP_24H_X5_B5_DUO52HI53LO:O02	CPC020_VCAP_24H_X5	O02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC020_VCAP_6H_X1_F1B3_DUO52HI53LO:O02	CPC020_VCAP_6H_X1	O02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC020_VCAP_6H_X2_B4_DUO52HI53LO:O02	CPC020_VCAP_6H_X2	O02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC020_VCAP_6H_X3_B4_DUO52HI53LO:O02	CPC020_VCAP_6H_X3	O02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC020_VCAP_6H_X4_B5_DUO52HI53LO:O02	CPC020_VCAP_6H_X4	O02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC020_VCAP_6H_X5_B5_DUO52HI53LO:O02	CPC020_VCAP_6H_X5	O02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC002_VCAP_24H_X1_B3_DUO52HI53LO:F15	CPC002_VCAP_24H_X1	F15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC002_VCAP_24H_X2_B3_DUO52HI53LO:F15	CPC002_VCAP_24H_X2	F15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC002_VCAP_24H_X3_B3_DUO52HI53LO:F15	CPC002_VCAP_24H_X3	F15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC002_VCAP_6H_X1_F1B5_DUO52HI53LO:F15	CPC002_VCAP_6H_X1	F15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC002_VCAP_6H_X2_F1B5_DUO52HI53LO:F15	CPC002_VCAP_6H_X2	F15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC002_VCAP_6H_X4_B5_DUO52HI53LO:F15	CPC002_VCAP_6H_X4	F15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC002_VCAP_6H_X5_B5_DUO52HI53LO:F15	CPC002_VCAP_6H_X5	F15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_VCAP_24H_X1_F1B5_DUO52HI53LO:E01	CPC004_VCAP_24H_X1	E01	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_VCAP_24H_X2_B5_DUO52HI53LO:E01	CPC004_VCAP_24H_X2	E01	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_VCAP_24H_X3_F1B5_DUO52HI53LO:E01	CPC004_VCAP_24H_X3	E01	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_VCAP_24H_X4.A2_F1B5_DUO52HI53LO:E01	CPC004_VCAP_24H_X4.A2	E01	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_VCAP_24H_X4_F1B5_DUO52HI53LO:E01	CPC004_VCAP_24H_X4	E01	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_VCAP_24H_X5_B5_DUO52HI53LO:E01	CPC004_VCAP_24H_X5	E01	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_VCAP_6H_X1_B5_DUO52HI53LO:E01	CPC004_VCAP_6H_X1	E01	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_VCAP_6H_X2_F1B5_DUO52HI53LO:E01	CPC004_VCAP_6H_X2	E01	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_VCAP_6H_X3_F1B5_DUO52HI53LO:E01	CPC004_VCAP_6H_X3	E01	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_VCAP_6H_X5_B5_DUO52HI53LO:E01	CPC004_VCAP_6H_X5	E01	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_VCAP_24H_X1_F1B5_DUO52HI53LO:F24	CPC020_VCAP_24H_X1	F24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_VCAP_24H_X1_F1B5_DUO52HI53LO:H08	CPC020_VCAP_24H_X1	H08	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_VCAP_24H_X2_F1B5_DUO52HI53LO:F24	CPC020_VCAP_24H_X2	F24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_VCAP_24H_X2_F1B5_DUO52HI53LO:H08	CPC020_VCAP_24H_X2	H08	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_VCAP_24H_X3_F1B5_DUO52HI53LO:F24	CPC020_VCAP_24H_X3	F24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_VCAP_24H_X3_F1B5_DUO52HI53LO:H08	CPC020_VCAP_24H_X3	H08	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_VCAP_24H_X4_B5_DUO52HI53LO:F24	CPC020_VCAP_24H_X4	F24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_VCAP_24H_X4_B5_DUO52HI53LO:H08	CPC020_VCAP_24H_X4	H08	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_VCAP_24H_X5_B5_DUO52HI53LO:F24	CPC020_VCAP_24H_X5	F24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_VCAP_24H_X5_B5_DUO52HI53LO:H08	CPC020_VCAP_24H_X5	H08	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_VCAP_6H_X1_F1B3_DUO52HI53LO:F24	CPC020_VCAP_6H_X1	F24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_VCAP_6H_X1_F1B3_DUO52HI53LO:H08	CPC020_VCAP_6H_X1	H08	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_VCAP_6H_X2_B4_DUO52HI53LO:F24	CPC020_VCAP_6H_X2	F24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_VCAP_6H_X2_B4_DUO52HI53LO:H08	CPC020_VCAP_6H_X2	H08	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_VCAP_6H_X3_B4_DUO52HI53LO:F24	CPC020_VCAP_6H_X3	F24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_VCAP_6H_X3_B4_DUO52HI53LO:H08	CPC020_VCAP_6H_X3	H08	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_VCAP_6H_X4_B5_DUO52HI53LO:F24	CPC020_VCAP_6H_X4	F24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_VCAP_6H_X4_B5_DUO52HI53LO:H08	CPC020_VCAP_6H_X4	H08	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_VCAP_6H_X5_B5_DUO52HI53LO:F24	CPC020_VCAP_6H_X5	F24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_VCAP_6H_X5_B5_DUO52HI53LO:H08	CPC020_VCAP_6H_X5	H08	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_VCAP_24H_X1_B3_DUO52HI53LO:N07	CPC005_VCAP_24H_X1	N07	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_VCAP_24H_X2_B3_DUO52HI53LO:N07	CPC005_VCAP_24H_X2	N07	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_VCAP_24H_X3_B3_DUO52HI53LO:N07	CPC005_VCAP_24H_X3	N07	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_VCAP_6H_X4_B5_DUO52HI53LO:N07	CPC005_VCAP_6H_X4	N07	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_VCAP_6H_X5_B5_DUO52HI53LO:N07	CPC005_VCAP_6H_X5	N07	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_VCAP_24H_X4_F1B5_DUO52HI53LO:N07	CPC005_VCAP_24H_X4	N07	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_VCAP_24H_X5_F2B4_DUO52HI53LO:N07	CPC005_VCAP_24H_X5	N07	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_VCAP_6H_X1_F1B3_DUO52HI53LO:N07	CPC005_VCAP_6H_X1	N07	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_VCAP_6H_X2_F1B3_DUO52HI53LO:N07	CPC005_VCAP_6H_X2	N07	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC002_VCAP_24H_X1_B3_DUO52HI53LO:K21	CPC002_VCAP_24H_X1	K21	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC002_VCAP_24H_X2_B3_DUO52HI53LO:K21	CPC002_VCAP_24H_X2	K21	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC002_VCAP_24H_X3_B3_DUO52HI53LO:K21	CPC002_VCAP_24H_X3	K21	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC002_VCAP_6H_X4_B5_DUO52HI53LO:K21	CPC002_VCAP_6H_X4	K21	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC002_VCAP_6H_X5_B5_DUO52HI53LO:K21	CPC002_VCAP_6H_X5	K21	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC011_VCAP_24H_X1_B5_DUO52HI53LO:O15	CPC011_VCAP_24H_X1	O15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC011_VCAP_24H_X2_F1B5_DUO52HI53LO:O15	CPC011_VCAP_24H_X2	O15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC011_VCAP_24H_X3_B5_DUO52HI53LO:O15	CPC011_VCAP_24H_X3	O15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC011_VCAP_24H_X4_B5_DUO52HI53LO:O15	CPC011_VCAP_24H_X4	O15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC011_VCAP_24H_X5_B5_DUO52HI53LO:O15	CPC011_VCAP_24H_X5	O15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC011_VCAP_6H_X2_F2B4_DUO52HI53LO:O15	CPC011_VCAP_6H_X2	O15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC011_VCAP_6H_X4_F1B5_DUO52HI53LO:O15	CPC011_VCAP_6H_X4	O15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC011_VCAP_6H_X5_F1B5_DUO52HI53LO:O15	CPC011_VCAP_6H_X5	O15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC002_VCAP_6H_X1_F1B5_DUO52HI53LO:K21	CPC002_VCAP_6H_X1	K21	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC002_VCAP_6H_X2_F1B5_DUO52HI53LO:K21	CPC002_VCAP_6H_X2	K21	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC011_VCAP_6H_X1_B5_DUO52HI53LO:O15	CPC011_VCAP_6H_X1	O15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC011_VCAP_6H_X3_B5_DUO52HI53LO:O15	CPC011_VCAP_6H_X3	O15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_VCAP_24H_X1_B3_DUO52HI53LO:P19	CPC005_VCAP_24H_X1	P19	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_VCAP_24H_X2_B3_DUO52HI53LO:P19	CPC005_VCAP_24H_X2	P19	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_VCAP_24H_X3_B3_DUO52HI53LO:P19	CPC005_VCAP_24H_X3	P19	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_VCAP_6H_X1_F1B3_DUO52HI53LO:P19	CPC005_VCAP_6H_X1	P19	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_VCAP_6H_X2_F1B3_DUO52HI53LO:P19	CPC005_VCAP_6H_X2	P19	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_VCAP_6H_X4_B5_DUO52HI53LO:P19	CPC005_VCAP_6H_X4	P19	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_VCAP_6H_X5_B5_DUO52HI53LO:P19	CPC005_VCAP_6H_X5	P19	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_VCAP_24H_X1_B5_DUO52HI53LO:J24	CPC009_VCAP_24H_X1	J24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_VCAP_24H_X2_F1B5_DUO52HI53LO:J24	CPC009_VCAP_24H_X2	J24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_VCAP_24H_X4_F1B5_DUO52HI53LO:J24	CPC009_VCAP_24H_X4	J24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_VCAP_24H_X5_F1B5_DUO52HI53LO:J24	CPC009_VCAP_24H_X5	J24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_VCAP_6H_X1_F1B5_DUO52HI53LO:J24	CPC009_VCAP_6H_X1	J24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_VCAP_6H_X2_F1B3_DUO52HI53LO:J24	CPC009_VCAP_6H_X2	J24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_VCAP_24H_X4_F1B5_DUO52HI53LO:P19	CPC005_VCAP_24H_X4	P19	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_VCAP_24H_X5_F2B4_DUO52HI53LO:P19	CPC005_VCAP_24H_X5	P19	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_VCAP_6H_X4_B5_DUO52HI53LO:J24	CPC009_VCAP_6H_X4	J24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_VCAP_6H_X5_B5_DUO52HI53LO:J24	CPC009_VCAP_6H_X5	J24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_VCAP_24H_X1_B3_DUO52HI53LO:F24	CPC005_VCAP_24H_X1	F24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_VCAP_24H_X2_B3_DUO52HI53LO:F24	CPC005_VCAP_24H_X2	F24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_VCAP_24H_X3_B3_DUO52HI53LO:F24	CPC005_VCAP_24H_X3	F24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_VCAP_6H_X1_F1B3_DUO52HI53LO:F24	CPC005_VCAP_6H_X1	F24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_VCAP_6H_X2_F1B3_DUO52HI53LO:F24	CPC005_VCAP_6H_X2	F24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_VCAP_6H_X4_B5_DUO52HI53LO:F24	CPC005_VCAP_6H_X4	F24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_VCAP_6H_X5_B5_DUO52HI53LO:F24	CPC005_VCAP_6H_X5	F24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_VCAP_24H_X1_B5_DUO52HI53LO:B24	CPC009_VCAP_24H_X1	B24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_VCAP_24H_X2_F1B5_DUO52HI53LO:B24	CPC009_VCAP_24H_X2	B24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_VCAP_24H_X4_F1B5_DUO52HI53LO:B24	CPC009_VCAP_24H_X4	B24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_VCAP_24H_X5_F1B5_DUO52HI53LO:B24	CPC009_VCAP_24H_X5	B24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_VCAP_6H_X1_F1B5_DUO52HI53LO:B24	CPC009_VCAP_6H_X1	B24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_VCAP_6H_X4_B5_DUO52HI53LO:B24	CPC009_VCAP_6H_X4	B24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_VCAP_6H_X5_B5_DUO52HI53LO:B24	CPC009_VCAP_6H_X5	B24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_VCAP_24H_X4_F1B5_DUO52HI53LO:F24	CPC005_VCAP_24H_X4	F24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_VCAP_24H_X5_F2B4_DUO52HI53LO:F24	CPC005_VCAP_24H_X5	F24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC011_VCAP_24H_X1_B5_DUO52HI53LO:P10	CPC011_VCAP_24H_X1	P10	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC011_VCAP_24H_X2_F1B5_DUO52HI53LO:P10	CPC011_VCAP_24H_X2	P10	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC011_VCAP_24H_X3_B5_DUO52HI53LO:P10	CPC011_VCAP_24H_X3	P10	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC011_VCAP_24H_X4_B5_DUO52HI53LO:P10	CPC011_VCAP_24H_X4	P10	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC011_VCAP_24H_X5_B5_DUO52HI53LO:P10	CPC011_VCAP_24H_X5	P10	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC011_VCAP_6H_X1_B5_DUO52HI53LO:P10	CPC011_VCAP_6H_X1	P10	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC011_VCAP_6H_X2_F2B4_DUO52HI53LO:P10	CPC011_VCAP_6H_X2	P10	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC011_VCAP_6H_X3_B5_DUO52HI53LO:P10	CPC011_VCAP_6H_X3	P10	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC011_VCAP_6H_X4_F1B5_DUO52HI53LO:P10	CPC011_VCAP_6H_X4	P10	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC011_VCAP_6H_X5_F1B5_DUO52HI53LO:P10	CPC011_VCAP_6H_X5	P10	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_VCAP_24H_X1_F1B5_DUO52HI53LO:B15	CPC020_VCAP_24H_X1	B15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_VCAP_24H_X2_F1B5_DUO52HI53LO:B15	CPC020_VCAP_24H_X2	B15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_VCAP_24H_X3_F1B5_DUO52HI53LO:B15	CPC020_VCAP_24H_X3	B15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_VCAP_24H_X4_B5_DUO52HI53LO:B15	CPC020_VCAP_24H_X4	B15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_VCAP_24H_X5_B5_DUO52HI53LO:B15	CPC020_VCAP_24H_X5	B15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_VCAP_6H_X1_F1B3_DUO52HI53LO:B15	CPC020_VCAP_6H_X1	B15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_VCAP_6H_X2_B4_DUO52HI53LO:B15	CPC020_VCAP_6H_X2	B15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_VCAP_6H_X3_B4_DUO52HI53LO:B15	CPC020_VCAP_6H_X3	B15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_VCAP_6H_X4_B5_DUO52HI53LO:B15	CPC020_VCAP_6H_X4	B15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_VCAP_6H_X5_B5_DUO52HI53LO:B15	CPC020_VCAP_6H_X5	B15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K19277754	CPC011_VCAP_24H_X2_F1B5_DUO52HI53LO:I12	CPC011_VCAP_24H_X2	I12	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K19277754	CPC011_VCAP_24H_X1_B5_DUO52HI53LO:I12	CPC011_VCAP_24H_X1	I12	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K19277754	CPC011_VCAP_24H_X3_B5_DUO52HI53LO:I12	CPC011_VCAP_24H_X3	I12	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K19277754	CPC011_VCAP_24H_X4_B5_DUO52HI53LO:I12	CPC011_VCAP_24H_X4	I12	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K19277754	CPC011_VCAP_24H_X5_B5_DUO52HI53LO:I12	CPC011_VCAP_24H_X5	I12	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K19277754	CPC011_VCAP_6H_X1_B5_DUO52HI53LO:I12	CPC011_VCAP_6H_X1	I12	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K19277754	CPC011_VCAP_6H_X2_F2B4_DUO52HI53LO:I12	CPC011_VCAP_6H_X2	I12	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K19277754	CPC011_VCAP_6H_X3_B5_DUO52HI53LO:I12	CPC011_VCAP_6H_X3	I12	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K19277754	CPC011_VCAP_6H_X4_F1B5_DUO52HI53LO:I12	CPC011_VCAP_6H_X4	I12	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K19277754	CPC011_VCAP_6H_X5_F1B5_DUO52HI53LO:I12	CPC011_VCAP_6H_X5	I12	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_VCAP_24H_X2_B5_DUO52HI53LO:H24	CPC004_VCAP_24H_X2	H24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_VCAP_24H_X5_B5_DUO52HI53LO:H24	CPC004_VCAP_24H_X5	H24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_VCAP_6H_X1_B5_DUO52HI53LO:H24	CPC004_VCAP_6H_X1	H24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_VCAP_6H_X2_F1B5_DUO52HI53LO:H24	CPC004_VCAP_6H_X2	H24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_VCAP_6H_X3_F1B5_DUO52HI53LO:H24	CPC004_VCAP_6H_X3	H24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_VCAP_6H_X5_B5_DUO52HI53LO:H24	CPC004_VCAP_6H_X5	H24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC011_VCAP_24H_X2_F1B5_DUO52HI53LO:I21	CPC011_VCAP_24H_X2	I21	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_VCAP_24H_X1_F1B5_DUO52HI53LO:H24	CPC004_VCAP_24H_X1	H24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_VCAP_24H_X3_F1B5_DUO52HI53LO:H24	CPC004_VCAP_24H_X3	H24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_VCAP_24H_X4.A2_F1B5_DUO52HI53LO:H24	CPC004_VCAP_24H_X4.A2	H24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_VCAP_24H_X4_F1B5_DUO52HI53LO:H24	CPC004_VCAP_24H_X4	H24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC011_VCAP_24H_X1_B5_DUO52HI53LO:I21	CPC011_VCAP_24H_X1	I21	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC011_VCAP_24H_X3_B5_DUO52HI53LO:I21	CPC011_VCAP_24H_X3	I21	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC011_VCAP_24H_X4_B5_DUO52HI53LO:I21	CPC011_VCAP_24H_X4	I21	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC011_VCAP_24H_X5_B5_DUO52HI53LO:I21	CPC011_VCAP_24H_X5	I21	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC011_VCAP_6H_X1_B5_DUO52HI53LO:I21	CPC011_VCAP_6H_X1	I21	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC011_VCAP_6H_X2_F2B4_DUO52HI53LO:I21	CPC011_VCAP_6H_X2	I21	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC011_VCAP_6H_X3_B5_DUO52HI53LO:I21	CPC011_VCAP_6H_X3	I21	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC011_VCAP_6H_X4_F1B5_DUO52HI53LO:I21	CPC011_VCAP_6H_X4	I21	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC011_VCAP_6H_X5_F1B5_DUO52HI53LO:I21	CPC011_VCAP_6H_X5	I21	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_VCAP_24H_X2_B5_DUO52HI53LO:H13	CPC004_VCAP_24H_X2	H13	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_VCAP_24H_X5_B5_DUO52HI53LO:H13	CPC004_VCAP_24H_X5	H13	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_VCAP_6H_X1_B5_DUO52HI53LO:H13	CPC004_VCAP_6H_X1	H13	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_VCAP_6H_X2_F1B5_DUO52HI53LO:H13	CPC004_VCAP_6H_X2	H13	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_VCAP_6H_X3_F1B5_DUO52HI53LO:H13	CPC004_VCAP_6H_X3	H13	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_VCAP_6H_X5_B5_DUO52HI53LO:H13	CPC004_VCAP_6H_X5	H13	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC011_VCAP_24H_X2_F1B5_DUO52HI53LO:L11	CPC011_VCAP_24H_X2	L11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_VCAP_24H_X1_F1B5_DUO52HI53LO:H13	CPC004_VCAP_24H_X1	H13	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_VCAP_24H_X3_F1B5_DUO52HI53LO:H13	CPC004_VCAP_24H_X3	H13	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_VCAP_24H_X4.A2_F1B5_DUO52HI53LO:H13	CPC004_VCAP_24H_X4.A2	H13	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_VCAP_24H_X4_F1B5_DUO52HI53LO:H13	CPC004_VCAP_24H_X4	H13	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC011_VCAP_24H_X1_B5_DUO52HI53LO:L11	CPC011_VCAP_24H_X1	L11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC011_VCAP_24H_X3_B5_DUO52HI53LO:L11	CPC011_VCAP_24H_X3	L11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC011_VCAP_24H_X4_B5_DUO52HI53LO:L11	CPC011_VCAP_24H_X4	L11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC011_VCAP_24H_X5_B5_DUO52HI53LO:L11	CPC011_VCAP_24H_X5	L11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC011_VCAP_6H_X1_B5_DUO52HI53LO:L11	CPC011_VCAP_6H_X1	L11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC011_VCAP_6H_X2_F2B4_DUO52HI53LO:L11	CPC011_VCAP_6H_X2	L11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC011_VCAP_6H_X3_B5_DUO52HI53LO:L11	CPC011_VCAP_6H_X3	L11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC011_VCAP_6H_X4_F1B5_DUO52HI53LO:L11	CPC011_VCAP_6H_X4	L11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC011_VCAP_6H_X5_F1B5_DUO52HI53LO:L11	CPC011_VCAP_6H_X5	L11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_VCAP_24H_X1_F1B5_DUO52HI53LO:J04	CPC004_VCAP_24H_X1	J04	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_VCAP_24H_X2_B5_DUO52HI53LO:J04	CPC004_VCAP_24H_X2	J04	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_VCAP_24H_X3_F1B5_DUO52HI53LO:J04	CPC004_VCAP_24H_X3	J04	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_VCAP_24H_X4.A2_F1B5_DUO52HI53LO:J04	CPC004_VCAP_24H_X4.A2	J04	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_VCAP_24H_X4_F1B5_DUO52HI53LO:J04	CPC004_VCAP_24H_X4	J04	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_VCAP_24H_X5_B5_DUO52HI53LO:J04	CPC004_VCAP_24H_X5	J04	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_VCAP_6H_X1_B5_DUO52HI53LO:J04	CPC004_VCAP_6H_X1	J04	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_VCAP_6H_X2_F1B5_DUO52HI53LO:J04	CPC004_VCAP_6H_X2	J04	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_VCAP_6H_X3_F1B5_DUO52HI53LO:J04	CPC004_VCAP_6H_X3	J04	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_VCAP_6H_X5_B5_DUO52HI53LO:J04	CPC004_VCAP_6H_X5	J04	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K31534764	CPC011_VCAP_24H_X2_F1B5_DUO52HI53LO:E15	CPC011_VCAP_24H_X2	E15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K31534764	CPC011_VCAP_6H_X2_F2B4_DUO52HI53LO:E15	CPC011_VCAP_6H_X2	E15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K31534764	CPC011_VCAP_6H_X4_F1B5_DUO52HI53LO:E15	CPC011_VCAP_6H_X4	E15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K31534764	CPC011_VCAP_6H_X5_F1B5_DUO52HI53LO:E15	CPC011_VCAP_6H_X5	E15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K31534764	CPC011_VCAP_24H_X1_B5_DUO52HI53LO:E15	CPC011_VCAP_24H_X1	E15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K31534764	CPC011_VCAP_24H_X3_B5_DUO52HI53LO:E15	CPC011_VCAP_24H_X3	E15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K31534764	CPC011_VCAP_24H_X4_B5_DUO52HI53LO:E15	CPC011_VCAP_24H_X4	E15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K31534764	CPC011_VCAP_24H_X5_B5_DUO52HI53LO:E15	CPC011_VCAP_24H_X5	E15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K31534764	CPC011_VCAP_6H_X1_B5_DUO52HI53LO:E15	CPC011_VCAP_6H_X1	E15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K31534764	CPC011_VCAP_6H_X3_B5_DUO52HI53LO:E15	CPC011_VCAP_6H_X3	E15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC003_VCAP_24H_X1_B3_DUO52HI53LO:P05	CPC003_VCAP_24H_X1	P05	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC003_VCAP_24H_X3_B3_DUO52HI53LO:P05	CPC003_VCAP_24H_X3	P05	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC003_VCAP_6H_X1_F2B4_DUO52HI53LO:P05	CPC003_VCAP_6H_X1	P05	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC003_VCAP_6H_X2_B5_DUO52HI53LO:P05	CPC003_VCAP_6H_X2	P05	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC003_VCAP_6H_X3_B5_DUO52HI53LO:P05	CPC003_VCAP_6H_X3	P05	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC003_VCAP_6H_X4_B5_DUO52HI53LO:P05	CPC003_VCAP_6H_X4	P05	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC003_VCAP_6H_X5_F1B5_DUO52HI53LO:P05	CPC003_VCAP_6H_X5	P05	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_VCAP_24H_X1_F1B5_DUO52HI53LO:H07	CPC004_VCAP_24H_X1	H07	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_VCAP_24H_X2_B5_DUO52HI53LO:H07	CPC004_VCAP_24H_X2	H07	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_VCAP_24H_X3_F1B5_DUO52HI53LO:H07	CPC004_VCAP_24H_X3	H07	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_VCAP_24H_X4_F1B5_DUO52HI53LO:H07	CPC004_VCAP_24H_X4	H07	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_VCAP_24H_X5_B5_DUO52HI53LO:H07	CPC004_VCAP_24H_X5	H07	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_VCAP_6H_X1_B5_DUO52HI53LO:H07	CPC004_VCAP_6H_X1	H07	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_VCAP_6H_X2_F1B5_DUO52HI53LO:H07	CPC004_VCAP_6H_X2	H07	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_VCAP_6H_X3_F1B5_DUO52HI53LO:H07	CPC004_VCAP_6H_X3	H07	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_VCAP_6H_X5_B5_DUO52HI53LO:H07	CPC004_VCAP_6H_X5	H07	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC011_VCAP_24H_X2_F1B5_DUO52HI53LO:D11	CPC011_VCAP_24H_X2	D11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC011_VCAP_6H_X2_F2B4_DUO52HI53LO:D11	CPC011_VCAP_6H_X2	D11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC011_VCAP_6H_X4_F1B5_DUO52HI53LO:D11	CPC011_VCAP_6H_X4	D11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC011_VCAP_6H_X5_F1B5_DUO52HI53LO:D11	CPC011_VCAP_6H_X5	D11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_VCAP_24H_X4.A2_F1B5_DUO52HI53LO:H07	CPC004_VCAP_24H_X4.A2	H07	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC011_VCAP_24H_X1_B5_DUO52HI53LO:D11	CPC011_VCAP_24H_X1	D11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC011_VCAP_24H_X3_B5_DUO52HI53LO:D11	CPC011_VCAP_24H_X3	D11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC011_VCAP_24H_X4_B5_DUO52HI53LO:D11	CPC011_VCAP_24H_X4	D11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC011_VCAP_24H_X5_B5_DUO52HI53LO:D11	CPC011_VCAP_24H_X5	D11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC011_VCAP_6H_X1_B5_DUO52HI53LO:D11	CPC011_VCAP_6H_X1	D11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC011_VCAP_6H_X3_B5_DUO52HI53LO:D11	CPC011_VCAP_6H_X3	D11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC002_VCAP_24H_X1_B3_DUO52HI53LO:H22	CPC002_VCAP_24H_X1	H22	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC002_VCAP_24H_X2_B3_DUO52HI53LO:H22	CPC002_VCAP_24H_X2	H22	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC002_VCAP_24H_X3_B3_DUO52HI53LO:H22	CPC002_VCAP_24H_X3	H22	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC002_VCAP_6H_X1_F1B5_DUO52HI53LO:H22	CPC002_VCAP_6H_X1	H22	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC002_VCAP_6H_X2_F1B5_DUO52HI53LO:H22	CPC002_VCAP_6H_X2	H22	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC002_VCAP_6H_X4_B5_DUO52HI53LO:H22	CPC002_VCAP_6H_X4	H22	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC002_VCAP_6H_X5_B5_DUO52HI53LO:H22	CPC002_VCAP_6H_X5	H22	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPC010_VCAP_24H_X1_B5_DUO52HI53LO:P24	CPC010_VCAP_24H_X1	P24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPC010_VCAP_24H_X2_F1B5_DUO52HI53LO:P24	CPC010_VCAP_24H_X2	P24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPC010_VCAP_24H_X4_F1B5_DUO52HI53LO:P24	CPC010_VCAP_24H_X4	P24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPC010_VCAP_24H_X5_F2B4_DUO52HI53LO:P24	CPC010_VCAP_24H_X5	P24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPC010_VCAP_6H_X2_F1B4_DUO52HI53LO:P24	CPC010_VCAP_6H_X2	P24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPC010_VCAP_6H_X3_F1B4_DUO52HI53LO:P24	CPC010_VCAP_6H_X3	P24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPC010_VCAP_6H_X4_F2B4_DUO52HI53LO:P24	CPC010_VCAP_6H_X4	P24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPC010_VCAP_6H_X5_B5_DUO52HI53LO:P24	CPC010_VCAP_6H_X5	P24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC009_VCAP_24H_X1_B5_DUO52HI53LO:K23	CPC009_VCAP_24H_X1	K23	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC009_VCAP_24H_X2_F1B5_DUO52HI53LO:K23	CPC009_VCAP_24H_X2	K23	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC009_VCAP_24H_X4_F1B5_DUO52HI53LO:K23	CPC009_VCAP_24H_X4	K23	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC009_VCAP_24H_X5_F1B5_DUO52HI53LO:K23	CPC009_VCAP_24H_X5	K23	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC009_VCAP_6H_X1_F1B5_DUO52HI53LO:K23	CPC009_VCAP_6H_X1	K23	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC009_VCAP_6H_X2_F1B3_DUO52HI53LO:K23	CPC009_VCAP_6H_X2	K23	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC009_VCAP_6H_X4_B5_DUO52HI53LO:K23	CPC009_VCAP_6H_X4	K23	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC009_VCAP_6H_X5_B5_DUO52HI53LO:K23	CPC009_VCAP_6H_X5	K23	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC011_VCAP_24H_X2_F1B5_DUO52HI53LO:I11	CPC011_VCAP_24H_X2	I11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC011_VCAP_24H_X1_B5_DUO52HI53LO:I11	CPC011_VCAP_24H_X1	I11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC011_VCAP_24H_X3_B5_DUO52HI53LO:I11	CPC011_VCAP_24H_X3	I11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC011_VCAP_24H_X4_B5_DUO52HI53LO:I11	CPC011_VCAP_24H_X4	I11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC011_VCAP_24H_X5_B5_DUO52HI53LO:I11	CPC011_VCAP_24H_X5	I11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC011_VCAP_6H_X1_B5_DUO52HI53LO:I11	CPC011_VCAP_6H_X1	I11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC011_VCAP_6H_X2_F2B4_DUO52HI53LO:I11	CPC011_VCAP_6H_X2	I11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC011_VCAP_6H_X3_B5_DUO52HI53LO:I11	CPC011_VCAP_6H_X3	I11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC011_VCAP_6H_X4_F1B5_DUO52HI53LO:I11	CPC011_VCAP_6H_X4	I11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC011_VCAP_6H_X5_F1B5_DUO52HI53LO:I11	CPC011_VCAP_6H_X5	I11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_VCAP_24H_X1_B3_DUO52HI53LO:E19	CPC005_VCAP_24H_X1	E19	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_VCAP_24H_X2_B3_DUO52HI53LO:E19	CPC005_VCAP_24H_X2	E19	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_VCAP_24H_X3_B3_DUO52HI53LO:E19	CPC005_VCAP_24H_X3	E19	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_VCAP_6H_X1_F1B3_DUO52HI53LO:E19	CPC005_VCAP_6H_X1	E19	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_VCAP_6H_X2_F1B3_DUO52HI53LO:E19	CPC005_VCAP_6H_X2	E19	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_VCAP_6H_X4_B5_DUO52HI53LO:E19	CPC005_VCAP_6H_X4	E19	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_VCAP_6H_X5_B5_DUO52HI53LO:E19	CPC005_VCAP_6H_X5	E19	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_VCAP_24H_X4_F1B5_DUO52HI53LO:E19	CPC005_VCAP_24H_X4	E19	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_VCAP_24H_X5_F2B4_DUO52HI53LO:E19	CPC005_VCAP_24H_X5	E19	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPC011_VCAP_24H_X1_B5_DUO52HI53LO:A16	CPC011_VCAP_24H_X1	A16	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPC011_VCAP_24H_X2_F1B5_DUO52HI53LO:A16	CPC011_VCAP_24H_X2	A16	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPC011_VCAP_24H_X3_B5_DUO52HI53LO:A16	CPC011_VCAP_24H_X3	A16	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPC011_VCAP_24H_X4_B5_DUO52HI53LO:A16	CPC011_VCAP_24H_X4	A16	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPC011_VCAP_24H_X5_B5_DUO52HI53LO:A16	CPC011_VCAP_24H_X5	A16	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPC011_VCAP_6H_X1_B5_DUO52HI53LO:A16	CPC011_VCAP_6H_X1	A16	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPC011_VCAP_6H_X2_F2B4_DUO52HI53LO:A16	CPC011_VCAP_6H_X2	A16	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPC011_VCAP_6H_X3_B5_DUO52HI53LO:A16	CPC011_VCAP_6H_X3	A16	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPC011_VCAP_6H_X4_F1B5_DUO52HI53LO:A16	CPC011_VCAP_6H_X4	A16	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPC011_VCAP_6H_X5_F1B5_DUO52HI53LO:A16	CPC011_VCAP_6H_X5	A16	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC002_VCAP_24H_X1_B3_DUO52HI53LO:J08	CPC002_VCAP_24H_X1	J08	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC002_VCAP_24H_X2_B3_DUO52HI53LO:J08	CPC002_VCAP_24H_X2	J08	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC002_VCAP_24H_X3_B3_DUO52HI53LO:J08	CPC002_VCAP_24H_X3	J08	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC002_VCAP_6H_X1_F1B5_DUO52HI53LO:J08	CPC002_VCAP_6H_X1	J08	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC002_VCAP_6H_X2_F1B5_DUO52HI53LO:J08	CPC002_VCAP_6H_X2	J08	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC002_VCAP_6H_X4_B5_DUO52HI53LO:J08	CPC002_VCAP_6H_X4	J08	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_VCAP_24H_X1_F1B5_DUO52HI53LO:K04	CPC020_VCAP_24H_X1	K04	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_VCAP_24H_X2_F1B5_DUO52HI53LO:K04	CPC020_VCAP_24H_X2	K04	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_VCAP_24H_X3_F1B5_DUO52HI53LO:K04	CPC020_VCAP_24H_X3	K04	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_VCAP_24H_X4_B5_DUO52HI53LO:K04	CPC020_VCAP_24H_X4	K04	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_VCAP_24H_X5_B5_DUO52HI53LO:K04	CPC020_VCAP_24H_X5	K04	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_VCAP_6H_X1_F1B3_DUO52HI53LO:K04	CPC020_VCAP_6H_X1	K04	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_VCAP_6H_X2_B4_DUO52HI53LO:K04	CPC020_VCAP_6H_X2	K04	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_VCAP_6H_X3_B4_DUO52HI53LO:K04	CPC020_VCAP_6H_X3	K04	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_VCAP_6H_X4_B5_DUO52HI53LO:K04	CPC020_VCAP_6H_X4	K04	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_VCAP_6H_X5_B5_DUO52HI53LO:K04	CPC020_VCAP_6H_X5	K04	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_VCAP_24H_X2_B5_DUO52HI53LO:I06	CPC004_VCAP_24H_X2	I06	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_VCAP_24H_X5_B5_DUO52HI53LO:I06	CPC004_VCAP_24H_X5	I06	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_VCAP_6H_X1_B5_DUO52HI53LO:I06	CPC004_VCAP_6H_X1	I06	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_VCAP_6H_X2_F1B5_DUO52HI53LO:I06	CPC004_VCAP_6H_X2	I06	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_VCAP_6H_X3_F1B5_DUO52HI53LO:I06	CPC004_VCAP_6H_X3	I06	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_VCAP_6H_X5_B5_DUO52HI53LO:I06	CPC004_VCAP_6H_X5	I06	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC011_VCAP_24H_X2_F1B5_DUO52HI53LO:K13	CPC011_VCAP_24H_X2	K13	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_VCAP_24H_X1_F1B5_DUO52HI53LO:I06	CPC004_VCAP_24H_X1	I06	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_VCAP_24H_X3_F1B5_DUO52HI53LO:I06	CPC004_VCAP_24H_X3	I06	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_VCAP_24H_X4.A2_F1B5_DUO52HI53LO:I06	CPC004_VCAP_24H_X4.A2	I06	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_VCAP_24H_X4_F1B5_DUO52HI53LO:I06	CPC004_VCAP_24H_X4	I06	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC011_VCAP_24H_X1_B5_DUO52HI53LO:K13	CPC011_VCAP_24H_X1	K13	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC011_VCAP_24H_X3_B5_DUO52HI53LO:K13	CPC011_VCAP_24H_X3	K13	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC011_VCAP_24H_X4_B5_DUO52HI53LO:K13	CPC011_VCAP_24H_X4	K13	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC011_VCAP_24H_X5_B5_DUO52HI53LO:K13	CPC011_VCAP_24H_X5	K13	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC011_VCAP_6H_X1_B5_DUO52HI53LO:K13	CPC011_VCAP_6H_X1	K13	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC011_VCAP_6H_X2_F2B4_DUO52HI53LO:K13	CPC011_VCAP_6H_X2	K13	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC011_VCAP_6H_X3_B5_DUO52HI53LO:K13	CPC011_VCAP_6H_X3	K13	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC011_VCAP_6H_X4_F1B5_DUO52HI53LO:K13	CPC011_VCAP_6H_X4	K13	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC011_VCAP_6H_X5_F1B5_DUO52HI53LO:K13	CPC011_VCAP_6H_X5	K13	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC002_VCAP_24H_X1_B3_DUO52HI53LO:H02	CPC002_VCAP_24H_X1	H02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC002_VCAP_24H_X2_B3_DUO52HI53LO:H02	CPC002_VCAP_24H_X2	H02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC002_VCAP_24H_X3_B3_DUO52HI53LO:H02	CPC002_VCAP_24H_X3	H02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC002_VCAP_6H_X1_F1B5_DUO52HI53LO:H02	CPC002_VCAP_6H_X1	H02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC002_VCAP_6H_X2_F1B5_DUO52HI53LO:H02	CPC002_VCAP_6H_X2	H02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC002_VCAP_6H_X4_B5_DUO52HI53LO:H02	CPC002_VCAP_6H_X4	H02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC002_VCAP_6H_X5_B5_DUO52HI53LO:H02	CPC002_VCAP_6H_X5	H02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC011_VCAP_24H_X2_F1B5_DUO52HI53LO:J05	CPC011_VCAP_24H_X2	J05	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC011_VCAP_24H_X1_B5_DUO52HI53LO:J05	CPC011_VCAP_24H_X1	J05	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC011_VCAP_24H_X3_B5_DUO52HI53LO:J05	CPC011_VCAP_24H_X3	J05	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC011_VCAP_24H_X4_B5_DUO52HI53LO:J05	CPC011_VCAP_24H_X4	J05	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC011_VCAP_24H_X5_B5_DUO52HI53LO:J05	CPC011_VCAP_24H_X5	J05	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC011_VCAP_6H_X2_F2B4_DUO52HI53LO:J05	CPC011_VCAP_6H_X2	J05	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC011_VCAP_6H_X3_B5_DUO52HI53LO:J05	CPC011_VCAP_6H_X3	J05	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC011_VCAP_6H_X4_F1B5_DUO52HI53LO:J05	CPC011_VCAP_6H_X4	J05	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC011_VCAP_6H_X5_F1B5_DUO52HI53LO:J05	CPC011_VCAP_6H_X5	J05	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_VCAP_24H_X1_B3_DUO52HI53LO:E10	CPC005_VCAP_24H_X1	E10	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_VCAP_24H_X2_B3_DUO52HI53LO:E10	CPC005_VCAP_24H_X2	E10	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_VCAP_24H_X3_B3_DUO52HI53LO:E10	CPC005_VCAP_24H_X3	E10	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_VCAP_6H_X1_F1B3_DUO52HI53LO:E10	CPC005_VCAP_6H_X1	E10	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_VCAP_6H_X2_F1B3_DUO52HI53LO:E10	CPC005_VCAP_6H_X2	E10	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_VCAP_6H_X4_B5_DUO52HI53LO:E10	CPC005_VCAP_6H_X4	E10	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_VCAP_6H_X5_B5_DUO52HI53LO:E10	CPC005_VCAP_6H_X5	E10	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_VCAP_24H_X4_F1B5_DUO52HI53LO:E10	CPC005_VCAP_24H_X4	E10	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_VCAP_24H_X5_F2B4_DUO52HI53LO:E10	CPC005_VCAP_24H_X5	E10	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC003_VCAP_24H_X1_B3_DUO52HI53LO:F01	CPC003_VCAP_24H_X1	F01	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC003_VCAP_24H_X3_B3_DUO52HI53LO:F01	CPC003_VCAP_24H_X3	F01	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC003_VCAP_6H_X1_F2B4_DUO52HI53LO:F01	CPC003_VCAP_6H_X1	F01	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC003_VCAP_6H_X2_B5_DUO52HI53LO:F01	CPC003_VCAP_6H_X2	F01	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC003_VCAP_6H_X3_B5_DUO52HI53LO:F01	CPC003_VCAP_6H_X3	F01	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC003_VCAP_6H_X4_B5_DUO52HI53LO:F01	CPC003_VCAP_6H_X4	F01	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC003_VCAP_6H_X5_F1B5_DUO52HI53LO:F01	CPC003_VCAP_6H_X5	F01	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC011_VCAP_24H_X2_F1B5_DUO52HI53LO:A13	CPC011_VCAP_24H_X2	A13	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC011_VCAP_24H_X1_B5_DUO52HI53LO:A13	CPC011_VCAP_24H_X1	A13	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC011_VCAP_24H_X3_B5_DUO52HI53LO:A13	CPC011_VCAP_24H_X3	A13	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC011_VCAP_24H_X4_B5_DUO52HI53LO:A13	CPC011_VCAP_24H_X4	A13	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC011_VCAP_24H_X5_B5_DUO52HI53LO:A13	CPC011_VCAP_24H_X5	A13	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC011_VCAP_6H_X1_B5_DUO52HI53LO:A13	CPC011_VCAP_6H_X1	A13	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC011_VCAP_6H_X2_F2B4_DUO52HI53LO:A13	CPC011_VCAP_6H_X2	A13	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC011_VCAP_6H_X3_B5_DUO52HI53LO:A13	CPC011_VCAP_6H_X3	A13	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC011_VCAP_6H_X4_F1B5_DUO52HI53LO:A13	CPC011_VCAP_6H_X4	A13	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC011_VCAP_6H_X5_F1B5_DUO52HI53LO:A13	CPC011_VCAP_6H_X5	A13	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_VCAP_24H_X1_F1B5_DUO52HI53LO:A16	CPC004_VCAP_24H_X1	A16	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_VCAP_24H_X2_B5_DUO52HI53LO:A16	CPC004_VCAP_24H_X2	A16	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_VCAP_24H_X3_F1B5_DUO52HI53LO:A16	CPC004_VCAP_24H_X3	A16	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_VCAP_24H_X4.A2_F1B5_DUO52HI53LO:A16	CPC004_VCAP_24H_X4.A2	A16	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_VCAP_24H_X4_F1B5_DUO52HI53LO:A16	CPC004_VCAP_24H_X4	A16	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_VCAP_24H_X5_B5_DUO52HI53LO:A16	CPC004_VCAP_24H_X5	A16	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_VCAP_6H_X1_B5_DUO52HI53LO:A16	CPC004_VCAP_6H_X1	A16	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_VCAP_6H_X2_F1B5_DUO52HI53LO:A16	CPC004_VCAP_6H_X2	A16	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_VCAP_6H_X3_F1B5_DUO52HI53LO:A16	CPC004_VCAP_6H_X3	A16	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_VCAP_6H_X5_B5_DUO52HI53LO:A16	CPC004_VCAP_6H_X5	A16	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC011_VCAP_24H_X2_F1B5_DUO52HI53LO:G23	CPC011_VCAP_24H_X2	G23	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC011_VCAP_6H_X2_F2B4_DUO52HI53LO:G23	CPC011_VCAP_6H_X2	G23	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC011_VCAP_6H_X4_F1B5_DUO52HI53LO:G23	CPC011_VCAP_6H_X4	G23	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC011_VCAP_6H_X5_F1B5_DUO52HI53LO:G23	CPC011_VCAP_6H_X5	G23	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC011_VCAP_24H_X3_B5_DUO52HI53LO:G23	CPC011_VCAP_24H_X3	G23	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC011_VCAP_24H_X4_B5_DUO52HI53LO:G23	CPC011_VCAP_24H_X4	G23	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC011_VCAP_24H_X5_B5_DUO52HI53LO:G23	CPC011_VCAP_24H_X5	G23	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC011_VCAP_6H_X1_B5_DUO52HI53LO:G23	CPC011_VCAP_6H_X1	G23	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC011_VCAP_6H_X3_B5_DUO52HI53LO:G23	CPC011_VCAP_6H_X3	G23	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-K83153774	CPC020_VCAP_24H_X1_F1B5_DUO52HI53LO:D15	CPC020_VCAP_24H_X1	D15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-K83153774	CPC020_VCAP_24H_X2_F1B5_DUO52HI53LO:D15	CPC020_VCAP_24H_X2	D15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-K83153774	CPC020_VCAP_24H_X3_F1B5_DUO52HI53LO:D15	CPC020_VCAP_24H_X3	D15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-K83153774	CPC020_VCAP_24H_X4_B5_DUO52HI53LO:D15	CPC020_VCAP_24H_X4	D15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-K83153774	CPC020_VCAP_24H_X5_B5_DUO52HI53LO:D15	CPC020_VCAP_24H_X5	D15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-K83153774	CPC020_VCAP_6H_X1_F1B3_DUO52HI53LO:D15	CPC020_VCAP_6H_X1	D15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-K83153774	CPC020_VCAP_6H_X2_B4_DUO52HI53LO:D15	CPC020_VCAP_6H_X2	D15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-K83153774	CPC020_VCAP_6H_X3_B4_DUO52HI53LO:D15	CPC020_VCAP_6H_X3	D15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-K83153774	CPC020_VCAP_6H_X4_B5_DUO52HI53LO:D15	CPC020_VCAP_6H_X4	D15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-K83153774	CPC020_VCAP_6H_X5_B5_DUO52HI53LO:D15	CPC020_VCAP_6H_X5	D15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_VCAP_24H_X1_F1B5_DUO52HI53LO:J08	CPC004_VCAP_24H_X1	J08	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_VCAP_24H_X2_B5_DUO52HI53LO:J08	CPC004_VCAP_24H_X2	J08	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_VCAP_24H_X3_F1B5_DUO52HI53LO:J08	CPC004_VCAP_24H_X3	J08	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_VCAP_24H_X4.A2_F1B5_DUO52HI53LO:J08	CPC004_VCAP_24H_X4.A2	J08	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_VCAP_24H_X4_F1B5_DUO52HI53LO:J08	CPC004_VCAP_24H_X4	J08	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_VCAP_24H_X5_B5_DUO52HI53LO:J08	CPC004_VCAP_24H_X5	J08	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_VCAP_6H_X2_F1B5_DUO52HI53LO:J08	CPC004_VCAP_6H_X2	J08	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_VCAP_6H_X3_F1B5_DUO52HI53LO:J08	CPC004_VCAP_6H_X3	J08	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_VCAP_6H_X5_B5_DUO52HI53LO:J08	CPC004_VCAP_6H_X5	J08	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_VCAP_24H_X1_B5_DUO52HI53LO:G10	CPC011_VCAP_24H_X1	G10	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_VCAP_24H_X2_F1B5_DUO52HI53LO:G10	CPC011_VCAP_24H_X2	G10	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_VCAP_24H_X3_B5_DUO52HI53LO:G10	CPC011_VCAP_24H_X3	G10	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_VCAP_24H_X4_B5_DUO52HI53LO:G10	CPC011_VCAP_24H_X4	G10	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_VCAP_24H_X5_B5_DUO52HI53LO:G10	CPC011_VCAP_24H_X5	G10	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_VCAP_24H_X2_F1B5_DUO52HI53LO:B03	CPC011_VCAP_24H_X2	B03	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_VCAP_6H_X2_F2B4_DUO52HI53LO:G10	CPC011_VCAP_6H_X2	G10	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_VCAP_6H_X4_F1B5_DUO52HI53LO:G10	CPC011_VCAP_6H_X4	G10	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_VCAP_6H_X5_F1B5_DUO52HI53LO:G10	CPC011_VCAP_6H_X5	G10	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_VCAP_24H_X1_B5_DUO52HI53LO:B03	CPC011_VCAP_24H_X1	B03	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_VCAP_24H_X3_B5_DUO52HI53LO:B03	CPC011_VCAP_24H_X3	B03	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_VCAP_24H_X4_B5_DUO52HI53LO:B03	CPC011_VCAP_24H_X4	B03	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_VCAP_24H_X5_B5_DUO52HI53LO:B03	CPC011_VCAP_24H_X5	B03	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_VCAP_6H_X1_B5_DUO52HI53LO:G10	CPC011_VCAP_6H_X1	G10	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_VCAP_6H_X3_B5_DUO52HI53LO:G10	CPC011_VCAP_6H_X3	G10	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_VCAP_6H_X1_B5_DUO52HI53LO:B03	CPC011_VCAP_6H_X1	B03	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_VCAP_6H_X2_F2B4_DUO52HI53LO:B03	CPC011_VCAP_6H_X2	B03	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_VCAP_6H_X3_B5_DUO52HI53LO:B03	CPC011_VCAP_6H_X3	B03	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_VCAP_6H_X4_F1B5_DUO52HI53LO:B03	CPC011_VCAP_6H_X4	B03	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_VCAP_6H_X5_F1B5_DUO52HI53LO:B03	CPC011_VCAP_6H_X5	B03	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_VCAP_24H_X1_B3_DUO52HI53LO:M14	CPC005_VCAP_24H_X1	M14	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_VCAP_24H_X2_B3_DUO52HI53LO:M14	CPC005_VCAP_24H_X2	M14	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_VCAP_24H_X3_B3_DUO52HI53LO:M14	CPC005_VCAP_24H_X3	M14	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_VCAP_24H_X4_F1B5_DUO52HI53LO:M14	CPC005_VCAP_24H_X4	M14	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_VCAP_24H_X5_F2B4_DUO52HI53LO:M14	CPC005_VCAP_24H_X5	M14	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_VCAP_6H_X1_F1B3_DUO52HI53LO:M14	CPC005_VCAP_6H_X1	M14	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_VCAP_6H_X2_F1B3_DUO52HI53LO:M14	CPC005_VCAP_6H_X2	M14	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_VCAP_6H_X4_B5_DUO52HI53LO:M14	CPC005_VCAP_6H_X4	M14	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_VCAP_6H_X5_B5_DUO52HI53LO:M14	CPC005_VCAP_6H_X5	M14	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_VCAP_24H_X1_F1B5_DUO52HI53LO:J06	CPC004_VCAP_24H_X1	J06	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_VCAP_24H_X2_B5_DUO52HI53LO:J06	CPC004_VCAP_24H_X2	J06	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_VCAP_24H_X3_F1B5_DUO52HI53LO:J06	CPC004_VCAP_24H_X3	J06	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_VCAP_24H_X4.A2_F1B5_DUO52HI53LO:J06	CPC004_VCAP_24H_X4.A2	J06	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_VCAP_24H_X4_F1B5_DUO52HI53LO:J06	CPC004_VCAP_24H_X4	J06	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_VCAP_24H_X5_B5_DUO52HI53LO:J06	CPC004_VCAP_24H_X5	J06	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_VCAP_6H_X1_B5_DUO52HI53LO:J06	CPC004_VCAP_6H_X1	J06	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_VCAP_6H_X2_F1B5_DUO52HI53LO:J06	CPC004_VCAP_6H_X2	J06	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_VCAP_6H_X3_F1B5_DUO52HI53LO:J06	CPC004_VCAP_6H_X3	J06	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_VCAP_6H_X5_B5_DUO52HI53LO:J06	CPC004_VCAP_6H_X5	J06	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC011_VCAP_24H_X1_B5_DUO52HI53LO:J19	CPC011_VCAP_24H_X1	J19	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC011_VCAP_24H_X2_F1B5_DUO52HI53LO:J19	CPC011_VCAP_24H_X2	J19	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC011_VCAP_24H_X3_B5_DUO52HI53LO:J19	CPC011_VCAP_24H_X3	J19	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC011_VCAP_24H_X4_B5_DUO52HI53LO:J19	CPC011_VCAP_24H_X4	J19	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC011_VCAP_24H_X5_B5_DUO52HI53LO:J19	CPC011_VCAP_24H_X5	J19	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC011_VCAP_6H_X2_F2B4_DUO52HI53LO:J19	CPC011_VCAP_6H_X2	J19	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC011_VCAP_6H_X4_F1B5_DUO52HI53LO:J19	CPC011_VCAP_6H_X4	J19	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC011_VCAP_6H_X5_F1B5_DUO52HI53LO:J19	CPC011_VCAP_6H_X5	J19	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC011_VCAP_6H_X1_B5_DUO52HI53LO:J19	CPC011_VCAP_6H_X1	J19	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC011_VCAP_6H_X3_B5_DUO52HI53LO:J19	CPC011_VCAP_6H_X3	J19	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
65833	N06AX17	milnacipran	CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2	CCN(CC)C(=O)C1(c2ccccc2)CC1CN	BRD-K02227374	CPC011_VCAP_24H_X2_F1B5_DUO52HI53LO:H14	CPC011_VCAP_24H_X2	H14	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
65833	N06AX17	milnacipran	CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2	CCN(CC)C(=O)C1(c2ccccc2)CC1CN	BRD-K02227374	CPC011_VCAP_6H_X2_F2B4_DUO52HI53LO:H14	CPC011_VCAP_6H_X2	H14	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
65833	N06AX17	milnacipran	CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2	CCN(CC)C(=O)C1(c2ccccc2)CC1CN	BRD-K02227374	CPC011_VCAP_6H_X4_F1B5_DUO52HI53LO:H14	CPC011_VCAP_6H_X4	H14	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
65833	N06AX17	milnacipran	CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2	CCN(CC)C(=O)C1(c2ccccc2)CC1CN	BRD-K02227374	CPC011_VCAP_6H_X5_F1B5_DUO52HI53LO:H14	CPC011_VCAP_6H_X5	H14	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
65833	N06AX17	milnacipran	CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2	CCN(CC)C(=O)C1(c2ccccc2)CC1CN	BRD-K02227374	CPC011_VCAP_24H_X1_B5_DUO52HI53LO:H14	CPC011_VCAP_24H_X1	H14	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
65833	N06AX17	milnacipran	CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2	CCN(CC)C(=O)C1(c2ccccc2)CC1CN	BRD-K02227374	CPC011_VCAP_24H_X3_B5_DUO52HI53LO:H14	CPC011_VCAP_24H_X3	H14	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
65833	N06AX17	milnacipran	CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2	CCN(CC)C(=O)C1(c2ccccc2)CC1CN	BRD-K02227374	CPC011_VCAP_24H_X4_B5_DUO52HI53LO:H14	CPC011_VCAP_24H_X4	H14	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
65833	N06AX17	milnacipran	CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2	CCN(CC)C(=O)C1(c2ccccc2)CC1CN	BRD-K02227374	CPC011_VCAP_24H_X5_B5_DUO52HI53LO:H14	CPC011_VCAP_24H_X5	H14	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
65833	N06AX17	milnacipran	CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2	CCN(CC)C(=O)C1(c2ccccc2)CC1CN	BRD-K02227374	CPC011_VCAP_6H_X1_B5_DUO52HI53LO:H14	CPC011_VCAP_6H_X1	H14	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
65833	N06AX17	milnacipran	CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2	CCN(CC)C(=O)C1(c2ccccc2)CC1CN	BRD-K02227374	CPC011_VCAP_6H_X3_B5_DUO52HI53LO:H14	CPC011_VCAP_6H_X3	H14	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC001_VCAP_24H_X1_B3_DUO52HI53LO:L21	CPC001_VCAP_24H_X1	L21	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC001_VCAP_24H_X2_B3_DUO52HI53LO:L21	CPC001_VCAP_24H_X2	L21	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC001_VCAP_24H_X3_B3_DUO52HI53LO:L21	CPC001_VCAP_24H_X3	L21	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC001_VCAP_24H_X4_F1B5_DUO52HI53LO:L21	CPC001_VCAP_24H_X4	L21	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC001_VCAP_24H_X5_F2B4_DUO52HI53LO:L21	CPC001_VCAP_24H_X5	L21	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC001_VCAP_6H_X1_F1B5_DUO52HI53LO:L21	CPC001_VCAP_6H_X1	L21	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC001_VCAP_6H_X2_B5_DUO52HI53LO:L21	CPC001_VCAP_6H_X2	L21	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC001_VCAP_6H_X3_F1B5_DUO52HI53LO:L21	CPC001_VCAP_6H_X3	L21	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC001_VCAP_6H_X4_B5_DUO52HI53LO:L21	CPC001_VCAP_6H_X4	L21	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC001_VCAP_24H_X4.A2_F1B5_DUO52HI53LO:L21	CPC001_VCAP_24H_X4.A2	L21	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC001_VCAP_6H_X1.A2_F1B5_DUO52HI53LO:L21	CPC001_VCAP_6H_X1.A2	L21	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_VCAP_24H_X2_B5_DUO52HI53LO:J03	CPC004_VCAP_24H_X2	J03	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_VCAP_24H_X5_B5_DUO52HI53LO:J03	CPC004_VCAP_24H_X5	J03	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_VCAP_6H_X1_B5_DUO52HI53LO:J03	CPC004_VCAP_6H_X1	J03	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_VCAP_6H_X2_F1B5_DUO52HI53LO:J03	CPC004_VCAP_6H_X2	J03	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_VCAP_6H_X3_F1B5_DUO52HI53LO:J03	CPC004_VCAP_6H_X3	J03	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_VCAP_6H_X5_B5_DUO52HI53LO:J03	CPC004_VCAP_6H_X5	J03	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_VCAP_24H_X1_B5_DUO52HI53LO:G22	CPC010_VCAP_24H_X1	G22	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_VCAP_24H_X2_F1B5_DUO52HI53LO:G22	CPC010_VCAP_24H_X2	G22	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_VCAP_24H_X3_F1B5_DUO52HI53LO:G22	CPC010_VCAP_24H_X3	G22	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_VCAP_24H_X4_F1B5_DUO52HI53LO:G22	CPC010_VCAP_24H_X4	G22	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_VCAP_24H_X5_F2B4_DUO52HI53LO:G22	CPC010_VCAP_24H_X5	G22	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_VCAP_6H_X1_F1B4_DUO52HI53LO:G22	CPC010_VCAP_6H_X1	G22	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_VCAP_6H_X2_F1B4_DUO52HI53LO:G22	CPC010_VCAP_6H_X2	G22	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_VCAP_6H_X3_F1B4_DUO52HI53LO:G22	CPC010_VCAP_6H_X3	G22	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_VCAP_6H_X4_F2B4_DUO52HI53LO:G22	CPC010_VCAP_6H_X4	G22	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_VCAP_6H_X5_B5_DUO52HI53LO:G22	CPC010_VCAP_6H_X5	G22	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC011_VCAP_24H_X2_F1B5_DUO52HI53LO:I05	CPC011_VCAP_24H_X2	I05	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_VCAP_24H_X1_F1B5_DUO52HI53LO:J03	CPC004_VCAP_24H_X1	J03	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_VCAP_24H_X3_F1B5_DUO52HI53LO:J03	CPC004_VCAP_24H_X3	J03	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_VCAP_24H_X4.A2_F1B5_DUO52HI53LO:J03	CPC004_VCAP_24H_X4.A2	J03	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_VCAP_24H_X4_F1B5_DUO52HI53LO:J03	CPC004_VCAP_24H_X4	J03	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC011_VCAP_24H_X1_B5_DUO52HI53LO:I05	CPC011_VCAP_24H_X1	I05	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC011_VCAP_24H_X3_B5_DUO52HI53LO:I05	CPC011_VCAP_24H_X3	I05	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC011_VCAP_24H_X4_B5_DUO52HI53LO:I05	CPC011_VCAP_24H_X4	I05	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC011_VCAP_24H_X5_B5_DUO52HI53LO:I05	CPC011_VCAP_24H_X5	I05	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC011_VCAP_6H_X1_B5_DUO52HI53LO:I05	CPC011_VCAP_6H_X1	I05	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC011_VCAP_6H_X2_F2B4_DUO52HI53LO:I05	CPC011_VCAP_6H_X2	I05	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC011_VCAP_6H_X3_B5_DUO52HI53LO:I05	CPC011_VCAP_6H_X3	I05	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC011_VCAP_6H_X4_F1B5_DUO52HI53LO:I05	CPC011_VCAP_6H_X4	I05	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC011_VCAP_6H_X5_F1B5_DUO52HI53LO:I05	CPC011_VCAP_6H_X5	I05	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC017_A549_24H_X1_F1B6_DUO52HI53LO:M02	CPC017_A549_24H_X1	M02	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC017_A549_24H_X2_F1B6_DUO52HI53LO:M02	CPC017_A549_24H_X2	M02	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC017_A549_24H_X3_F1B6_DUO52HI53LO:M02	CPC017_A549_24H_X3	M02	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC017_A549_6H_X1_F1B4_DUO52HI53LO:M02	CPC017_A549_6H_X1	M02	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC017_A549_6H_X2_F1B4_DUO52HI53LO:M02	CPC017_A549_6H_X2	M02	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC017_A549_6H_X3_F1B4_DUO52HI53LO:M02	CPC017_A549_6H_X3	M02	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC020_A549_6H_X1.L2_F2B5_DUO52HI53LO:F21	CPC020_A549_6H_X1.L2	F21	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC020_A549_6H_X3.L2_F2B5_DUO52HI53LO:F21	CPC020_A549_6H_X3.L2	F21	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_A549_24H_X1_B3_DUO52HI53LO:C12	CPC005_A549_24H_X1	C12	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_A549_24H_X2_B3_DUO52HI53LO:C12	CPC005_A549_24H_X2	C12	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_A549_24H_X3_B3_DUO52HI53LO:C12	CPC005_A549_24H_X3	C12	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_A549_6H_X1_B3_DUO52HI53LO:C12	CPC005_A549_6H_X1	C12	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_A549_6H_X2_B3_DUO52HI53LO:C12	CPC005_A549_6H_X2	C12	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_A549_6H_X3_B3_DUO52HI53LO:C12	CPC005_A549_6H_X3	C12	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_A549_6H_X1.L2_F2B5_DUO52HI53LO:H14	CPC020_A549_6H_X1.L2	H14	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_A549_6H_X1.L2_F2B5_DUO52HI53LO:L24	CPC020_A549_6H_X1.L2	L24	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_A549_6H_X3.L2_F2B5_DUO52HI53LO:H14	CPC020_A549_6H_X3.L2	H14	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_A549_6H_X3.L2_F2B5_DUO52HI53LO:L24	CPC020_A549_6H_X3.L2	L24	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC018_A549_24H_X1_F1B6_DUO52HI53LO:F20	CPC018_A549_24H_X1	F20	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC018_A549_24H_X2_F1B6_DUO52HI53LO:F20	CPC018_A549_24H_X2	F20	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC018_A549_6H_X1_F1B3_DUO52HI53LO:F20	CPC018_A549_6H_X1	F20	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC018_A549_6H_X2_F1B3_DUO52HI53LO:F20	CPC018_A549_6H_X2	F20	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC018_A549_6H_X3_F1B4_DUO52HI53LO:F20	CPC018_A549_6H_X3	F20	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC020_A549_6H_X1.L2_F2B5_DUO52HI53LO:P19	CPC020_A549_6H_X1.L2	P19	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC020_A549_6H_X3.L2_F2B5_DUO52HI53LO:P19	CPC020_A549_6H_X3.L2	P19	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_A549_24H_X1_F1B6_DUO52HI53LO:N08	CPC016_A549_24H_X1	N08	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_A549_24H_X2_F1B6_DUO52HI53LO:N08	CPC016_A549_24H_X2	N08	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_A549_24H_X3_F1B6_DUO52HI53LO:N08	CPC016_A549_24H_X3	N08	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_A549_6H_X1_F1B4_DUO52HI53LO:N08	CPC016_A549_6H_X1	N08	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_A549_6H_X2_F1B4_DUO52HI53LO:N08	CPC016_A549_6H_X2	N08	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_A549_24H_X1_F1B6_DUO52HI53LO:N08	CPC016_A549_24H_X1	N08	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_A549_24H_X2_F1B6_DUO52HI53LO:N08	CPC016_A549_24H_X2	N08	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_A549_24H_X3_F1B6_DUO52HI53LO:N08	CPC016_A549_24H_X3	N08	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_A549_6H_X1_F1B4_DUO52HI53LO:N08	CPC016_A549_6H_X1	N08	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_A549_6H_X2_F1B4_DUO52HI53LO:N08	CPC016_A549_6H_X2	N08	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
3947	N06AA07	lofepramine	CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)CC(=O)C4=CC=C(C=C4)Cl	CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1	BRD-K82147103	CPC011_A549_24H_X1_F1B6_DUO52HI53LO:M10	CPC011_A549_24H_X1	M10	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
3947	N06AA07	lofepramine	CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)CC(=O)C4=CC=C(C=C4)Cl	CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1	BRD-K82147103	CPC011_A549_24H_X3_F1B6_DUO52HI53LO:M10	CPC011_A549_24H_X3	M10	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
3947	N06AA07	lofepramine	CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)CC(=O)C4=CC=C(C=C4)Cl	CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1	BRD-K82147103	CPC011_A549_24H_X5_F1B6_DUO52HI53LO:M10	CPC011_A549_24H_X5	M10	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
3947	N06AA07	lofepramine	CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)CC(=O)C4=CC=C(C=C4)Cl	CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1	BRD-K82147103	CPC011_A549_6H_X1_F1B3_DUO52HI53LO:M10	CPC011_A549_6H_X1	M10	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
3947	N06AA07	lofepramine	CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)CC(=O)C4=CC=C(C=C4)Cl	CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1	BRD-K82147103	CPC011_A549_6H_X2_F1B3_DUO52HI53LO:M10	CPC011_A549_6H_X2	M10	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
3947	N06AA07	lofepramine	CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)CC(=O)C4=CC=C(C=C4)Cl	CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1	BRD-K82147103	CPC011_A549_6H_X3_F1B3_DUO52HI53LO:M10	CPC011_A549_6H_X3	M10	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC017_A549_24H_X1_F1B6_DUO52HI53LO:L04	CPC017_A549_24H_X1	L04	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC017_A549_24H_X2_F1B6_DUO52HI53LO:L04	CPC017_A549_24H_X2	L04	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC017_A549_24H_X3_F1B6_DUO52HI53LO:L04	CPC017_A549_24H_X3	L04	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC017_A549_6H_X1_F1B4_DUO52HI53LO:L04	CPC017_A549_6H_X1	L04	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC017_A549_6H_X2_F1B4_DUO52HI53LO:L04	CPC017_A549_6H_X2	L04	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC017_A549_6H_X3_F1B4_DUO52HI53LO:L04	CPC017_A549_6H_X3	L04	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC015_A549_24H_X1_F1B6_DUO52HI53LO:J10	CPC015_A549_24H_X1	J10	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC015_A549_24H_X2_F1B6_DUO52HI53LO:J10	CPC015_A549_24H_X2	J10	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC015_A549_24H_X3_F1B6_DUO52HI53LO:J10	CPC015_A549_24H_X3	J10	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC015_A549_6H_X1.L2_F2B5_DUO52HI53LO:J10	CPC015_A549_6H_X1.L2	J10	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC015_A549_6H_X2.L2_F2B5_DUO52HI53LO:J10	CPC015_A549_6H_X2.L2	J10	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC018_A549_24H_X1_F1B6_DUO52HI53LO:J19	CPC018_A549_24H_X1	J19	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC018_A549_24H_X2_F1B6_DUO52HI53LO:J19	CPC018_A549_24H_X2	J19	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC018_A549_6H_X1_F1B3_DUO52HI53LO:J19	CPC018_A549_6H_X1	J19	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC018_A549_6H_X2_F1B3_DUO52HI53LO:J19	CPC018_A549_6H_X2	J19	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC018_A549_6H_X3_F1B4_DUO52HI53LO:J19	CPC018_A549_6H_X3	J19	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC015_A549_24H_X1_F1B6_DUO52HI53LO:L03	CPC015_A549_24H_X1	L03	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC015_A549_24H_X2_F1B6_DUO52HI53LO:L03	CPC015_A549_24H_X2	L03	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC015_A549_24H_X3_F1B6_DUO52HI53LO:L03	CPC015_A549_24H_X3	L03	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC015_A549_6H_X1.L2_F2B5_DUO52HI53LO:L03	CPC015_A549_6H_X1.L2	L03	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC015_A549_6H_X2.L2_F2B5_DUO52HI53LO:L03	CPC015_A549_6H_X2.L2	L03	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC018_A549_24H_X1_F1B6_DUO52HI53LO:A20	CPC018_A549_24H_X1	A20	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC018_A549_24H_X2_F1B6_DUO52HI53LO:A20	CPC018_A549_24H_X2	A20	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC018_A549_6H_X1_F1B3_DUO52HI53LO:A20	CPC018_A549_6H_X1	A20	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC018_A549_6H_X2_F1B3_DUO52HI53LO:A20	CPC018_A549_6H_X2	A20	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC018_A549_6H_X3_F1B4_DUO52HI53LO:A20	CPC018_A549_6H_X3	A20	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC017_A549_24H_X1_F1B6_DUO52HI53LO:O16	CPC017_A549_24H_X1	O16	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC017_A549_24H_X2_F1B6_DUO52HI53LO:O16	CPC017_A549_24H_X2	O16	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC017_A549_24H_X3_F1B6_DUO52HI53LO:O16	CPC017_A549_24H_X3	O16	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC017_A549_6H_X1_F1B4_DUO52HI53LO:O16	CPC017_A549_6H_X1	O16	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC017_A549_6H_X2_F1B4_DUO52HI53LO:O16	CPC017_A549_6H_X2	O16	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC017_A549_6H_X3_F1B4_DUO52HI53LO:O16	CPC017_A549_6H_X3	O16	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC011_A549_24H_X1_F1B6_DUO52HI53LO:G15	CPC011_A549_24H_X1	G15	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC011_A549_24H_X3_F1B6_DUO52HI53LO:G15	CPC011_A549_24H_X3	G15	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC011_A549_24H_X5_F1B6_DUO52HI53LO:G15	CPC011_A549_24H_X5	G15	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC011_A549_6H_X1_F1B3_DUO52HI53LO:G15	CPC011_A549_6H_X1	G15	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC011_A549_6H_X2_F1B3_DUO52HI53LO:G15	CPC011_A549_6H_X2	G15	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC011_A549_6H_X3_F1B3_DUO52HI53LO:G15	CPC011_A549_6H_X3	G15	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC017_A549_24H_X1_F1B6_DUO52HI53LO:I07	CPC017_A549_24H_X1	I07	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC017_A549_24H_X2_F1B6_DUO52HI53LO:I07	CPC017_A549_24H_X2	I07	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC017_A549_24H_X3_F1B6_DUO52HI53LO:I07	CPC017_A549_24H_X3	I07	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC017_A549_6H_X1_F1B4_DUO52HI53LO:I07	CPC017_A549_6H_X1	I07	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC017_A549_6H_X2_F1B4_DUO52HI53LO:I07	CPC017_A549_6H_X2	I07	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC017_A549_6H_X3_F1B4_DUO52HI53LO:I07	CPC017_A549_6H_X3	I07	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC020_A549_6H_X1.L2_F2B5_DUO52HI53LO:O02	CPC020_A549_6H_X1.L2	O02	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC020_A549_6H_X3.L2_F2B5_DUO52HI53LO:O02	CPC020_A549_6H_X3.L2	O02	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC017_A549_24H_X1_F1B6_DUO52HI53LO:I11	CPC017_A549_24H_X1	I11	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC017_A549_24H_X2_F1B6_DUO52HI53LO:I11	CPC017_A549_24H_X2	I11	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC017_A549_24H_X3_F1B6_DUO52HI53LO:I11	CPC017_A549_24H_X3	I11	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC017_A549_6H_X1_F1B4_DUO52HI53LO:I11	CPC017_A549_6H_X1	I11	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC017_A549_6H_X2_F1B4_DUO52HI53LO:I11	CPC017_A549_6H_X2	I11	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC017_A549_6H_X3_F1B4_DUO52HI53LO:I11	CPC017_A549_6H_X3	I11	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC017_A549_24H_X1_F1B6_DUO52HI53LO:K18	CPC017_A549_24H_X1	K18	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC017_A549_24H_X2_F1B6_DUO52HI53LO:K18	CPC017_A549_24H_X2	K18	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC017_A549_24H_X3_F1B6_DUO52HI53LO:K18	CPC017_A549_24H_X3	K18	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC017_A549_6H_X1_F1B4_DUO52HI53LO:K18	CPC017_A549_6H_X1	K18	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC017_A549_6H_X2_F1B4_DUO52HI53LO:K18	CPC017_A549_6H_X2	K18	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC017_A549_6H_X3_F1B4_DUO52HI53LO:K18	CPC017_A549_6H_X3	K18	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_A549_6H_X1.L2_F2B5_DUO52HI53LO:F24	CPC020_A549_6H_X1.L2	F24	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_A549_6H_X1.L2_F2B5_DUO52HI53LO:H08	CPC020_A549_6H_X1.L2	H08	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_A549_6H_X3.L2_F2B5_DUO52HI53LO:F24	CPC020_A549_6H_X3.L2	F24	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_A549_6H_X3.L2_F2B5_DUO52HI53LO:H08	CPC020_A549_6H_X3.L2	H08	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_A549_24H_X1_B3_DUO52HI53LO:N07	CPC005_A549_24H_X1	N07	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_A549_24H_X2_B3_DUO52HI53LO:N07	CPC005_A549_24H_X2	N07	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_A549_24H_X3_B3_DUO52HI53LO:N07	CPC005_A549_24H_X3	N07	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_A549_6H_X1_B3_DUO52HI53LO:N07	CPC005_A549_6H_X1	N07	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_A549_6H_X2_B3_DUO52HI53LO:N07	CPC005_A549_6H_X2	N07	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_A549_6H_X3_B3_DUO52HI53LO:N07	CPC005_A549_6H_X3	N07	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC011_A549_24H_X1_F1B6_DUO52HI53LO:O15	CPC011_A549_24H_X1	O15	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC011_A549_24H_X3_F1B6_DUO52HI53LO:O15	CPC011_A549_24H_X3	O15	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC011_A549_24H_X5_F1B6_DUO52HI53LO:O15	CPC011_A549_24H_X5	O15	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC011_A549_6H_X1_F1B3_DUO52HI53LO:O15	CPC011_A549_6H_X1	O15	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC011_A549_6H_X2_F1B3_DUO52HI53LO:O15	CPC011_A549_6H_X2	O15	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC011_A549_6H_X3_F1B3_DUO52HI53LO:O15	CPC011_A549_6H_X3	O15	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC018_A549_24H_X1_F1B6_DUO52HI53LO:H09	CPC018_A549_24H_X1	H09	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC018_A549_24H_X2_F1B6_DUO52HI53LO:H09	CPC018_A549_24H_X2	H09	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC018_A549_6H_X1_F1B3_DUO52HI53LO:H09	CPC018_A549_6H_X1	H09	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC018_A549_6H_X2_F1B3_DUO52HI53LO:H09	CPC018_A549_6H_X2	H09	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC018_A549_6H_X3_F1B4_DUO52HI53LO:H09	CPC018_A549_6H_X3	H09	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_A549_24H_X1_B3_DUO52HI53LO:P19	CPC005_A549_24H_X1	P19	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_A549_24H_X2_B3_DUO52HI53LO:P19	CPC005_A549_24H_X2	P19	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_A549_24H_X3_B3_DUO52HI53LO:P19	CPC005_A549_24H_X3	P19	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_A549_6H_X1_B3_DUO52HI53LO:P19	CPC005_A549_6H_X1	P19	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_A549_6H_X2_B3_DUO52HI53LO:P19	CPC005_A549_6H_X2	P19	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_A549_6H_X3_B3_DUO52HI53LO:P19	CPC005_A549_6H_X3	P19	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_A549_24H_X1_F1B6_DUO52HI53LO:J24	CPC009_A549_24H_X1	J24	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_A549_24H_X4_F1B6_DUO52HI53LO:J24	CPC009_A549_24H_X4	J24	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_A549_6H_X2_F1B3_DUO52HI53LO:J24	CPC009_A549_6H_X2	J24	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_A549_6H_X1_B4_DUO52HI53LO:J24	CPC009_A549_6H_X1	J24	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_A549_6H_X3_B4_DUO52HI53LO:J24	CPC009_A549_6H_X3	J24	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_A549_24H_X1_B3_DUO52HI53LO:F24	CPC005_A549_24H_X1	F24	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_A549_24H_X2_B3_DUO52HI53LO:F24	CPC005_A549_24H_X2	F24	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_A549_24H_X3_B3_DUO52HI53LO:F24	CPC005_A549_24H_X3	F24	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_A549_6H_X1_B3_DUO52HI53LO:F24	CPC005_A549_6H_X1	F24	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_A549_6H_X2_B3_DUO52HI53LO:F24	CPC005_A549_6H_X2	F24	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_A549_6H_X3_B3_DUO52HI53LO:F24	CPC005_A549_6H_X3	F24	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_A549_24H_X1_F1B6_DUO52HI53LO:B24	CPC009_A549_24H_X1	B24	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_A549_24H_X4_F1B6_DUO52HI53LO:B24	CPC009_A549_24H_X4	B24	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_A549_6H_X1_B4_DUO52HI53LO:B24	CPC009_A549_6H_X1	B24	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_A549_6H_X2_F1B3_DUO52HI53LO:B24	CPC009_A549_6H_X2	B24	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_A549_6H_X3_B4_DUO52HI53LO:B24	CPC009_A549_6H_X3	B24	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC011_A549_24H_X1_F1B6_DUO52HI53LO:P10	CPC011_A549_24H_X1	P10	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC011_A549_24H_X3_F1B6_DUO52HI53LO:P10	CPC011_A549_24H_X3	P10	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC011_A549_24H_X5_F1B6_DUO52HI53LO:P10	CPC011_A549_24H_X5	P10	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC011_A549_6H_X1_F1B3_DUO52HI53LO:P10	CPC011_A549_6H_X1	P10	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC011_A549_6H_X2_F1B3_DUO52HI53LO:P10	CPC011_A549_6H_X2	P10	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC011_A549_6H_X3_F1B3_DUO52HI53LO:P10	CPC011_A549_6H_X3	P10	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_A549_6H_X1.L2_F2B5_DUO52HI53LO:B15	CPC020_A549_6H_X1.L2	B15	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_A549_6H_X3.L2_F2B5_DUO52HI53LO:B15	CPC020_A549_6H_X3.L2	B15	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K19277754	CPC011_A549_24H_X1_F1B6_DUO52HI53LO:I12	CPC011_A549_24H_X1	I12	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K19277754	CPC011_A549_24H_X3_F1B6_DUO52HI53LO:I12	CPC011_A549_24H_X3	I12	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K19277754	CPC011_A549_24H_X5_F1B6_DUO52HI53LO:I12	CPC011_A549_24H_X5	I12	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K19277754	CPC011_A549_6H_X1_F1B3_DUO52HI53LO:I12	CPC011_A549_6H_X1	I12	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K19277754	CPC011_A549_6H_X2_F1B3_DUO52HI53LO:I12	CPC011_A549_6H_X2	I12	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K19277754	CPC011_A549_6H_X3_F1B3_DUO52HI53LO:I12	CPC011_A549_6H_X3	I12	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC011_A549_24H_X1_F1B6_DUO52HI53LO:I21	CPC011_A549_24H_X1	I21	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC011_A549_24H_X3_F1B6_DUO52HI53LO:I21	CPC011_A549_24H_X3	I21	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC011_A549_24H_X5_F1B6_DUO52HI53LO:I21	CPC011_A549_24H_X5	I21	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC015_A549_24H_X1_F1B6_DUO52HI53LO:L01	CPC015_A549_24H_X1	L01	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC015_A549_24H_X2_F1B6_DUO52HI53LO:L01	CPC015_A549_24H_X2	L01	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC015_A549_24H_X3_F1B6_DUO52HI53LO:L01	CPC015_A549_24H_X3	L01	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC015_A549_6H_X1.L2_F2B5_DUO52HI53LO:L01	CPC015_A549_6H_X1.L2	L01	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC015_A549_6H_X2.L2_F2B5_DUO52HI53LO:L01	CPC015_A549_6H_X2.L2	L01	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC011_A549_6H_X1_F1B3_DUO52HI53LO:I21	CPC011_A549_6H_X1	I21	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC011_A549_6H_X2_F1B3_DUO52HI53LO:I21	CPC011_A549_6H_X2	I21	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC011_A549_6H_X3_F1B3_DUO52HI53LO:I21	CPC011_A549_6H_X3	I21	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC011_A549_24H_X1_F1B6_DUO52HI53LO:L11	CPC011_A549_24H_X1	L11	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC011_A549_24H_X3_F1B6_DUO52HI53LO:L11	CPC011_A549_24H_X3	L11	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC011_A549_24H_X5_F1B6_DUO52HI53LO:L11	CPC011_A549_24H_X5	L11	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC015_A549_24H_X1_F1B6_DUO52HI53LO:K04	CPC015_A549_24H_X1	K04	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC015_A549_24H_X2_F1B6_DUO52HI53LO:K04	CPC015_A549_24H_X2	K04	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC015_A549_24H_X3_F1B6_DUO52HI53LO:K04	CPC015_A549_24H_X3	K04	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC015_A549_6H_X1.L2_F2B5_DUO52HI53LO:K04	CPC015_A549_6H_X1.L2	K04	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC015_A549_6H_X2.L2_F2B5_DUO52HI53LO:K04	CPC015_A549_6H_X2.L2	K04	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC011_A549_6H_X1_F1B3_DUO52HI53LO:L11	CPC011_A549_6H_X1	L11	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC011_A549_6H_X2_F1B3_DUO52HI53LO:L11	CPC011_A549_6H_X2	L11	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC011_A549_6H_X3_F1B3_DUO52HI53LO:L11	CPC011_A549_6H_X3	L11	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC015_A549_24H_X1_F1B6_DUO52HI53LO:L05	CPC015_A549_24H_X1	L05	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC015_A549_24H_X2_F1B6_DUO52HI53LO:L05	CPC015_A549_24H_X2	L05	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC015_A549_24H_X3_F1B6_DUO52HI53LO:L05	CPC015_A549_24H_X3	L05	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC015_A549_6H_X1.L2_F2B5_DUO52HI53LO:L05	CPC015_A549_6H_X1.L2	L05	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC015_A549_6H_X2.L2_F2B5_DUO52HI53LO:L05	CPC015_A549_6H_X2.L2	L05	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K31534764	CPC011_A549_24H_X1_F1B6_DUO52HI53LO:E15	CPC011_A549_24H_X1	E15	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K31534764	CPC011_A549_24H_X3_F1B6_DUO52HI53LO:E15	CPC011_A549_24H_X3	E15	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K31534764	CPC011_A549_24H_X5_F1B6_DUO52HI53LO:E15	CPC011_A549_24H_X5	E15	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K31534764	CPC011_A549_6H_X1_F1B3_DUO52HI53LO:E15	CPC011_A549_6H_X1	E15	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K31534764	CPC011_A549_6H_X2_F1B3_DUO52HI53LO:E15	CPC011_A549_6H_X2	E15	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K31534764	CPC011_A549_6H_X3_F1B3_DUO52HI53LO:E15	CPC011_A549_6H_X3	E15	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC016_A549_24H_X1_F1B6_DUO52HI53LO:M15	CPC016_A549_24H_X1	M15	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC016_A549_24H_X2_F1B6_DUO52HI53LO:M15	CPC016_A549_24H_X2	M15	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC016_A549_24H_X3_F1B6_DUO52HI53LO:M15	CPC016_A549_24H_X3	M15	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC016_A549_6H_X1_F1B4_DUO52HI53LO:M15	CPC016_A549_6H_X1	M15	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC016_A549_6H_X2_F1B4_DUO52HI53LO:M15	CPC016_A549_6H_X2	M15	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC011_A549_24H_X1_F1B6_DUO52HI53LO:D11	CPC011_A549_24H_X1	D11	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC011_A549_24H_X3_F1B6_DUO52HI53LO:D11	CPC011_A549_24H_X3	D11	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC011_A549_24H_X5_F1B6_DUO52HI53LO:D11	CPC011_A549_24H_X5	D11	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC011_A549_6H_X1_F1B3_DUO52HI53LO:D11	CPC011_A549_6H_X1	D11	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC011_A549_6H_X2_F1B3_DUO52HI53LO:D11	CPC011_A549_6H_X2	D11	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC011_A549_6H_X3_F1B3_DUO52HI53LO:D11	CPC011_A549_6H_X3	D11	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC015_A549_24H_X1_F1B6_DUO52HI53LO:I22	CPC015_A549_24H_X1	I22	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC015_A549_24H_X2_F1B6_DUO52HI53LO:I22	CPC015_A549_24H_X2	I22	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC015_A549_24H_X3_F1B6_DUO52HI53LO:I22	CPC015_A549_24H_X3	I22	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC015_A549_6H_X1.L2_F2B5_DUO52HI53LO:I22	CPC015_A549_6H_X1.L2	I22	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC015_A549_6H_X2.L2_F2B5_DUO52HI53LO:I22	CPC015_A549_6H_X2.L2	I22	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC016_A549_24H_X1_F1B6_DUO52HI53LO:M20	CPC016_A549_24H_X1	M20	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC016_A549_24H_X2_F1B6_DUO52HI53LO:M20	CPC016_A549_24H_X2	M20	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC016_A549_24H_X3_F1B6_DUO52HI53LO:M20	CPC016_A549_24H_X3	M20	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC016_A549_6H_X1_F1B4_DUO52HI53LO:M20	CPC016_A549_6H_X1	M20	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC016_A549_6H_X2_F1B4_DUO52HI53LO:M20	CPC016_A549_6H_X2	M20	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPC010_A549_24H_X2_F1B6_DUO52HI53LO:P24	CPC010_A549_24H_X2	P24	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPC010_A549_6H_X1_B4_DUO52HI53LO:P24	CPC010_A549_6H_X1	P24	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPC010_A549_6H_X3_F1B3_DUO52HI53LO:P24	CPC010_A549_6H_X3	P24	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC009_A549_24H_X1_F1B6_DUO52HI53LO:K23	CPC009_A549_24H_X1	K23	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC009_A549_24H_X4_F1B6_DUO52HI53LO:K23	CPC009_A549_24H_X4	K23	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC009_A549_6H_X1_B4_DUO52HI53LO:K23	CPC009_A549_6H_X1	K23	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC009_A549_6H_X2_F1B3_DUO52HI53LO:K23	CPC009_A549_6H_X2	K23	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC011_A549_24H_X1_F1B6_DUO52HI53LO:I11	CPC011_A549_24H_X1	I11	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC011_A549_24H_X3_F1B6_DUO52HI53LO:I11	CPC011_A549_24H_X3	I11	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC011_A549_24H_X5_F1B6_DUO52HI53LO:I11	CPC011_A549_24H_X5	I11	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC011_A549_6H_X1_F1B3_DUO52HI53LO:I11	CPC011_A549_6H_X1	I11	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC011_A549_6H_X2_F1B3_DUO52HI53LO:I11	CPC011_A549_6H_X2	I11	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC011_A549_6H_X3_F1B3_DUO52HI53LO:I11	CPC011_A549_6H_X3	I11	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_A549_24H_X1_B3_DUO52HI53LO:E19	CPC005_A549_24H_X1	E19	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_A549_24H_X2_B3_DUO52HI53LO:E19	CPC005_A549_24H_X2	E19	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_A549_24H_X3_B3_DUO52HI53LO:E19	CPC005_A549_24H_X3	E19	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_A549_6H_X1_B3_DUO52HI53LO:E19	CPC005_A549_6H_X1	E19	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_A549_6H_X2_B3_DUO52HI53LO:E19	CPC005_A549_6H_X2	E19	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_A549_6H_X3_B3_DUO52HI53LO:E19	CPC005_A549_6H_X3	E19	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPC011_A549_24H_X1_F1B6_DUO52HI53LO:A16	CPC011_A549_24H_X1	A16	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPC011_A549_24H_X3_F1B6_DUO52HI53LO:A16	CPC011_A549_24H_X3	A16	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPC011_A549_24H_X5_F1B6_DUO52HI53LO:A16	CPC011_A549_24H_X5	A16	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPC011_A549_6H_X1_F1B3_DUO52HI53LO:A16	CPC011_A549_6H_X1	A16	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPC011_A549_6H_X2_F1B3_DUO52HI53LO:A16	CPC011_A549_6H_X2	A16	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4235	N06AG02	moclobemide	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	BRD-K07237224	CPC011_A549_6H_X3_F1B3_DUO52HI53LO:A16	CPC011_A549_6H_X3	A16	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC016_A549_24H_X1_F1B6_DUO52HI53LO:O06	CPC016_A549_24H_X1	O06	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC016_A549_24H_X2_F1B6_DUO52HI53LO:O06	CPC016_A549_24H_X2	O06	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC016_A549_24H_X3_F1B6_DUO52HI53LO:O06	CPC016_A549_24H_X3	O06	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC016_A549_6H_X1_F1B4_DUO52HI53LO:O06	CPC016_A549_6H_X1	O06	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC016_A549_6H_X2_F1B4_DUO52HI53LO:O06	CPC016_A549_6H_X2	O06	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_A549_6H_X1.L2_F2B5_DUO52HI53LO:K04	CPC020_A549_6H_X1.L2	K04	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_A549_6H_X3.L2_F2B5_DUO52HI53LO:K04	CPC020_A549_6H_X3.L2	K04	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC011_A549_24H_X1_F1B6_DUO52HI53LO:K13	CPC011_A549_24H_X1	K13	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC011_A549_24H_X3_F1B6_DUO52HI53LO:K13	CPC011_A549_24H_X3	K13	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC011_A549_24H_X5_F1B6_DUO52HI53LO:K13	CPC011_A549_24H_X5	K13	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC016_A549_24H_X1_F1B6_DUO52HI53LO:N14	CPC016_A549_24H_X1	N14	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC016_A549_24H_X2_F1B6_DUO52HI53LO:N14	CPC016_A549_24H_X2	N14	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC016_A549_24H_X3_F1B6_DUO52HI53LO:N14	CPC016_A549_24H_X3	N14	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC016_A549_6H_X1_F1B4_DUO52HI53LO:N14	CPC016_A549_6H_X1	N14	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC016_A549_6H_X2_F1B4_DUO52HI53LO:N14	CPC016_A549_6H_X2	N14	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC011_A549_6H_X1_F1B3_DUO52HI53LO:K13	CPC011_A549_6H_X1	K13	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC011_A549_6H_X2_F1B3_DUO52HI53LO:K13	CPC011_A549_6H_X2	K13	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC011_A549_6H_X3_F1B3_DUO52HI53LO:K13	CPC011_A549_6H_X3	K13	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC011_A549_24H_X1_F1B6_DUO52HI53LO:J05	CPC011_A549_24H_X1	J05	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC011_A549_24H_X3_F1B6_DUO52HI53LO:J05	CPC011_A549_24H_X3	J05	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC011_A549_24H_X5_F1B6_DUO52HI53LO:J05	CPC011_A549_24H_X5	J05	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC016_A549_24H_X1_F1B6_DUO52HI53LO:K22	CPC016_A549_24H_X1	K22	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC016_A549_24H_X2_F1B6_DUO52HI53LO:K22	CPC016_A549_24H_X2	K22	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC016_A549_24H_X3_F1B6_DUO52HI53LO:K22	CPC016_A549_24H_X3	K22	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC016_A549_6H_X1_F1B4_DUO52HI53LO:K22	CPC016_A549_6H_X1	K22	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC016_A549_6H_X2_F1B4_DUO52HI53LO:K22	CPC016_A549_6H_X2	K22	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC011_A549_6H_X1_F1B3_DUO52HI53LO:J05	CPC011_A549_6H_X1	J05	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC011_A549_6H_X2_F1B3_DUO52HI53LO:J05	CPC011_A549_6H_X2	J05	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC011_A549_6H_X3_F1B3_DUO52HI53LO:J05	CPC011_A549_6H_X3	J05	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_A549_24H_X1_B3_DUO52HI53LO:E10	CPC005_A549_24H_X1	E10	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_A549_24H_X2_B3_DUO52HI53LO:E10	CPC005_A549_24H_X2	E10	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_A549_24H_X3_B3_DUO52HI53LO:E10	CPC005_A549_24H_X3	E10	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_A549_6H_X1_B3_DUO52HI53LO:E10	CPC005_A549_6H_X1	E10	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_A549_6H_X2_B3_DUO52HI53LO:E10	CPC005_A549_6H_X2	E10	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_A549_6H_X3_B3_DUO52HI53LO:E10	CPC005_A549_6H_X3	E10	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC011_A549_24H_X1_F1B6_DUO52HI53LO:A13	CPC011_A549_24H_X1	A13	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC011_A549_24H_X3_F1B6_DUO52HI53LO:A13	CPC011_A549_24H_X3	A13	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC011_A549_24H_X5_F1B6_DUO52HI53LO:A13	CPC011_A549_24H_X5	A13	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC016_A549_24H_X1_F1B6_DUO52HI53LO:C19	CPC016_A549_24H_X1	C19	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC016_A549_24H_X2_F1B6_DUO52HI53LO:C19	CPC016_A549_24H_X2	C19	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC016_A549_24H_X3_F1B6_DUO52HI53LO:C19	CPC016_A549_24H_X3	C19	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC016_A549_6H_X1_F1B4_DUO52HI53LO:C19	CPC016_A549_6H_X1	C19	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC016_A549_6H_X2_F1B4_DUO52HI53LO:C19	CPC016_A549_6H_X2	C19	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC011_A549_6H_X1_F1B3_DUO52HI53LO:A13	CPC011_A549_6H_X1	A13	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC011_A549_6H_X2_F1B3_DUO52HI53LO:A13	CPC011_A549_6H_X2	A13	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC011_A549_6H_X3_F1B3_DUO52HI53LO:A13	CPC011_A549_6H_X3	A13	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC011_A549_24H_X1_F1B6_DUO52HI53LO:G23	CPC011_A549_24H_X1	G23	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC011_A549_24H_X3_F1B6_DUO52HI53LO:G23	CPC011_A549_24H_X3	G23	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC011_A549_24H_X5_F1B6_DUO52HI53LO:G23	CPC011_A549_24H_X5	G23	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC011_A549_6H_X1_F1B3_DUO52HI53LO:G23	CPC011_A549_6H_X1	G23	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC011_A549_6H_X2_F1B3_DUO52HI53LO:G23	CPC011_A549_6H_X2	G23	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC011_A549_6H_X3_F1B3_DUO52HI53LO:G23	CPC011_A549_6H_X3	G23	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC016_A549_24H_X1_F1B6_DUO52HI53LO:H06	CPC016_A549_24H_X1	H06	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC016_A549_24H_X2_F1B6_DUO52HI53LO:H06	CPC016_A549_24H_X2	H06	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC016_A549_24H_X3_F1B6_DUO52HI53LO:H06	CPC016_A549_24H_X3	H06	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC016_A549_6H_X1_F1B4_DUO52HI53LO:H06	CPC016_A549_6H_X1	H06	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC016_A549_6H_X2_F1B4_DUO52HI53LO:H06	CPC016_A549_6H_X2	H06	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-K83153774	CPC020_A549_6H_X1.L2_F2B5_DUO52HI53LO:D15	CPC020_A549_6H_X1.L2	D15	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-K83153774	CPC020_A549_6H_X3.L2_F2B5_DUO52HI53LO:D15	CPC020_A549_6H_X3.L2	D15	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_A549_24H_X1_F1B6_DUO52HI53LO:G10	CPC011_A549_24H_X1	G10	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_A549_24H_X3_F1B6_DUO52HI53LO:G10	CPC011_A549_24H_X3	G10	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_A549_24H_X5_F1B6_DUO52HI53LO:G10	CPC011_A549_24H_X5	G10	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_A549_24H_X1_F1B6_DUO52HI53LO:B03	CPC011_A549_24H_X1	B03	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_A549_24H_X3_F1B6_DUO52HI53LO:B03	CPC011_A549_24H_X3	B03	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_A549_24H_X5_F1B6_DUO52HI53LO:B03	CPC011_A549_24H_X5	B03	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_A549_6H_X1_F1B3_DUO52HI53LO:G10	CPC011_A549_6H_X1	G10	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_A549_6H_X2_F1B3_DUO52HI53LO:G10	CPC011_A549_6H_X2	G10	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_A549_6H_X3_F1B3_DUO52HI53LO:G10	CPC011_A549_6H_X3	G10	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC015_A549_24H_X1_F1B6_DUO52HI53LO:L09	CPC015_A549_24H_X1	L09	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC015_A549_24H_X2_F1B6_DUO52HI53LO:L09	CPC015_A549_24H_X2	L09	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC015_A549_24H_X3_F1B6_DUO52HI53LO:L09	CPC015_A549_24H_X3	L09	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC015_A549_6H_X1.L2_F2B5_DUO52HI53LO:L09	CPC015_A549_6H_X1.L2	L09	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC015_A549_6H_X2.L2_F2B5_DUO52HI53LO:L09	CPC015_A549_6H_X2.L2	L09	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_A549_6H_X1_F1B3_DUO52HI53LO:B03	CPC011_A549_6H_X1	B03	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_A549_6H_X2_F1B3_DUO52HI53LO:B03	CPC011_A549_6H_X2	B03	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC011_A549_6H_X3_F1B3_DUO52HI53LO:B03	CPC011_A549_6H_X3	B03	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_A549_24H_X1_B3_DUO52HI53LO:M14	CPC005_A549_24H_X1	M14	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_A549_24H_X2_B3_DUO52HI53LO:M14	CPC005_A549_24H_X2	M14	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_A549_24H_X3_B3_DUO52HI53LO:M14	CPC005_A549_24H_X3	M14	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_A549_6H_X1_B3_DUO52HI53LO:M14	CPC005_A549_6H_X1	M14	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_A549_6H_X2_B3_DUO52HI53LO:M14	CPC005_A549_6H_X2	M14	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_A549_6H_X3_B3_DUO52HI53LO:M14	CPC005_A549_6H_X3	M14	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC011_A549_24H_X1_F1B6_DUO52HI53LO:J19	CPC011_A549_24H_X1	J19	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC011_A549_24H_X3_F1B6_DUO52HI53LO:J19	CPC011_A549_24H_X3	J19	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC011_A549_24H_X5_F1B6_DUO52HI53LO:J19	CPC011_A549_24H_X5	J19	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC011_A549_6H_X1_F1B3_DUO52HI53LO:J19	CPC011_A549_6H_X1	J19	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC011_A549_6H_X2_F1B3_DUO52HI53LO:J19	CPC011_A549_6H_X2	J19	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC011_A549_6H_X3_F1B3_DUO52HI53LO:J19	CPC011_A549_6H_X3	J19	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC015_A549_24H_X1_F1B6_DUO52HI53LO:L07	CPC015_A549_24H_X1	L07	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC015_A549_24H_X2_F1B6_DUO52HI53LO:L07	CPC015_A549_24H_X2	L07	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC015_A549_24H_X3_F1B6_DUO52HI53LO:L07	CPC015_A549_24H_X3	L07	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC015_A549_6H_X1.L2_F2B5_DUO52HI53LO:L07	CPC015_A549_6H_X1.L2	L07	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC015_A549_6H_X2.L2_F2B5_DUO52HI53LO:L07	CPC015_A549_6H_X2.L2	L07	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
65833	N06AX17	milnacipran	CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2	CCN(CC)C(=O)C1(c2ccccc2)CC1CN	BRD-K02227374	CPC011_A549_24H_X1_F1B6_DUO52HI53LO:H14	CPC011_A549_24H_X1	H14	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
65833	N06AX17	milnacipran	CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2	CCN(CC)C(=O)C1(c2ccccc2)CC1CN	BRD-K02227374	CPC011_A549_24H_X3_F1B6_DUO52HI53LO:H14	CPC011_A549_24H_X3	H14	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
65833	N06AX17	milnacipran	CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2	CCN(CC)C(=O)C1(c2ccccc2)CC1CN	BRD-K02227374	CPC011_A549_24H_X5_F1B6_DUO52HI53LO:H14	CPC011_A549_24H_X5	H14	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
65833	N06AX17	milnacipran	CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2	CCN(CC)C(=O)C1(c2ccccc2)CC1CN	BRD-K02227374	CPC011_A549_6H_X1_F1B3_DUO52HI53LO:H14	CPC011_A549_6H_X1	H14	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
65833	N06AX17	milnacipran	CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2	CCN(CC)C(=O)C1(c2ccccc2)CC1CN	BRD-K02227374	CPC011_A549_6H_X2_F1B3_DUO52HI53LO:H14	CPC011_A549_6H_X2	H14	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
65833	N06AX17	milnacipran	CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2	CCN(CC)C(=O)C1(c2ccccc2)CC1CN	BRD-K02227374	CPC011_A549_6H_X3_F1B3_DUO52HI53LO:H14	CPC011_A549_6H_X3	H14	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC017_A549_24H_X1_F1B6_DUO52HI53LO:F21	CPC017_A549_24H_X1	F21	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC017_A549_24H_X2_F1B6_DUO52HI53LO:F21	CPC017_A549_24H_X2	F21	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC017_A549_24H_X3_F1B6_DUO52HI53LO:F21	CPC017_A549_24H_X3	F21	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC017_A549_6H_X1_F1B4_DUO52HI53LO:F21	CPC017_A549_6H_X1	F21	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC017_A549_6H_X2_F1B4_DUO52HI53LO:F21	CPC017_A549_6H_X2	F21	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC017_A549_6H_X3_F1B4_DUO52HI53LO:F21	CPC017_A549_6H_X3	F21	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_A549_24H_X2_F1B6_DUO52HI53LO:G22	CPC010_A549_24H_X2	G22	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_A549_24H_X4_F1B6_DUO52HI53LO:G22	CPC010_A549_24H_X4	G22	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_A549_6H_X1_B4_DUO52HI53LO:G22	CPC010_A549_6H_X1	G22	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_A549_6H_X3_F1B3_DUO52HI53LO:G22	CPC010_A549_6H_X3	G22	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC011_A549_24H_X1_F1B6_DUO52HI53LO:I05	CPC011_A549_24H_X1	I05	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC011_A549_24H_X3_F1B6_DUO52HI53LO:I05	CPC011_A549_24H_X3	I05	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC011_A549_24H_X5_F1B6_DUO52HI53LO:I05	CPC011_A549_24H_X5	I05	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC015_A549_24H_X1_F1B6_DUO52HI53LO:K18	CPC015_A549_24H_X1	K18	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC015_A549_24H_X2_F1B6_DUO52HI53LO:K18	CPC015_A549_24H_X2	K18	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC015_A549_24H_X3_F1B6_DUO52HI53LO:K18	CPC015_A549_24H_X3	K18	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC015_A549_6H_X1.L2_F2B5_DUO52HI53LO:K18	CPC015_A549_6H_X1.L2	K18	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC015_A549_6H_X2.L2_F2B5_DUO52HI53LO:K18	CPC015_A549_6H_X2.L2	K18	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC011_A549_6H_X1_F1B3_DUO52HI53LO:I05	CPC011_A549_6H_X1	I05	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC011_A549_6H_X2_F1B3_DUO52HI53LO:I05	CPC011_A549_6H_X2	I05	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC011_A549_6H_X3_F1B3_DUO52HI53LO:I05	CPC011_A549_6H_X3	I05	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC020_HCC515_6H_X2_F1B3_DUO52HI53LO:F21	CPC020_HCC515_6H_X2	F21	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC020_HCC515_6H_X3_B4_DUO52HI53LO:F21	CPC020_HCC515_6H_X3	F21	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_HCC515_24H_X1_B3_DUO52HI53LO:E11	CPC004_HCC515_24H_X1	E11	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_HCC515_24H_X2_B3_DUO52HI53LO:E11	CPC004_HCC515_24H_X2	E11	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_HCC515_24H_X3_B3_DUO52HI53LO:E11	CPC004_HCC515_24H_X3	E11	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_HCC515_6H_X1_B3_DUO52HI53LO:E11	CPC004_HCC515_6H_X1	E11	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_HCC515_6H_X2_B3_DUO52HI53LO:E11	CPC004_HCC515_6H_X2	E11	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC004_HCC515_6H_X3_B3_DUO52HI53LO:E11	CPC004_HCC515_6H_X3	E11	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_HCC515_6H_X2_F1B3_DUO52HI53LO:H14	CPC020_HCC515_6H_X2	H14	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_HCC515_6H_X2_F1B3_DUO52HI53LO:L24	CPC020_HCC515_6H_X2	L24	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_HCC515_6H_X3_B4_DUO52HI53LO:H14	CPC020_HCC515_6H_X3	H14	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC020_HCC515_6H_X3_B4_DUO52HI53LO:L24	CPC020_HCC515_6H_X3	L24	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_HCC515_6H_X2_F1B4_DUO52HI53LO:C12	CPC005_HCC515_6H_X2	C12	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	CPC005_HCC515_6H_X3_F1B3_DUO52HI53LO:C12	CPC005_HCC515_6H_X3	C12	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC020_HCC515_6H_X2_F1B3_DUO52HI53LO:P19	CPC020_HCC515_6H_X2	P19	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC020_HCC515_6H_X3_B4_DUO52HI53LO:P19	CPC020_HCC515_6H_X3	P19	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC002_HCC515_24H_X1_B3_DUO52HI53LO:G20	CPC002_HCC515_24H_X1	G20	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC002_HCC515_24H_X2_B3_DUO52HI53LO:G20	CPC002_HCC515_24H_X2	G20	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC002_HCC515_24H_X3_B3_DUO52HI53LO:G20	CPC002_HCC515_24H_X3	G20	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC002_HCC515_6H_X1_B3_DUO52HI53LO:G20	CPC002_HCC515_6H_X1	G20	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC002_HCC515_6H_X2_B3_DUO52HI53LO:G20	CPC002_HCC515_6H_X2	G20	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC002_HCC515_6H_X3_B3_DUO52HI53LO:G20	CPC002_HCC515_6H_X3	G20	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_HCC515_6H_X1_B3_DUO52HI53LO:I02	CPC004_HCC515_6H_X1	I02	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_HCC515_6H_X2_B3_DUO52HI53LO:I02	CPC004_HCC515_6H_X2	I02	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_HCC515_6H_X3_B3_DUO52HI53LO:I02	CPC004_HCC515_6H_X3	I02	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_HCC515_24H_X1_B3_DUO52HI53LO:I02	CPC004_HCC515_24H_X1	I02	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_HCC515_24H_X2_B3_DUO52HI53LO:I02	CPC004_HCC515_24H_X2	I02	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_HCC515_24H_X3_B3_DUO52HI53LO:I02	CPC004_HCC515_24H_X3	I02	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_HCC515_6H_X1_B3_DUO52HI53LO:I02	CPC004_HCC515_6H_X1	I02	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_HCC515_6H_X2_B3_DUO52HI53LO:I02	CPC004_HCC515_6H_X2	I02	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_HCC515_6H_X3_B3_DUO52HI53LO:I02	CPC004_HCC515_6H_X3	I02	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_HCC515_24H_X1_B3_DUO52HI53LO:I02	CPC004_HCC515_24H_X1	I02	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_HCC515_24H_X2_B3_DUO52HI53LO:I02	CPC004_HCC515_24H_X2	I02	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC004_HCC515_24H_X3_B3_DUO52HI53LO:I02	CPC004_HCC515_24H_X3	I02	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC001_HCC515_24H_X1_B3_DUO52HI53LO:O20	CPC001_HCC515_24H_X1	O20	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC001_HCC515_24H_X2_B3_DUO52HI53LO:O20	CPC001_HCC515_24H_X2	O20	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC001_HCC515_24H_X3_B3_DUO52HI53LO:O20	CPC001_HCC515_24H_X3	O20	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC001_HCC515_6H_X1_B3_DUO52HI53LO:O20	CPC001_HCC515_6H_X1	O20	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC001_HCC515_6H_X2_B3_DUO52HI53LO:O20	CPC001_HCC515_6H_X2	O20	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC003_HCC515_24H_X1_B3_DUO52HI53LO:I02	CPC003_HCC515_24H_X1	I02	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC003_HCC515_24H_X2_B3_DUO52HI53LO:I02	CPC003_HCC515_24H_X2	I02	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC003_HCC515_24H_X3_B3_DUO52HI53LO:I02	CPC003_HCC515_24H_X3	I02	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC003_HCC515_6H_X1_B3_DUO52HI53LO:I02	CPC003_HCC515_6H_X1	I02	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC003_HCC515_6H_X2_B3_DUO52HI53LO:I02	CPC003_HCC515_6H_X2	I02	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC003_HCC515_6H_X3_B3_DUO52HI53LO:I02	CPC003_HCC515_6H_X3	I02	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC002_HCC515_24H_X1_B3_DUO52HI53LO:O11	CPC002_HCC515_24H_X1	O11	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC002_HCC515_24H_X2_B3_DUO52HI53LO:O11	CPC002_HCC515_24H_X2	O11	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC002_HCC515_24H_X3_B3_DUO52HI53LO:O11	CPC002_HCC515_24H_X3	O11	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC002_HCC515_6H_X1_B3_DUO52HI53LO:O11	CPC002_HCC515_6H_X1	O11	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC002_HCC515_6H_X2_B3_DUO52HI53LO:O11	CPC002_HCC515_6H_X2	O11	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC002_HCC515_6H_X3_B3_DUO52HI53LO:O11	CPC002_HCC515_6H_X3	O11	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_HCC515_24H_X1_B3_DUO52HI53LO:J02	CPC004_HCC515_24H_X1	J02	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_HCC515_24H_X2_B3_DUO52HI53LO:J02	CPC004_HCC515_24H_X2	J02	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_HCC515_24H_X3_B3_DUO52HI53LO:J02	CPC004_HCC515_24H_X3	J02	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_HCC515_6H_X1_B3_DUO52HI53LO:J02	CPC004_HCC515_6H_X1	J02	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC004_HCC515_6H_X2_B3_DUO52HI53LO:J02	CPC004_HCC515_6H_X2	J02	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC004_HCC515_6H_X1_B3_DUO52HI53LO:K17	CPC004_HCC515_6H_X1	K17	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC004_HCC515_6H_X2_B3_DUO52HI53LO:K17	CPC004_HCC515_6H_X2	K17	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC004_HCC515_6H_X3_B3_DUO52HI53LO:K17	CPC004_HCC515_6H_X3	K17	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC004_HCC515_24H_X1_B3_DUO52HI53LO:K17	CPC004_HCC515_24H_X1	K17	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC004_HCC515_24H_X2_B3_DUO52HI53LO:K17	CPC004_HCC515_24H_X2	K17	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC004_HCC515_24H_X3_B3_DUO52HI53LO:K17	CPC004_HCC515_24H_X3	K17	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_HCC515_6H_X1_B3_DUO52HI53LO:G23	CPC004_HCC515_6H_X1	G23	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_HCC515_6H_X2_B3_DUO52HI53LO:G23	CPC004_HCC515_6H_X2	G23	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_HCC515_6H_X3_B3_DUO52HI53LO:G23	CPC004_HCC515_6H_X3	G23	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_HCC515_24H_X1_B3_DUO52HI53LO:G23	CPC004_HCC515_24H_X1	G23	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_HCC515_24H_X2_B3_DUO52HI53LO:G23	CPC004_HCC515_24H_X2	G23	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC004_HCC515_24H_X3_B3_DUO52HI53LO:G23	CPC004_HCC515_24H_X3	G23	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC002_HCC515_6H_X1_B3_DUO52HI53LO:F11	CPC002_HCC515_6H_X1	F11	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC002_HCC515_6H_X3_B3_DUO52HI53LO:F11	CPC002_HCC515_6H_X3	F11	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC020_HCC515_6H_X2_F1B3_DUO52HI53LO:O02	CPC020_HCC515_6H_X2	O02	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC020_HCC515_6H_X3_B4_DUO52HI53LO:O02	CPC020_HCC515_6H_X3	O02	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC002_HCC515_24H_X1_B3_DUO52HI53LO:F11	CPC002_HCC515_24H_X1	F11	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC002_HCC515_24H_X2_B3_DUO52HI53LO:F11	CPC002_HCC515_24H_X2	F11	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC002_HCC515_24H_X3_B3_DUO52HI53LO:F11	CPC002_HCC515_24H_X3	F11	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC002_HCC515_24H_X1_B3_DUO52HI53LO:F15	CPC002_HCC515_24H_X1	F15	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC002_HCC515_24H_X2_B3_DUO52HI53LO:F15	CPC002_HCC515_24H_X2	F15	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC002_HCC515_24H_X3_B3_DUO52HI53LO:F15	CPC002_HCC515_24H_X3	F15	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC002_HCC515_6H_X1_B3_DUO52HI53LO:F15	CPC002_HCC515_6H_X1	F15	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC002_HCC515_6H_X2_B3_DUO52HI53LO:F15	CPC002_HCC515_6H_X2	F15	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC002_HCC515_6H_X3_B3_DUO52HI53LO:F15	CPC002_HCC515_6H_X3	F15	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_HCC515_24H_X1_B3_DUO52HI53LO:E01	CPC004_HCC515_24H_X1	E01	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_HCC515_24H_X2_B3_DUO52HI53LO:E01	CPC004_HCC515_24H_X2	E01	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_HCC515_24H_X3_B3_DUO52HI53LO:E01	CPC004_HCC515_24H_X3	E01	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_HCC515_6H_X1_B3_DUO52HI53LO:E01	CPC004_HCC515_6H_X1	E01	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_HCC515_6H_X2_B3_DUO52HI53LO:E01	CPC004_HCC515_6H_X2	E01	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC004_HCC515_6H_X3_B3_DUO52HI53LO:E01	CPC004_HCC515_6H_X3	E01	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_HCC515_6H_X2_F1B3_DUO52HI53LO:F24	CPC020_HCC515_6H_X2	F24	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_HCC515_6H_X2_F1B3_DUO52HI53LO:H08	CPC020_HCC515_6H_X2	H08	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_HCC515_6H_X3_B4_DUO52HI53LO:F24	CPC020_HCC515_6H_X3	F24	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC020_HCC515_6H_X3_B4_DUO52HI53LO:H08	CPC020_HCC515_6H_X3	H08	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_HCC515_6H_X2_F1B4_DUO52HI53LO:N07	CPC005_HCC515_6H_X2	N07	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K03319035	CPC005_HCC515_6H_X3_F1B3_DUO52HI53LO:N07	CPC005_HCC515_6H_X3	N07	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC002_HCC515_24H_X1_B3_DUO52HI53LO:K21	CPC002_HCC515_24H_X1	K21	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC002_HCC515_24H_X2_B3_DUO52HI53LO:K21	CPC002_HCC515_24H_X2	K21	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC002_HCC515_24H_X3_B3_DUO52HI53LO:K21	CPC002_HCC515_24H_X3	K21	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC002_HCC515_6H_X1_B3_DUO52HI53LO:K21	CPC002_HCC515_6H_X1	K21	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC002_HCC515_6H_X2_B3_DUO52HI53LO:K21	CPC002_HCC515_6H_X2	K21	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC002_HCC515_6H_X3_B3_DUO52HI53LO:K21	CPC002_HCC515_6H_X3	K21	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_HCC515_6H_X1_F1B3_DUO52HI53LO:J24	CPC009_HCC515_6H_X1	J24	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_HCC515_6H_X2_B4_DUO52HI53LO:J24	CPC009_HCC515_6H_X2	J24	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC009_HCC515_6H_X3_B4_DUO52HI53LO:J24	CPC009_HCC515_6H_X3	J24	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_HCC515_6H_X2_F1B4_DUO52HI53LO:P19	CPC005_HCC515_6H_X2	P19	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	CPC005_HCC515_6H_X3_F1B3_DUO52HI53LO:P19	CPC005_HCC515_6H_X3	P19	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_HCC515_6H_X1_F1B3_DUO52HI53LO:B24	CPC009_HCC515_6H_X1	B24	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_HCC515_6H_X2_B4_DUO52HI53LO:B24	CPC009_HCC515_6H_X2	B24	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC009_HCC515_6H_X3_B4_DUO52HI53LO:B24	CPC009_HCC515_6H_X3	B24	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_HCC515_6H_X2_F1B4_DUO52HI53LO:F24	CPC005_HCC515_6H_X2	F24	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2771	N06AB04	citalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-A47598013	CPC005_HCC515_6H_X3_F1B3_DUO52HI53LO:F24	CPC005_HCC515_6H_X3	F24	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_HCC515_6H_X2_F1B3_DUO52HI53LO:B15	CPC020_HCC515_6H_X2	B15	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-A62326914	CPC020_HCC515_6H_X3_B4_DUO52HI53LO:B15	CPC020_HCC515_6H_X3	B15	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_HCC515_24H_X1_B3_DUO52HI53LO:H24	CPC004_HCC515_24H_X1	H24	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_HCC515_24H_X2_B3_DUO52HI53LO:H24	CPC004_HCC515_24H_X2	H24	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_HCC515_24H_X3_B3_DUO52HI53LO:H24	CPC004_HCC515_24H_X3	H24	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_HCC515_6H_X1_B3_DUO52HI53LO:H24	CPC004_HCC515_6H_X1	H24	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_HCC515_6H_X2_B3_DUO52HI53LO:H24	CPC004_HCC515_6H_X2	H24	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC004_HCC515_6H_X3_B3_DUO52HI53LO:H24	CPC004_HCC515_6H_X3	H24	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_HCC515_24H_X1_B3_DUO52HI53LO:H13	CPC004_HCC515_24H_X1	H13	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_HCC515_24H_X2_B3_DUO52HI53LO:H13	CPC004_HCC515_24H_X2	H13	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_HCC515_24H_X3_B3_DUO52HI53LO:H13	CPC004_HCC515_24H_X3	H13	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_HCC515_6H_X1_B3_DUO52HI53LO:H13	CPC004_HCC515_6H_X1	H13	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_HCC515_6H_X2_B3_DUO52HI53LO:H13	CPC004_HCC515_6H_X2	H13	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC004_HCC515_6H_X3_B3_DUO52HI53LO:H13	CPC004_HCC515_6H_X3	H13	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_HCC515_24H_X1_B3_DUO52HI53LO:J04	CPC004_HCC515_24H_X1	J04	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_HCC515_24H_X2_B3_DUO52HI53LO:J04	CPC004_HCC515_24H_X2	J04	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_HCC515_24H_X3_B3_DUO52HI53LO:J04	CPC004_HCC515_24H_X3	J04	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_HCC515_6H_X1_B3_DUO52HI53LO:J04	CPC004_HCC515_6H_X1	J04	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_HCC515_6H_X2_B3_DUO52HI53LO:J04	CPC004_HCC515_6H_X2	J04	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC004_HCC515_6H_X3_B3_DUO52HI53LO:J04	CPC004_HCC515_6H_X3	J04	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC003_HCC515_24H_X1_B3_DUO52HI53LO:P05	CPC003_HCC515_24H_X1	P05	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC003_HCC515_24H_X2_B3_DUO52HI53LO:P05	CPC003_HCC515_24H_X2	P05	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC003_HCC515_24H_X3_B3_DUO52HI53LO:P05	CPC003_HCC515_24H_X3	P05	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC003_HCC515_6H_X1_B3_DUO52HI53LO:P05	CPC003_HCC515_6H_X1	P05	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC003_HCC515_6H_X3_B3_DUO52HI53LO:P05	CPC003_HCC515_6H_X3	P05	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_HCC515_6H_X1_B3_DUO52HI53LO:H07	CPC004_HCC515_6H_X1	H07	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_HCC515_6H_X2_B3_DUO52HI53LO:H07	CPC004_HCC515_6H_X2	H07	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_HCC515_6H_X3_B3_DUO52HI53LO:H07	CPC004_HCC515_6H_X3	H07	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_HCC515_24H_X1_B3_DUO52HI53LO:H07	CPC004_HCC515_24H_X1	H07	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_HCC515_24H_X2_B3_DUO52HI53LO:H07	CPC004_HCC515_24H_X2	H07	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC004_HCC515_24H_X3_B3_DUO52HI53LO:H07	CPC004_HCC515_24H_X3	H07	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC002_HCC515_24H_X1_B3_DUO52HI53LO:H22	CPC002_HCC515_24H_X1	H22	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC002_HCC515_24H_X2_B3_DUO52HI53LO:H22	CPC002_HCC515_24H_X2	H22	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC002_HCC515_24H_X3_B3_DUO52HI53LO:H22	CPC002_HCC515_24H_X3	H22	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC002_HCC515_6H_X1_B3_DUO52HI53LO:H22	CPC002_HCC515_6H_X1	H22	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC002_HCC515_6H_X2_B3_DUO52HI53LO:H22	CPC002_HCC515_6H_X2	H22	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC002_HCC515_6H_X3_B3_DUO52HI53LO:H22	CPC002_HCC515_6H_X3	H22	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPC010_HCC515_6H_X1_B4_DUO52HI53LO:P24	CPC010_HCC515_6H_X1	P24	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPC010_HCC515_6H_X2_B4_DUO52HI53LO:P24	CPC010_HCC515_6H_X2	P24	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4472	N06AF02	nialamide	C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	BRD-K12102668	CPC010_HCC515_6H_X3_B4_DUO52HI53LO:P24	CPC010_HCC515_6H_X3	P24	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC009_HCC515_6H_X1_F1B3_DUO52HI53LO:K23	CPC009_HCC515_6H_X1	K23	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC009_HCC515_6H_X2_B4_DUO52HI53LO:K23	CPC009_HCC515_6H_X2	K23	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
3675	N06AF03	phenelzine	C1=CC=C(C=C1)CCNN	NNCCc1ccccc1	BRD-K87024524	CPC009_HCC515_6H_X3_B4_DUO52HI53LO:K23	CPC009_HCC515_6H_X3	K23	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_HCC515_6H_X2_F1B4_DUO52HI53LO:E19	CPC005_HCC515_6H_X2	E19	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-A43974575	CPC005_HCC515_6H_X3_F1B3_DUO52HI53LO:E19	CPC005_HCC515_6H_X3	E19	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC002_HCC515_24H_X1_B3_DUO52HI53LO:J08	CPC002_HCC515_24H_X1	J08	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC002_HCC515_24H_X2_B3_DUO52HI53LO:J08	CPC002_HCC515_24H_X2	J08	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC002_HCC515_24H_X3_B3_DUO52HI53LO:J08	CPC002_HCC515_24H_X3	J08	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC002_HCC515_6H_X1_B3_DUO52HI53LO:J08	CPC002_HCC515_6H_X1	J08	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC002_HCC515_6H_X2_B3_DUO52HI53LO:J08	CPC002_HCC515_6H_X2	J08	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC002_HCC515_6H_X3_B3_DUO52HI53LO:J08	CPC002_HCC515_6H_X3	J08	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_HCC515_6H_X2_F1B3_DUO52HI53LO:K04	CPC020_HCC515_6H_X2	K04	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4528	N06AX04	nomifensine	CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3	CN1Cc2c(N)cccc2C(c2ccccc2)C1	BRD-A29644307	CPC020_HCC515_6H_X3_B4_DUO52HI53LO:K04	CPC020_HCC515_6H_X3	K04	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_HCC515_24H_X1_B3_DUO52HI53LO:I06	CPC004_HCC515_24H_X1	I06	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_HCC515_24H_X2_B3_DUO52HI53LO:I06	CPC004_HCC515_24H_X2	I06	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_HCC515_24H_X3_B3_DUO52HI53LO:I06	CPC004_HCC515_24H_X3	I06	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_HCC515_6H_X1_B3_DUO52HI53LO:I06	CPC004_HCC515_6H_X1	I06	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_HCC515_6H_X2_B3_DUO52HI53LO:I06	CPC004_HCC515_6H_X2	I06	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC004_HCC515_6H_X3_B3_DUO52HI53LO:I06	CPC004_HCC515_6H_X3	I06	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC002_HCC515_24H_X1_B3_DUO52HI53LO:H02	CPC002_HCC515_24H_X1	H02	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC002_HCC515_24H_X2_B3_DUO52HI53LO:H02	CPC002_HCC515_24H_X2	H02	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC002_HCC515_24H_X3_B3_DUO52HI53LO:H02	CPC002_HCC515_24H_X3	H02	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC002_HCC515_6H_X1_B3_DUO52HI53LO:H02	CPC002_HCC515_6H_X1	H02	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC002_HCC515_6H_X2_B3_DUO52HI53LO:H02	CPC002_HCC515_6H_X2	H02	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC002_HCC515_6H_X3_B3_DUO52HI53LO:H02	CPC002_HCC515_6H_X3	H02	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_HCC515_6H_X2_F1B4_DUO52HI53LO:E10	CPC005_HCC515_6H_X2	E10	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4199	N06AX07	minaprine	CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	BRD-K02867583	CPC005_HCC515_6H_X3_F1B3_DUO52HI53LO:E10	CPC005_HCC515_6H_X3	E10	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC003_HCC515_24H_X1_B3_DUO52HI53LO:F01	CPC003_HCC515_24H_X1	F01	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC003_HCC515_24H_X2_B3_DUO52HI53LO:F01	CPC003_HCC515_24H_X2	F01	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC003_HCC515_24H_X3_B3_DUO52HI53LO:F01	CPC003_HCC515_24H_X3	F01	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC003_HCC515_6H_X1_B3_DUO52HI53LO:F01	CPC003_HCC515_6H_X1	F01	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC003_HCC515_6H_X2_B3_DUO52HI53LO:F01	CPC003_HCC515_6H_X2	F01	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC003_HCC515_6H_X3_B3_DUO52HI53LO:F01	CPC003_HCC515_6H_X3	F01	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_HCC515_24H_X1_B3_DUO52HI53LO:A16	CPC004_HCC515_24H_X1	A16	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_HCC515_24H_X2_B3_DUO52HI53LO:A16	CPC004_HCC515_24H_X2	A16	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_HCC515_24H_X3_B3_DUO52HI53LO:A16	CPC004_HCC515_24H_X3	A16	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_HCC515_6H_X1_B3_DUO52HI53LO:A16	CPC004_HCC515_6H_X1	A16	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_HCC515_6H_X2_B3_DUO52HI53LO:A16	CPC004_HCC515_6H_X2	A16	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC004_HCC515_6H_X3_B3_DUO52HI53LO:A16	CPC004_HCC515_6H_X3	A16	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-K83153774	CPC020_HCC515_6H_X2_F1B3_DUO52HI53LO:D15	CPC020_HCC515_6H_X2	D15	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-K83153774	CPC020_HCC515_6H_X3_B4_DUO52HI53LO:D15	CPC020_HCC515_6H_X3	D15	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_HCC515_24H_X1_B3_DUO52HI53LO:J08	CPC004_HCC515_24H_X1	J08	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_HCC515_24H_X2_B3_DUO52HI53LO:J08	CPC004_HCC515_24H_X2	J08	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_HCC515_24H_X3_B3_DUO52HI53LO:J08	CPC004_HCC515_24H_X3	J08	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_HCC515_6H_X1_B3_DUO52HI53LO:J08	CPC004_HCC515_6H_X1	J08	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_HCC515_6H_X2_B3_DUO52HI53LO:J08	CPC004_HCC515_6H_X2	J08	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC004_HCC515_6H_X3_B3_DUO52HI53LO:J08	CPC004_HCC515_6H_X3	J08	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_HCC515_6H_X2_F1B4_DUO52HI53LO:M14	CPC005_HCC515_6H_X2	M14	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
68870	N06AX14	tianeptine	CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	BRD-A53077924	CPC005_HCC515_6H_X3_F1B3_DUO52HI53LO:M14	CPC005_HCC515_6H_X3	M14	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_HCC515_24H_X1_B3_DUO52HI53LO:J06	CPC004_HCC515_24H_X1	J06	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_HCC515_24H_X2_B3_DUO52HI53LO:J06	CPC004_HCC515_24H_X2	J06	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_HCC515_24H_X3_B3_DUO52HI53LO:J06	CPC004_HCC515_24H_X3	J06	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_HCC515_6H_X1_B3_DUO52HI53LO:J06	CPC004_HCC515_6H_X1	J06	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_HCC515_6H_X2_B3_DUO52HI53LO:J06	CPC004_HCC515_6H_X2	J06	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC004_HCC515_6H_X3_B3_DUO52HI53LO:J06	CPC004_HCC515_6H_X3	J06	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC001_HCC515_24H_X1_B3_DUO52HI53LO:L21	CPC001_HCC515_24H_X1	L21	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC001_HCC515_24H_X2_B3_DUO52HI53LO:L21	CPC001_HCC515_24H_X2	L21	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC001_HCC515_24H_X3_B3_DUO52HI53LO:L21	CPC001_HCC515_24H_X3	L21	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC001_HCC515_6H_X1_B3_DUO52HI53LO:L21	CPC001_HCC515_6H_X1	L21	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC001_HCC515_6H_X2_B3_DUO52HI53LO:L21	CPC001_HCC515_6H_X2	L21	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_HCC515_6H_X1_B4_DUO52HI53LO:G22	CPC010_HCC515_6H_X1	G22	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_HCC515_6H_X2_B4_DUO52HI53LO:G22	CPC010_HCC515_6H_X2	G22	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC010_HCC515_6H_X3_B4_DUO52HI53LO:G22	CPC010_HCC515_6H_X3	G22	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_HCC515_24H_X1_B3_DUO52HI53LO:J03	CPC004_HCC515_24H_X1	J03	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_HCC515_24H_X2_B3_DUO52HI53LO:J03	CPC004_HCC515_24H_X2	J03	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_HCC515_24H_X3_B3_DUO52HI53LO:J03	CPC004_HCC515_24H_X3	J03	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_HCC515_6H_X1_B3_DUO52HI53LO:J03	CPC004_HCC515_6H_X1	J03	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_HCC515_6H_X2_B3_DUO52HI53LO:J03	CPC004_HCC515_6H_X2	J03	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC004_HCC515_6H_X3_B3_DUO52HI53LO:J03	CPC004_HCC515_6H_X3	J03	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC017_ASC_24H_X1_B7_DUO52HI53LO:M02	CPC017_ASC_24H_X1	M02	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC017_ASC_24H_X2_B7_DUO52HI53LO:M02	CPC017_ASC_24H_X2	M02	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC017_ASC_24H_X3_B7_DUO52HI53LO:M02	CPC017_ASC_24H_X3	M02	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC017_ASC_24H_X4_B7_DUO52HI53LO:M02	CPC017_ASC_24H_X4	M02	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC018_ASC_24H_X1_B7_DUO52HI53LO:F20	CPC018_ASC_24H_X1	F20	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC018_ASC_24H_X2_B7_DUO52HI53LO:F20	CPC018_ASC_24H_X2	F20	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC018_ASC_24H_X4_B7_DUO52HI53LO:F20	CPC018_ASC_24H_X4	F20	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_ASC_24H_X1_B7_DUO52HI53LO:N08	CPC016_ASC_24H_X1	N08	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_ASC_24H_X3_B7_DUO52HI53LO:N08	CPC016_ASC_24H_X3	N08	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_ASC_24H_X4_B7_DUO52HI53LO:N08	CPC016_ASC_24H_X4	N08	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_ASC_24H_X1_B7_DUO52HI53LO:N08	CPC016_ASC_24H_X1	N08	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_ASC_24H_X3_B7_DUO52HI53LO:N08	CPC016_ASC_24H_X3	N08	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_ASC_24H_X4_B7_DUO52HI53LO:N08	CPC016_ASC_24H_X4	N08	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC017_ASC_24H_X1_B7_DUO52HI53LO:L04	CPC017_ASC_24H_X1	L04	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC017_ASC_24H_X2_B7_DUO52HI53LO:L04	CPC017_ASC_24H_X2	L04	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC017_ASC_24H_X3_B7_DUO52HI53LO:L04	CPC017_ASC_24H_X3	L04	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC017_ASC_24H_X4_B7_DUO52HI53LO:L04	CPC017_ASC_24H_X4	L04	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC015_ASC_24H_X1_B7_DUO52HI53LO:J10	CPC015_ASC_24H_X1	J10	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC015_ASC_24H_X2_B7_DUO52HI53LO:J10	CPC015_ASC_24H_X2	J10	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC015_ASC_24H_X3_B7_DUO52HI53LO:J10	CPC015_ASC_24H_X3	J10	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC015_ASC_24H_X4_B7_DUO52HI53LO:J10	CPC015_ASC_24H_X4	J10	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC018_ASC_24H_X1_B7_DUO52HI53LO:J19	CPC018_ASC_24H_X1	J19	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC018_ASC_24H_X2_B7_DUO52HI53LO:J19	CPC018_ASC_24H_X2	J19	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC018_ASC_24H_X4_B7_DUO52HI53LO:J19	CPC018_ASC_24H_X4	J19	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC015_ASC_24H_X1_B7_DUO52HI53LO:L03	CPC015_ASC_24H_X1	L03	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC015_ASC_24H_X2_B7_DUO52HI53LO:L03	CPC015_ASC_24H_X2	L03	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC015_ASC_24H_X3_B7_DUO52HI53LO:L03	CPC015_ASC_24H_X3	L03	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC015_ASC_24H_X4_B7_DUO52HI53LO:L03	CPC015_ASC_24H_X4	L03	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC018_ASC_24H_X1_B7_DUO52HI53LO:A20	CPC018_ASC_24H_X1	A20	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC018_ASC_24H_X2_B7_DUO52HI53LO:A20	CPC018_ASC_24H_X2	A20	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC018_ASC_24H_X4_B7_DUO52HI53LO:A20	CPC018_ASC_24H_X4	A20	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC017_ASC_24H_X1_B7_DUO52HI53LO:O16	CPC017_ASC_24H_X1	O16	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC017_ASC_24H_X2_B7_DUO52HI53LO:O16	CPC017_ASC_24H_X2	O16	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC017_ASC_24H_X3_B7_DUO52HI53LO:O16	CPC017_ASC_24H_X3	O16	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC017_ASC_24H_X4_B7_DUO52HI53LO:O16	CPC017_ASC_24H_X4	O16	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC017_ASC_24H_X1_B7_DUO52HI53LO:I07	CPC017_ASC_24H_X1	I07	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC017_ASC_24H_X2_B7_DUO52HI53LO:I07	CPC017_ASC_24H_X2	I07	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC017_ASC_24H_X3_B7_DUO52HI53LO:I07	CPC017_ASC_24H_X3	I07	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC017_ASC_24H_X4_B7_DUO52HI53LO:I07	CPC017_ASC_24H_X4	I07	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC017_ASC_24H_X1_B7_DUO52HI53LO:I11	CPC017_ASC_24H_X1	I11	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC017_ASC_24H_X2_B7_DUO52HI53LO:I11	CPC017_ASC_24H_X2	I11	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC017_ASC_24H_X3_B7_DUO52HI53LO:I11	CPC017_ASC_24H_X3	I11	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC017_ASC_24H_X4_B7_DUO52HI53LO:I11	CPC017_ASC_24H_X4	I11	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC017_ASC_24H_X1_B7_DUO52HI53LO:K18	CPC017_ASC_24H_X1	K18	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC017_ASC_24H_X2_B7_DUO52HI53LO:K18	CPC017_ASC_24H_X2	K18	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC017_ASC_24H_X3_B7_DUO52HI53LO:K18	CPC017_ASC_24H_X3	K18	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC017_ASC_24H_X4_B7_DUO52HI53LO:K18	CPC017_ASC_24H_X4	K18	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC018_ASC_24H_X1_B7_DUO52HI53LO:H09	CPC018_ASC_24H_X1	H09	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC018_ASC_24H_X2_B7_DUO52HI53LO:H09	CPC018_ASC_24H_X2	H09	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC018_ASC_24H_X4_B7_DUO52HI53LO:H09	CPC018_ASC_24H_X4	H09	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC015_ASC_24H_X1_B7_DUO52HI53LO:L01	CPC015_ASC_24H_X1	L01	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC015_ASC_24H_X2_B7_DUO52HI53LO:L01	CPC015_ASC_24H_X2	L01	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC015_ASC_24H_X3_B7_DUO52HI53LO:L01	CPC015_ASC_24H_X3	L01	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC015_ASC_24H_X4_B7_DUO52HI53LO:L01	CPC015_ASC_24H_X4	L01	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC015_ASC_24H_X1_B7_DUO52HI53LO:K04	CPC015_ASC_24H_X1	K04	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC015_ASC_24H_X2_B7_DUO52HI53LO:K04	CPC015_ASC_24H_X2	K04	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC015_ASC_24H_X3_B7_DUO52HI53LO:K04	CPC015_ASC_24H_X3	K04	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC015_ASC_24H_X4_B7_DUO52HI53LO:K04	CPC015_ASC_24H_X4	K04	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC015_ASC_24H_X1_B7_DUO52HI53LO:L05	CPC015_ASC_24H_X1	L05	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC015_ASC_24H_X2_B7_DUO52HI53LO:L05	CPC015_ASC_24H_X2	L05	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC015_ASC_24H_X3_B7_DUO52HI53LO:L05	CPC015_ASC_24H_X3	L05	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC015_ASC_24H_X4_B7_DUO52HI53LO:L05	CPC015_ASC_24H_X4	L05	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC016_ASC_24H_X1_B7_DUO52HI53LO:M15	CPC016_ASC_24H_X1	M15	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC016_ASC_24H_X3_B7_DUO52HI53LO:M15	CPC016_ASC_24H_X3	M15	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC016_ASC_24H_X4_B7_DUO52HI53LO:M15	CPC016_ASC_24H_X4	M15	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC015_ASC_24H_X1_B7_DUO52HI53LO:I22	CPC015_ASC_24H_X1	I22	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC015_ASC_24H_X2_B7_DUO52HI53LO:I22	CPC015_ASC_24H_X2	I22	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC015_ASC_24H_X3_B7_DUO52HI53LO:I22	CPC015_ASC_24H_X3	I22	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC015_ASC_24H_X4_B7_DUO52HI53LO:I22	CPC015_ASC_24H_X4	I22	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC016_ASC_24H_X1_B7_DUO52HI53LO:M20	CPC016_ASC_24H_X1	M20	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC016_ASC_24H_X3_B7_DUO52HI53LO:M20	CPC016_ASC_24H_X3	M20	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC016_ASC_24H_X4_B7_DUO52HI53LO:M20	CPC016_ASC_24H_X4	M20	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC016_ASC_24H_X1_B7_DUO52HI53LO:O06	CPC016_ASC_24H_X1	O06	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC016_ASC_24H_X3_B7_DUO52HI53LO:O06	CPC016_ASC_24H_X3	O06	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC016_ASC_24H_X4_B7_DUO52HI53LO:O06	CPC016_ASC_24H_X4	O06	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC016_ASC_24H_X1_B7_DUO52HI53LO:N14	CPC016_ASC_24H_X1	N14	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC016_ASC_24H_X3_B7_DUO52HI53LO:N14	CPC016_ASC_24H_X3	N14	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC016_ASC_24H_X4_B7_DUO52HI53LO:N14	CPC016_ASC_24H_X4	N14	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC016_ASC_24H_X1_B7_DUO52HI53LO:K22	CPC016_ASC_24H_X1	K22	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC016_ASC_24H_X3_B7_DUO52HI53LO:K22	CPC016_ASC_24H_X3	K22	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC016_ASC_24H_X4_B7_DUO52HI53LO:K22	CPC016_ASC_24H_X4	K22	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC016_ASC_24H_X1_B7_DUO52HI53LO:C19	CPC016_ASC_24H_X1	C19	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC016_ASC_24H_X3_B7_DUO52HI53LO:C19	CPC016_ASC_24H_X3	C19	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC016_ASC_24H_X4_B7_DUO52HI53LO:C19	CPC016_ASC_24H_X4	C19	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC016_ASC_24H_X1_B7_DUO52HI53LO:H06	CPC016_ASC_24H_X1	H06	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC016_ASC_24H_X3_B7_DUO52HI53LO:H06	CPC016_ASC_24H_X3	H06	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC016_ASC_24H_X4_B7_DUO52HI53LO:H06	CPC016_ASC_24H_X4	H06	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC015_ASC_24H_X1_B7_DUO52HI53LO:L09	CPC015_ASC_24H_X1	L09	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC015_ASC_24H_X2_B7_DUO52HI53LO:L09	CPC015_ASC_24H_X2	L09	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC015_ASC_24H_X3_B7_DUO52HI53LO:L09	CPC015_ASC_24H_X3	L09	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC015_ASC_24H_X4_B7_DUO52HI53LO:L09	CPC015_ASC_24H_X4	L09	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC015_ASC_24H_X1_B7_DUO52HI53LO:L07	CPC015_ASC_24H_X1	L07	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC015_ASC_24H_X2_B7_DUO52HI53LO:L07	CPC015_ASC_24H_X2	L07	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC015_ASC_24H_X3_B7_DUO52HI53LO:L07	CPC015_ASC_24H_X3	L07	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC015_ASC_24H_X4_B7_DUO52HI53LO:L07	CPC015_ASC_24H_X4	L07	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC017_ASC_24H_X1_B7_DUO52HI53LO:F21	CPC017_ASC_24H_X1	F21	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC017_ASC_24H_X2_B7_DUO52HI53LO:F21	CPC017_ASC_24H_X2	F21	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC017_ASC_24H_X3_B7_DUO52HI53LO:F21	CPC017_ASC_24H_X3	F21	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC017_ASC_24H_X4_B7_DUO52HI53LO:F21	CPC017_ASC_24H_X4	F21	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC015_ASC_24H_X1_B7_DUO52HI53LO:K18	CPC015_ASC_24H_X1	K18	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC015_ASC_24H_X2_B7_DUO52HI53LO:K18	CPC015_ASC_24H_X2	K18	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC015_ASC_24H_X3_B7_DUO52HI53LO:K18	CPC015_ASC_24H_X3	K18	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC015_ASC_24H_X4_B7_DUO52HI53LO:K18	CPC015_ASC_24H_X4	K18	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC017_NPC_24H_X1_B7_DUO52HI53LO:M02	CPC017_NPC_24H_X1	M02	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC017_NPC_24H_X2_B7_DUO52HI53LO:M02	CPC017_NPC_24H_X2	M02	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC017_NPC_24H_X3_B7_DUO52HI53LO:M02	CPC017_NPC_24H_X3	M02	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC017_NPC_24H_X4_B7_DUO52HI53LO:M02	CPC017_NPC_24H_X4	M02	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC018_NPC_24H_X1_B7_DUO52HI53LO:F20	CPC018_NPC_24H_X1	F20	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC018_NPC_24H_X2_B7_DUO52HI53LO:F20	CPC018_NPC_24H_X2	F20	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC018_NPC_24H_X3_B7_DUO52HI53LO:F20	CPC018_NPC_24H_X3	F20	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_NPC_24H_X1_B7_DUO52HI53LO:N08	CPC016_NPC_24H_X1	N08	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_NPC_24H_X2_B7_DUO52HI53LO:N08	CPC016_NPC_24H_X2	N08	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_NPC_24H_X3_B7_DUO52HI53LO:N08	CPC016_NPC_24H_X3	N08	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_NPC_24H_X4_B7_DUO52HI53LO:N08	CPC016_NPC_24H_X4	N08	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_NPC_24H_X1_B7_DUO52HI53LO:N08	CPC016_NPC_24H_X1	N08	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_NPC_24H_X2_B7_DUO52HI53LO:N08	CPC016_NPC_24H_X2	N08	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_NPC_24H_X3_B7_DUO52HI53LO:N08	CPC016_NPC_24H_X3	N08	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_NPC_24H_X4_B7_DUO52HI53LO:N08	CPC016_NPC_24H_X4	N08	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC017_NPC_24H_X1_B7_DUO52HI53LO:L04	CPC017_NPC_24H_X1	L04	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC017_NPC_24H_X2_B7_DUO52HI53LO:L04	CPC017_NPC_24H_X2	L04	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC017_NPC_24H_X3_B7_DUO52HI53LO:L04	CPC017_NPC_24H_X3	L04	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC017_NPC_24H_X4_B7_DUO52HI53LO:L04	CPC017_NPC_24H_X4	L04	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC015_NPC_24H_X1_B7_DUO52HI53LO:J10	CPC015_NPC_24H_X1	J10	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC015_NPC_24H_X2_B7_DUO52HI53LO:J10	CPC015_NPC_24H_X2	J10	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC015_NPC_24H_X3_B7_DUO52HI53LO:J10	CPC015_NPC_24H_X3	J10	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC015_NPC_24H_X4_B7_DUO52HI53LO:J10	CPC015_NPC_24H_X4	J10	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC018_NPC_24H_X1_B7_DUO52HI53LO:J19	CPC018_NPC_24H_X1	J19	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC018_NPC_24H_X2_B7_DUO52HI53LO:J19	CPC018_NPC_24H_X2	J19	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC018_NPC_24H_X3_B7_DUO52HI53LO:J19	CPC018_NPC_24H_X3	J19	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC015_NPC_24H_X1_B7_DUO52HI53LO:L03	CPC015_NPC_24H_X1	L03	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC015_NPC_24H_X2_B7_DUO52HI53LO:L03	CPC015_NPC_24H_X2	L03	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC015_NPC_24H_X3_B7_DUO52HI53LO:L03	CPC015_NPC_24H_X3	L03	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC015_NPC_24H_X4_B7_DUO52HI53LO:L03	CPC015_NPC_24H_X4	L03	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC018_NPC_24H_X1_B7_DUO52HI53LO:A20	CPC018_NPC_24H_X1	A20	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC018_NPC_24H_X2_B7_DUO52HI53LO:A20	CPC018_NPC_24H_X2	A20	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC018_NPC_24H_X3_B7_DUO52HI53LO:A20	CPC018_NPC_24H_X3	A20	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC017_NPC_24H_X1_B7_DUO52HI53LO:O16	CPC017_NPC_24H_X1	O16	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC017_NPC_24H_X2_B7_DUO52HI53LO:O16	CPC017_NPC_24H_X2	O16	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC017_NPC_24H_X3_B7_DUO52HI53LO:O16	CPC017_NPC_24H_X3	O16	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC017_NPC_24H_X4_B7_DUO52HI53LO:O16	CPC017_NPC_24H_X4	O16	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC017_NPC_24H_X1_B7_DUO52HI53LO:I07	CPC017_NPC_24H_X1	I07	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC017_NPC_24H_X2_B7_DUO52HI53LO:I07	CPC017_NPC_24H_X2	I07	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC017_NPC_24H_X3_B7_DUO52HI53LO:I07	CPC017_NPC_24H_X3	I07	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC017_NPC_24H_X4_B7_DUO52HI53LO:I07	CPC017_NPC_24H_X4	I07	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC017_NPC_24H_X1_B7_DUO52HI53LO:I11	CPC017_NPC_24H_X1	I11	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC017_NPC_24H_X2_B7_DUO52HI53LO:I11	CPC017_NPC_24H_X2	I11	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC017_NPC_24H_X3_B7_DUO52HI53LO:I11	CPC017_NPC_24H_X3	I11	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC017_NPC_24H_X4_B7_DUO52HI53LO:I11	CPC017_NPC_24H_X4	I11	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC017_NPC_24H_X1_B7_DUO52HI53LO:K18	CPC017_NPC_24H_X1	K18	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC017_NPC_24H_X2_B7_DUO52HI53LO:K18	CPC017_NPC_24H_X2	K18	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC017_NPC_24H_X3_B7_DUO52HI53LO:K18	CPC017_NPC_24H_X3	K18	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC017_NPC_24H_X4_B7_DUO52HI53LO:K18	CPC017_NPC_24H_X4	K18	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC018_NPC_24H_X1_B7_DUO52HI53LO:H09	CPC018_NPC_24H_X1	H09	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC018_NPC_24H_X2_B7_DUO52HI53LO:H09	CPC018_NPC_24H_X2	H09	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC018_NPC_24H_X3_B7_DUO52HI53LO:H09	CPC018_NPC_24H_X3	H09	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	NMH001_NPC_24H_X1_B6_DUO52HI53LO:G06	NMH001_NPC_24H_X1	G06	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	NMH001_NPC_24H_X2.L2_B6_DUO52HI53LO:G06	NMH001_NPC_24H_X2.L2	G06	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	NMH001_NPC_24H_X2_B6_DUO52HI53LO:G06	NMH001_NPC_24H_X2	G06	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	NMH001_NPC_24H_X3.L2_B6_DUO52HI53LO:G06	NMH001_NPC_24H_X3.L2	G06	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	NMH001_NPC_6H_X1_B6_DUO52HI53LO:G06	NMH001_NPC_6H_X1	G06	trt_cp	10.0	um	6	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	NMH001_NPC_6H_X2.L2_B6_DUO52HI53LO:G06	NMH001_NPC_6H_X2.L2	G06	trt_cp	10.0	um	6	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	NMH001_NPC_6H_X3_B6_DUO52HI53LO:G06	NMH001_NPC_6H_X3	G06	trt_cp	10.0	um	6	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC015_NPC_24H_X1_B7_DUO52HI53LO:L01	CPC015_NPC_24H_X1	L01	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC015_NPC_24H_X1_B7_DUO52HI53LO:K04	CPC015_NPC_24H_X1	K04	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC015_NPC_24H_X2_B7_DUO52HI53LO:K04	CPC015_NPC_24H_X2	K04	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC015_NPC_24H_X3_B7_DUO52HI53LO:K04	CPC015_NPC_24H_X3	K04	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC015_NPC_24H_X4_B7_DUO52HI53LO:K04	CPC015_NPC_24H_X4	K04	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC015_NPC_24H_X1_B7_DUO52HI53LO:L05	CPC015_NPC_24H_X1	L05	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC015_NPC_24H_X2_B7_DUO52HI53LO:L05	CPC015_NPC_24H_X2	L05	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC015_NPC_24H_X3_B7_DUO52HI53LO:L05	CPC015_NPC_24H_X3	L05	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC015_NPC_24H_X4_B7_DUO52HI53LO:L05	CPC015_NPC_24H_X4	L05	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC016_NPC_24H_X1_B7_DUO52HI53LO:M15	CPC016_NPC_24H_X1	M15	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC016_NPC_24H_X2_B7_DUO52HI53LO:M15	CPC016_NPC_24H_X2	M15	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC016_NPC_24H_X3_B7_DUO52HI53LO:M15	CPC016_NPC_24H_X3	M15	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC016_NPC_24H_X4_B7_DUO52HI53LO:M15	CPC016_NPC_24H_X4	M15	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC015_NPC_24H_X1_B7_DUO52HI53LO:I22	CPC015_NPC_24H_X1	I22	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC015_NPC_24H_X2_B7_DUO52HI53LO:I22	CPC015_NPC_24H_X2	I22	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC015_NPC_24H_X3_B7_DUO52HI53LO:I22	CPC015_NPC_24H_X3	I22	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC015_NPC_24H_X4_B7_DUO52HI53LO:I22	CPC015_NPC_24H_X4	I22	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC016_NPC_24H_X1_B7_DUO52HI53LO:M20	CPC016_NPC_24H_X1	M20	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC016_NPC_24H_X2_B7_DUO52HI53LO:M20	CPC016_NPC_24H_X2	M20	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC016_NPC_24H_X3_B7_DUO52HI53LO:M20	CPC016_NPC_24H_X3	M20	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC016_NPC_24H_X4_B7_DUO52HI53LO:M20	CPC016_NPC_24H_X4	M20	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K47029922	NMH001_NPC_24H_X2.L2_B6_DUO52HI53LO:P04	NMH001_NPC_24H_X2.L2	P04	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K47029922	NMH001_NPC_24H_X3.L2_B6_DUO52HI53LO:P04	NMH001_NPC_24H_X3.L2	P04	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K47029922	NMH001_NPC_24H_X1_B6_DUO52HI53LO:P04	NMH001_NPC_24H_X1	P04	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K47029922	NMH001_NPC_24H_X2_B6_DUO52HI53LO:P04	NMH001_NPC_24H_X2	P04	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K47029922	NMH001_NPC_6H_X1_B6_DUO52HI53LO:P04	NMH001_NPC_6H_X1	P04	trt_cp	10.0	um	6	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K47029922	NMH001_NPC_6H_X2.L2_B6_DUO52HI53LO:P04	NMH001_NPC_6H_X2.L2	P04	trt_cp	10.0	um	6	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K47029922	NMH001_NPC_6H_X3_B6_DUO52HI53LO:P04	NMH001_NPC_6H_X3	P04	trt_cp	10.0	um	6	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K88809146	NMH002_NPC_24H_X1_B6_DUO52HI53LO:H08	NMH002_NPC_24H_X1	H08	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K88809146	NMH002_NPC_24H_X2_B6_DUO52HI53LO:H08	NMH002_NPC_24H_X2	H08	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K88809146	NMH002_NPC_24H_X3_B6_DUO52HI53LO:H08	NMH002_NPC_24H_X3	H08	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K88809146	NMH002_NPC_6H_X1_B6_DUO52HI53LO:H08	NMH002_NPC_6H_X1	H08	trt_cp	10.0	um	6	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K88809146	NMH002_NPC_6H_X2_B6_DUO52HI53LO:H08	NMH002_NPC_6H_X2	H08	trt_cp	10.0	um	6	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K88809146	NMH002_NPC_6H_X3_B6_DUO52HI53LO:H08	NMH002_NPC_6H_X3	H08	trt_cp	10.0	um	6	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC016_NPC_24H_X1_B7_DUO52HI53LO:O06	CPC016_NPC_24H_X1	O06	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC016_NPC_24H_X2_B7_DUO52HI53LO:O06	CPC016_NPC_24H_X2	O06	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC016_NPC_24H_X3_B7_DUO52HI53LO:O06	CPC016_NPC_24H_X3	O06	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC016_NPC_24H_X4_B7_DUO52HI53LO:O06	CPC016_NPC_24H_X4	O06	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC016_NPC_24H_X1_B7_DUO52HI53LO:N14	CPC016_NPC_24H_X1	N14	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC016_NPC_24H_X2_B7_DUO52HI53LO:N14	CPC016_NPC_24H_X2	N14	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC016_NPC_24H_X3_B7_DUO52HI53LO:N14	CPC016_NPC_24H_X3	N14	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC016_NPC_24H_X4_B7_DUO52HI53LO:N14	CPC016_NPC_24H_X4	N14	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC016_NPC_24H_X1_B7_DUO52HI53LO:K22	CPC016_NPC_24H_X1	K22	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC016_NPC_24H_X2_B7_DUO52HI53LO:K22	CPC016_NPC_24H_X2	K22	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC016_NPC_24H_X3_B7_DUO52HI53LO:K22	CPC016_NPC_24H_X3	K22	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC016_NPC_24H_X4_B7_DUO52HI53LO:K22	CPC016_NPC_24H_X4	K22	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC016_NPC_24H_X1_B7_DUO52HI53LO:C19	CPC016_NPC_24H_X1	C19	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC016_NPC_24H_X2_B7_DUO52HI53LO:C19	CPC016_NPC_24H_X2	C19	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC016_NPC_24H_X3_B7_DUO52HI53LO:C19	CPC016_NPC_24H_X3	C19	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC016_NPC_24H_X4_B7_DUO52HI53LO:C19	CPC016_NPC_24H_X4	C19	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC016_NPC_24H_X1_B7_DUO52HI53LO:H06	CPC016_NPC_24H_X1	H06	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC016_NPC_24H_X2_B7_DUO52HI53LO:H06	CPC016_NPC_24H_X2	H06	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC016_NPC_24H_X4_B7_DUO52HI53LO:H06	CPC016_NPC_24H_X4	H06	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC015_NPC_24H_X1_B7_DUO52HI53LO:L09	CPC015_NPC_24H_X1	L09	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC015_NPC_24H_X2_B7_DUO52HI53LO:L09	CPC015_NPC_24H_X2	L09	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC015_NPC_24H_X3_B7_DUO52HI53LO:L09	CPC015_NPC_24H_X3	L09	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC015_NPC_24H_X4_B7_DUO52HI53LO:L09	CPC015_NPC_24H_X4	L09	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC015_NPC_24H_X1_B7_DUO52HI53LO:L07	CPC015_NPC_24H_X1	L07	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC015_NPC_24H_X2_B7_DUO52HI53LO:L07	CPC015_NPC_24H_X2	L07	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC015_NPC_24H_X3_B7_DUO52HI53LO:L07	CPC015_NPC_24H_X3	L07	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC015_NPC_24H_X4_B7_DUO52HI53LO:L07	CPC015_NPC_24H_X4	L07	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC017_NPC_24H_X1_B7_DUO52HI53LO:F21	CPC017_NPC_24H_X1	F21	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC017_NPC_24H_X2_B7_DUO52HI53LO:F21	CPC017_NPC_24H_X2	F21	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC017_NPC_24H_X3_B7_DUO52HI53LO:F21	CPC017_NPC_24H_X3	F21	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC017_NPC_24H_X4_B7_DUO52HI53LO:F21	CPC017_NPC_24H_X4	F21	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-K32814891	NMH001_NPC_24H_X1_B6_DUO52HI53LO:N11	NMH001_NPC_24H_X1	N11	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-K32814891	NMH001_NPC_24H_X2.L2_B6_DUO52HI53LO:N11	NMH001_NPC_24H_X2.L2	N11	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-K32814891	NMH001_NPC_24H_X3.L2_B6_DUO52HI53LO:N11	NMH001_NPC_24H_X3.L2	N11	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-K32814891	NMH001_NPC_6H_X1_B6_DUO52HI53LO:N11	NMH001_NPC_6H_X1	N11	trt_cp	10.0	um	6	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-K32814891	NMH001_NPC_6H_X2.L2_B6_DUO52HI53LO:N11	NMH001_NPC_6H_X2.L2	N11	trt_cp	10.0	um	6	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-K32814891	NMH001_NPC_6H_X3_B6_DUO52HI53LO:N11	NMH001_NPC_6H_X3	N11	trt_cp	10.0	um	6	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC015_NPC_24H_X1_B7_DUO52HI53LO:K18	CPC015_NPC_24H_X1	K18	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC015_NPC_24H_X2_B7_DUO52HI53LO:K18	CPC015_NPC_24H_X2	K18	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC015_NPC_24H_X3_B7_DUO52HI53LO:K18	CPC015_NPC_24H_X3	K18	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC015_NPC_24H_X4_B7_DUO52HI53LO:K18	CPC015_NPC_24H_X4	K18	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC017_PHH_24H_X2_B7_DUO52HI53LO:M02	CPC017_PHH_24H_X2	M02	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC017_PHH_24H_X3_B7_DUO52HI53LO:M02	CPC017_PHH_24H_X3	M02	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC017_PHH_24H_X4_B7_DUO52HI53LO:M02	CPC017_PHH_24H_X4	M02	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC018_PHH_24H_X1_B7_DUO52HI53LO:F20	CPC018_PHH_24H_X1	F20	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC018_PHH_24H_X2_B7_DUO52HI53LO:F20	CPC018_PHH_24H_X2	F20	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC018_PHH_24H_X4_B7_DUO52HI53LO:F20	CPC018_PHH_24H_X4	F20	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC017_PHH_24H_X2_B7_DUO52HI53LO:L04	CPC017_PHH_24H_X2	L04	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC017_PHH_24H_X3_B7_DUO52HI53LO:L04	CPC017_PHH_24H_X3	L04	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC017_PHH_24H_X4_B7_DUO52HI53LO:L04	CPC017_PHH_24H_X4	L04	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC015_PHH_24H_X2_B7_DUO52HI53LO:J10	CPC015_PHH_24H_X2	J10	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC015_PHH_24H_X4_B7_DUO52HI53LO:J10	CPC015_PHH_24H_X4	J10	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC018_PHH_24H_X1_B7_DUO52HI53LO:J19	CPC018_PHH_24H_X1	J19	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC018_PHH_24H_X2_B7_DUO52HI53LO:J19	CPC018_PHH_24H_X2	J19	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC018_PHH_24H_X4_B7_DUO52HI53LO:J19	CPC018_PHH_24H_X4	J19	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC015_PHH_24H_X2_B7_DUO52HI53LO:L03	CPC015_PHH_24H_X2	L03	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC015_PHH_24H_X4_B7_DUO52HI53LO:L03	CPC015_PHH_24H_X4	L03	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC018_PHH_24H_X1_B7_DUO52HI53LO:A20	CPC018_PHH_24H_X1	A20	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC018_PHH_24H_X2_B7_DUO52HI53LO:A20	CPC018_PHH_24H_X2	A20	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC018_PHH_24H_X4_B7_DUO52HI53LO:A20	CPC018_PHH_24H_X4	A20	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC017_PHH_24H_X2_B7_DUO52HI53LO:O16	CPC017_PHH_24H_X2	O16	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC017_PHH_24H_X3_B7_DUO52HI53LO:O16	CPC017_PHH_24H_X3	O16	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC017_PHH_24H_X4_B7_DUO52HI53LO:O16	CPC017_PHH_24H_X4	O16	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC017_PHH_24H_X2_B7_DUO52HI53LO:I07	CPC017_PHH_24H_X2	I07	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC017_PHH_24H_X3_B7_DUO52HI53LO:I07	CPC017_PHH_24H_X3	I07	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC017_PHH_24H_X4_B7_DUO52HI53LO:I07	CPC017_PHH_24H_X4	I07	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC017_PHH_24H_X2_B7_DUO52HI53LO:I11	CPC017_PHH_24H_X2	I11	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC017_PHH_24H_X3_B7_DUO52HI53LO:I11	CPC017_PHH_24H_X3	I11	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC017_PHH_24H_X4_B7_DUO52HI53LO:I11	CPC017_PHH_24H_X4	I11	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC017_PHH_24H_X2_B7_DUO52HI53LO:K18	CPC017_PHH_24H_X2	K18	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC017_PHH_24H_X3_B7_DUO52HI53LO:K18	CPC017_PHH_24H_X3	K18	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC017_PHH_24H_X4_B7_DUO52HI53LO:K18	CPC017_PHH_24H_X4	K18	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC018_PHH_24H_X1_B7_DUO52HI53LO:H09	CPC018_PHH_24H_X1	H09	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC018_PHH_24H_X2_B7_DUO52HI53LO:H09	CPC018_PHH_24H_X2	H09	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC018_PHH_24H_X4_B7_DUO52HI53LO:H09	CPC018_PHH_24H_X4	H09	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC015_PHH_24H_X4_B7_DUO52HI53LO:L01	CPC015_PHH_24H_X4	L01	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC015_PHH_24H_X2_B7_DUO52HI53LO:K04	CPC015_PHH_24H_X2	K04	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC015_PHH_24H_X4_B7_DUO52HI53LO:K04	CPC015_PHH_24H_X4	K04	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC015_PHH_24H_X2_B7_DUO52HI53LO:L05	CPC015_PHH_24H_X2	L05	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC015_PHH_24H_X4_B7_DUO52HI53LO:L05	CPC015_PHH_24H_X4	L05	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC015_PHH_24H_X2_B7_DUO52HI53LO:I22	CPC015_PHH_24H_X2	I22	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC015_PHH_24H_X4_B7_DUO52HI53LO:I22	CPC015_PHH_24H_X4	I22	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC015_PHH_24H_X2_B7_DUO52HI53LO:L09	CPC015_PHH_24H_X2	L09	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC015_PHH_24H_X4_B7_DUO52HI53LO:L09	CPC015_PHH_24H_X4	L09	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC015_PHH_24H_X2_B7_DUO52HI53LO:L07	CPC015_PHH_24H_X2	L07	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC015_PHH_24H_X4_B7_DUO52HI53LO:L07	CPC015_PHH_24H_X4	L07	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC017_PHH_24H_X4_B7_DUO52HI53LO:F21	CPC017_PHH_24H_X4	F21	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC015_PHH_24H_X2_B7_DUO52HI53LO:K18	CPC015_PHH_24H_X2	K18	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC015_PHH_24H_X4_B7_DUO52HI53LO:K18	CPC015_PHH_24H_X4	K18	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC017_SKB_24H_X2_B7_DUO52HI53LO:M02	CPC017_SKB_24H_X2	M02	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
2995	N06AA01	desipramine	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCCN1c2ccccc2CCc2ccccc21	BRD-K60762818	CPC017_SKB_24H_X3_B7_DUO52HI53LO:M02	CPC017_SKB_24H_X3	M02	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC018_SKB_24H_X1_B7_DUO52HI53LO:F20	CPC018_SKB_24H_X1	F20	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC018_SKB_24H_X2_B7_DUO52HI53LO:F20	CPC018_SKB_24H_X2	F20	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
2801	N06AA04	clomipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	BRD-K52989797	CPC018_SKB_24H_X3_B7_DUO52HI53LO:F20	CPC018_SKB_24H_X3	F20	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_SKB_24H_X1_B7_DUO52HI53LO:N08	CPC016_SKB_24H_X1	N08	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_SKB_24H_X2_B7_DUO52HI53LO:N08	CPC016_SKB_24H_X2	N08	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_SKB_24H_X1_B7_DUO52HI53LO:N08	CPC016_SKB_24H_X1	N08	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_SKB_24H_X2_B7_DUO52HI53LO:N08	CPC016_SKB_24H_X2	N08	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC017_SKB_24H_X2_B7_DUO52HI53LO:L04	CPC017_SKB_24H_X2	L04	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
9419	N06AA08	dibenzepin	CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	BRD-K79145749	CPC017_SKB_24H_X3_B7_DUO52HI53LO:L04	CPC017_SKB_24H_X3	L04	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC015_SKB_24H_X2_B7_DUO52HI53LO:J10	CPC015_SKB_24H_X2	J10	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	CPC015_SKB_24H_X3_B7_DUO52HI53LO:J10	CPC015_SKB_24H_X3	J10	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC018_SKB_24H_X1_B7_DUO52HI53LO:J19	CPC018_SKB_24H_X1	J19	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC018_SKB_24H_X2_B7_DUO52HI53LO:J19	CPC018_SKB_24H_X2	J19	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
4543	N06AA10	nortriptyline	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CNCCC=C1c2ccccc2CCc2ccccc21	BRD-K91263825	CPC018_SKB_24H_X3_B7_DUO52HI53LO:J19	CPC018_SKB_24H_X3	J19	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC015_SKB_24H_X2_B7_DUO52HI53LO:L03	CPC015_SKB_24H_X2	L03	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
4976	N06AA11	protriptyline	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13	CNCCCC1c2ccccc2C=Cc2ccccc21	BRD-K42098891	CPC015_SKB_24H_X3_B7_DUO52HI53LO:L03	CPC015_SKB_24H_X3	L03	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC018_SKB_24H_X1_B7_DUO52HI53LO:A20	CPC018_SKB_24H_X1	A20	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC018_SKB_24H_X2_B7_DUO52HI53LO:A20	CPC018_SKB_24H_X2	A20	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K36616567	CPC018_SKB_24H_X3_B7_DUO52HI53LO:A20	CPC018_SKB_24H_X3	A20	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC017_SKB_24H_X2_B7_DUO52HI53LO:O16	CPC017_SKB_24H_X2	O16	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K37694030	CPC017_SKB_24H_X3_B7_DUO52HI53LO:O16	CPC017_SKB_24H_X3	O16	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC017_SKB_24H_X2_B7_DUO52HI53LO:I07	CPC017_SKB_24H_X2	I07	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
667477	N06AA12	doxepin	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc21	BRD-K54462405	CPC017_SKB_24H_X3_B7_DUO52HI53LO:I07	CPC017_SKB_24H_X3	I07	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC017_SKB_24H_X2_B7_DUO52HI53LO:I11	CPC017_SKB_24H_X2	I11	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
5284550	N06AA16	dosulepin	CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CSc2ccccc21	BRD-K54759182	CPC017_SKB_24H_X3_B7_DUO52HI53LO:I11	CPC017_SKB_24H_X3	I11	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC017_SKB_24H_X2_B7_DUO52HI53LO:K18	CPC017_SKB_24H_X2	K18	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
2170	N06AA17	amoxapine	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	BRD-K02265150	CPC017_SKB_24H_X3_B7_DUO52HI53LO:K18	CPC017_SKB_24H_X3	K18	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC018_SKB_24H_X1_B7_DUO52HI53LO:H09	CPC018_SKB_24H_X1	H09	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC018_SKB_24H_X2_B7_DUO52HI53LO:H09	CPC018_SKB_24H_X2	H09	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
4011	N06AA21	maprotiline	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	CNCCCC12CCC(c3ccccc31)c1ccccc12	BRD-K25433859	CPC018_SKB_24H_X3_B7_DUO52HI53LO:H09	CPC018_SKB_24H_X3	H09	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC015_SKB_24H_X2_B7_DUO52HI53LO:L01	CPC015_SKB_24H_X2	L01	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
43815	N06AB05	paroxetine	C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	BRD-K37991163	CPC015_SKB_24H_X3_B7_DUO52HI53LO:L01	CPC015_SKB_24H_X3	L01	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC015_SKB_24H_X2_B7_DUO52HI53LO:K04	CPC015_SKB_24H_X2	K04	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
68617	N06AB06	sertraline	CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21	BRD-K82036761	CPC015_SKB_24H_X3_B7_DUO52HI53LO:K04	CPC015_SKB_24H_X3	K04	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC015_SKB_24H_X2_B7_DUO52HI53LO:L05	CPC015_SKB_24H_X2	L05	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
2081	N06AB07	alaproclate	CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	BRD-A14966924	CPC015_SKB_24H_X3_B7_DUO52HI53LO:L05	CPC015_SKB_24H_X3	L05	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC016_SKB_24H_X1_B7_DUO52HI53LO:M15	CPC016_SKB_24H_X1	M15	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC016_SKB_24H_X2_B7_DUO52HI53LO:M15	CPC016_SKB_24H_X2	M15	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC016_SKB_24H_X3_B7_DUO52HI53LO:M15	CPC016_SKB_24H_X3	M15	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC015_SKB_24H_X2_B7_DUO52HI53LO:I22	CPC015_SKB_24H_X2	I22	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
146570	N06AB10	escitalopram	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	BRD-K70301876	CPC015_SKB_24H_X3_B7_DUO52HI53LO:I22	CPC015_SKB_24H_X3	I22	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC016_SKB_24H_X1_B7_DUO52HI53LO:M20	CPC016_SKB_24H_X1	M20	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC016_SKB_24H_X2_B7_DUO52HI53LO:M20	CPC016_SKB_24H_X2	M20	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC016_SKB_24H_X3_B7_DUO52HI53LO:M20	CPC016_SKB_24H_X3	M20	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC016_SKB_24H_X1_B7_DUO52HI53LO:O06	CPC016_SKB_24H_X1	O06	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC016_SKB_24H_X2_B7_DUO52HI53LO:O06	CPC016_SKB_24H_X2	O06	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC016_SKB_24H_X3_B7_DUO52HI53LO:O06	CPC016_SKB_24H_X3	O06	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC016_SKB_24H_X1_B7_DUO52HI53LO:N14	CPC016_SKB_24H_X1	N14	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC016_SKB_24H_X2_B7_DUO52HI53LO:N14	CPC016_SKB_24H_X2	N14	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC016_SKB_24H_X3_B7_DUO52HI53LO:N14	CPC016_SKB_24H_X3	N14	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC016_SKB_24H_X1_B7_DUO52HI53LO:K22	CPC016_SKB_24H_X1	K22	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC016_SKB_24H_X2_B7_DUO52HI53LO:K22	CPC016_SKB_24H_X2	K22	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC016_SKB_24H_X3_B7_DUO52HI53LO:K22	CPC016_SKB_24H_X3	K22	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC016_SKB_24H_X1_B7_DUO52HI53LO:C19	CPC016_SKB_24H_X1	C19	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC016_SKB_24H_X2_B7_DUO52HI53LO:C19	CPC016_SKB_24H_X2	C19	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC016_SKB_24H_X3_B7_DUO52HI53LO:C19	CPC016_SKB_24H_X3	C19	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC016_SKB_24H_X1_B7_DUO52HI53LO:H06	CPC016_SKB_24H_X1	H06	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC016_SKB_24H_X2_B7_DUO52HI53LO:H06	CPC016_SKB_24H_X2	H06	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC016_SKB_24H_X3_B7_DUO52HI53LO:H06	CPC016_SKB_24H_X3	H06	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC015_SKB_24H_X2_B7_DUO52HI53LO:L09	CPC015_SKB_24H_X2	L09	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
444	N06AX12	bupropion	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	BRD-A05186015	CPC015_SKB_24H_X3_B7_DUO52HI53LO:L09	CPC015_SKB_24H_X3	L09	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC015_SKB_24H_X2_B7_DUO52HI53LO:L07	CPC015_SKB_24H_X2	L07	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
5656	N06AX16	venlafaxine	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	BRD-A51714012	CPC015_SKB_24H_X3_B7_DUO52HI53LO:L07	CPC015_SKB_24H_X3	L07	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC017_SKB_24H_X2_B7_DUO52HI53LO:F21	CPC017_SKB_24H_X2	F21	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-A43974499	CPC017_SKB_24H_X3_B7_DUO52HI53LO:F21	CPC017_SKB_24H_X3	F21	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC015_SKB_24H_X2_B7_DUO52HI53LO:K18	CPC015_SKB_24H_X2	K18	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
60835	N06AX21	duloxetine	CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	BRD-K71103788	CPC015_SKB_24H_X3_B7_DUO52HI53LO:K18	CPC015_SKB_24H_X3	K18	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_6H_X1_B10:O03	BRAF001_HEK293T_6H_X1	O03	trt_cp	10.0	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_6H_X1_B10:O04	BRAF001_HEK293T_6H_X1	O04	trt_cp	2.5	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_6H_X1_B10:O11	BRAF001_HEK293T_6H_X1	O11	trt_cp	10.0	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_6H_X1_B10:O12	BRAF001_HEK293T_6H_X1	O12	trt_cp	2.5	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_6H_X1_B10:O19	BRAF001_HEK293T_6H_X1	O19	trt_cp	10.0	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_6H_X1_B10:O20	BRAF001_HEK293T_6H_X1	O20	trt_cp	2.5	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_6H_X1_B10:P03	BRAF001_HEK293T_6H_X1	P03	trt_cp	0.625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_6H_X1_B10:P04	BRAF001_HEK293T_6H_X1	P04	trt_cp	0.15625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_6H_X1_B10:P11	BRAF001_HEK293T_6H_X1	P11	trt_cp	0.625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_6H_X1_B10:P12	BRAF001_HEK293T_6H_X1	P12	trt_cp	0.15625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_6H_X1_B10:P19	BRAF001_HEK293T_6H_X1	P19	trt_cp	0.625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_6H_X1_B10:P20	BRAF001_HEK293T_6H_X1	P20	trt_cp	0.15625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_6H_X2_B10:O03	BRAF001_HEK293T_6H_X2	O03	trt_cp	10.0	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_6H_X2_B10:O04	BRAF001_HEK293T_6H_X2	O04	trt_cp	2.5	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_6H_X2_B10:O11	BRAF001_HEK293T_6H_X2	O11	trt_cp	10.0	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_6H_X2_B10:O12	BRAF001_HEK293T_6H_X2	O12	trt_cp	2.5	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_6H_X2_B10:O19	BRAF001_HEK293T_6H_X2	O19	trt_cp	10.0	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_6H_X2_B10:O20	BRAF001_HEK293T_6H_X2	O20	trt_cp	2.5	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_6H_X2_B10:P03	BRAF001_HEK293T_6H_X2	P03	trt_cp	0.625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_6H_X2_B10:P04	BRAF001_HEK293T_6H_X2	P04	trt_cp	0.15625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_6H_X2_B10:P11	BRAF001_HEK293T_6H_X2	P11	trt_cp	0.625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_6H_X2_B10:P12	BRAF001_HEK293T_6H_X2	P12	trt_cp	0.15625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_6H_X2_B10:P19	BRAF001_HEK293T_6H_X2	P19	trt_cp	0.625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_6H_X2_B10:P20	BRAF001_HEK293T_6H_X2	P20	trt_cp	0.15625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_6H_X3_B10:O03	BRAF001_HEK293T_6H_X3	O03	trt_cp	10.0	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_6H_X3_B10:O04	BRAF001_HEK293T_6H_X3	O04	trt_cp	2.5	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_6H_X3_B10:O11	BRAF001_HEK293T_6H_X3	O11	trt_cp	10.0	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_6H_X3_B10:O12	BRAF001_HEK293T_6H_X3	O12	trt_cp	2.5	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_6H_X3_B10:O19	BRAF001_HEK293T_6H_X3	O19	trt_cp	10.0	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_6H_X3_B10:O20	BRAF001_HEK293T_6H_X3	O20	trt_cp	2.5	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_6H_X3_B10:P03	BRAF001_HEK293T_6H_X3	P03	trt_cp	0.625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_6H_X3_B10:P04	BRAF001_HEK293T_6H_X3	P04	trt_cp	0.15625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_6H_X3_B10:P11	BRAF001_HEK293T_6H_X3	P11	trt_cp	0.625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_6H_X3_B10:P12	BRAF001_HEK293T_6H_X3	P12	trt_cp	0.15625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_6H_X3_B10:P19	BRAF001_HEK293T_6H_X3	P19	trt_cp	0.625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_6H_X3_B10:P20	BRAF001_HEK293T_6H_X3	P20	trt_cp	0.15625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_24H_X1_B10:O03	BRAF001_HEK293T_24H_X1	O03	trt_cp	10.0	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_24H_X1_B10:O04	BRAF001_HEK293T_24H_X1	O04	trt_cp	2.5	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_24H_X1_B10:O11	BRAF001_HEK293T_24H_X1	O11	trt_cp	10.0	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_24H_X1_B10:O12	BRAF001_HEK293T_24H_X1	O12	trt_cp	2.5	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_24H_X1_B10:O19	BRAF001_HEK293T_24H_X1	O19	trt_cp	10.0	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_24H_X1_B10:O20	BRAF001_HEK293T_24H_X1	O20	trt_cp	2.5	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_24H_X1_B10:P03	BRAF001_HEK293T_24H_X1	P03	trt_cp	0.625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_24H_X1_B10:P04	BRAF001_HEK293T_24H_X1	P04	trt_cp	0.15625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_24H_X1_B10:P11	BRAF001_HEK293T_24H_X1	P11	trt_cp	0.625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_24H_X1_B10:P12	BRAF001_HEK293T_24H_X1	P12	trt_cp	0.15625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_24H_X1_B10:P19	BRAF001_HEK293T_24H_X1	P19	trt_cp	0.625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_24H_X1_B10:P20	BRAF001_HEK293T_24H_X1	P20	trt_cp	0.15625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_24H_X2_B10:O03	BRAF001_HEK293T_24H_X2	O03	trt_cp	10.0	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_24H_X2_B10:O04	BRAF001_HEK293T_24H_X2	O04	trt_cp	2.5	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_24H_X2_B10:O11	BRAF001_HEK293T_24H_X2	O11	trt_cp	10.0	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_24H_X2_B10:O12	BRAF001_HEK293T_24H_X2	O12	trt_cp	2.5	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_24H_X2_B10:O19	BRAF001_HEK293T_24H_X2	O19	trt_cp	10.0	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_24H_X2_B10:O20	BRAF001_HEK293T_24H_X2	O20	trt_cp	2.5	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_24H_X2_B10:P03	BRAF001_HEK293T_24H_X2	P03	trt_cp	0.625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_24H_X2_B10:P04	BRAF001_HEK293T_24H_X2	P04	trt_cp	0.15625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_24H_X2_B10:P11	BRAF001_HEK293T_24H_X2	P11	trt_cp	0.625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_24H_X2_B10:P12	BRAF001_HEK293T_24H_X2	P12	trt_cp	0.15625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_24H_X2_B10:P20	BRAF001_HEK293T_24H_X2	P20	trt_cp	0.15625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_24H_X3_B10:O03	BRAF001_HEK293T_24H_X3	O03	trt_cp	10.0	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_24H_X3_B10:O04	BRAF001_HEK293T_24H_X3	O04	trt_cp	2.5	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_24H_X3_B10:O11	BRAF001_HEK293T_24H_X3	O11	trt_cp	10.0	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_24H_X3_B10:O12	BRAF001_HEK293T_24H_X3	O12	trt_cp	2.5	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_24H_X3_B10:P03	BRAF001_HEK293T_24H_X3	P03	trt_cp	0.625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_24H_X3_B10:P04	BRAF001_HEK293T_24H_X3	P04	trt_cp	0.15625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_24H_X3_B10:P11	BRAF001_HEK293T_24H_X3	P11	trt_cp	0.625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
3696	N06AA02	imipramine	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCCN1c2ccccc2CCc2ccccc21	BRD-K38436528	BRAF001_HEK293T_24H_X3_B10:P12	BRAF001_HEK293T_24H_X3	P12	trt_cp	0.15625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_6H_X1_B10:O07	BRAF001_HEK293T_6H_X1	O07	trt_cp	10.0	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_6H_X1_B10:O08	BRAF001_HEK293T_6H_X1	O08	trt_cp	2.5	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_6H_X1_B10:O15	BRAF001_HEK293T_6H_X1	O15	trt_cp	10.0	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_6H_X1_B10:O16	BRAF001_HEK293T_6H_X1	O16	trt_cp	2.5	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_6H_X1_B10:O23	BRAF001_HEK293T_6H_X1	O23	trt_cp	10.0	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_6H_X1_B10:O24	BRAF001_HEK293T_6H_X1	O24	trt_cp	2.5	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_6H_X1_B10:P07	BRAF001_HEK293T_6H_X1	P07	trt_cp	0.625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_6H_X1_B10:P08	BRAF001_HEK293T_6H_X1	P08	trt_cp	0.15625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_6H_X1_B10:P15	BRAF001_HEK293T_6H_X1	P15	trt_cp	0.625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_6H_X1_B10:P16	BRAF001_HEK293T_6H_X1	P16	trt_cp	0.15625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_6H_X1_B10:P23	BRAF001_HEK293T_6H_X1	P23	trt_cp	0.625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_6H_X1_B10:P24	BRAF001_HEK293T_6H_X1	P24	trt_cp	0.15625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_6H_X2_B10:O07	BRAF001_HEK293T_6H_X2	O07	trt_cp	10.0	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_6H_X2_B10:O08	BRAF001_HEK293T_6H_X2	O08	trt_cp	2.5	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_6H_X2_B10:O15	BRAF001_HEK293T_6H_X2	O15	trt_cp	10.0	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_6H_X2_B10:O16	BRAF001_HEK293T_6H_X2	O16	trt_cp	2.5	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_6H_X2_B10:O23	BRAF001_HEK293T_6H_X2	O23	trt_cp	10.0	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_6H_X2_B10:O24	BRAF001_HEK293T_6H_X2	O24	trt_cp	2.5	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_6H_X2_B10:P07	BRAF001_HEK293T_6H_X2	P07	trt_cp	0.625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_6H_X2_B10:P08	BRAF001_HEK293T_6H_X2	P08	trt_cp	0.15625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_6H_X2_B10:P15	BRAF001_HEK293T_6H_X2	P15	trt_cp	0.625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_6H_X2_B10:P16	BRAF001_HEK293T_6H_X2	P16	trt_cp	0.15625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_6H_X2_B10:P23	BRAF001_HEK293T_6H_X2	P23	trt_cp	0.625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_6H_X2_B10:P24	BRAF001_HEK293T_6H_X2	P24	trt_cp	0.15625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_6H_X3_B10:O07	BRAF001_HEK293T_6H_X3	O07	trt_cp	10.0	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_6H_X3_B10:O08	BRAF001_HEK293T_6H_X3	O08	trt_cp	2.5	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_6H_X3_B10:O15	BRAF001_HEK293T_6H_X3	O15	trt_cp	10.0	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_6H_X3_B10:O16	BRAF001_HEK293T_6H_X3	O16	trt_cp	2.5	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_6H_X3_B10:O23	BRAF001_HEK293T_6H_X3	O23	trt_cp	10.0	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_6H_X3_B10:O24	BRAF001_HEK293T_6H_X3	O24	trt_cp	2.5	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_6H_X3_B10:P07	BRAF001_HEK293T_6H_X3	P07	trt_cp	0.625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_6H_X3_B10:P08	BRAF001_HEK293T_6H_X3	P08	trt_cp	0.15625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_6H_X3_B10:P15	BRAF001_HEK293T_6H_X3	P15	trt_cp	0.625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_6H_X3_B10:P16	BRAF001_HEK293T_6H_X3	P16	trt_cp	0.15625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_6H_X3_B10:P23	BRAF001_HEK293T_6H_X3	P23	trt_cp	0.625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_6H_X3_B10:P24	BRAF001_HEK293T_6H_X3	P24	trt_cp	0.15625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_24H_X1_B10:O07	BRAF001_HEK293T_24H_X1	O07	trt_cp	10.0	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_24H_X1_B10:O08	BRAF001_HEK293T_24H_X1	O08	trt_cp	2.5	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_24H_X1_B10:O15	BRAF001_HEK293T_24H_X1	O15	trt_cp	10.0	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_24H_X1_B10:O16	BRAF001_HEK293T_24H_X1	O16	trt_cp	2.5	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_24H_X1_B10:O23	BRAF001_HEK293T_24H_X1	O23	trt_cp	10.0	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_24H_X1_B10:O24	BRAF001_HEK293T_24H_X1	O24	trt_cp	2.5	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_24H_X1_B10:P07	BRAF001_HEK293T_24H_X1	P07	trt_cp	0.625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_24H_X1_B10:P08	BRAF001_HEK293T_24H_X1	P08	trt_cp	0.15625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_24H_X1_B10:P15	BRAF001_HEK293T_24H_X1	P15	trt_cp	0.625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_24H_X1_B10:P16	BRAF001_HEK293T_24H_X1	P16	trt_cp	0.15625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_24H_X1_B10:P23	BRAF001_HEK293T_24H_X1	P23	trt_cp	0.625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_24H_X1_B10:P24	BRAF001_HEK293T_24H_X1	P24	trt_cp	0.15625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_24H_X2_B10:O07	BRAF001_HEK293T_24H_X2	O07	trt_cp	10.0	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_24H_X2_B10:O08	BRAF001_HEK293T_24H_X2	O08	trt_cp	2.5	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_24H_X2_B10:O15	BRAF001_HEK293T_24H_X2	O15	trt_cp	10.0	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_24H_X2_B10:O16	BRAF001_HEK293T_24H_X2	O16	trt_cp	2.5	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_24H_X2_B10:P07	BRAF001_HEK293T_24H_X2	P07	trt_cp	0.625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_24H_X2_B10:P08	BRAF001_HEK293T_24H_X2	P08	trt_cp	0.15625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_24H_X2_B10:P15	BRAF001_HEK293T_24H_X2	P15	trt_cp	0.625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_24H_X2_B10:P16	BRAF001_HEK293T_24H_X2	P16	trt_cp	0.15625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_24H_X2_B10:P23	BRAF001_HEK293T_24H_X2	P23	trt_cp	0.625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_24H_X2_B10:P24	BRAF001_HEK293T_24H_X2	P24	trt_cp	0.15625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_24H_X3_B10:O07	BRAF001_HEK293T_24H_X3	O07	trt_cp	10.0	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_24H_X3_B10:O08	BRAF001_HEK293T_24H_X3	O08	trt_cp	2.5	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_24H_X3_B10:O15	BRAF001_HEK293T_24H_X3	O15	trt_cp	10.0	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_24H_X3_B10:O16	BRAF001_HEK293T_24H_X3	O16	trt_cp	2.5	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_24H_X3_B10:O23	BRAF001_HEK293T_24H_X3	O23	trt_cp	10.0	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_24H_X3_B10:P07	BRAF001_HEK293T_24H_X3	P07	trt_cp	0.625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_24H_X3_B10:P08	BRAF001_HEK293T_24H_X3	P08	trt_cp	0.15625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_24H_X3_B10:P15	BRAF001_HEK293T_24H_X3	P15	trt_cp	0.625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_24H_X3_B10:P16	BRAF001_HEK293T_24H_X3	P16	trt_cp	0.15625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_24H_X3_B10:P23	BRAF001_HEK293T_24H_X3	P23	trt_cp	0.625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
2160	N06AA09	amitriptyline	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2CCc2ccccc21	BRD-K53737926	BRAF001_HEK293T_24H_X3_B10:P24	BRAF001_HEK293T_24H_X3	P24	trt_cp	0.15625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_NEU_24H_X2_B7_DUO52HI53LO:N08	CPC016_NEU_24H_X2	N08	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_NEU_24H_X3_B7_DUO52HI53LO:N08	CPC016_NEU_24H_X3	N08	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_NEU_24H_X2_B7_DUO52HI53LO:N08	CPC016_NEU_24H_X2	N08	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
5584	N06AA06	trimipramine	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	BRD-A19195498	CPC016_NEU_24H_X3_B7_DUO52HI53LO:N08	CPC016_NEU_24H_X3	N08	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	NMH001_NEU_24H_X1.L2_B6_DUO52HI53LO:G06	NMH001_NEU_24H_X1.L2	G06	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	NMH001_NEU_24H_X2.L2_B6_DUO52HI53LO:G06	NMH001_NEU_24H_X2.L2	G06	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	NMH001_NEU_24H_X3.L2_B6_DUO52HI53LO:G06	NMH001_NEU_24H_X3.L2	G06	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	NMH001_NEU_6H_X1_B6_DUO52HI53LO:G06	NMH001_NEU_6H_X1	G06	trt_cp	10.0	um	6	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	NMH001_NEU_6H_X2_B6_DUO52HI53LO:G06	NMH001_NEU_6H_X2	G06	trt_cp	10.0	um	6	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	NMH001_NEU_6H_X3.L2_B6_DUO52HI53LO:G06	NMH001_NEU_6H_X3.L2	G06	trt_cp	10.0	um	6	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	NMH001_NEU_6H_X3_B6_DUO52HI53LO:G06	NMH001_NEU_6H_X3	G06	trt_cp	10.0	um	6	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC016_NEU_24H_X2_B7_DUO52HI53LO:M15	CPC016_NEU_24H_X2	M15	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC016_NEU_24H_X3_B7_DUO52HI53LO:M15	CPC016_NEU_24H_X3	M15	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
5324346	N06AB08	fluvoxamine	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	BRD-K72676686	CPC016_NEU_24H_X4_B7_DUO52HI53LO:M15	CPC016_NEU_24H_X4	M15	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC016_NEU_24H_X2_B7_DUO52HI53LO:M20	CPC016_NEU_24H_X2	M20	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC016_NEU_24H_X3_B7_DUO52HI53LO:M20	CPC016_NEU_24H_X3	M20	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
3759	N06AF01	isocarboxazid	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Cc1cc(C(=O)NNCc2ccccc2)no1	BRD-K93332168	CPC016_NEU_24H_X4_B7_DUO52HI53LO:M20	CPC016_NEU_24H_X4	M20	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K47029922	NMH001_NEU_24H_X1.L2_B6_DUO52HI53LO:P04	NMH001_NEU_24H_X1.L2	P04	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K47029922	NMH001_NEU_24H_X2.L2_B6_DUO52HI53LO:P04	NMH001_NEU_24H_X2.L2	P04	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K47029922	NMH001_NEU_24H_X3.L2_B6_DUO52HI53LO:P04	NMH001_NEU_24H_X3.L2	P04	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K47029922	NMH001_NEU_6H_X1_B6_DUO52HI53LO:P04	NMH001_NEU_6H_X1	P04	trt_cp	10.0	um	6	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K47029922	NMH001_NEU_6H_X2_B6_DUO52HI53LO:P04	NMH001_NEU_6H_X2	P04	trt_cp	10.0	um	6	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K47029922	NMH001_NEU_6H_X3.L2_B6_DUO52HI53LO:P04	NMH001_NEU_6H_X3.L2	P04	trt_cp	10.0	um	6	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K47029922	NMH001_NEU_6H_X3_B6_DUO52HI53LO:P04	NMH001_NEU_6H_X3	P04	trt_cp	10.0	um	6	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K88809146	NMH002_NEU_24H_X1_B6_DUO52HI53LO:H08	NMH002_NEU_24H_X1	H08	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K88809146	NMH002_NEU_24H_X2_B6_DUO52HI53LO:H08	NMH002_NEU_24H_X2	H08	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K88809146	NMH002_NEU_24H_X3_B6_DUO52HI53LO:H08	NMH002_NEU_24H_X3	H08	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K88809146	NMH002_NEU_6H_X1_B6_DUO52HI53LO:H08	NMH002_NEU_6H_X1	H08	trt_cp	10.0	um	6	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K88809146	NMH002_NEU_6H_X2_B6_DUO52HI53LO:H08	NMH002_NEU_6H_X2	H08	trt_cp	10.0	um	6	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K88809146	NMH002_NEU_6H_X3_B6_DUO52HI53LO:H08	NMH002_NEU_6H_X3	H08	trt_cp	10.0	um	6	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC016_NEU_24H_X2_B7_DUO52HI53LO:O06	CPC016_NEU_24H_X2	O06	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC016_NEU_24H_X3_B7_DUO52HI53LO:O06	CPC016_NEU_24H_X3	O06	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
4184	N06AX03	mianserin	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	CN1CCN2c3ccccc3Cc3ccccc3C2C1	BRD-A19661776	CPC016_NEU_24H_X4_B7_DUO52HI53LO:O06	CPC016_NEU_24H_X4	O06	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC016_NEU_24H_X2_B7_DUO52HI53LO:N14	CPC016_NEU_24H_X2	N14	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC016_NEU_24H_X3_B7_DUO52HI53LO:N14	CPC016_NEU_24H_X3	N14	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
5533	N06AX05	trazodone	C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	BRD-K70778732	CPC016_NEU_24H_X4_B7_DUO52HI53LO:N14	CPC016_NEU_24H_X4	N14	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC016_NEU_24H_X2_B7_DUO52HI53LO:K22	CPC016_NEU_24H_X2	K22	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC016_NEU_24H_X3_B7_DUO52HI53LO:K22	CPC016_NEU_24H_X3	K22	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
4449	N06AX06	nefazodone	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	BRD-K90789829	CPC016_NEU_24H_X4_B7_DUO52HI53LO:K22	CPC016_NEU_24H_X4	K22	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC016_NEU_24H_X2_B7_DUO52HI53LO:C19	CPC016_NEU_24H_X2	C19	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC016_NEU_24H_X3_B7_DUO52HI53LO:C19	CPC016_NEU_24H_X3	C19	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
2377	N06AX08	bifemelane	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2	CNCCCCOc1ccccc1Cc1ccccc1	BRD-K18779551	CPC016_NEU_24H_X4_B7_DUO52HI53LO:C19	CPC016_NEU_24H_X4	C19	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC016_NEU_24H_X2_B7_DUO52HI53LO:H06	CPC016_NEU_24H_X2	H06	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC016_NEU_24H_X3_B7_DUO52HI53LO:H06	CPC016_NEU_24H_X3	H06	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
4205	N06AX11	mirtazapine	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	CN1CCN2c3ncccc3Cc3ccccc3C2C1	BRD-A64977602	CPC016_NEU_24H_X4_B7_DUO52HI53LO:H06	CPC016_NEU_24H_X4	H06	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-K32814891	NMH001_NEU_24H_X1.L2_B6_DUO52HI53LO:N11	NMH001_NEU_24H_X1.L2	N11	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-K32814891	NMH001_NEU_24H_X2.L2_B6_DUO52HI53LO:N11	NMH001_NEU_24H_X2.L2	N11	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-K32814891	NMH001_NEU_24H_X3.L2_B6_DUO52HI53LO:N11	NMH001_NEU_24H_X3.L2	N11	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-K32814891	NMH001_NEU_6H_X1_B6_DUO52HI53LO:N11	NMH001_NEU_6H_X1	N11	trt_cp	10.0	um	6	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-K32814891	NMH001_NEU_6H_X2_B6_DUO52HI53LO:N11	NMH001_NEU_6H_X2	N11	trt_cp	10.0	um	6	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-K32814891	NMH001_NEU_6H_X3.L2_B6_DUO52HI53LO:N11	NMH001_NEU_6H_X3.L2	N11	trt_cp	10.0	um	6	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-K32814891	NMH001_NEU_6H_X3_B6_DUO52HI53LO:N11	NMH001_NEU_6H_X3	N11	trt_cp	10.0	um	6	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	NMH001_FIBRNPC_24H_X1_B6_DUO52HI53LO:G06	NMH001_FIBRNPC_24H_X1	G06	trt_cp	10.0	um	24	h	FIBRNPC	iPSC	FIBRNPC	-666	-666	normal	skin	-666	adherent	-666	-666	-666	-666	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	NMH001_FIBRNPC_24H_X3_B6_DUO52HI53LO:G06	NMH001_FIBRNPC_24H_X3	G06	trt_cp	10.0	um	24	h	FIBRNPC	iPSC	FIBRNPC	-666	-666	normal	skin	-666	adherent	-666	-666	-666	-666	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	NMH001_FIBRNPC_6H_X1_B6_DUO52HI53LO:G06	NMH001_FIBRNPC_6H_X1	G06	trt_cp	10.0	um	6	h	FIBRNPC	iPSC	FIBRNPC	-666	-666	normal	skin	-666	adherent	-666	-666	-666	-666	-666
3386	N06AB03	fluoxetine	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	BRD-A31159102	NMH001_FIBRNPC_6H_X2.L2_B6_DUO52HI53LO:G06	NMH001_FIBRNPC_6H_X2.L2	G06	trt_cp	10.0	um	6	h	FIBRNPC	iPSC	FIBRNPC	-666	-666	normal	skin	-666	adherent	-666	-666	-666	-666	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K47029922	NMH001_FIBRNPC_24H_X1_B6_DUO52HI53LO:P04	NMH001_FIBRNPC_24H_X1	P04	trt_cp	10.0	um	24	h	FIBRNPC	iPSC	FIBRNPC	-666	-666	normal	skin	-666	adherent	-666	-666	-666	-666	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K47029922	NMH001_FIBRNPC_24H_X3_B6_DUO52HI53LO:P04	NMH001_FIBRNPC_24H_X3	P04	trt_cp	10.0	um	24	h	FIBRNPC	iPSC	FIBRNPC	-666	-666	normal	skin	-666	adherent	-666	-666	-666	-666	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K47029922	NMH001_FIBRNPC_6H_X1_B6_DUO52HI53LO:P04	NMH001_FIBRNPC_6H_X1	P04	trt_cp	10.0	um	6	h	FIBRNPC	iPSC	FIBRNPC	-666	-666	normal	skin	-666	adherent	-666	-666	-666	-666	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K47029922	NMH001_FIBRNPC_6H_X2.L2_B6_DUO52HI53LO:P04	NMH001_FIBRNPC_6H_X2.L2	P04	trt_cp	10.0	um	6	h	FIBRNPC	iPSC	FIBRNPC	-666	-666	normal	skin	-666	adherent	-666	-666	-666	-666	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K88809146	NMH002_FIBRNPC_24H_X1_B6_DUO52HI53LO:H08	NMH002_FIBRNPC_24H_X1	H08	trt_cp	10.0	um	24	h	FIBRNPC	iPSC	FIBRNPC	-666	-666	normal	skin	-666	adherent	-666	-666	-666	-666	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K88809146	NMH002_FIBRNPC_24H_X2_B6_DUO52HI53LO:H08	NMH002_FIBRNPC_24H_X2	H08	trt_cp	10.0	um	24	h	FIBRNPC	iPSC	FIBRNPC	-666	-666	normal	skin	-666	adherent	-666	-666	-666	-666	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K88809146	NMH002_FIBRNPC_24H_X3_B6_DUO52HI53LO:H08	NMH002_FIBRNPC_24H_X3	H08	trt_cp	10.0	um	24	h	FIBRNPC	iPSC	FIBRNPC	-666	-666	normal	skin	-666	adherent	-666	-666	-666	-666	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K88809146	NMH002_FIBRNPC_6H_X1_B6_DUO52HI53LO:H08	NMH002_FIBRNPC_6H_X1	H08	trt_cp	10.0	um	6	h	FIBRNPC	iPSC	FIBRNPC	-666	-666	normal	skin	-666	adherent	-666	-666	-666	-666	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K88809146	NMH002_FIBRNPC_6H_X2_B6_DUO52HI53LO:H08	NMH002_FIBRNPC_6H_X2	H08	trt_cp	10.0	um	6	h	FIBRNPC	iPSC	FIBRNPC	-666	-666	normal	skin	-666	adherent	-666	-666	-666	-666	-666
19493	N06AF04	tranylcypromine	C1C(C1N)C2=CC=CC=C2	NC1CC1c1ccccc1	BRD-K88809146	NMH002_FIBRNPC_6H_X3_B6_DUO52HI53LO:H08	NMH002_FIBRNPC_6H_X3	H08	trt_cp	10.0	um	6	h	FIBRNPC	iPSC	FIBRNPC	-666	-666	normal	skin	-666	adherent	-666	-666	-666	-666	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-K32814891	NMH001_FIBRNPC_6H_X1_B6_DUO52HI53LO:N11	NMH001_FIBRNPC_6H_X1	N11	trt_cp	10.0	um	6	h	FIBRNPC	iPSC	FIBRNPC	-666	-666	normal	skin	-666	adherent	-666	-666	-666	-666	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-K32814891	NMH001_FIBRNPC_24H_X1_B6_DUO52HI53LO:N11	NMH001_FIBRNPC_24H_X1	N11	trt_cp	10.0	um	24	h	FIBRNPC	iPSC	FIBRNPC	-666	-666	normal	skin	-666	adherent	-666	-666	-666	-666	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-K32814891	NMH001_FIBRNPC_24H_X3_B6_DUO52HI53LO:N11	NMH001_FIBRNPC_24H_X3	N11	trt_cp	10.0	um	24	h	FIBRNPC	iPSC	FIBRNPC	-666	-666	normal	skin	-666	adherent	-666	-666	-666	-666	-666
127151	N06AX18	reboxetine	CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	BRD-K32814891	NMH001_FIBRNPC_6H_X2.L2_B6_DUO52HI53LO:N11	NMH001_FIBRNPC_6H_X2.L2	N11	trt_cp	10.0	um	6	h	FIBRNPC	iPSC	FIBRNPC	-666	-666	normal	skin	-666	adherent	-666	-666	-666	-666	-666
